WorldWideScience

Sample records for acute herpes zoster

  1. Herpes zoster and diabetes.

    Science.gov (United States)

    Kalra, Sanjay; Chawla, Aastha

    2016-08-01

    This review is a succinct description of the relationship between herpes zoster and diabetes. It makes a strong case for screening for diabetes in all patients of herpes zoster, and for using insulin to achieve optimal glycaemic control in persons with concomitant diabetes and herpes zoster. It highlights potential impact of dipeptidyl peptidase 4 inhibitor therapy and statin usage on herpes zoster incidence.

  2. Typical case: herpes zoster

    Directory of Open Access Journals (Sweden)

    Guilherme Cristianini Baldivia

    2015-04-01

    Full Text Available Summary The varicella zoster virus is the causative agent of herpes zoster and varicella. In herpes zoster, the virus dormant within dorsal root ganglia is reactivated, resulting in painful vesicular lesions overlying an erythematous base.

  3. Herpes Zoster Oticus

    Science.gov (United States)

    ... Page You are here Home » Disorders » All Disorders Herpes Zoster Oticus Information Page Herpes Zoster Oticus Information Page What research is being ... neurotropic viruses and development of neurological diseases including herpes simplex and varicella-zoster viruses. × What research is ...

  4. Pulsed Radiofrequency to the Dorsal Root Ganglion in Acute Herpes Zoster and Postherpetic Neuralgia.

    Science.gov (United States)

    Kim, Koohyun; Jo, Daehyun; Kim, EungDon

    2017-03-01

    Latent varicella zoster virus reactivates mainly in sensory ganglia such as the dorsal root ganglion (DRG) or trigeminal ganglion. The DRG contains many receptor channels and is an important region for pain signal transduction. Sustained abnormal electrical activity to the spinal cord via the DRG in acute herpes zoster can result in neuropathic conditions such as postherpetic neuralgia (PHN). Although the efficacy of pulsed radiofrequency (PRF) application to the DRG in various pain conditions has been previously reported, the application of PRF to the DRG in patients with herpes zoster has not yet been studied. The aim of the present study was to compare the clinical effects of PRF to the DRG in patients with herpes zoster to those of PRF to the DRG in patients with PHN. Retrospective comparative study. University hospital pain center in Korea. The medical records of 58 patients who underwent PRF to the DRG due to zoster related pain (herpes zoster or PHN) were retrospectively analyzed. Patients were divided into 2 groups according to the timing of PRF after zoster onset: an early PRF group (within 90 days) and a PHN PRF group (more than 90 days). The efficacy of PRF was assessed by a numeric rating scale (NRS) and by recording patient medication doses before PRF and at one week, 4 weeks, 8 weeks, and 12 weeks after PRF. Pain intensity was decreased after PRF in all participants. However, the degree of pain reduction was significantly higher in the early PRF group. Moreover, more patients discontinued their medication in the early PRF group, and the PRF success rate was also higher in the early PRF group. The relatively small sample size from a single center, short duration of review of medical records, and the retrospective nature of the study. PRF to the DRG is a useful treatment for treatment-resistant cases of herpes zoster and PHN. Particularly in herpes zoster patients with intractable pain, application of PRF to the DRG should be considered for pain control

  5. Herpes Zoster Ophthalmicus.

    Science.gov (United States)

    Johnson, Julie L; Amzat, Rianot; Martin, Nicolle

    2015-09-01

    Herpes zoster is a commonly encountered disorder. It is estimated that there are approximately 1 million new cases of herpes zoster in the United States annually, with an incidence of 3.2 per 1000 person-years. Patients with HIV have the greatest risk of developing herpes zoster ophthalmicus compared with the general population. Other risk factors include advancing age, use of immunosuppressive medications, and primary infection in infancy or in utero. Vaccination against the virus is a primary prevention modality. Primary treatments include antivirals, analgesics, and anticonvulsants. Management may require surgical intervention and comanagement with pain specialists, psychiatrists, and infectious disease specialists. Copyright © 2015 Elsevier Inc. All rights reserved.

  6. The Uncommon Localization of Herpes Zoster

    OpenAIRE

    Cukic, Vesna

    2016-01-01

    Introduction: Herpes zoster is an acute, cutaneous viral infection caused by the reactivation of varicella-zoster virus (VZV) that is the cause of varicella. It is an acute neurological disease which can often lead to serious postherpetic neuralgia (PHN). Different nerves can be included with the skin rash in the area of its enervation especially cranial nerves (CV) and intercostal nerves. Case report: In this report we present a patient with herpes zoster which involved ulnar nerve with skin...

  7. Herpes zoster infection

    Directory of Open Access Journals (Sweden)

    Mohit Bansal

    2012-01-01

    Full Text Available Herpes zoster (HZ or ′shingles′ results from reactivation of the varicella-zoster virus (VZV. Developmental anomalies, osteonecrosis of jaw bones, and facial scarring are the other complications associated with it. Primary VZV infections in sero-negative individuals are known as varicella or chicken pox. Secondary or reactivated disease is known as shingles or herpes zoster. Early diagnosis and prompt treatment of the disease in the prodromal phase by the use of antiviral agents should be the mainstay of its management. This paper presents a case report of such an infection and its management.

  8. Herpes zoster (shingles) disseminated (image)

    Science.gov (United States)

    Herpes zoster (shingles) normally occurs in a limited area that follows a dermatome (see the "dermatome" picture). In individuals with damaged immune systems, herpes zoster may be widespread (disseminated), causing serious illness. ...

  9. Acute pancreatitis associated with herpes zoster: case report and literature review.

    Science.gov (United States)

    Wang, Zhen; Ye, Jun; Han, Yue-Hua

    2014-12-21

    Varicella-zoster virus (VZV) is a type of herpes virus known to cause varicella, mainly in young children, and herpes zoster in adults. Although generally non-lethal, VZV infection can be associated with serious complications, particularly in adults. Acute pancreatitis caused by VZV infection is a rare event, with reports primarily concerning immunocompromised individuals. Here we report a 44-year-old immunocompetent female who developed acute pancreatitis associated with VZV infection. The patient presented with vomiting and persistent pain in the upper quadrant less than one week after diagnosis and treatment for a herpes zoster-related rash with stabbing pain on the abdomen and dorsal right trunk side. A diagnosis of acute pancreatitis was confirmed based on abdominal pain, elevated levels of urine and serum amylase, and findings of peri-pancreatic exudation and effusions by computed tomography and magnetic resonance cholangiopancreatography. This case highlights that, though rare, acute pancreatitis should be considered in VZV patients who complain of abdominal pain, especially in the epigastric area. Early detection and proper treatment are needed to prevent the condition from deteriorating further and to minimize mortality.

  10. Herpes zoster - typical and atypical presentations.

    Science.gov (United States)

    Dayan, Roy Rafael; Peleg, Roni

    2017-08-01

    Varicella- zoster virus infection is an intriguing medical entity that involves many medical specialties including infectious diseases, immunology, dermatology, and neurology. It can affect patients from early childhood to old age. Its treatment requires expertise in pain management and psychological support. While varicella is caused by acute viremia, herpes zoster occurs after the dormant viral infection, involving the cranial nerve or sensory root ganglia, is re-activated and spreads orthodromically from the ganglion, via the sensory nerve root, to the innervated target tissue (skin, cornea, auditory canal, etc.). Typically, a single dermatome is involved, although two or three adjacent dermatomes may be affected. The lesions usually do not cross the midline. Herpes zoster can also present with unique or atypical clinical manifestations, such as glioma, zoster sine herpete and bilateral herpes zoster, which can be a challenging diagnosis even for experienced physicians. We discuss the epidemiology, pathophysiology, diagnosis and management of Herpes Zoster, typical and atypical presentations.

  11. High Risk of Herpes Zoster among Patients with Advance Acute Kidney Injury--A Population-Based Study.

    Science.gov (United States)

    Yang, Wei-Shun; Hu, Fu-Chang; Chen, Meng-Kan; Ko, Wen-Je; Chen, Likwang; Wu, Kwan-Dun; Wu, Vin-Cent

    2015-09-03

    The risk for herpes zoster (HZ) in acute kidney injury (AKI) survivors was never explored. We identified 2,387 adults in the Taiwan National Health Insurance Research Database who recovered from dialysis-requiring AKI and matched them with non-recovery and non-AKI patients by propensity score. During a mean follow-up of 2.7 years, the incidences of HZ were 6.9, 8.2 and 4.8 episodes per 1,000 person-years in AKI-non-recovery, AKI-recovery and non-AKI group, respectively. The recovery group was more likely to develop herpes zoster than those without acute kidney injury [incidence-rate ratios 1.71, 95% confidence interval 1.16-2.52; p = 0.007]. Patients without acute kidney injury were less likely to develop herpes zoster than those AKI, recovered from dialysis or not (hazard ratio HR 0.66, 95% CI 0.46-0.95). Dialysis-requiring acute kidney injury poses a long-term risk of herpes zoster after hospital discharge. Even patients who have recovered from dialysis still carry a significantly higher risk of developing herpes zoster.

  12. Atypical presentation of herpes zoster in a case with acute myeloblastic leukemia

    Institute of Scientific and Technical Information of China (English)

    Fesih Aktar; Sinan Akbayram; Necmettin Akdeniz; Sirac Aktar; Cihangir Akgn; Murat Doan; Hseyin aksen; Ahmet Faik Oner

    2013-01-01

    Herpes zoster (HZ) is often associated with painful erythematous vesicular eruptions of the skin or mucous membranes. Approximately 10% to 30% of the population will suffer from HZ during their lifetime. HZ is infrequent in healthy children. However, diminished cellular immunity seems to increase risk of reactivation because incidence increases with age and in immunocompromised states. We report a 7-year-old girl with acute myeloblastic leukemia HZ infection on the right palmar, elbow and forearm region (C7, C8 and T1 dermatomes). We want to indicate unusual localization of HZ on the acute myeloblastic leukemia child patient.

  13. The Uncommon Localization of Herpes Zoster

    Science.gov (United States)

    Cukic, Vesna

    2016-01-01

    Introduction: Herpes zoster is an acute, cutaneous viral infection caused by the reactivation of varicella-zoster virus (VZV) that is the cause of varicella. It is an acute neurological disease which can often lead to serious postherpetic neuralgia (PHN). Different nerves can be included with the skin rash in the area of its enervation especially cranial nerves (CV) and intercostal nerves. Case report: In this report we present a patient with herpes zoster which involved ulnar nerve with skin rash in the region of ulnar innervations in women with no disease previously diagnosed. The failure of her immune system may be explained by great emotional stress and overwork she had been exposed to with neglecting proper nutrition in that period. Conclusion: Herpes zoster may involve any nerve with characteristic skin rash in the area of its innervations, and failure in immune system which leads reactivation of VZV may be caused by other factors besides the underlying illness. PMID:26980938

  14. Herpes Zoster Vaccination: Controversies and Common Clinical Questions.

    Science.gov (United States)

    Van Epps, Puja; Schmader, Kenneth E; Canaday, David H

    2016-01-01

    Herpes zoster, clinically referred to as shingles, is an acute, cutaneous viral infection caused by reactivation of the varicella zoster virus, the same virus that causes chickenpox. The incidence of herpes zoster and its complications increase with decline in cell-mediated immunity, including age-associated decline. The most effective management strategy for herpes zoster is prevention of the disease through vaccination in those who are most vulnerable. Despite the demonstrated efficacy in reducing the incidence and severity of herpes zoster, the uptake of vaccine remains low. Here, we will discuss the controversies that surround the live herpes zoster vaccine and address the common clinical questions that arise. We will also discuss the new adjuvanted herpes zoster vaccine currently under investigation.

  15. The Effects of 830 nm Light-Emitting Diode Therapy on Acute Herpes Zoster Ophthalmicus: A Pilot Study

    Science.gov (United States)

    Park, Kui Young; Han, Tae Young; Kim, In Su; Yeo, In Kwon; Kim, Myeung Nam

    2013-01-01

    Background Skin lesions and pain are the most distinctive features of herpes zoster. Light-emitting diode (LED) therapy is an effective treatment known for its wound-healing effects. Objective To determine whether the LED treatment affects wound healing and acute pain in acute herpes zoster ophthalmicus. Methods We recruited 28 consecutive Korean patients with acute herpes zoster ophthalmicus for the study. In the control group (group A), 14 subjects received oral famcyclovir. In the experimental group (group B), 14 subjects received oral famcyclovir and 830 nm LED phototherapy on days 0, 4, 7, and 10. In order to estimate the time for wound healing, we measured the duration from the vesicle formation to when the lesion crust fell off. The visual analogue scale (VAS) was used for the estimation of pain on days 4, 7, 10, and 14. Results The mean time required for wound healing was 13.14±2.34 days in group B and 15.92±2.55 days in group A (p=0.006). From day 4, the mean VAS score showed a greater improvement in group B, compared with group A. A marginal but not statistically significant difference in the VAS scores was observed between the two groups (p=0.095). Conclusion LED treatment for acute herpes zoster ophthalmicus leads to faster wound healing and a lower pain score. PMID:23717006

  16. Transient Receptor Potential Vanilloid-1 in Epidermal Keratinocytes May Contribute to Acute Pain in Herpes Zoster.

    Science.gov (United States)

    Han, Sang Bum; Kim, Hyeree; Cho, Sang Hyun; Lee, Jeong Deuk; Chung, Jin Ho; Kim, Hei Sung

    2016-03-01

    The role of transient receptor potential vanilloid-1 (TRPV1) in the initiation of neurogenic inflammation and transduction of pain is well established. In this study 33 patients with herpes zoster (HZ) were recruited from a single centre and underwent a questionnaire interview at their first visit. Punch biopsies from the HZ lesions and the contralateral unaffected skin were performed to localize and quantify the expression of TRPV1. Immunofluorescent staining for TRPV1 was most prominent in the epidermal keratinocytes. Both TRPV1 mRNA and protein levels were significantly higher in the HZ epidermis than in control epidermis (relative ratio 1.62 ± 0.27, p = 0.033 and 2.55 ± 0.51, p = 0.005, respectively). Protein TRPV1 ratio (HZ lesion/control) correlated with the degree of pain (measured on a visual analogue scale; VAS) (p = 0.017) and was significantly lower in patients who had taken either HZ medication or painkillers prior to their visit. These results suggest that non-neuronal TRPV1 may contribute to acute pain in herpes zoster.

  17. Efficacy of low dose gabapentin in acute herpes zoster for preventing postherpetic neuralgia: a prospective controlled study.

    Science.gov (United States)

    Lee, Eo G; Lee, Hee J; Hyun, Dong J; Min, Kyunghoon; Kim, Dong H; Yoon, Moon S

    2016-05-01

    Postherpetic neuralgia (PHN) is a sequela of herpes zoster that adversely affects quality of life seriously. The risk factors for PHN are well known but the effective interventions that reduce the incidence of PHN are less studied. The objective of this study is to evaluate the efficacy of treatment with gabapentin in patients with acute herpes zoster for preventing PHN. We performed a prospective randomized controlled study of 120 participants diagnosed with acute herpes zoster, aged 50 and over and complaining moderate to severe pain. All patients were treated with valacyclovir and acetaminophen. Half of the participants were assigned to the gabapentin group and received gabapentin 300 mg three times a day additionally. The intensity of pain at every visit and the incidence of PHN in both groups were measured. Total 52 and 49 patients in the gabapentin group and the control group, respectively, had completed 12 weeks of follow-up period. Although the incidence of PHN was higher in the control group, the difference was not statistically significant (6.1% vs. 3.8%, p = 0.67). Our results indicate that the use of low-dose gabapentin in acute herpes zoster seems not effective in the prevention of PHN.

  18. [Herpes zoster and postherpetic neuralgia].

    Science.gov (United States)

    Wollina, U; Machetanz, J

    2016-08-01

    Herpes zoster develops by endogenous reactivation of varizella zoster virus (VZV). Incidence increases with age. Females are more frequently affected than males. The reactivation rate in seropositive individuals is about 20 %. After a short prodromal stage, herpetiform-grouped vesicles appear in segmental arrangement. Pain and paresthesia are typical zoster symptoms. Complications like bacterial superinfections, vasculopathy, paresis, and oculopathy may occur. During pregnancy herpes zoster is a threat for mother and child. Among elderly patients, cardiovascular risk is increased during the first week of herpes zoster infection. Postherpetic neuropathy is feared. Diagnosis can be made clinically and by the use of polymerase chain reaction. First-line treatment is systemic antiviral drug therapy with either acyclovir or brivudine. Adjuvant therapies consist of pain management and topical treatment.

  19. Ramsay hunt syndrome (herpes zoster oticus

    Directory of Open Access Journals (Sweden)

    S Karthiga Kannan

    2012-01-01

    Full Text Available Ramsay Hunt syndrome (RHS is defined as an acute peripheral facial neuropathy caused by the reactivated latent varicella zoster virus (VZV in the geniculate ganglion; characterized with erythematous vesicular rash of the skin of the ear canal, auricle, facial skin, oral mucosa and facial palsy (also known as herpes zoster oticus. This article reports a case of Ramsay Hunt Syndrome (RHS in a 37-year-old male patient depicting the classical signs.

  20. Clinical characteristics of headache or facial pain prior to the development of acute herpes zoster of the head.

    Science.gov (United States)

    Lee, Hye Lim; Yeo, Minju; Choi, Gi Hwa; Lee, Ji Yeoun; Kim, Ji Seon; Shin, Dong-Ick; Lee, Sang-Soo; Lee, Sung-Hyun

    2017-01-01

    When physicians encounter patients with headache or facial pain (preeruptive pain) associated with acute herpes zoster of the head, especially before the appearance of characteristic skin eruptions (preeruptive phase), they typically find it difficult to make clinical impressions and apply appropriate diagnostic or therapeutic procedures. The objectives of this study were to describe the clinical characteristics of headache or facial pain associated with acute herpes zoster of the head and to elucidate the association between the manifestation of these symptoms in the preeruptive phase and incoming herpes zoster. We retrospectively analyzed the clinical features of 152 patients with acute herpes zoster involving only the head who presented within 10days of rash onset at Chungbuk National University Hospital, a tertiary hospital in Chungcheongbuk-do in South Korea, between January 2011 and December 2015. The mean age of the patients was 54.3±19.8years. One hundred patients had herpes zoster in the trigeminal nerve, 34 in the nervus intermedius, and 18 in the upper cervical nerves. Preeruptive pain was present in 112 (73.7%) patients and had a mean duration of 3.0±1.3days (range, 1-6days). Severity of pain was associated with the presence of preeruptive pain (p=0.040). Headache or facial pain was limited to the ipsilateral side of the face and head in all patients, except for two who had with severe symptoms of meningitis, and was of moderate to severe intensity (90.1%). Pain of a stabbing nature was observed in 128 (84.2%) patients, and 146 (96.1%) reported experiencing this type of pain for the first time. Pain awakened 94 (61.8%) patients from sleep. Sixty-one (54.5%) of the 112 patients with preeruptive pain visited a hospital during the preeruptive phase; their preeruptive phase was significantly longer (pherpes zoster (n=5, 8.2%); migraine (n=3, 4.9%); pain associated with upper respiratory tract infection (n=3, 4.9%); parotitis (n=2, 3.3%); dry eye (n=2, 3

  1. Herpes zoster: A clinicocytopathological insight

    Directory of Open Access Journals (Sweden)

    Snehal Shah

    2016-01-01

    Full Text Available Herpes zoster or shingles is reactivation of the varicella zoster virus that had entered the cutaneous nerve endings during an earlier episode of chicken pox traveled to the dorsal root ganglia and remained in a latent form. This condition is characterized by occurrence of multiple, painful, unilateral vesicles and ulceration which shows a typical single dermatome involvement. In this case report, we present a patient with herpes zoster involving the mandibular division of the trigeminal nerve, with unilateral vesicles over the right side of lower third of face along the trigeminal nerve tract, with intraoral involvement of buccal mucosa, labial mucosa and the tongue of the same side. Cytopathology revealed classic features of herpes infection including inclusion bodies, perinuclear halo and multinucleated cells.

  2. Acupuncture in acute herpes zoster pain therapy (ACUZoster – design and protocol of a randomised controlled trial

    Directory of Open Access Journals (Sweden)

    Pfab Florian

    2009-08-01

    Full Text Available Abstract Background Acute herpes zoster is a prevalent condition. One of its major symptoms is pain, which can highly influence patient's quality of life. Pain therapy is limited. Acupuncture is supposed to soften neuropathic pain conditions and might therefore act as a therapeutic alternative. Objective of the present study is to investigate whether a 4 week semi-standardised acupuncture is non-inferior to sham laser acupuncture and the anticonvulsive drug gabapentine in the treatment of pain associated with herpes zoster. Methods/Design Three-armed, randomised, placebo-controlled trial with a total follow-up time of 6 months. Up to estimated 336 patients (interim analyses with acute herpes zoster pain (VAS > 30 mm will be randomised to one of three groups (a semi-standardised acupuncture (168 patients; (b gabapentine with individualised dosage between 900–3600 mg/d (84 patients; (c sham laser acupuncture. Intervention takes place over 4 weeks, all patients will receive analgesic therapy (non-opioid analgesics: metamizol or paracetamol and opioids: tramadol or morphine. Therapy phase includes 4 weeks in which group (a and (c consist of 12 sessions per patient, (b visits depend on patients needs. Main outcome measure is to assess the alteration of pain intensity before and 1 week after treatment sessions (visual analogue scale VAS 0–100 mm. Secondary outcome measure are: alteration of pain intensity and frequency of pain attacks; alteration of different aspects of pain evaluated by standardised pain questionnaires (NPI, PDI, SES; effects on quality of life (SF 36; analgesic demand; alteration of sensoric perception by systematic quantitative sensory testing (QST; incidence of postherpetic neuralgia; side effects and cost effectiveness. Credibility of treatments will be assessed. Discussion This study is the first large-scale randomised placebo controlled trial to evaluate the efficacy of acupuncture compared to gabapentine and sham treatment

  3. Correlation of serum inflammatory cytokine and immunoglobulin content with post-herpetic neuralgia in patients with acute herpes zoster

    Institute of Scientific and Technical Information of China (English)

    Hai-Jun Shi; Zhi-Qiang Cui

    2017-01-01

    Objective:To study the correlation of serum inflammatory cytokine and immunoglobulin content with post-herpetic neuralgia in patients with acute herpes zoster.Methods:Patients diagnosed with herpes zoster in our hospital between May 2012 and October 2015 were selected and divided into herpes zoster-post-herpetic neuralgia group (VZV-PHN group) and herpes zoster-control group (VZV-Con group) according to the incidence of post-herpetic neuralgia (PHN); healthy volunteers receiving physical examination in our hospital during the same period were selected as normal control group (Con group).Results: Serumβ-EP, NT, IFN-γ and IL-2 levels of VZV-PHN group and VZV-Con group were significantly lower than those of Con group (P<0.05), while SP, VGF, CGRP, IL-4, IL-6, IL-17, IL-21, TNF-α, IL-10, TGF-β1, IgG, IgM and IgA levels were significantly higher than those of Con group (P<0.05); serumβ-EP, NT, IFN-γ, IL-2, IgG, IgM and IgA levels of VZV-PHN group were significantly lower than those of VZV-Con group (P<0.05) while SP, VGF, CGRP, IL-4, IL-6, IL-17, IL-21, TNF-α, IL-10 and TGF-β1 levels were significantly higher than those of VZV-Con group (P<0.05);β-EP and NT were positively correlated with IFN-γ, IL-2, IgG, IgM and IgA, and negatively correlated with IL-4, IL-6, IL-17, IL-21, TNF-α, IL-10 and TGF-β1; SP, VGF and CGRP were negatively correlated with IFN-γ, IL-2, IgG, IgM and IgA, and positively correlated with IL-4, IL-6, IL-17, IL-21, TNF-α, IL-10 and TGF-β1.Conclusions:Abnormal secretion of inflammatory cytokines and immunoglobulin caused by humoral immune and cellular immune response disorder is associated with the occurrence of post-herpetic neuralgia in patients with acute herpes zoster.

  4. Acute Cardiovascular Events after Herpes Zoster: A Self-Controlled Case Series Analysis in Vaccinated and Unvaccinated Older Residents of the United States.

    Directory of Open Access Journals (Sweden)

    Caroline Minassian

    2015-12-01

    Full Text Available Herpes zoster is common and can have serious consequences. Additionally, emerging data suggest an increased risk of acute cardiovascular events following herpes zoster. However, to our knowledge, existing association studies compare outcomes between individuals and are therefore vulnerable to between-person confounding. In this study, we used a within-person study design to quantify any short-term increased risk of acute cardiovascular events (stroke and myocardial infarction [MI] after zoster and to assess whether zoster vaccination modifies this association.The self-controlled case series method was used to estimate rates of stroke and acute MI in defined periods after herpes zoster compared to other time periods, within individuals. Participants were fully eligible Medicare beneficiaries aged ≥ 65 y with a herpes zoster diagnosis and either an ischemic stroke (n = 42,954 or MI (n = 24,237 between 1 January 2006 and 31 December 2011. Age-adjusted incidence ratios (IRs for stroke and MI during predefined periods up to 12 mo after zoster relative to unexposed time periods were calculated using conditional Poisson regression. We observed a marked increase in the rate of acute cardiovascular events in the first week after zoster diagnosis: a 2.4-fold increased ischemic stroke rate (IR 2.37, 95% CI 2.17-2.59 and a 1.7-fold increased MI rate (IR 1.68, 95% CI 1.47-1.92, followed by a gradual resolution over 6 mo. Zoster vaccination did not appear to modify the association with MI (interaction p-value = 0.44. We also found no evidence for a difference in the IR for ischemic stroke between vaccinated (IR 1.14, 95% CI 0.75-1.74 and unvaccinated (IR 1.78, 95% CI 1.68-1.88 individuals during the first 4 wk after zoster diagnosis (interaction p-value = 0.28. The relatively few vaccinated individuals limited the study's power to assess the role of vaccination.Stroke and MI rates are transiently increased after exposure to herpes zoster. We found no

  5. HPV and Herpes Zoster Vaccines

    Directory of Open Access Journals (Sweden)

    Özlem Karabudak

    2008-12-01

    Full Text Available Genital warts and Herpes Zoster are relatively frequent encountered diseases in dermatology practice. Cervical cancers are also caused by some spesific types of human papillomaviruses. The purpose of this review is to give some knowledge about the vaccines which were developed for these diseases. (Turkderm 2008; 42: 108-12

  6. An updated approach to treating and preventing herpes zoster.

    Science.gov (United States)

    Garrubba, Carl; Donkers, Kelly

    2013-12-01

    Varicella zoster virus (VZV) causes chickenpox and herpes zoster. Herpes zoster is a common infection in older adults and can lead to potentially debilitating postherpetic neuralgia. This article reviews the diagnosis and management of herpes zoster, including strategies to reduce disease frequency and severity with the herpes zoster vaccine.

  7. Report of a child with acute herpes zoster ophthalmicus induced partial third nerve palsy

    Institute of Scientific and Technical Information of China (English)

    Suraida AR; Evelyn-Tai LM; Madhusudhan; LK Thavaratnam; Mohtar Ibrahim; Wan Hazabbah WH

    2015-01-01

    Herpes zoster is a reactivation of the varicella zoster virus (VZV), which may remain dormant in the dorsal root ganglion of the trigeminal nerve for decades after the patient's initial exposure. The ophthalmic branch of the trigeminal nerve, i.e., the innervation to the ocular structures, is one of the most commonly involved dermatomes, giving rise to herpes zoster ophthalmicus (HZO). A 10-year-old indigenous Malaysian girl presented with a complaint of painful blurring of vision in the right eye for one week. It was followed a few days later by cutaneous vesicular eruptions over the right side of her face and nose and drooping of the right upper lid, associated with double vision. In children, the disease usually follows a mild course, resolving without residual damage. However, this child achieved a best corrected visual acuity of only 6/36 in the affected eye due to corneal scarring. The rashes healed by formation of disfiguring keloids over the right nasal area. This is another rarely reported complication of HZO in immunocompetent individuals.

  8. Herpes zoster oticus: A rare clinical entity

    Directory of Open Access Journals (Sweden)

    Shailesh Gondivkar

    2010-01-01

    Full Text Available Herpes zoster oticus also known as Ramsay Hunt syndrome is a rare complication of herpes zoster in which reactivation of latent varicella zoster virus infection in the geniculate ganglion causes otalgia, auricular vesicles, and peripheral facial paralysis. Ramsay Hunt syndrome is rare in children and affects both sexes equally. Incidence and clinical severity increases when host immunity is compromised. Because these symptoms do not always present at the onset, this syndrome can be misdiagnosed. Although secondary to Bell′s palsy in terms of the cause of acute atraumatic peripheral facial paralysis, Ramsay Hunt syndrome, with incidence ranged from 0.3 to 18%, has a worse prognosis. Herpes zoster oticus accounts for about 12% cases of facial palsy, which is usually unilateral and complete and full recovery occurs in only about 20% of untreated patients. The most advisable method to treat Ramsay Hunt syndrome is the combination therapy with acyclovir and prednisone but still not promising, and several prerequisites are required for better results. We present a case of 32-year-old man suffering from Ramsay Hunt syndrome with grade V facial palsy treated effectively with rehabilitation program, after the termination of the combination therapy of acyclovir and prednisone.

  9. Herpes Zoster Ophthalmicus Presenting as Acute Orbital Myositis Preceding a Skin Rash: A Case Report

    Energy Technology Data Exchange (ETDEWEB)

    Oh, Ha Yeun; Cho, Seong Whi [Dept. of Radiology, Kangwon National University Hospital, Chuncheon (Korea, Republic of); Kim, Sung Hun [Dept. of Neurology, Kangwon National University Hospital, Chuncheon (Korea, Republic of)

    2012-03-15

    Herpes zoster ophthalmicus, in which orbital symptoms and signs appear before the onset of a skin rash, is very rare. We experienced such a case and therefore report on it via magnetic resonance imaging. A 48-year-old man with pain and swelling of left eye and headache presented 2 days before onset of a zoster skin rash. On orbit-al MRI, edematous thickening of the left lateral rectus muscle with high signal intensity was revealed. After contrast injection, the lateral rectus muscle demonstrated heterogenous enhancement. Also, diffuse contrast enhancement was noted at left preseptal space, lacrimal gland and periorbital soft tissue. The man was treated with antiviral agents and prednisolone. Two weeks later, he recovered from the skin manifestations and most of the orbital manifestations except for the diplopia and restricted lateral movement.

  10. Immunity and the burden of herpes zoster.

    Science.gov (United States)

    Choi, Won Suk; Kwon, Soon Sun; Lee, Jacob; Choi, Su-Mi; Lee, Jin Soo; Eom, Joong Sik; Sohn, Jang Wook; Choeng, Hee Jin

    2014-03-01

    The burden of herpes zoster may be related to patients' immunity, although this has not been studied extensively. This hypothesis was tested in a matched case-control study of patients with herpes zoster who sought treatment at one of seven university hospitals in Korea from January 1, 2007, to December 31, 2010. Patients diagnosed with herpes zoster were placed into three groups based on their immune status: severely immunocompromised, mild-to-moderately immunocompromised, and normal immunity. Each patient in the severely immunocompromised group was matched with one patient in the mild-to-moderately immunocompromised group and one patient in the normal immunity group in the same hospital based on age, sex, and date of herpes zoster onset. A total of 582 patients with herpes zoster were included in the analysis: 194 in each of the three groups. Patients in the severely immunocompromised group had the highest herpes zoster-related hospitalization rate as compared to patients in the mild-to-moderately immunocompromised and normal immune groups (P herpes zoster-related medical cost increased significantly with the deterioration of patients' immunity (P herpes zoster burden was observed as the patients' immunity decreased. Therefore, effective measures are necessary to prevent herpes zoster and reduce its burden in severely immunocompromised patients.

  11. Herpes zoster post-herpetic neuralgia.

    Science.gov (United States)

    Feller, L; Jadwat, Y; Bouckaert, M

    2005-11-01

    Post-herpetic neuralgia (PHN) is the most frequent complication of herpes zoster and often results in significant morbidity and a reduction in the patient's quality of life. The peripheral nerve injury that occurs during the acute phase of herpes zoster (HZ) leads to an abnormal tonic impulse discharge from primary nociceptive afferent neurons which induce slow temporal summation. This "wind-up" phenomenon is responsible for continuous partial depolarisation of second-order neurons with increased spontaneous impulse discharge and expanded receptive fields within the dorsal horn nociceptive neurons. The abnormal central processing involves the activation of N-methyl-D-aspartate (NMDA) receptors resulting in neuropathic pain, characterized by spontaneous pain, hyperalgesia and allodynia which is typical of PHN. In addition, tonic input from non-nociceptive AB afferent neurons, maintained by sympathetic efferent activity, contribute to the development and maintenance of neuropathic pain in general, and a burning sensation in particular.

  12. Herpes Zoster Ophthalmicus in HIV/AIDS

    Directory of Open Access Journals (Sweden)

    Boateng Wiafe MD MSc

    2003-01-01

    Full Text Available Herpes zoster is a common infection caused by the human herpes virus 3, the same virus that causes chickenpox. It is a member of herpes viridae, the same family as the herpes simplex virus, Epstein- Barr virus, and cytomegalovirus. Herpes zoster ophthalmicus occurs when a latent varicella zoster virus in the trigeminal ganglia involving the ophthalmic division of the nerve is reactivated. Of the three divisions of the fifth cranial nerve, the ophthalmic is involved 20 times more frequently than the other divisions.

  13. Polyneuritis cranialis following herpes zoster

    Directory of Open Access Journals (Sweden)

    Radhakrishna H

    2000-01-01

    Full Text Available Herpes zoster is a common clinical condition involving cranial nerves. We encountered 3 cases in which multiple cranial nerves were involved besides the commoner ones. All the three cases were treated with acyclovir and oral steroids. Recovery of motor function was only partial in all three cases when reviewed 2 months after discharge. The clinical details and a brief review of literature are presented.

  14. Rare Occurrence of Herpes Zoster of Trigeminal Nerve following Extraction of Tooth

    Directory of Open Access Journals (Sweden)

    A. Winnifred Christy

    2015-01-01

    Full Text Available Herpes Zoster also known as Shingles is an acute viral infection which is an extremely painful and incapacitating ailment. It results from the reactivation of the varicella zoster virus. The triggering factors for the onset of an attack of Herpes Zoster include some form of immunosuppression. The diagnosis of Herpes Zoster can be made on proper medical history and a thorough clinical examination. Here is the report of a male patient affected by Herpes Zoster infection which followed after extraction of a lower first molar.

  15. [Preauricular injection of betamethasone depot and acyclovir for the treatment of acute herpes zoster ophthalmicus].

    Science.gov (United States)

    Arenas-Archila, E; Alvizu, F; Muñoz-Sarmiento, D

    2015-04-01

    Several treatments have been described for the management of patients with herpes zoster ophthalmicus (HZO). However, the progress of these patients is usually slow, and many of them develop postherpetic neuritis (PHN). In the present paper, three clinical cases are presented, in which a significant symptomatic improvement was obtained by using a preauricular injection of a mixture of betamethasone depot combined with acyclovir. PHN did not develop in any of them. The preauricular injection of betamethasone depot and acyclovir could be a good alternative for the management of HZO. Copyright © 2013 Sociedad Española de Oftalmología. Published by Elsevier España, S.L.U. All rights reserved.

  16. Herpes Zoster in Healthy Children: A Retrospective Study

    Directory of Open Access Journals (Sweden)

    Birgül Tepe

    2016-06-01

    Full Text Available Objective: Herpes zoster is an acute dermatomal viral infection caused by the reactivation of varicella zoster virus. While it is commonly seen among elderly and immunocompromised individuals, it is rare in healthy children. The aim of this study was to evaluate the clinical features, treatment and complications of healthy children with herpes zoster. Methods: Thirty one patients aged between 0-16 years who were admitted to our clinic with the diagnosis of herpes zoster, between January 2014 and December 2014, were evaluated retrospectively for age, gender, month of admission, complaint, history of chickenpox infection or varicella vaccination, triggering factors, dermatomal involvement, complications and treatment. Results: Among 31 patients with diagnosis of herpes zoster, 19 were boys (61.3% and 12 were girls (38.7%. The mean of age was 9.12±4.4 years. Twenty patients had thoracic (64.5%, six had lumbar (19.4% and five had cervical involvements (16.2%. The most frequent symptoms were pruritus and pain, respectively. Six patients were administered topical treatment and 25 patients were treated with both systemic and topical treatments. Complication was not observed. Conclusion: Herpes zoster is also being encountered increasingly in healthy children nowadays. It is benign and generally no complications are observed. Incidence can vary because of geographic and socioeconomic differences like vaccination programs.

  17. Acupuncture Treatment of Herpes Zoster

    Institute of Scientific and Technical Information of China (English)

    胡金生

    2001-01-01

    @@Case History Song××, a male middle school teacher aged 58 years, paid his first visit on August 7, 2000, with the chief complaint of pain in the left hypochondrium for 20 days. The patient stated that he suddenly got a sharp burning pain in the left hypochondrium in mid July. The pain gradually radiated to the upper abdominal area, meanwhile red herpes appeared in the hypochondriac region. He had been diagnosed as having herpes zoster, and treated in several nearby hospitals with fluid infusion and medication. As a result, the herpes partly disappeared. But the sharp burning pain still remained, which could not be relieved by administration of analgetics. The patient was then recommended by his friends for treatment here. The patient used to be in a anxious state of mind, and had a wiry pulse and disorder of the liver-qi. The patients had been disturbed by problems of his students and worried about his aged mother's illness, and had poor sleep. Physical examination showed that the patient had a slightly fat figure and sickly complexion, but was in a clear mind. His blood pressure was 140/90 mmHg, and heart rate 75 times/min. No abnormal signs were found in the heart and lungs. Prominent dark red herpes with obvious local tenderness was found on the skin surface of the left hypochondrium and upper abdome.

  18. Herpes zoster infection: Report of a treated case

    Directory of Open Access Journals (Sweden)

    Kotya Naik Maloth

    2015-01-01

    Full Text Available Herpes zoster (HZ is an acute infectious viral disease result from reactivation of the DNA varicella-zoster virus, which occurs more frequently among older adults and immunocompromised persons. The most common complication of HZ is postherpetic neuralgia, a chronic often debilitating pain condition that can last months or even years. Deaths attributable to zoster are common among immunocompromised persons. Prompt treatment with the antiviral drugs, corticosteroids and analgesics decrease the severity and duration of acute pain from HZ. Here, we report a treated case of HZ in 35-year-old male involving all three branches of the trigeminal nerve without any complication.

  19. A Case of Almost Painless Herpes Zoster Presenting with Symptoms of Cystitis, Penile Numbness, and Acute Vestibular Failure

    Directory of Open Access Journals (Sweden)

    Hussain Al-Sardar

    2013-01-01

    Full Text Available Herpes zoster (shingles is an acute, painful, vesicular, and cutaneous eruption caused by varicella zoster virus, the same virus which causes chicken pox. It is due to the reactivation of the virus which remains dormant in sensory ganglions following chicken pox. It is usually confined to a single dermatome but may involve 2-3 dermatomes. Typically, it is a unilateral lesion which can affect both cranial and peripheral nerves. It is usually a self-limiting disease; however, it may cause significant morbidity especially in the elderly. It is more common in older people and individuals with immunocompromised conditions. Antiviral drugs can shorten the duration and the severity of the illness and need to be started as soon as possible after the appearance of the rash. Gabapentin and tricyclic antidepressant are effective in postherpetic neuralgia. Vaccine can reduce the risk of infection and its associated pain. Typically, it occurs once in a lifetime, but some individuals may have more than one episode.

  20. Herpes Zoster Immunization in Older Adults Has Big Benefits.

    Science.gov (United States)

    Breivik, Harald

    2015-09-01

    A case of acute herpes zoster neuralgia (shingles) in a 78-year-old patient is described. The value and importance of immunizing against herpes zoster to decrease the incidence and severity of both acute herpes zoster neuralgia and postherpetic neuralgia are described. --This report is adapted from paineurope 2015: Issue 1, ©Haymarket Medical Publications Ltd., and is presented with permission. paineurope is provided as a service to pain management by Mundipharma International, Ltd., and is distributed free of charge to health care professionals in Europe. Archival issues can be viewed via the Web site: www.paineurope.com , at which health professionals can find links to the original articles and request copies of the quarterly publication and access additional pain education and pain management resources.

  1. Disseminated Herpes Zoster in Association with HIV

    Directory of Open Access Journals (Sweden)

    Kuchabal D

    2000-01-01

    Full Text Available HIV infected individuals are susceptible to a wide variety of skin manifestations due to profound defect in cell-mediated immunity. We describe 2 patients with Disseminated Herpes Zoster, both the patients has associated HIV infection.

  2. Herpes Zoster and Post-Herpetic Neuralgia

    NARCIS (Netherlands)

    van Wijck, Albert J. M.; Wallace, Mark; Mekhail, Nagy; van Kleef, Maarten

    2011-01-01

    Herpes zoster infection is caused by a reactivation of the latent varicella zoster virus that causes chicken pox. It appears predominantly in older adults whose immunity for the virus has waned. The natural course of the disease is usually favorable, and the symptoms disappear spontaneously within a

  3. Forebyggelse af herpes zoster med vaccination

    DEFF Research Database (Denmark)

    Kofoed, Kristian; Rønholt, Finn; Gerstoft, Jan

    2011-01-01

    Herpes zoster (HZ) and post-herpetic neuralgia (PHN) are frequently occurring diseases in elderly and in immuno-compromised persons. The live attenuated HZ vaccine boosts an existing immune response, so that the already established varicella-zoster virus infection is kept latent. Vaccination has...

  4. Herpes zoster oticus: diagnosis and management.

    Science.gov (United States)

    Muecke, M; Amedee, R G

    1993-08-01

    Herpes zoster oticus (Ramsay Hunt syndrome) is recognized as a polycranial neuritis caused by the DNA virus Herpes zoster and characterized by damage to sensory and motor nerves, including the audio-vestibular apparatus. Common presenting symptoms include cutaneous auricular vesicles, severe otalgia, inflammation of the pinna, and occasionally unilateral sudden facial paralysis. This article reviews the medical management of this disease, including the efficacy of antibiotics, corticosteroids, and acyclovir, along with the role of surgical decompression of the facial nerve.

  5. Management and Prevention of Herpes Zoster: A Canadian Perspective

    Directory of Open Access Journals (Sweden)

    Guy Boivin

    2010-01-01

    Full Text Available Varicella-zoster virus reactivation leads to herpes zoster – the main complication of which is postherpetic neuralgia (PHN. Rapid antiviral therapy initiated within 72 h of rash onset has been shown to accelerate rash healing, reduce the duration of acute pain and, to some extent, attenuate the development and duration of PHN. Other adjunctive therapies such as analgesics, antidepressants and some anticonvulsants are frequently required in the management of severe PHN. A live, attenuated zoster vaccine has been recently shown to significantly decrease herpes zoster incidence, PHN and the overall burden of illness when administered to adults older than 60 years of age. This new prophylactic modality has been reported to be cost-effective in the Canadian context, especially in the 60- to 75-year-old age group.

  6. Herpes zoster-associeret morbiditet hos børn i kemoterapi for akut lymfoblastaer leukaemi

    DEFF Research Database (Denmark)

    Sørensen, Gitte Vrelits; Helgestad, Jon; Rosthøj, Steen

    2009-01-01

    INTRODUCTION: Herpes zoster rarely occurs in healthy children, but may occur frequently and may take a complicated course in children receiving chemotherapy. We aimed to assess morbidity from herpes zoster in children with acute lymphoblastic leukemia (ALL). MATERIAL AND METHODS: Reviewing records...

  7. Herpes Zoster Ophthalmicus in a Healthy Nigerian Child

    African Journals Online (AJOL)

    ... virus (HIV) I and II. Keywords: Healthy child, herpes zoster ophthalmicus, ocular complications ... screened and both of them tested negative to type I and II. HIV. Symptoms .... Analysis of varicella-zoster virus and herpes simplex virus in.

  8. Superior orbital fissure syndrome in herpes zoster ophthalmicus.

    LENUS (Irish Health Repository)

    Kirwan, R P

    2012-02-01

    AIM: To report a case of superior orbital fissure syndrome (SOFS) in a patient with herpes zoster ophthalmicus (HZO). MATERIALS AND METHODS: A case report. RESULTS: A 71-year-old male with HZO presented acutely to accident and emergency complaining of right vision loss, double vision and drowsiness. The right visual acuity was counting fingers. There was no relative afferent pupillary defect. He had interstitial keratitis, ptosis, proptosis and total ophthalmoplaegia. The signs indicated HZO complicated by SOFS. Brain imaging and lumbar puncture confirmed the diagnosis of varicella zoster encephalitis. Systemic acyclovir and prednisolone led to recovery of visual acuity and ocular motility in addition to resolution of his proptosis and ptosis. CONCLUSION: SOFS is a rare complication of herpes zoster infection. With the appropriate treatment and follow-up, patients may be reassured that recovery of their visual acuity and ocular motility will occur.

  9. Risk Factors for Herpes Zoster Among Adults.

    Science.gov (United States)

    Marin, Mona; Harpaz, Rafael; Zhang, John; Wollan, Peter C; Bialek, Stephanie R; Yawn, Barbara P

    2016-09-01

    Background.  The causes of varicella-zoster virus reactivation and herpes zoster (HZ) are largely unknown. We assessed potential risk factors for HZ, the data for which cannot be obtained from the medical sector. Methods.  We conducted a matched case-control study. We established active surveillance in Olmsted County, Minnesota to identify HZ occurring among persons age ≥50 years during 2010-2011. Cases were confirmed by medical record review. Herpes zoster-free controls were age- and sex-matched to cases. Risk factor data were obtained by telephone interview. Results.  We enrolled 389 HZ case patients and 511 matched controls; the median age was 65 and 66 years, respectively. Herpes zoster was associated with family history of HZ (adjusted odds ratio [aOR] = 1.65); association was highest with first-degree or multiple relatives (aOR = 1.87 and 3.08, respectively). Herpes zoster was also associated with prior HZ episodes (aOR = 1.82), sleep disturbance (aOR = 2.52), depression (aOR = 3.81), and recent weight loss (aOR = 1.95). Stress was a risk factor for HZ (aOR = 2.80), whereas a dose-response relationship was not noted. All associations indicated were statistically significant (P .1). Conclusions.  We identified several important risk factors for HZ; however, the key attributable causes of HZ remain unknown.

  10. Herpes zoster: klinik, diagnostik og behandling

    DEFF Research Database (Denmark)

    Kofoed, Kristian; Rønholt, Finn; Gerstoft, Jan

    2011-01-01

    Herpes zoster (HZ) is a painful vesicular rash localized to one dermatome. Post-herpetic neuralgia (PHN) is persistent pain three months after the rash started. In recent years several Cochrane reviews and clinical studies on how to treat HZ and PHN have been published. These studies show...

  11. Recurrent Herpes Zoster- A Marker of AIDS

    Directory of Open Access Journals (Sweden)

    Mazumdar Gautam

    2003-01-01

    Full Text Available A 32 year old female presented to us with herpes zoster involving the T 8 to T 10 dermatomes. She had a scar involving the same dermatomes on the other half of the body. Investigations revealed that both the patient and her husband were HIV positive with CD4 cell count less than 200.

  12. Herpes zoster: klinik, diagnostik og behandling

    DEFF Research Database (Denmark)

    Kofoed, Kristian; Rønholt, Finn; Gerstoft, Jan

    2011-01-01

    Herpes zoster (HZ) is a painful vesicular rash localized to one dermatome. Post-herpetic neuralgia (PHN) is persistent pain three months after the rash started. In recent years several Cochrane reviews and clinical studies on how to treat HZ and PHN have been published. These studies show...

  13. Herpes zoster eye complications: rates and trends.

    Science.gov (United States)

    Yawn, Barbara P; Wollan, Peter C; St Sauver, Jennifer L; Butterfield, Linda C

    2013-06-01

    To provide population-based data on the risk, types, and outcomes of eye involvement in herpes zoster (HZ). A cohort study based on review of the medical records of patients in whom HZ was diagnosed between January 1, 1980, and December 31, 2007, was performed. Herpes zoster was confirmed by the presence of the typical rash and symptoms or by laboratory testing, and eye involvement was confirmed by ophthalmologists' evaluation. Information was collected on all eye diagnoses and on HZ eye-related visits, treatments, procedures, and outcomes. Of the 7370 individuals with HZ in any dermatome, 184 (2.5%) had eye involvement. The mean age of the 184 was 62.6 years, and 5 cases occurred in patients younger than 21. Overall, 6.5% (12) were immunosuppressed at the time of the eye complications. The rate of increase in HZ eye involvement was 23% by decade from 1980 to 2007. Common eye complications were keratitis (n=144, 76.2%), uveitis/iritis (n=88, 46.6%), and conjunctivitis (n=67, 35.4%). Recurrent keratitis and recurrent iritis/uveitis occurred in 6.9% (13) and 7.4% (14), respectively. Outcomes included 6 patients (3.3%) with new vision decrements to 20/200 or worse. Two individuals had successful corneal transplants. Another 6 individuals (3.3%) had lid ptosis that affected vision, including 1 elderly woman with permanent unilateral tarsorrhaphy. Severe HZ eye pain was reported to be directly responsible for 1 unsuccessful suicide attempt. Acute retinal necrosis did not develop in any individual. A mean of 10.8 eye visits per patient with HZ and eye involvement was reported to continue for a mean of 308 days. Eye complications are common and result in considerable health care use and permanent vision decrement in about 6.6% (6) of individuals with HZ eye involvement. Most health care use and long-term adverse outcomes occurred in patients in whom prevention of HZ with the zoster vaccine would be possible. Copyright © 2013 Mayo Foundation for Medical Education and

  14. Eye and Periocular Skin Involvement in Herpes Zoster Infection

    Science.gov (United States)

    Kalogeropoulos, Chris D.; Bassukas, Ioannis D.; Moschos, Marilita M.; Tabbara, Khalid F.

    2015-01-01

    Herpes zoster ophthalmicus (HZO) is a clinical manifestation of the reactivation of latent varicella zoster virus (VZV) infection and is more common in people with diminished cell-mediated immunity. Lesions and pain correspond to the affected dermatomes, mostly in first or second trigeminal branch and progress from maculae, papules to vesicles and form pustules, and crusts. Complications are cutaneous, visceral, neurological, ocular, but the most debilitating is post-herpetic neuralgia. Herpes zoster ophthalmicus may affect all the ophthalmic structures, but most severe eye-threatening complications are panuveitis, acute retinal necrosis (ARN) and progressive outer retinal necrosis (PORN) as well. Antiviral medications remain the primary therapy, mainly useful in preventing ocular involvement when begun within 72 hours after the onset of the rash. Timely diagnosis and management of HZO are critical in limiting visual morbidity. Vaccine in adults over 60 was found to be highly effective to boost waning immunity what reduces both the burden of herpes zoster (HZ) disease and the incidence of post-herpetic neuralgia (PHN). PMID:27800502

  15. Prophylactic Antiviral Treatment in Recurrent Herpes Zoster: A Case Report

    Directory of Open Access Journals (Sweden)

    Hatice Gamze Bayram

    2011-06-01

    Full Text Available Herpes zoster (HZ occurs in older ages with activation of varicella-zoster virus (VZV which persists in a dormant phase within the dorsal root ganglia. The incidence of HZ in immunosuppressed patients is 20-100 times higher and the clinical progress is more severe than in immunocompetent individuals. A 48-year-old man who had been diagnosed with acute myelocytic leukemia type M3 and had been treated with immunosuppressive agents was admitted to our clinic. The patient was clinically diagnosed as having HZ. He was treated with acyclovir 800 mg five times daily for 7 days. In the consecutive three months, he attended our clinic again with similar complaints. The left cervical (C5, C6 dermatomes were involved at the fourth attack of HZ. Multinucleated giant cells were determined on the Tzanck smear. VZV DNA was detected by polymerase chain reaction (PCR. Treatment with valacyclovir 1 g three times daily for 14 days was prescribed and then, prophylactic treatment with valacyclovir 500 mg two times a day was administered. Although immunosuppressive treatment was continued, no new attacks of herpes zoster occurred. We think that prophylactic antiviral therapy should be initiated in immunosuppressive individuals who have recurrent herpes zoster attacks.

  16. Herpes zoster correlates with pyogenic liver abscesses in Taiwan.

    Science.gov (United States)

    Mei-Ling, Shen; Kuan-Fu, Liao; Sung-Mao, Tsai; Cheng-Li, Lin Ms; Shih-Wei, Lai

    2016-12-01

    The purpose of the paper was to explore the relationship between herpes zoster and pyogenic liver abscesses in Taiwan. This was a nationwide cohort study. Using the database of the Taiwan National Health Insurance Program, there were 33049 subjects aged 20-84 years who were newly diagnosed with herpes zoster from 1998 to 2010 that were selected for our study, and they were our herpes zoster group. 131707 randomly selected subjects without herpes zoster were our non-herpes zoster group. Both groups were matched by sex, age, other comorbidities, and the index year of their herpes zoster diagnosis. The incidence of pyogenic liver abscesses at the end of 2011 was then estimated. The multivariable Cox proportional hazard regression model was used to estimate the hazard ratio and 95% confidence interval for pyogenic liver abscesses associated with herpes zoster and other comorbidities. The overall incidence rate was 1.38-fold higher in the herpes zoster group than in the non-herpes zoster group (4.47 vs. 3.25 per 10000 person-years, 95% confidence interval 1.32, 1.44). After controlling for potential confounding factors, the adjusted hazard ratio of pyogenic liver abscesses was 1.34 in the herpes zoster group (95% confidence interval 1.05, 1.72) when compared with the non-herpes zoster group. Sex (in this case male), age, presence of biliary stones, chronic kidney diseases, chronic liver diseases, cancers, and diabetes mellitus were also significantly associated with pyogenic liver abscesses. Patients with herpes zoster are associated with an increased hazard of developing pyogenic liver abscesses.

  17. Forebyggelse af herpes zoster med vaccination

    DEFF Research Database (Denmark)

    Kofoed, Kristian; Rønholt, Finn; Gerstoft, Jan

    2011-01-01

    Herpes zoster (HZ) and post-herpetic neuralgia (PHN) are frequently occurring diseases in elderly and in immuno-compromised persons. The live attenuated HZ vaccine boosts an existing immune response, so that the already established varicella-zoster virus infection is kept latent. Vaccination has...... been shown to halve the risk of HZ, and the risk of PHN is reduced by two thirds in people = 60 years. The vaccine is approved for persons aged = 50 years. However, the clinical efficacy of the vaccine is best studied in people aged = 60 years. The vaccine has so far not shown any serious side-effects....

  18. Herpes zoster laryngitis accompanied by Ramsay Hunt syndrome.

    Science.gov (United States)

    Lee, Dong Hoon; Yoon, Tae Mi; Lee, Joon Kyoo; Joo, Young Eun; Lim, Sang Chul

    2013-01-01

    The most common presentation of herpes zoster in the head and neck region is called Ramsay Hunt syndrome (RHS), which rarely accompanies multiple cranial neuropathy. Herpes zoster also involves the mucous membrane of the tongue, palate, pharynx, and larynx. Herpes zoster infection of the larynx accompanied by Ramsay Hunt syndrome with cranial polyneuropathy is extremely rare, with only few reported cases in the literature. At the time of this report, a review of the medical literature disclosed 4 reported cases of herpes zoster laryngitis accompanied by Ramsay Hunt syndrome. Herein, we present 2 additional cases and report the clinical outcome of cranial polyneuropathy with a review of the literature.

  19. Effect of early stellate ganglion blockade for facial pain from acute herpes zoster and incidence of postherpetic neuralgia.

    Science.gov (United States)

    Makharita, Mohamed Y; Amr, Yasser Mohamed; El-Bayoumy, Youssef

    2012-01-01

    The incidence of postherpetic neuralgia (PHN) has been reported to be 25% among those over the age of 50 years treated with antiviral medication. The role of sympathetic block in its prevention remains questionable. The aim of this study is to determine whether early stellate ganglion blockade for acute herpes zoster of the face will reduce the intensity and duration of acute herpetic pain, and if the blockade has the potential to prevent or reduce the incidence and/or severity of PHN. Randomized, controlled, double blind trial. Hospital, outpatient setting. Sixty-four patients over 50 years were assigned to receive a stellate ganglion block using either 8 mL saline (Group 1) or 6 mL bupivacaine 0.125% and 8 mg dexamethasone in a total volume of 8 mL (Group 2). All procedures were performed under fluoroscopy. All patients received pregabalin in a dose of 150 mg twice daily. Acetaminophen was available as needed. Pain assessment using the visual analog scale and amount of analgesic being taken was measured at the initial visit (basal), weekly for 6 weeks after the procedure and after 2, 3, and 6 months. Once a patient reported mild pain during the trial, pregabalin was tapered by 75 mg every other day; the patients who succeeded in this step were recorded in each group. The time of complete resolution of pain and incidence of persistent postherpetic pain was reported. Each patient's satisfaction was evaluated. There was a significantly shorter duration of pain noticed in Group 2 (P = 0.002). A significantly lower incidence of PHN was encountered in Group 2 after 3 months (P = 0.043) and 6 months (P = 0.035). Significantly more patient satisfaction was reported in Group 2 after 3 and 6 months. By the fourth week, 29 patients in Group 2 reported no pain. Two patients reported mild pain after 3 months which was resolved by the sixth month. In Group 1, 22 patients reported no pain by the sixth week and 8 patients reported moderate pain after 2 and 3 months; by the sixth

  20. Herpes zoster in breast cancer patients after radiotherapy

    Energy Technology Data Exchange (ETDEWEB)

    Dunst, J.; Steil, B.; Furch, S.; Fach, A. [Halle-Wittenberg Univ., Halle (Germany). Dept. of Radiotherapy; Bormann, G.; Marsch, W. [Halle-Wittenberg Univ., Halle (Germany). Dept. of Dermatology

    2000-11-01

    Purpose: We have studied the incidence of herpes zoster in patients with adjuvant radiotherapy for breast cancer with special emphasis on possible correlations with other prognostic factors or survival. Patients and Methods: From 1/1985 through 12/1993, 1 155 breast cancer patients received postoperative radiotherapy with curative intent in our department. After mastectomy 961 patients were irradiated and after breast-preserving treatment 194 patients. The age ranged from 34 to 79 years, the median follow-up was 3.1 years (range: 0.3 to 12.4 years). There were 443 women (38%) pre- and 712 (62%) postmenopausal. 21% had T3- to T4-tumors, 55% had axillary lymph node involvement, and 65% received additional systemic hormonal and/or cytotoxic therapy. In case of postmastectomy radiotherapy, the lateral chest wall and lymphatics (axilla, parasternal and supraclavicular nodes) were irradiated with an anterior photon field to 50 Gy (axilla 44 Gy) and most of the chest wall with an electron field to 44 Gy in 2-Gy fractions. After breast-preservation, the breast was irradiated via tangential fields with 6- to 8-MV photons up to 50 Gy plus 8 Gy electron boost to the tumor bed. Most of the patients were followed routinely in the department for 2 to 5 years. The frequency of zoster was determined retrospectively by reviewing the patients' records. Results: A zoster after radiotherapy occurred in 41/1 155 patients (3.7%), mostly within the first 2 years after completion of radiotherapy. All infections remained localized and there was no evidence for systemic infections. Type of treatment (mastectomy vs breast-preservation) had no impact on the frequency of herpes zoster (36/961 patients after mastectomy and 5/194 patients after breast-preservation). There was also no correlation with other prognostic factors such as age, menopausal status, stage of disease or the use of adjuvant chemotherapy, nor was the occurrence of zoster linked to the degree of acute skin reaction in

  1. Herpes Zoster: A Clinicopathologic Correlation with Literature Review

    Directory of Open Access Journals (Sweden)

    N Malathi

    2014-01-01

    Full Text Available Herpes zoster is an acute infectious viral disease of an extremely painful and incapacitating nature. It is characterized by inflammation of dorsal root ganglia or extra medullary cranial nerve ganglia, associated with vesicular eruptions in the areas supplied by the affected nerve. Herewith we report a case of herpes zoster involving two branches—the maxillary and ophthalmic branch of trigeminal nerve. The demonstration of typical viral inclusion bodies by exfoliative cytology from the lesional site aided the rapid diagnosis of the lesion thereby facilitating an early initiation of therapy and improving patient compliance. The article also outlines the history, epidemiology and the natural course of the disease with a discussion of the review of literature.

  2. TREATMENT OF 19 CASES OF HERPES ZOSTER WITH ACUPOINT-INJECTION, ACUPUNCTURE AND MOXIBUSTION

    Institute of Scientific and Technical Information of China (English)

    ZHAO Xiaoyun

    2002-01-01

    @@ Herpes zoster is an acute dermatosis caused by chlckenpox virus inflammation and marked mainly by violent pain and cord-like herpes on the skin surface. In traditional Chinese medicine, it is termed as "She Chuan Chuang"(蛇串疮). The intolerable pain exits in the whole process of the disease even a few weeks or months after disappearance of the herpes, causing the patient to suffer a lot. From April of 1997 to June of 2002, the author adopted acupoint-injection and acupuncture therapies to treat 19 cases of herpes zoster and achieved satisfactory results, here is the report.

  3. Benzalkonium Chloride Intoxication Mimicking Herpes Zoster Encephalitis

    Directory of Open Access Journals (Sweden)

    Ekrem Güler

    2011-06-01

    Full Text Available Benzalkonium chloride (BAC is a frequently used disinfectant and its most well-known side effect is contact dermatitis. In this report, two children who had vesicular dermatitis, headache, lethargy, fever and encephalopathy mimicking Herpes zoster encephalitis were presented. Their consciousness level improved on the second day. From the medical history it was understood that the mother had applied 20% BAC solution to the scalps of two children. The aim of the presentation of this report is to draw attention to the fact that BAC application to the scalp for treating pediculosis capitis may resemble the herpes encephalitis clinical picture.

  4. Mitochondrial Haplogroups as a Risk Factor for Herpes Zoster.

    Science.gov (United States)

    Levinson, Rebecca T; Hulgan, Todd; Kalams, Spyros A; Fessel, Joshua P; Samuels, David C

    2016-10-01

    Background.  Herpes zoster, or shingles, is a common, painful reactivation of latent varicella zoster virus infection. Understanding host factors that predispose to herpes zoster may permit development of more effective prevention strategies. Our objective was to examine mitochondrial haplogroups as a potential host factor related to herpes zoster incidence. Methods.  Study participants were drawn from BioVU, a deoxyribonucleic acid (DNA) biobank connected to deidentified electronic medical records (EMRs) from Vanderbilt University Medical Center. Our study used 9691 Caucasian individuals with herpes zoster status determined by International Classification of Diseases, Ninth Revision codes 053-053.9. Cases and controls were matched on sex and date of birth within 5 years. Mitochondrial haplogroups were defined from mitochondrial DNA variants genotyped on the Illumina 660W or Illumina Infinium Human-Exome Beadchip. Sex and date of birth were extracted from the EMR. Results.  European mitochondrial haplogroup H had a protective association with herpes zoster status (odds ratio [OR] = .82; 95% confidence interval [CI], .71-.94; P = .005), whereas haplogroup clade IWX was a risk factor for herpes zoster status (OR = 1.38; 95% CI, 1.07-1.77; P = .01). Conclusions.  Mitochondrial haplogroup influences herpes zoster risk. Knowledge of a patient's mitochondrial haplogroup could allow for a precision approach to the management of herpes zoster risk through vaccination strategies and management of other modifiable risk factors.

  5. Benzalkonium Chloride Intoxication Mimicking Herpes Zoster Encephalitis

    OpenAIRE

    Güler, Ekrem; Olgar, Şeref; Davutoğlu, Mehmet; Garipardıç, Mesut; Karabiber, Hamza

    2011-01-01

    Benzalkonium chloride (BAC) is a frequently used disinfectant and its most well-known side effect is contact dermatitis. In this report, two children who had vesicular dermatitis, headache, lethargy, fever and encephalopathy mimicking Herpes zoster encephalitis were presented. Their consciousness level improved on the second day. From the medical history it was understood that the mother had applied 20% BAC solution to the scalps of two children. The aim of the presentation of this report is ...

  6. Benzalkonium Chloride Intoxication Mimicking Herpes Zoster Encephalitis

    OpenAIRE

    Ekrem Güler; Şeref Olgar; Mehmet Davutoğlu; Mesut Garipardıç; Hamza Karabiber

    2014-01-01

    Benzalkonium chloride (BAC) is a frequently used disinfectant and its most well-known side effect is contact dermatitis. In this report, two children who had vesicular dermatitis, headache, lethargy, fever and encephalopathy mimicking Herpes zoster encephalitis were presented. Their consciousness level improved on the second day. From the medical history it was understood that the mother had applied 20% BAC solution to the scalps of two children. The aim of the presentation of this report is...

  7. Monoparesis secondary to herpes zoster.

    LENUS (Irish Health Repository)

    Bilal, S

    2011-06-01

    We describe a 90-year-old woman with right upper limb monoparesis secondary to varicella zoster virus infection as a result of extensive inflammatory involvement of the entire brachial plexus at root level. To our knowledge, this is the first report of entire brachial plexus involvement in a living patient of such advanced age. Despite a delay in presentation and thus initiation of treatment, a favourable clinical response was observed.

  8. Update on recommendations for use of herpes zoster vaccine.

    Science.gov (United States)

    Hales, Craig M; Harpaz, Rafael; Ortega-Sanchez, Ismael; Bialek, Stephanie R

    2014-08-22

    Herpes zoster vaccine (Zostavax [Merck & Co., Inc.]) was licensed in 2006 and recommended by the Advisory Committee on Immunization Practices (ACIP) in 2008 for prevention of herpes zoster (shingles) and its complications among adults aged ≥60 years. The Food and Drug Administration (FDA) approved the use of Zostavax in 2011 for adults aged 50 through 59 years based on a large study of safety and efficacy in this age group. ACIP initially considered the use of herpes zoster vaccine among adults aged 50 through 59 years in June 2011, but declined to recommend the vaccine in this age group, citing shortages of Zostavax and limited data on long-term protection afforded by herpes zoster vaccine. In October 2013, ACIP reviewed the epidemiology of herpes zoster and its complications, herpes zoster vaccine supply, short-term vaccine efficacy in adults aged 50 through 59 years, short- and long- term vaccine efficacy and effectiveness in adults aged ≥60 years, an updated cost-effectiveness analysis, and deliberations of the ACIP herpes zoster work group, all of which are summarized in this report. No vote was taken, and ACIP maintained its current recommendation that herpes zoster vaccine be routinely recommended for adults aged ≥60 years. Meeting minutes are available at http://www.cdc.gov/vaccines/acip/meetings/meetings-info.html.

  9. [Clinical presentations of Herpes Zoster Ophthalmicus (diagnosis and therapy)].

    Science.gov (United States)

    Chernakova, G M; Kleshcheva, E A; Semenova, T B

    Approximately a quarter of the world's population at some point in life is at risk of developing shingles (Herpes Zoster). In 10-20% of cases the first branch of the trigeminal nerve gets involved (Herpes Zoster Ophthalmicus, HZO). Ophthalmic complications of HZO are able to cause a significant reduction in visual function.

  10. Clinical and morphological characteristics of herpes zoster in south India

    Directory of Open Access Journals (Sweden)

    Dubey Anand

    2005-01-01

    Full Text Available One hundred and seven cases (6 children and 101 adults of herpes zoster were recruited over a period of two years. The frequency of herpes zoster amongst skin OPD cases was found to be 0.34 per cent. The male to female ratio was 1.74:1. The most common prodromal symptom seen was paresthesia in 25 (23.36% cases followed by itching in 21 (19.62% cases.Most common presenting complaint was pain in 97 (90.65% cases. Ninety nine cases had classical herpes zoster followed by necrotic / ulcerated herpes zoster in 5 cases and hemorrhagic herpes zoster in 3 cases. Thoracic dermatome was the most common dermatome involved in 64 (59.8% cases followed by cervical in 17 (15.8% cases. Unidermatomal involvement was seen in 81 (75.7% cases, followed by multidermatomal in 18 (16.8% cases and disseminated in 8 (7.4% cases. Forty six cases were screened for HIV, out of them; six cases (4 males, 2 females were seropositive for HIV. Classical herpes zoster was a feature in four cases; however, one case each also had necrotic and hemorrhagic form of herpes zoster. To conclude, herpes zoster commonly occurs in young adults in India with presenting symptoms such as pain, itching and fever.

  11. Herpes zoster on the face in the elderly.

    Science.gov (United States)

    Nair, Preeti; Gharote, Harshkant; Singh, Pooja; Jain-Choudhary, Palak

    2014-10-19

    Herpes zoster is a localised disease caused by reactivation of the varicella zoster virus that enters the cutaneous nerve endings during an earlier episode of chicken pox, travels to the dorsal root ganglia, and remains in latent form. The condition is characterised by occurrence of multiple, painful, unilateral vesicles and ulceration, and shows a typical single dermatome innervated by single dorsal root or cranial sensory ganglion. Involvement of three or more dermatomes is known as disseminated zoster and seen in immunocompromised individuals. Complications of herpes zoster include ocular sequelae, bacterial superinfection of the lesions, meningoencephalitis and postherpetic neuralgia. The incidence of herpes zoster increases with age and immunosuppression, therefore prompt management is necessary to avoid morbidity and mortality in these individuals. We present two case reports of herpes zoster, one involving the maxillary and mandibular branches of the trigeminal nerve while the other involves all branches of the trigeminal nerve.

  12. Cutaneous varicella zoster virus infection following zoster vaccination: report of post-vaccination herpes zoster skin infection and literature review of zoster vaccination efficacy and guidelines.

    Science.gov (United States)

    Stiff, Katherine M; Cohen, Philip R

    2017-06-15

    BackgroundHerpes zoster vaccine is currently recommended in the United States for immune competent individuals ≥60 years. The efficacy of the herpes zoster vaccine decreases with age and with time following vaccination.PurposeAn elderly man with herpes zoster following vaccination is described. The guidelines for vaccination and issues regarding re-vaccination are reviewed. PubMed was used to search the following terms: efficacy, elderly, herpes zoster, herpes zoster incidence, herpes zoster recurrence, and vaccination. The papers and relevant citations were reviewed. The clinical features of a patient with post-vaccination herpes zoster skin infection are presented; in addition, vaccine efficacy and guidelines are reviewed.ResultsA 91-year-old man, vaccinated for herpes zoster 10 years earlier, presented with crusted erosions on his face corresponding to the area innervated by the ophthalmic division of the left trigeminal nerve. Evaluation using polymerase chain reaction confirmed the diagnosis of herpes zoster.ConclusionsHerpes zoster vaccine decreases in efficacy with both age and number of years following vaccination. Therefore, booster shots or revaccination in the older population may be of benefit.

  13. A Rare Complication of Herpes Zoster: Segmental Zoster Paresis

    Directory of Open Access Journals (Sweden)

    Hooi Khee Teo

    2016-01-01

    Full Text Available Herpes zoster is a common presentation in both the community and emergency department; however segmental zoster paresis is a rare complication that can lead to misdiagnosis. We present a case of a 74-year-old Indian gentleman with a background of well controlled diabetes mellitus, hypertension, and ischaemic heart disease who presented with sudden right lower limb weakness. This was preceded by a 5-day history of paraesthesia starting in the right foot and ascending up the right lower limb. On examination, there was a characteristic vesicular rash in the L2/3 region with MRC grading 3/5 in the right hip flexors. The rest of the neurological examination was unremarkable. MRI of the spine did not show any evidence of spinal disease. The patient was initiated on IV acyclovir with improvement of the lower limb weakness to MRC grading 5/5 as the vesicles improved. This is an interesting case as it highlights a rare presentation of zoster: segmental motor paresis that recovered fully with resolution of the rash. It shows the importance of recognizing motor neuropathy as a complication of shingles as it has a very good prognosis with most patients regaining full motor function of the affected limb with treatment.

  14. [Pain in herpes zoster: Prevention and treatment].

    Science.gov (United States)

    Calvo-Mosquera, G; González-Cal, A; Calvo-Rodríguez, D; Primucci, C Y; Plamenov-Dipchikov, P

    Shingles is a painful rash that results from reactivation of latent varicella-zoster virus in the dorsal root ganglia or cranial nerves. In this article an update is presented on the prevention and pharmacological treatment of the secondary pain from the virus infection. The most effective way to prevent post-herpetic neuralgia and its consequences is the prevention of herpes itself. A live attenuated vaccine (the Oka strain varicella zoster virus) has been available for several years, and is approved in adults aged 50 years old. Although this vaccine has shown to be effective against herpes zoster and post-herpetic neuralgia, its effectiveness decreases with age and is contraindicated in patients with some form of immunosuppression. Today the recombinant vaccines provide an alternative, and may be administered to immunocompromised persons. Copyright © 2016 Sociedad Española de Médicos de Atención Primaria (SEMERGEN). Publicado por Elsevier España, S.L.U. All rights reserved.

  15. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.

    NARCIS (Netherlands)

    Melker, Hester E de; Berbers, Guy A M; Hahné, Susan J M; Rümke, Hans; Hof, Susan van den; Wit, G Ardine de; Boot, Hein J

    2006-01-01

    We studied the epidemiology of varicella (chickenpox) and herpes zoster (shingles) in The Netherlands to assess the desirability to implement routine varicella zoster virus vaccination in The Netherlands. Data on seroprevalence of varicella zoster virus in the general population (1995-1996), consult

  16. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.

    NARCIS (Netherlands)

    Melker, Hester E de; Berbers, Guy A M; Hahné, Susan J M; Rümke, Hans; Hof, Susan van den; Wit, G Ardine de; Boot, Hein J

    2006-01-01

    We studied the epidemiology of varicella (chickenpox) and herpes zoster (shingles) in The Netherlands to assess the desirability to implement routine varicella zoster virus vaccination in The Netherlands. Data on seroprevalence of varicella zoster virus in the general population (1995-1996),

  17. Clinical and immunologic features of recurrent herpes zoster (HZ).

    Science.gov (United States)

    Nakamura, Yuki; Miyagawa, Fumi; Okazaki, Aiko; Okuno, Yoshinobu; Mori, Yasuko; Iso, Hiroyasu; Yamanishi, Koichi; Asada, Hideo

    2016-11-01

    Recurrent herpes zoster (HZ) is thought to be rare, but there have been few large-scale studies of recurrent HZ. We conducted a large-scale prospective cohort study to characterize recurrent HZ. We examined 12,522 participants aged 50 years or older in Shozu County and followed them up for 3 years. We compared the incidence of HZ and postherpetic neuralgia, severity of skin lesions and acute pain, cell-mediated immunity, and varicella-zoster virus-specific antibody titer between primary and recurrent HZ. A total of 401 participants developed HZ: 341 with primary HZ and 60 with recurrent HZ. Skin lesions and acute pain were significantly milder and the incidence of postherpetic neuralgia was lower in patients aged 50 to 79 years with recurrent HZ than in those with primary HZ. Varicella-zoster virus skin test induced a stronger reaction in patients aged 50 to 79 years with recurrent HZ than in those with primary HZ. Information on previous HZ episodes was self-reported by participants, so it could not be confirmed that they actually had a history of HZ. Recurrent HZ was associated with milder clinical symptoms than primary HZ, probably because of stronger varicella-zoster virus-specific cell-mediated immunity in the patients with recurrence. Copyright © 2016 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

  18. Diaphragmatic paralysis associated with herpes zoster and HIV-tuberculosis co-infection.

    Science.gov (United States)

    Benabdellah, A; Souhil, Touati; Farouk, Zaoui Omar

    2014-08-01

    Motor complications after herpes zoster are not uncommon. There have been reports of muscular paralysis following herpes zoster. The association between diaphragmatic paralysis and zoster was first reported in 1949 by Halpern. The case presented below showed diaphragmatic involvement following herpes zoster in a HIV-tuberculosis coinfected patient.

  19. A case report of abdominal distention caused by herpes zoster

    Institute of Scientific and Technical Information of China (English)

    Su-Rong Zhou; Chuan-Yu Liu

    2012-01-01

    Gastrointestinal complications caused by herpes zoster are extremely rare.Here,we described a case of abdominal distention caused by herpes zoster.The patient was a 59-year-old female who suffered from unexplained paroxysmal and a burning pain on the right part of her waist and abdomen,accompanied by abdominal distention.Intestinal pseudo-obstruction was diagnosed by abdominal radiography.Distention of the right abdominal wall was still apparent after one month.In this report,we found that recovery from abdominal distention caused by herpes zoster is difficult and may require surgical intervention.

  20. Nutritional factors in herpes zoster, postherpetic neuralgia, and zoster vaccination.

    Science.gov (United States)

    Chen, Jen-Yin; Chang, Chia-Yu; Lin, Yung-Song; Hu, Miao-Lin

    2012-12-01

    Herpes zoster (HZ) results from a reactivation of latent varicella-zoster virus (VZV). HZ and its most common complication, termed postherpetic neuralgia (PHN), often cause long-term psychological distress and physical disabilities leading to profoundly negative impacts on the quality of patients' lives. The incidence and severity of HZ and PHN increase with advanced age as a consequence of declining cell-mediated immunity. Aging has been linked to progressive senescence of the immune system and also is associated with a greater susceptibility to nutritional deficiencies. Suppressing VZV reactivation depends on intact cell-mediated immunity, which requires adequate nutrients to maintain its efficient function. Contrarily, nutritional deficiencies may lead to dysfunction of the host immune responses. Recently, micronutrient deficiencies have been shown to increase the risk of HZ and PHN and to affect the immune response to vaccinations, whereas nutritional supplements effectively reduce herpetic pain and pain in patients with PHN. As the elderly population grows, the incidence and severity of HZ and PHN are expected to increase and cause a substantial financial burden on the health care system. Thus, enhancing knowledge of the risk factors of HZ and PHN and developing better interventions to treat and prevent HZ and PHN are important to public health. This article provides an overview of the present understanding of the association among nutritional deficiencies, diminished cell-mediated immunity, and the risk of HZ and PHN, and then illustrates the potential of nutritional intervention in the prevention, vaccination, and management of HZ and PHN.

  1. Recurrent herpes zoster with segmental paresis and postherpetic neuralgia

    Directory of Open Access Journals (Sweden)

    Martić Vesna

    2014-01-01

    Full Text Available Introduction. Postherpetic neuralgia and segmental paresis represent rare complications of herpes zoster infection. Recurrent herpes zoster is also rare and occurs within the first 3 years of the begining of the illness in only 1.4% of cases but it is generally higher in cases of chronic lymphatic leukemia (3.5%. Case report. We presented a patient with lymphatic leukemia who during the remission had 3 episodes of herpes zoster over a year. All of them took different parts of the body. One of these episodes was complicated by postherpetic neuralgia and segmental paresis. A complete recovery was seen in all the three episodes. Conclusion. As immunosuppression is one of mechanisms of virus reactivation, it is likely associated with the described rare complications of herpes zoster.

  2. Cost-effectiveness of vaccination against herpes zoster

    NARCIS (Netherlands)

    de Boer, Pieter; Wilschut, Jan C.; Postma, Maarten J.

    2014-01-01

    Herpes zoster (HZ) is a common disease among elderly, which may develop into a severe pain syndrome labeled postherpetic neuralgia (PHN). A live-attenuated varicella zoster virus vaccine has been shown to be effective in reducing the incidence and burden of illness of HZ and PHN, providing the oppor

  3. Herpes zoster ophthalmicus associated with abducens palsy

    Directory of Open Access Journals (Sweden)

    Nibrass Chaker

    2014-01-01

    Full Text Available The extraocular muscle palsies associated with herpes zoster ophthalmicus (HZO are transient, self-limiting conditions, usually seen in elderly patients. There are different treatment recommendations for paralytic complications, but prognosis has generally reported to be favorable. A 75-year-old male patient presented with diplopia. Clinical history revealed left facial vesicular eruptions and pain treated by oral aciclovir 1 week following symptom onset. On examination, we observed cicatricial lesions with crusts involving left hemiface, a limitation in abduction of the left eye, and a superficial punctuate keratitis (SPK with decreased visual acuity (4/10. Examination of the right eye was unremarkable. Hess screen test confirmed left six nerve palsy.

  4. [Herpes zoster-induced neuralgia (neuropathy)].

    Science.gov (United States)

    Maksimova, M Yu; Sineva, N A; Vodopyanov, N P

    2014-01-01

    Neuralgia (neuropathy) is the most common manifestation of herpes zoster (HZ). In spinal and cranial neuralgia, there are 3 types of pain: 1) spontaneous, persistent, burning pain; 2) intermittent sharp pain; 3) pain occurring with nonpainful stimulation. The skin exhibits areas of hypesthesia, anesthesia, and dysesthesia. Ophthalmic neuralgia (of the first branch of the trigeminal nerve) is encountered in 20% of HZ cases. HZ of the auricle and external auditory meatus concurrent with facial and vestibulocochlear neuropathy is diagnosed as Ramsay Hunt syndrome. Postherpetic neuralgia (neuropathy) is characterized by pain present for 3 months or more after the appearance of herpetic eruptions. Combined therapy involving the earlier use of antiviral agents, tricyclic antidepressants, analgesics, and neuromidine is the most effective option for HZ-induced neuralgia (neuropathy).

  5. Assessment of skin test with varicella-zoster virus antigen for predicting the risk of herpes zoster.

    Science.gov (United States)

    Okuno, Y; Takao, Y; Miyazaki, Y; Ohnishi, F; Okeda, M; Yano, S; Kumihashi, H; Gomi, Y; Maeda, K; Ishikawa, T; Mori, Y; Asada, H; Iso, H; Yamanishi, K

    2013-04-01

    The Shozu Herpes Zoster (SHEZ) Study was designed to clarify the incidence of and predictive and immunological factors for herpes zoster in a defined community-based Japanese population. As part of this series, a total of 5683 residents aged ≥50 years received a varicella-zoster virus (VZV) skin test with VZV antigen, and 48 h later, the erythema and oedema were assessed by measuring the longest diameter. The diameters of both the erythema and oedema decreased with the increasing age of the subject. Sixty-three subjects contracted herpes zoster within a year after receiving the VZV skin test. Analysis of the herpes zoster incidence rate vs. the skin test reaction revealed that the shorter the diameter of erythema or oedema, the greater the likelihood of herpes zoster. These results demonstrated that the VZV skin test is an excellent surrogate marker for predicting the risk of herpes zoster.

  6. Peptic ulcer as a risk factor for postherpetic neuralgia in adult patients with herpes zoster.

    Science.gov (United States)

    Chen, Jen-Yin; Lan, Kuo-Mao; Sheu, Ming-Jen; Tseng, Su-Feng; Weng, Shih-Feng; Hu, Miao-Lin

    2015-02-01

    Postherpetic neuralgia is the most common complication of herpes zoster. Identifying predictors for postherpetic neuralgia may help physicians screen herpes zoster patients at risk of postherpetic neuralgia and undertake preventive strategies. Peptic ulcer has been linked to immunological dysfunctions and malnutrition, both of which are predictors of postherpetic neuralgia. The aim of this retrospective case-control study was to determine whether adult herpes zoster patients with peptic ulcer were at greater risk of postherpetic neuralgia. Adult zoster patients without postherpetic neuralgia and postherpetic neuralgia patients were automatically selected from a medical center's electronic database using herpes zoster/postherpetic neuralgia ICD-9 codes supported with inclusion and exclusion criteria. Consequently, medical record review was performed to validate the diagnostic codes and all pertaining data including peptic ulcer, Helicobacter pylori (H. pylori) infection and ulcerogenic medications. Because no standard pain intensity measurement exists, opioid usage was used as a proxy measurement for moderate to severe pain. In total, 410 zoster patients without postherpetic neuralgia and 115 postherpetic neuralgia patients were included. Multivariate logistic regressions identified 60 years of age and older, peptic ulcer and greater acute herpetic pain as independent predictors for postherpetic neuralgia. Among etiologies of peptic ulcer, H. pylori infection and usage of non-selective nonsteroidal anti-inflammatory drugs were significantly associated with the increased risk of postherpetic neuralgia; conversely, other etiologies were not significantly associated with the postherpetic neuralgia risk. In conclusion, 60 years of age and older, peptic ulcer and greater acute herpetic pain are independent predictors for postherpetic neuralgia in adult herpes zoster patients.

  7. [Pain associated with craniofacial and cervical herpes zoster].

    Science.gov (United States)

    George, B; Lory, C

    2007-10-01

    Ophthalmological and cervical involvement of herpes zoster virus ranks second and third, respectively, in terms of localization frequency. Involvement of the cranial nerves is a particular sign of complications, notably ocular complications, possibly compromising the visual or facial prognosis through involvement of the VIIth nerve, which is responsible for facial paralysis. These types of involvement should be rapidly diagnosed and treated so as to limit these complications. The pain associated with herpes zoster remains frequent and difficult to treat, even if today the criteria for defining postzoster pain is increasingly refined. Antalgic and antiviral treatment should be initiated early, from the very first signs, to attempt to reduce the incidence of this postzoster pain. The risk factors, associated with the development of postzoster pain are age over 50 years, the severity of the skin rash and the intensity of the acute pain, and the existence of a prodromic pain phase before onset. The European Federation of Neurological Societies has recently published guidelines on the pharmacological treatments for postzoster pain. Nerve block treatments remain at a limited evidence level. Patients with postzoster pain should be managed by teams specializing in pain management as soon as conventional treatments fail.

  8. Herpes zoster caused by vaccine-strain varicella zoster virus in an immunocompetent recipient of zoster vaccine.

    Science.gov (United States)

    Tseng, Hung Fu; Schmid, D Scott; Harpaz, Rafael; LaRussa, Philip; Jensen, Nancy J; Rivailler, Pierre; Radford, Kay; Folster, Jennifer; Jacobsen, Steven J

    2014-04-01

    We report the first laboratory-documented case of herpes zoster caused by the attenuated varicella zoster virus (VZV) contained in Zostavax in a 68-year-old immunocompetent adult with strong evidence of prior wild-type VZV infection. The complete genome sequence of the isolate revealed that the strain carried 15 of 42 (36%) recognized varicella vaccine-associated single-nucleotide polymorphisms, including all 5 of the fixed vaccine markers present in nearly all of the strains in the vaccine. The case of herpes zoster was relatively mild and resolved without complications.

  9. Posterior Ischemic Optic Neuropathy following Herpes Zoster Ophthalmicus

    Directory of Open Access Journals (Sweden)

    Mohammad Pakravan

    2009-01-01

    Full Text Available

    PURPOSE: To report a case of posterior ischemic optic neuropathy (PION following herpes zoster ophthalmicus (HZO. CASE REPORT: A 58-year-old woman with history of recent HZO in her right eye presented with acute painless loss of vision in the same eye to no light perception. Examination revealed a positive relative afferent pupillary defect and a normal appearing optic disc. Inflammatory and infiltrative lesions of the optic nerve were ruled out by laboratory and imaging studies. The patient received systemic acyclovir and prednisolone. Three months later, visual acuity improved to counting fingers, but the optic disc became pale and atrophic leading to a presumptive diagnosis of PION. Considering the positive PCR test for varicella zoster virus and the short time interval between the two presentations, HZO was considered as the most probable cause of the optic neuropathy. CONCLUSION: Herpes zoster ophthalmicus can be associated with PION.

  10. Herpes zoster on segmental vitiligo: Wolf’s isotopic response?

    Directory of Open Access Journals (Sweden)

    Mankesh Lal Gambhir

    2014-04-01

    Full Text Available “Wolf’s isotopic response” describes the occurrence of a new skin disorder at the site of another, unrelated and already healed skin disease. In most cases of isotopic response, the initial dermatosis is herpes zoster, herpes simplex, varicella, thrombophlebitis, scrofuloderma and striae distense. The most frequent second dermatoses are granulomatous reactions, particularly granuloma annulare, and lichenoid diseases. Various etiological reasons including viral, immunologic, neural and vascular have been put forth. We report here a case in which the second disease was herpes zoster that appeared over the same dermatomes of pre-existing segmental vitiligo. The occurrence of vitiligo as first and herpes zoster as second disease in the “Wolf’s isotopic response” has not, to the best of our knowledge, been reported previously.

  11. Shingles (Herpes Zoster) Vaccine (Zostavax(®)): A Review in the Prevention of Herpes Zoster and Postherpetic Neuralgia.

    Science.gov (United States)

    Keating, Gillian M

    2016-06-01

    Zostavax(®) is a live attenuated shingles (herpes zoster) vaccine approved in the EU for the prevention of herpes zoster (HZ) and postherpetic neuralgia (PHN) in adults aged ≥50 years. Zoster vaccine protected against HZ in adults aged 50-59 years (ZEST trial) and ≥60 years [Shingles Prevention Study (SPS)], and also reduced the burden of illness associated with HZ and the risk of PHN in adults aged ≥60 years (SPS). A large amount of real-world data also supports the efficacy of zoster vaccine. Results of the SPS Short- and Long-Term Persistence Substudies and real-world studies indicate that zoster vaccine provided continued benefit in the longer term, albeit with a gradual decline in vaccine efficacy over time; long-term effectiveness studies are ongoing. The need for a booster dose is still unknown, but a study showed that, if necessary, a booster dose administered to adults aged ≥70 years who received their first dose of zoster vaccine ≥10 years previously was immunogenic. Zoster vaccine had a favourable safety and tolerability profile, with the most commonly reported adverse events being non-severe injection-site reactions. In conclusion, zoster vaccine reduces the incidence of HZ and PHN, thereby reducing the burden of illness associated with HZ; improved uptake of zoster vaccine is needed.

  12. Herpes Zoster infection and radiation therapy

    Energy Technology Data Exchange (ETDEWEB)

    Hayakawa, K.; Okazaki, A.; Mitsuhashi, N.; Ito, I.; Niibe, H. (Gunma Univ., Maebashi (Japan). School of Medicine)

    1981-02-01

    Between 1970 and 1979, among 3,320 patients with malignant neoplasms, herpes zoster (HZ) occurred in 54 (1.6%) after radiation therapy. The incidence of HZ infection was increased in patients with epipharyngeal cancer (10.0%), malignant lymphoma (5.7%), ovarial tumor (3.7%) and testicular tumor (3.6%). Most of these patients received extensive radiation therapy along the spinal cord and/or nerve roots. The location of HZ infection was divided as follows; HZ infectious lesion located in the area of (I-A) innervated segment of the irradiated nerve root (75.9%), (I-B) irradiated dermatome (5.6%) and (II) not associated with radiation field (18.5%). In 44 patients of I-A and B, HZ infection developed within a year, particularly in three months (22 cases) after the completion of irradiation. This latent period between completing irradiation and the development of HZ infection was likely to be compatible with the period between radiation therapy and earlier radiation injury. Among 10 patients in Group II, 7 patients developed HZ infection more than a year after radiation therapy. The cumulative survival of these patients except for the patients with malignant lymphoma was 66.7% and so HZ infection was considered to have no prognostic significance.

  13. Isolated, complete paralytic mydriasis secondary to herpes zoster ophthalmicus.

    Science.gov (United States)

    Czyz, Craig N; Bacon, Thomas S; Petrie, Thomas P; Justice, Joshua D; Cahill, Kenneth V

    2013-06-01

    Herpes zoster ophthalmicus is a manifestation of herpes zoster when the ophthalmic division of the trigeminal nerve becomes involved. Ocular symptoms are varied and mainly due to inflammatory mechanisms. Total, external and/or internal ophthalmoplegias, as well as isolated third, fourth and sixth cranial nerve palsies have all been reported as complications. In a minority of cases, concurrent pupillary paralysis has been documented. The presentation of complete paralytic mydriasis as the sole cranial nerve complication following herpes zoster ophthalmicus infection is a rare finding. The postulated pathophysiologic aetiology is a partial third nerve palsy with the pupillary fibres for light and accommodation-convergence affected and motor fibres spared. The mechanism responsible for the postulated lesion is speculative.

  14. Herpes Zoster Duplex Unilateralis: Two Cases and Brief Literature Review

    Science.gov (United States)

    Son, Jee Hee; Chung, Bo Young; Kim, Hye One; Cho, Hee Jin

    2016-01-01

    Cases involving dermatomal herpes zoster in two or more locations are rare, especially in immunocompetent patients. When two noncontiguous dermatomes are involved, if affected unilaterally, it is called herpes zoster duplex unilateralis; if bilaterally, bilateralis. Here, we report two cases of herpes zoster duplex unilateralis. A 66-year-old man presented with painful erythematous grouped vesicles on his left scalp, forehead, trunk, and back (left [Lt.] V1, Lt. T8). Histologic findings were consistent with herpetic infection. A 33-year-old woman presented with painful erythematous grouped vesicles and crust on her left forehead and neck (Lt. V1, Lt. C5). Both patients were treated with oral administration of famcyclovir 750 mg/day for seven days. PMID:27904277

  15. Recurrent herpes zoster in a child with SLE

    Directory of Open Access Journals (Sweden)

    Jain C

    1995-01-01

    Full Text Available A 12-year-old girl had systemic lupus erythematosus (SLE and type IV lupus nephritis since three-and-a-half years. She was treated with prednisolone and cyclophosphamide. She had first attack of herpes zoster (HZ involving eighth and ninth thoracic segments on right side at the age of nine years. Second attack occurred on the same segments on same side at the age of twelve years. The second attack of herpes zoster was treated with oral acyclovir 400 mg five times a day for seven days plus analgesics and multi-vitamins. Most probably this is the first case of recurrent herpes zoster (RHZ in a child in Indian literature.

  16. Herpes Zoster-Induced Ogilvie’s Syndrome

    Directory of Open Access Journals (Sweden)

    Irfan Masood

    2015-01-01

    Full Text Available Ogilvie’s syndrome due to herpes zoster infection is a rare manifestation of VZV reactivation. The onset of rash of herpes zoster and the symptoms of intestinal obstruction can occur at different time intervals posing a significant diagnostic challenge resulting in avoidable surgical interventions. Herein, we describe a case of 35-year-old male who presented with 6-day history of constipation and colicky abdominal pain along with an exquisitely tender and vesicular skin eruption involving the T8–T11 dermatome. Abdominal X-ray and ultrasound revealed generalized gaseous distention of the large intestine with air up to the rectum consistent with paralytic ileus. Colonoscopy did not show any obstructing lesion. A diagnosis of Ogilvie’s syndrome associated with herpes zoster was made. He was conservatively managed with nasogastric decompression, IV fluids, and acyclovir. The patient had an uneventful recovery and was later discharged.

  17. Herpes zoster at two different sites in the same individual

    Directory of Open Access Journals (Sweden)

    Kolalapudi Seetharam

    1995-01-01

    Full Text Available Herpes zoster occuring at two different sites in the same individual at the same time, involving more than two segments at each site has rarely been reported. We recently observed two such cases. The first patient was HIV-infected 10 year old haemophiliac who had zoster involving the distribution of the right C4, 5, 6 and left L 2, 3, 4 dermatomes and the second one was a 50 year old renal transplant recipient on immunosuppressive drugs who developed zoster at left C3, 4, 5 and left T 7, 8, 9.

  18. Purpuric herpes zoster in patients in therapy with clopidogrel.

    Science.gov (United States)

    Veraldi, S; Vaira, F; Nazzaro, G

    2015-08-01

    Clopidogrel is an adenosine diphosphate receptor antagonist used for the prevention of vascular events in patients with atherothrombotic diseases manifested by recent myocardial infarction, ischemic stroke or peripheral arterial disease. Diarrhoea, rash and pruritus are rather common side effects of clopidogrel. Other side effects include epistaxis, nausea, abdominal pain, vomiting, gastritis, gastric and duodenal ulcer. Thrombocytopenia is the most common laboratory abnormality. Leucopenia and neutropenia are rare. We report three cases of purpuric herpes zoster in patients in therapy with clopidogrel. To our knowledge, only one case of haemorrhagic herpes zoster has been published in a patient in therapy with this drug.

  19. Varicella-Zoster Virus Vasculopathy: The Growing Association Between Herpes Zoster and Strokes.

    Science.gov (United States)

    Powell, David R; Patel, Shiddhi; Franco-Paredes, Carlos

    2015-09-01

    Varicella-zoster virus (VZV) is herpes virus that after its reactivation from nerve ganglia to cause herpes zoster may lead to a variety of neurologic complications, including encephalitis, meningitis, retinal necrosis or myelitis. In addition, VZV can spread to arteries in the central nervous system and cause hemorrhagic or ischemic complications due to an inflammatory vasculopathy. In fact, there is a growing epidemiological and clinical recognition that there is an association between VZV reactivation and subsequent strokes. Herein, we present a case of an immune compromised individual with reactivation of VZV causing dermatomal herpes zoster followed by multifocal vasculopathy. We also review the literature to highlight key aspects of VZV-associated vasculopathy.

  20. Herpes zoster correlates with increased risk of Parkinson's disease in older people

    Science.gov (United States)

    Lai, Shih-Wei; Lin, Chih-Hsueh; Lin, Hsien-Feng; Lin, Cheng-Li; Lin, Cheng-Chieh; Liao, Kuan-Fu

    2017-01-01

    Abstract Little is known on the relationship between herpes zoster and Parkinson's disease in older people. This study aimed to explore whether herpes zoster could be associated with Parkinson's disease in older people in Taiwan. We conducted a retrospective cohort study using the claim data of the Taiwan National Health Insurance Program. There were 10,296 subjects aged 65 years and older with newly diagnosed herpes zoster as the herpes zoster group and 39,405 randomly selected subjects aged 65 years and older without a diagnosis of herpes zoster as the nonherpes zoster group from 1998 to 2010. Both groups were followed up until subjects received a diagnosis of Parkinson's disease. This follow-up design would explore whether subjects with herpes zoster were at an increased risk of Parkinson's disease. Relative risks were estimated by adjusted hazard ratio (HR) and 95% confidence interval (CI) using the multivariable Cox proportional hazards regression model. The incidence of Parkinson's disease was higher in the herpes zoster group than that in the nonherpes zoster group (4.86 vs 4.00 per 1000 person-years, 95% CI 1.14, 1.29). After adjustment for confounding factors, the multivariable Cox proportional hazards regression model revealed that the adjusted HR of Parkinson's disease was 1.17 for the herpes zoster group (95% CI 1.10, 1.25), compared with the nonherpes zoster group. Older people with herpes zoster confer a slightly increased hazard of developing Parkinson's disease when compared to those without herpes zoster. We think that herpes zoster correlates with increased risk of Parkinson's disease in older people. When older people with herpes zoster seek help, clinicians should pay more attention to the development of the cardinal symptoms of Parkinson's disease. PMID:28207515

  1. The dynamics of neopterin level in patients with herpes zoster

    Directory of Open Access Journals (Sweden)

    A. L. Yakubenko

    2015-01-01

    Full Text Available Neopterin is a specific marker of cellular immunity and monocytes/macrophages activation. Correlation between serum neopterin levels and clinical features of herpes zoster is unknown.The objective of the study was to determine the concentration of serum neopterin in patients with herpes zoster.Methods: 55 patients with herpes zoster (30 HIV-positive and 25 HIV-negative were included. Serum neopterin levels were measured three times during the observation period (before onset of treatment with acyclovir, on the 3rd day of treatment and after healing of skin lesions. The clinical course and dynamics of laboratory data were also evaluated.Results: The study showed that elevated serum neopterin levels were found in all patients with herpes zoster. Neopterin concentrations were significantly reduced during acyclovir treatment (from 30 (17; 32 to 12 (11; 27 nmol/L (p = 0,0000001, but remained above the upper limit of normal by the time skin lesions were healed in most patients. Neopterin levels before and after treatment weren’t associated with HIV-status. Neopterin concentration was slightly higher in patients with HIV infection on the third day of observation only, that could reflect the abnormal immunoreactivity of this host. Neopterin levels in patients with varicella zoster viremia were higher compared to patients without viremia on the third day of treatment with acyclovir (23.5 (12,7; 30,0 and 12 (4,2, 24,5 nmol/L, respectively, p = 0,037.Conclusions: These results suggest that the dynamics of serum neopterin could be a marker of effectiveness of immune response in herpes zoster.

  2. Effect of a Zoster Vaccine on Herpes Zoster-Related Interference with Functional Status and Health-Related Quality of Life Measures in Older Adults

    Science.gov (United States)

    Schmader, Kenneth E.; Johnson, Gary R.; Saddier, Patricia; Ciarleglio, Maria; Wang, William W.B.; Zhang, Jane H.; Chan, Ivan S.F.; Yeh, Shing-Shing; Levin, Myron J.; Harbecke, Ruth M.; Oxman, Michael N.

    2010-01-01

    Objective To determine the efficacy of a zoster vaccine on herpes zoster related interference with activities of daily living (ADL) and health-related quality of life (HRQL). Design Randomized double-blind placebo controlled trial. Setting 22 US sites. Patients 38,546 women and men ≥60 years of age. Intervention Zoster vaccine or placebo. Measurements Herpes zoster Burden of Interference with ADL and HRQL using ratings from the Zoster Brief Pain Inventory and SF-12 Mental and Physical Component Scores. Vaccine efficacy was calculated for the modified-intention-to-treat trial population and solely among those subjects who developed herpes zoster. Results For the modified-intention-to-treat population, the overall zoster vaccine efficacy was 66% (95% CI: 55, 74) for Zoster Brief Pain Inventory ADL Burden of Interference Score and 55% (95% CI: 48, 61) for both the SF-12 Mental and Physical Component Scores. Among subjects who developed herpes zoster, zoster vaccine reduced the Zoster Brief Pain Inventory ADL Burden of Interference Score by 31% (95% CI: 12, 51) respectively, and did not significantly reduce the impact on HRQL. Conclusions Zoster vaccine reduced the burden of herpes zoster related interference with ADL in the population of vaccinees and among vaccinees who developed herpes zoster. Zoster vaccine reduced the impact of herpes zoster on HRQL in the population of vaccinees but not among vaccinees who developed herpes zoster. PMID:20863322

  3. Increasing trends of herpes zoster in Australia.

    Directory of Open Access Journals (Sweden)

    Raina MacIntyre

    Full Text Available Increasing trends in incidence of herpes zoster (HZ have been reported in Australia and internationally. This may reflect the impact of childhood VZV vaccination programs introduced universally in Australia in late 2005. The objective of this study was to evaluate changes in incidence of HZ and PHN in Australia over time, and associated healthcare resource utilisation.Australian data on general practice (GP encounters for HZ, specific antiviral prescribing data from the pharmaceutical benefits scheme, emergency department presentations from the states of NSW and Victoria and national hospitalisation data for HZ were analysed for time trends using regression models. Two time periods (2000-2006 and 2006-2013 were compared which correspond broadly with the pre- and post- universal VZV vaccination period.All data sources showed increasing rates of HZ with age and over time. The GP database showed a significant annual increase in encounters for HZ of 2.5 per 100,000 between 1998 and 2013, and the rates of prescriptions for HZ increased by 4.2% per year between 2002 and 2012. In the 60+ population HZ incidence was estimated to increase from 11.9 to 15.4 per 1,000 persons using GP data or from 12.8 to 14.2 per 1,000 persons using prescription data (p<0.05, between the two periods. Hospitalisation data did not show the same increasing trend over time, except for the age group ≥80 years. Most emergency visits for HZ were not admitted, and showed significant increases over time.The burden of HZ in Australia is substantial, and continues to increase over time. This increase is seen both pre- and post-universal VZV vaccination in 2005, and is most prominent in the older population. The substantial burden of HZ, along with ageing of the Australian population and the importance of healthy ageing, warrants consideration of HZ vaccination for the elderly.

  4. Breakthrough VZV infection after immunization, presenting as herpes zoster.

    NARCIS (Netherlands)

    Schade, R.P.; Bakkers, J.; Cornelissen, M.; Koster-Kamphuis, L.; Melchers, W.J.G.; Galama, J.M.D.

    2008-01-01

    An immunocompromized, VZV-vaccinated child had a breakthrough infection with VZV, acquired at a day-care centre during a chickenpox outbreak. Interestingly, the infection manifested as herpes zoster of 1 dermatome. Typing showed wild-type virus, which suggests that exogenous reinfection with a new s

  5. Herpes zoster in psoriasis patients treated with tofacitinib

    DEFF Research Database (Denmark)

    Winthrop, Kevin L; Lebwohl, Mark; Cohen, Arnon D

    2017-01-01

    BACKGROUND: Tofacitinib is an oral Janus kinase (JAK) inhibitor. Immunomodulatory therapies can increase the risk for herpes zoster (HZ) in patients with psoriasis. OBJECTIVE: To evaluate the relationship between tofacitinib use and HZ risk. METHODS: We used phases 2 and 3 and long-term extension...

  6. Penile herpes zoster: an unusual location for a common disease

    Directory of Open Access Journals (Sweden)

    Milan Bjekic

    2011-12-01

    Full Text Available Herpes zoster is a common dermatological condition which affects up to 20% of the population, most frequently involving the thoracic and facial dermatomes with sacral lesions occurring rarely and only a few reported cases of penile shingles. Case report: We report two cases of unusual penile clinical presentations of varicella zoster virus infection in immunocompetent men. The patients presented with grouped clusters of vesicles and erythema on the left side of penile shaft and posterior aspect of the left thigh and buttock, involving s2-s4 dermatomes. The lesions resolved quickly upon administration of oral antiviral therapy. Conclusion: Penile herpes zoster should not be overlooked in patients with unilateral vesicular rash.

  7. Penile herpes zoster: an unusual location for a common disease

    Directory of Open Access Journals (Sweden)

    Milan Bjekic

    Full Text Available Herpes zoster is a common dermatological condition which affects up to 20% of the population, most frequently involving the thoracic and facial dermatomes with sacral lesions occurring rarely and only a few reported cases of penile shingles. Case report: We report two cases of unusual penile clinical presentations of varicella zoster virus infection in immunocompetent men. The patients presented with grouped clusters of vesicles and erythema on the left side of penile shaft and posterior aspect of the left thigh and buttock, involving s2-s4 dermatomes. The lesions resolved quickly upon administration of oral antiviral therapy. Conclusion: Penile herpes zoster should not be overlooked in patients with unilateral vesicular rash.

  8. Increased risk of cardiovascular events in patients with herpes zoster: a population-based study.

    Science.gov (United States)

    Wu, Po-yuan; Lin, Cheng-Li; Sung, Fung-Chang; Chou, Tzu-Chieh; Lee, Yuan-Teh

    2014-05-01

    The association between herpes zoster and cardiovascular complications remains vague with limited study on the association between these two disorders. This study evaluated the risk of cardiovascular diseases in patients with herpes zoster. From insurance claims data of Taiwan, 19,483 patients with herpes zoster diagnosed in 1998-2008 and 77,932 subjects without herpes zoster were identified in this study. Both cohorts were followed up until the end of 2010 to measure the incidence of arrhythmia and coronary artery disease. The incidence rate ratio and adjusted hazard ratio (HR) of the cardiovascular complications with 95% confidence interval (CI) were estimated. The incidence of arrhythmia was 1.17-fold greater in the herpes zoster cohort than in the non-herpes zoster cohort (13.2 vs. 11.3 per 1,000 person-years), with an adjusted HR of 1.16 (P herpes zoster cohort was 1.16-fold higher than that in the non-herpes zoster cohort (9.02 vs. 7.83 per 1,000 person-years), with an adjusted HR of 1.11 (P herpes zoster diagnosis. The risk measured for these disorders declined over time. Comorbidities of hypertension, diabetes, and hyperlipidemia also contributed to these cardiovascular disorders with greater extent. It is concluded that the contribution of herpes zoster to the risk of arrhythmia and cardiovascular diseases is less strong than that of hypertension, diabetes, and hyperlipidemia.

  9. Incidence of herpes zoster infections in juvenile idiopathic arthritis patients.

    Science.gov (United States)

    Nimmrich, S; Horneff, G

    2015-03-01

    The risk of herpes zoster among patients with juvenile idiopathic arthritis (JIA) exposed to biologics has not been evaluated. We determined incidence rates of herpes zoster among children with JIA in correlation with medication at time of occurrence and total drug exposure. The German biologics register database was used to identify patients with herpes zoster. Crude infection rates and incidence ratios (IRR) were compared to published rates. Demographics and overall exposure and particular exposure time to corticosteroids, immunosuppressive drugs and biologics were analyzed. The JIA cohort included 3,042 patients with 5,557.9 person-years of follow-up; 1,628 have used corticosteroids, 2,930 methotrexate and 1,685 etanercept. In total, 17 herpes zoster events have been documented [6/1,000 patients (3.5-9.0); 3.1/1,000 patient-years (1.9-4.9)]. Thus, the incidence rate in JIA patients was higher than expected [IRR 2.9 (1.8-4.5), p herpes zoster. Compared to the healthy population, a significant higher IRR is observed in JIA patients who received a monotherapy with etanercept or in combination with steroids and methotrexate, but not in JIA patients exposed to methotrexate without biologics. In comparison with our control group of patients treated with methotrexate, the IRR was higher for exposure to etanercept monotherapy and combination of etanercept and corticosteroids irrespective of methotrexate use. A generally higher incidence rate in JIA patients treated with etanercept was observed. No serious or refractory manifestations occurred.

  10. Herpes zoster – available epidemiological data in Slovenia

    Directory of Open Access Journals (Sweden)

    Maja Sočan

    2006-09-01

    Full Text Available Background: Herpes zoster results from reactivation of latent varicella zoster virus (VZV in dorsal nerve ganglia. Herpes zoster is characterized by a painful dermatomal vesicular rash. Reactivation results from impaired cell-mediated immunity. The determinants of reactivation in individuals with no underlying immunosuppression are poorly understood. The introduction of vaccination against varicella is expected to lower the incidence rate of chicken pox. The influence of vaccination on herpes zoster morbidity is not clear and demands enhanced surveillance. Before the introduction of vaccination, the available epidemiological data should be analyzed for the availability, value and shortcomings.Methods: The data from two electronic data-sets of Institute of Public Health of the Republic Slovenia were analysed: notified cases and number of consultations on primary level for herpes zoster – »ZUBSTAT« (data set of all first visits in primary care, Institute of Public Health of the Republic Slovenia. The data were stratified by age and sex. The hospitalization data were extracted from Eletronic data set for diseases which require hospitalization (entitled BOLOB, IPH. For notified and hospitalized cases also the month when shigles appeared was available.Results: The number of notified cases increased steadily from year 1995 when mandatory reporting has been implemented. In year 2005 the incidence rate rose to 74/100,000. Approximately a quarter of cases (23.4 % was 70 years of age or older. According to the second data-set, which encompasses first visits in primary care, 5891 to 6527 patients were coded as herpes zoster. The incidence rate increases with age, being highest after age of 65 years (675 to 760/100,000. Women have higher incidence rate of herpes zoster in almost all age groups. The distribution of notified cases suggests seasonal peak in summer. The highest number of admissions was in September and October.Conclusions: The number of

  11. Management and Prevention of Herpes Zoster Ocular Disease.

    Science.gov (United States)

    Cohen, Elisabeth J

    2015-10-01

    Herpes zoster (HZ) is caused by reactivation of latent varicella zoster virus (VZV) in people who have had chicken pox, usually resulting in a painful, unilateral, dermatomal, vesicular rash. Herpes zoster ophthalmicus occurs when the first division of cranial nerve V is involved. HZ is common, with approximately 1 million new cases per year in the United States, and occurs in 1 in 3 persons. Although the rate of HZ increases with age, over half of all cases occur under the age of 60 years. Complications of herpes zoster ophthalmicus include eye disease, postherpetic neuralgia (PHN), and strokes. VZV has also been found in temporal arteritis biopsies. There is growing evidence that HZ is followed by chronic active VZV infection contributing to these complications. In view of this, and the efficacy of suppressive antiviral treatment in reducing recurrent herpes simplex keratitis, a randomized controlled trial of suppressive valacyclovir to reduce new or worsening anterior segment disease and/or PHN is needed. The zoster vaccine (ZV) is safe and effective in reducing the burden of illness, severity of PHN, and incidence of HZ. It is Centers for Disease Control and Prevention recommended for persons aged 60 years and above without impaired cellular immunity, and Food and Drug Administration approved for those aged 50 and older. It is most effective in preventing HZ in recipients in their 50s. Because of underusage of the ZV, it has not impacted the epidemiology of the disease. Barriers to its use include cost, variable reimbursement, frozen storage, and lack of a strong recommendation by doctors.

  12. Herpes Zoster Ophthalmicus: A Review for the Internist.

    Science.gov (United States)

    Vrcek, Ivan; Choudhury, Eileen; Durairaj, Vikram

    2017-01-01

    Herpes zoster ophthalmicus occurs due to reactivation of the varicella zoster virus in the ophthalmic branch of the fifth cranial nerve. This disease primarily affects the elderly as well as the immunocompromised and can result in a wide range of ophthalmic morbidity. Systemic antiviral therapy is the mainstay of treatment; however, consultation with an ophthalmologist is typically indicated. Herein we present a review of this common entity including epidemiology, pathophysiology, evaluation, treatment, follow-up, and an update on the current body of literature. Copyright © 2016 Elsevier Inc. All rights reserved.

  13. Prevention strategies for herpes zoster and post-herpetic neuralgia

    Science.gov (United States)

    Levin, Myron J.; Gershon, Anne A.; Dworkin, Robert H.; Brisson, Marc; Stanberry, Lawrence

    2017-01-01

    SUMMARY Impairment of varicella zoster virus (VZV)-specific cell-mediated immunity, including impairment due to immunosenescence, is associated with an increased risk of developing herpes zoster (HZ), whereas levels of anti-VZV antibodies do not correlate with HZ risk. This crucial role of VZV-specific cell-mediated immunity suggests that boosting these responses by vaccination will be an effective strategy for reducing the burden of HZ. Other strategies focus on preventing the major complication of HZ – post-herpetic neuralgia. These strategies include pre-emptive treatment with drugs such as tricyclic antidepressants, anticonvulsants and analgesics. PMID:20510262

  14. Bullous Variant of Sweet’s Syndrome after Herpes Zoster Virus Infection

    OpenAIRE

    2011-01-01

    Aim: Cutaneous manifestations of Sweet’s syndrome (SS) are typically painful plaque-forming erythematous papules, while bullae are quite uncommon. We present a case of bullous variant of SS in acute myeloid leukaemia. In this case, herpes infection of the left mandible had preceded the development of SS. Case Report: A 75-year-old male with myelodysplastic syndrome first presented with herpes zoster virus infection-like bullae and erosive plaques on the left side of the face and neck. Treatme...

  15. Varicella Zoster Virus in Saliva of Patients With Herpes Zoster

    Science.gov (United States)

    Mehta, Satish K.; Tyring, Stephen K.; Gilden, Donald H.; Cohrs, Randall J.; Leal, Melanie J.; Castro, Victoria A.; Feiveson, Alan H.; Ott, C. Mark; Pierson, Duane L.

    2007-01-01

    Background. VZV DNA is present in saliva of healthy astronauts and patients with Ramsay Hunt syndrome (geniculate zoster). We hypothesized that a prospective analysis of patients with zoster would detect VZV in saliva independent of zoster location. Methods. We treated 54 patients with valacyclovir. On the first treatment day, 7- and 14-days later, pain was scored and saliva examined for VZV DNA. Saliva from six subjects with chronic pain and 14 healthy subjects was similarly studied. Results. Follow-up data was available for 50/54 patients. Pain decreased in 43/50 (86 percent), disappeared in 37 (74 percent), recurred after disappearing in three (6 percent) and increased in four (8 percent). VZV DNA was found in every patient the day treatment was started, decreased in 47/50 (94 percent), transiently increased in three (6 percent) before decreasing, increased in two (4 percent) and disappeared in 41 (82 percent). There was a positive correlation between the presence of VZV DNA and pain, as well as between the VZV DNA copy number and pain (Pzoster patients.

  16. Incidence of Herpes Zoster in relationship with Climate Factors from 2009 to 2011

    Directory of Open Access Journals (Sweden)

    Herning Adinda

    2015-09-01

    Full Text Available Background: Herpes zoster, or shingles, is a skin or mucous infection caused by the reactivation of varicella-zoster virus (VZV. Seasonal pattern of herpes zoster incidence was reported in some countries, indicating that emergence of this disease was caused by the reactivation of latent Varicella-Zoster Virus (VZV rather than new exposures to VZV. On the other hand, the VZV primary infection difference between tropical and temperate zones may have implications for virus reactivation as herpes zoster. The aim of this study was to identify the incidence of herpes zoster in Dr. Hasan Sadikin General Hospital Bandung, West Java related to the change of rainfall, air temperature and humidity from 2009 to 2011. Methods: A descriptive retrospective study was carried out to 341 medical records of herpes zoster patients from Dr. Hasan Sadikin General Hospital Bandung periode 2009 to 2011. Data on climate factors, i.e. rainfall, air temperature, and relative humidity, were obtained from the Indonesian Meteorology, Climatology, and Geophysical Agency. The collected data were presented using tables and figures. Result: The highest number of herpes zoster cases occured during the period when the highest annually total rainfall and annually mean relative humidity occurred. Conclusions: The finding of this study shows that herpes zoster cases have the same pattern with the rainfall and relative humidity. These findings can inform better prevention of herpes zoster. However, further research is needed to get more comprehensive understanding on this relationship.

  17. Valacyclovir versus acyclovir for the treatment of herpes zoster ophthalmicus in immunocompetent patients.

    Science.gov (United States)

    Schuster, Alexander K; Harder, Björn C; Schlichtenbrede, Frank C; Jarczok, Marc N; Tesarz, Jonas

    2016-11-14

    Herpes zoster ophthalmicus affects the eye and vision, and is caused by the reactivation of the varicella zoster virus in the distribution of the first division of the trigeminal nerve. An aggressive management of acute herpes zoster ophthalmicus with systemic antiviral medication is generally recommended as the standard first-line treatment for herpes zoster ophthalmicus infections. Both acyclovir and its prodrug valacyclovir are medications that are approved for the systemic treatment of herpes zoster. Although it is known that valacyclovir has an improved bioavailability and steadier plasma concentration, it is currently unclear as to whether this leads to better treatment results and less ocular complications. To assess the effects of valacyclovir versus acyclovir for the systemic antiviral treatment of herpes zoster ophthalmicus in immunocompetent patients. We searched CENTRAL (which contains the Cochrane Eyes and Vision Trials Register; 2016, Issue 5), Ovid MEDLINE, Ovid MEDLINE In-Process and Other Non-Indexed Citations, Ovid MEDLINE Daily, Ovid OLDMEDLINE (January 1946 to June 2016), Embase (January 1980 to June 2016), Web of Science Conference Proceedings Citation Index-Science (CPCI-S; January 1990 to June 2016), BIOSIS Previews (January 1969 to June 2016), the ISRCTN registry (www.isrctn.com/editAdvancedSearch), ClinicalTrials.gov (www.clinicaltrials.gov), and the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP; www.who.int/ictrp/search/en). We did not use any date or language restrictions in the electronic searches for trials. We last searched the electronic databases on 13 June 2016. We considered all randomised controlled trials (RCTs) in which systemic valacyclovir was compared to systemic acyclovir medication for treatment of herpes zoster ophthalmicus. There were no language restrictions. Two review authors independently selected trials, evaluated the risk of bias in included trials, and extracted and analysed

  18. Herpes zoster in multiple myeloma patients during bortezomib treatment

    Directory of Open Access Journals (Sweden)

    I. N. Nazarova

    2011-01-01

    Full Text Available Recent advances in multiple myeloma (MM treatment associated with new drug use including bortezomib. Experiences in wide ambul atory drug use confirm therapy success for this serious disease, but at the same time reveals the most common side effects. One of th e most significant is the reactivation of Herpes zoster , which leads to decrease MM therapy results because of inability to perform standard therapy in these patients. Literature data and own experiences about reactivation of Herpes zoster during bortezomib therapy as monothe rapy and in combination, which varies from 7 to 34% according to different authors and 25% of own experiences, is presented. Treatment and preventive schedule of this complication are shown.

  19. Increased risk of herpes zoster in children with cancer: A nationwide population-based cohort study.

    Science.gov (United States)

    Lin, Hsiao-Chuan; Chao, Yu-Hua; Wu, Kang-Hsi; Yen, Ting-Yu; Hsu, Yu-Lung; Hsieh, Tsung-Hsueh; Wei, Hsiu-Mei; Wu, Jhong-Lin; Muo, Chih-Hsin; Hwang, Kao-Pin; Peng, Ching-Tien; Lin, Cheng-Chieh; Li, Tsai-Chung

    2016-07-01

    Herpes zoster is rare in healthy children, but immunocompromised persons have an increased risk of herpes zoster and severe diseases. Considering the very limited information on herpes zoster in children with cancer, we performed a nationwide population-based cohort study to estimate the incidence of herpes zoster in children with cancer and to explore the association between the 2 diseases.Data were obtained from the National Health Research Institutes Database in Taiwan. A total of 4432 children with newly diagnosed cancer between 2000 and 2007 were identified as the cancer cohort, and 17,653 children without cancer frequency-matched by sex and age at entry were considered the noncancer cohort. The association between herpes zoster and childhood cancer was determined.Children with cancer had a higher risk of herpes zoster. The incidence rate of herpes zoster was higher in the cancer cohort than in the noncancer cohort (20.7 vs 2.4 per 10,000 person-years; IRR = 8.6; 95% CI = 4.8-15.6). The cumulative incidence was significantly higher in the cancer cohort (P herpes zoster. In addition to early antiviral treatment, vaccination with heat-treated zoster vaccine or adjuvanted subunit vaccine could be an appropriate policy to decrease the incidence in children with cancer.

  20. Herpes zoster infection, vaccination and immunocompromised rheumatology patients.

    LENUS (Irish Health Repository)

    O'Connor, Mortimer B

    2013-01-01

    Varicella is a self-limiting and relatively mild disease of childhood, although it is frequently more severe and complicated among the immunocompromised rheumatology patients on immunomodulator therapies. In addition, future reactivation of the dormant virus in dorsal root ganglia may cause herpes zoster infection, which can be very debilitating. In this manuscript, we discuss the nature of this infection along with its potential vaccine especially among rheumatology patients.

  1. Post herpes-zoster scar sarcoidosis with pulmonary involvement

    Directory of Open Access Journals (Sweden)

    Archana Singal

    2014-01-01

    Full Text Available Cutaneous sarcoidosis presents with a wide range of clinical presentations. An uncommon cutaneous manifestation is infiltration of old cutaneous scars with non-caseating granulomas known as scar sarcoidosis. Most of the patients with this clinical entity have other systemic manifestations, particularly pulmonary changes. We report a case of a 50 years old man, presenting with cutaneous sarcoidosis overlying scars of healed herpes zoster.

  2. Risk of Stroke and Myocardial Infarction After Herpes Zoster in Older Adults in a US Community Population.

    Science.gov (United States)

    Yawn, Barbara P; Wollan, Peter C; Nagel, Maria A; Gilden, Don

    2016-01-01

    To assess the risk of stroke and myocardial infarction (MI) after herpes zoster in a US community population of older adults. We performed a community cohort study (January 1, 1986, to October 1, 2011) comparing the risk of stroke and MI in 4862 adult residents of Olmsted County, Minnesota, 50 years and older with and without herpes zoster and 19,433 sex- and age-matched individuals with no history of herpes zoster. Odds ratios are presented for MI and stroke at 3, 6, 12, and 36 months after index herpes zoster plus hazard ratios for long-term risk (up to 28.6 years). Individuals with herpes zoster had more risk or confounding factors for MI and stroke, suggesting that they had worse health status overall. When controlling for the multiple risk factors, those with herpes zoster were at increased risk for stroke at 3 months after herpes zoster compared with those without a history of herpes zoster (odds ratio, 1.53; 95% CI, 1.10-2.33; P=.04). The association between herpes zoster and MI at 3 months was not robust across analytic methods. Herpes zoster was not associated with an increased risk of stroke or MI at any point beyond 3 months. Herpes zoster was associated with only a short-term increased risk of stroke, which may be preventable with the prevention of herpes zoster. Copyright © 2016 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

  3. Longitudinal analysis of varicella-zoster virus DNA on the ocular surface associated with herpes zoster ophthalmicus

    NARCIS (Netherlands)

    Zaal, M.J.; Volker-Dieben, H.J.; Wienesen, M.; D'Amaro, J.; Kijlstra, A.

    2001-01-01

    PURPOSE: Longitudinal analysis of varicella-zoster virus DNA on the ocular surface of patients with herpes zoster ophthalmicus. METHODS: Clinical specimens were obtained from the bulbar conjunctival surface with a cotton-tipped swab at weekly intervals for 6 consecutive weeks from 21 patients with a

  4. Longitudinal analysis of varicella-zoster virus DNA on the ocular surface associated with herpes zoster ophthalmicus

    NARCIS (Netherlands)

    Zaal, M.J.; Volker-Dieben, H.J.; Wienesen, M.; Amaro, D' J.; Kijlstra, A.

    2001-01-01

    PURPOSE: Longitudinal analysis of varicella-zoster virus DNA on the ocular surface of patients with herpes zoster ophthalmicus. METHODS: Clinical specimens were obtained from the bulbar conjunctival surface with a cotton-tipped swab at weekly intervals for 6 consecutive weeks from 21 patients with

  5. Occipital neuralgia evoked by facial herpes zoster infection.

    Science.gov (United States)

    Kihara, Takeshi; Shimohama, Shun

    2006-01-01

    Occipital neuralgia is a pain syndrome which may usually be induced by spasms of the cervical muscles or trauma to the greater or lesser occipital nerves. We report a patient with occipital neuralgia followed by facial herpes lesion. A 74-year-old male experienced sudden-onset severe headache in the occipital area. The pain was localized to the distribution of the right side of the greater occipital nerve, and palpation of the right greater occipital nerve reproduces the pain. He was diagnosed with occipital neuralgia according to ICHD-II criteria. A few days later, the occipital pain was followed by reddening of the skin and the appearance, of varying size, of vesicles on the right side of his face (the maxillary nerve and the mandibular nerve region). This was diagnosed as herpes zoster. This case represents a combination of facial herpes lesions and pain in the C2 and C3 regions. The pain syndromes can be confusing, and the classic herpes zoster infection should be considered even when no skin lesions are established.

  6. Herpes Zoster Infections in SLE in a University Hospital in Saudi Arabia: Risk Factors and Outcomes

    Directory of Open Access Journals (Sweden)

    Afsar Sayeeda

    2010-01-01

    (0/23. None of the patients had postherpetic neuralgia or bacterial super infection. Immunosuppressive medications were discontinued at the time of diagnosis of Zoster in 19 of 32 patients and all patients received antiviral medications.There were no permanent neurologic deficits or deaths. We conclude that Herpes Zoster infections occur at increased frequency among patients with SLE and carry significant morbidity. Immunosuppressive therapy and severe manifestations of lupus may be risk factors for the development of Herpes Zoster although not necessarily at the time of disease flare or immunosuppressive therapy. Our study suggests that although Herpes Zoster occurs frequently in patients with SLE, it has a relatively benign course.

  7. DUAL EPISODES OF HERPES ZOSTER IN A SINGLE YEAR IN IMMUNOCOMPETENT MALE CASE REPORT

    Directory of Open Access Journals (Sweden)

    Gaurav

    2014-12-01

    Full Text Available Herpes zoster, is a viral disease characterised by painful skin rash with blister in a limited area on one side of body. Varicella zoster virus1 is the cause of both varicella (Chicken pox and zoster (Shingles.It initially causes chicken pox and then remains latent for decades in cranial nerve, dorsal root and autonomic nervous system ganglia. 2 Three genotypes of this alpha – herpesvirus have been identified and shown to have geographical variations. 3 The virus gets reactivated after a variable period of time to cause zoster. Recurrences of zoster4 are common in immune-compromised patients, those having lymphoma, hiv, diabeties or on immune-supressive drugs especially the more profound suppression required for bone marrow transplantation. 5,6 However recurrences are rare in immune-competent individuals. We report here a case of recurrent herpes zoster in a immune-competent male within 1 year of the first attack of herpes zoster

  8. Herpes zoster vaccine effectiveness and manifestations of herpes zoster and associated pain by vaccination status.

    Science.gov (United States)

    Marin, Mona; Yawn, Barbara P; Hales, Craig M; Wollan, Peter C; Bialek, Stephanie R; Zhang, John; Kurland, Marge J; Harpaz, Rafael

    2015-01-01

    Options for managing herpes zoster (HZ)-related pain and complications have limited effectiveness, making HZ prevention through vaccination an important strategy. Limited data are available on HZ vaccine effectiveness against confirmed HZ and manifestations of HZ among vaccinated persons. We conducted a matched case-control study to assess HZ vaccine effectiveness for prevention of HZ and other HZ-related outcomes and a cohort study of persons with HZ to compare HZ-related outcomes by vaccination status. Cases were identified through active surveillance among persons age ≥ 60 years with HZ onset and health-care encounters during 2010-2011 in Southeastern Minnesota. Controls were age- and sex-matched to cases. Data were collected by medical record review and from participants via interviews and daily pain diaries. 266 HZ case-patients and 362 matched controls were enrolled in the vaccine effectiveness studies and 303 case-patients in the cohort study of HZ characteristics by vaccination status. Vaccination was associated with 54% (95% CI:32%-69%) reduction in HZ incidence, 58% (95% CI:31%-75%) reduction in HZ prodromal symptoms, and 70% (95% CI:33%-87%) reduction in medically-attended prodrome. HZ vaccine was statistically significant effective at preventing postherpetic neuralgia (PHN) measured at 30 d after rash onset, 61% (95% CI: 22%-80%). Among persons who developed HZ, no differences were found by vaccination status in severity or duration of HZ pain after rash onset. In this population-based study, HZ vaccination was associated with >50% reduction in HZ, HZ prodrome, and medically-attended prodrome.

  9. A rare case of Herpes zoster oticus in an immunocompetent patient

    Directory of Open Access Journals (Sweden)

    Ganesh Prabhakar Dhavalshankh

    2012-10-01

    Full Text Available Herpes zoster oticus in healthy persons is uncommon, though it has been described in immunocompromised patients. We describe a case of disseminated herpes zoster oticus in an elderly man with no apparent immunosuppressive condition. The patient was treated successfully with oral Acyclovir. We suggest that disseminated zoster can occur in an immunocompetent host and should be promptly recognized and treated to prevent serious complications.

  10. Herpes zoster reactivation after extracorporeal shock wave lithotripsy: A case report

    Directory of Open Access Journals (Sweden)

    Krishnamoorthy Hariharan

    2016-01-01

    Full Text Available Herpes zoster is a reactivated varicella-zoster virus (VZV infection of the sensory nerve ganglion, peripheral nerve, and its branches. Mechanical trauma to the nervous system can reactivate VZV. It is well known that extracorporeal shock wave lithotripsy (SWL can produce mechanical damage to the tissue. We report a rare case of herpes zoster reactivation after SWL for treatment of 1.2 cm size renal stone in a 63-year-old male patient.

  11. Abdominal distention and constipation followed by herpes zoster infection in a 2-month-old female infant.

    Science.gov (United States)

    Wang, Hongfeng; Fang, Fang

    2015-08-01

    Gastrointestinal symptoms of herpes zoster in infants are rarely reported. A 2-month-old female infant presented with herpes zoster and additional complication of abdominal distention and constipation. While rashes resolved, abdominal distention and constipation improved soon. To our knowledge, this is the first report of gastrointestinal complication of herpes zoster in infants. Physicians should be aware of the potential for motor involvement of herpes zoster in such infants. Herpes zoster should be considered during the diagnosis in the event of infants presenting with constipation.

  12. A systematic review and meta-analysis on herpes zoster and the risk of cardiac and cerebrovascular events.

    Science.gov (United States)

    Erskine, Nathaniel; Tran, Hoang; Levin, Leonard; Ulbricht, Christine; Fingeroth, Joyce; Kiefe, Catarina; Goldberg, Robert J; Singh, Sonal

    2017-01-01

    Patients who develop herpes zoster or herpes zoster ophthalmicus may be at risk for cerebrovascular and cardiac complications. We systematically reviewed the published literature to determine the association between herpes zoster and its subtypes with the occurrence of cerebrovascular and cardiac events. Systematic searches of PubMed (MEDLINE), SCOPUS (Embase) and Google Scholar were performed in December 2016. Eligible studies were cohort, case-control, and self-controlled case-series examining the association between herpes zoster or subtypes of herpes zoster with the occurrence of cerebrovascular and cardiac events including stroke, transient ischemic attack, coronary heart disease, and myocardial infarction. Data on the occurrence of the examined events were abstracted. Odds ratios and their accompanying confidence intervals were estimated using random and fixed effects models with statistical heterogeneity estimated with the I2 statistic. Twelve studies examining 7.9 million patients up to 28 years after the onset of herpes zoster met our pre-defined eligibility criteria. Random and fixed effects meta-analyses showed that herpes zoster, type unspecified, and herpes zoster ophthalmicus were associated with a significantly increased risk of cerebrovascular events, without any evidence of statistical heterogeneity. Our meta-analysis also found a significantly increased risk of cardiac events associated with herpes zoster, type unspecified. Our results are consistent with the accumulating body of evidence that herpes zoster and herpes zoster ophthalmicus are significantly associated with cerebrovascular and cardiovascular events.

  13. Possible enhancement of BP180 autoantibody production by herpes zoster.

    Science.gov (United States)

    Kamiya, Koji; Aoyama, Yumi; Suzuki, Takahiro; Niwa, Haruo; Horio, Ai; Nishio, Eiichi; Tokura, Yoshiki

    2016-02-01

    Bullous pemphigoid (BP) is an autoimmune blistering disease caused by autoantibodies against type XVII collagen/BP180 (BP180). Although the mechanisms of autoantibody production remain to be elucidated, herpes virus infections have been identified as a possible triggering factor for pemphigus. We report a case of herpes zoster (HZ) having anti-BP180 serum antibodies. The patient developed sudden-onset, tense blisters and edematous erythema on the right anterior chest, shoulder and upper back. Histopathology showed remarkable degeneration of keratinocytes, acantholysis and blister formation with ballooning cells, indicating herpes virus infection. A polymerase chain reaction analysis of varicella zoster virus (VZV) was positive in crusts and effusions from the skin lesions, confirming the definitive diagnosis of HZ. Notably, we found that the patient had anti-BP180 serum antibodies in association with the occurrence of HZ. After successful treatment with valacyclovir hydrochloride for 7 days, the serum levels of anti-BP180 antibodies decreased in accordance with the improvement of skin lesions. These findings suggest that the production of anti-BP180 antibodies could be triggered by the reactivation of VZV.

  14. Herpes Zoster in a 3-month-old infant

    Directory of Open Access Journals (Sweden)

    Duarte Malveiro

    2015-12-01

    Full Text Available Introduction: Herpes Zoster (HZ is rare in infancy and results from reactivation of varicella-zoster virus, latent in the dorsal root ganglia of sensory or cranial nerves after primary infection (chickenpox. Case Report: We describe the case of an healthy infant, three months old, without previous clinical symptoms of chickenpox, in spite of having contacted with the disease at two weeks of life. She was hospitalized for vesicular-papular rash involving unilaterally dermatomes L4 and L5 and was treated with acyclovir with good clinical outcome. Conclusion: The immaturity of the immune system and the interference of maternal antibodies contribute to the manifestation of HZ in the first year of life. In a previously healthy child it is not recommended the exclusion of underlying immunodeficiency or malignant disease.

  15. Herpes zoster correlates with increased risk of Parkinson's disease in older people: A population-based cohort study in Taiwan.

    Science.gov (United States)

    Lai, Shih-Wei; Lin, Chih-Hsueh; Lin, Hsien-Feng; Lin, Cheng-Li; Lin, Cheng-Chieh; Liao, Kuan-Fu

    2017-02-01

    Little is known on the relationship between herpes zoster and Parkinson's disease in older people. This study aimed to explore whether herpes zoster could be associated with Parkinson's disease in older people in Taiwan.We conducted a retrospective cohort study using the claim data of the Taiwan National Health Insurance Program. There were 10,296 subjects aged 65 years and older with newly diagnosed herpes zoster as the herpes zoster group and 39,405 randomly selected subjects aged 65 years and older without a diagnosis of herpes zoster as the nonherpes zoster group from 1998 to 2010. Both groups were followed up until subjects received a diagnosis of Parkinson's disease. This follow-up design would explore whether subjects with herpes zoster were at an increased risk of Parkinson's disease. Relative risks were estimated by adjusted hazard ratio (HR) and 95% confidence interval (CI) using the multivariable Cox proportional hazards regression model.The incidence of Parkinson's disease was higher in the herpes zoster group than that in the nonherpes zoster group (4.86 vs 4.00 per 1000 person-years, 95% CI 1.14, 1.29). After adjustment for confounding factors, the multivariable Cox proportional hazards regression model revealed that the adjusted HR of Parkinson's disease was 1.17 for the herpes zoster group (95% CI 1.10, 1.25), compared with the nonherpes zoster group.Older people with herpes zoster confer a slightly increased hazard of developing Parkinson's disease when compared to those without herpes zoster. We think that herpes zoster correlates with increased risk of Parkinson's disease in older people. When older people with herpes zoster seek help, clinicians should pay more attention to the development of the cardinal symptoms of Parkinson's disease.

  16. Hospitalizations realted to herpes zoster infection in the Canary Islands, Spain (2005-2014).

    Science.gov (United States)

    García-Rojas, Amós; Gil-Prieto, Ruth; Núñez-Gallo, Domingo Ángel; Matute-Cruz, Petra; Gil-de-Miguel, Angel

    2017-08-24

    Herpes zoster is an important problem of public health especially among the elderly in Spain. A population-based retrospective epidemiological study to estimate the burden of herpes zoster requiring hospitalization in the Canary Islands, Spain was conducted by using data from the national surveillance system for hospital data, Conjunto Mínimo Básico de Datos. Records of all patients admitted to hospital with a diagnosis of herpes zoster in any position and cases of primary diagnosis (ICD-9-MC codes 053.0-053.9) during a 10-year period (2005-2014), were selected. A total of 1088 hospitalizations with a primary or secondary diagnosis of herpes zoster were identified during the study period. Annually there were 6.99 hospitalizations by herpes zoster per 100,000 population. It increases with age reaching a maximum in persons ≥85 years of age (43.98 admissions per 100,000). Average length of hospitalization was 16 days and 73 patients died, with a case-fatality rate of 4.03%. In 22% of the cases hospitalized, herpes zoster was the primary diagnosis. The hospitalization burden of herpes zoster in adults in the Canary Islands was still important during the last decade and justify the implementation of preventive measures, like vaccination in the elderly or other high risk groups to reduce the most severe cases of the disease.

  17. Herpes Zoster and Postherpetic Neuralgia: Practical Consideration for Prevention and Treatment

    Science.gov (United States)

    2015-01-01

    Herpes zoster (HZ) is a transient disease caused by the reactivation of latent varicella zoster virus (VZV) in spinal or cranial sensory ganglia. It is characterized by a painful rash in the affected dermatome. Postherpetic neuralgia (PHN) is the most troublesome side effect associated with HZ. However, PHN is often resistant to current analgesic treatments such as antidepressants, anticonvulsants, opioids, and topical agents including lidocaine patches and capsaicin cream and can persist for several years. The risk factors for reactivation of HZ include advanced age and compromised cell-mediated immunity (CMI). Early diagnosis and treatment with antiviral agents plus intervention treatments is believed to shorten the duration and severity of acute HZ and reduce the risk of PHN. Prophylactic vaccination against VZV can be the best option to prevent or reduce the incidence of HZ and PHN. This review focuses on the pathophysiology, clinical features, and management of HZ and PHN, as well as the efficacy of the HZ vaccine. PMID:26175877

  18. Herpes zoster: Epidemiología y clínica Clinical and epidemiological aspects of Herpes zoster

    OpenAIRE

    Claudia Vujacich; Emmanuel Poggi; Diego Cecchini; Pablo Luchetti; Daniel Stamboulian

    2008-01-01

    El herpes zoster (HZ) constituye una enfermedad de distribución mundial; sin embargo, existen es casos datos comunicados sobre la misma en países de Latinoamérica. Con el objetivo de evaluar aspectos clínicos y epidemiológicos de esta enfermedad en nuestra población, realizamos un análisis retrospectivo de historias clínicas de un centro privado de referencia en enfermedades infecciosas en Buenos Aires, Argentina (período: 2000-2005). Se realizó un análisis estadístico univariado para evaluar...

  19. Clinical and biological differences between recurrent herpes simplex virus and varicella-zoster virus infections

    Energy Technology Data Exchange (ETDEWEB)

    Straus, S.E. (National Institute of Allergy and Infectious Diseases, Bethesda, MD (USA))

    1989-12-01

    The major features that distinguish recurrent herpes simplex virus infections from zoster are illustrated in this article by two case histories. The clinical and epidemiologic features that characterize recurrent herpes simplex virus and varicella-zoster virus infections are reviewed. It is noted that herpesvirus infections are more common and severe in patients with cellular immune deficiency. Each virus evokes both humoral and cellular immune response in the course of primary infection. DNA hybridization studies with RNA probes labelled with sulfur-35 indicate that herpes simplex viruses persist within neurons, and that varicella-zoster virus is found in the satellite cells that encircle the neurons.

  20. Disease burden of herpes zoster in Sweden - predominance in the elderly and in women - a register based study

    Science.gov (United States)

    2013-01-01

    Background The herpes zoster burden of disease in Sweden is not well investigated. There is no Swedish immunization program to prevent varicella zoster virus infections. A vaccine against herpes zoster and its complications is now available. The aim of this study was to estimate the herpes zoster burden of disease and to establish a pre-vaccination baseline of the minimum incidence of herpes zoster. Methods Data were collected from the Swedish National Health Data Registers including the Patient Register, the Pharmacy Register, and the Cause of Death Register. The herpes zoster burden of disease in Sweden was estimated by analyzing the overall, and age and gender differences in the antiviral prescriptions, hospitalizations and complications during 2006-2010 and mortality during 2006-2009. Results Annually, 270 per 100,000 persons received antiviral treatment for herpes zoster, and the prescription rate increased with age. It was approximately 50% higher in females than in males in the age 50+ population (rate ratio 1.39; 95% CI, 1.22 to 1.58). The overall hospitalization rate for herpes zoster was 6.9/100,000 with an approximately three-fold increase for patients over 80 years of age compared to the age 70-79 group. A gender difference in hospitalization rates was observed: 8.1/100,000 in females and 5.6/100,000 in males. Herpes zoster, with a registered complication, was found in about one third of the hospitalized patients and the most common complications involved the peripheral and central nervous systems. Death due to herpes zoster was a rare event. Conclusions The results of this study demonstrate the significant burden of herpes zoster disease in the pre-zoster vaccination era. A strong correlation with age in the herpes zoster- related incidence, hospitalization, complications, and mortality rates was found. In addition, the study provides further evidence of the female predominance in herpes zoster disease. PMID:24330510

  1. Distrofia simpática reflexa pós herpes zoster Reflex sympathetic dystrophy following herpes zoster

    Directory of Open Access Journals (Sweden)

    Catia Susana Harumi Minami

    2004-08-01

    Full Text Available A distrofia simpática reflexa (DSR é uma síndrome dolorosa pouco entendida que consiste na presença de múltiplos sinais e sintomas incluindo dor, edema, alterações cutâneas distróficas e disfunção autonômica envolvendo uma ou mais extremidades. Nem sempre a DSR pós-herpes zóster é facilmente reconhecida. Poucos relatos dessa complicação foram publicados, o que torna interessante esta descrição. Apresentamos o caso de uma mulher branca, de 65 anos de idade cujos sinais e sintomas característicos de DSR no membro superior direito surgiram após 4 semanas do aparecimento das lesões de herpes zóster envolvendo trajeto dermatomérico. Com o diagnóstico precoce e abordagem terapêutica com calcitonina nasal e fisioterapia houve melhoras funcional e álgica satisfatórias em um mês de tratamento.The reflex sympathetic dystrophy (RSD is a poorly understood, painful syndrome that consists of multiple clinical manifestations, including pain, swelling, dystrophic cutaneous changes and autonomic dysfunction involving one or more extremities. The RSD following herpes zoster is not always easily recognized, and only a few documented cases of this complication have been reported, what makes this report even more interesting. We present the case of a 65 years old white woman, with characteristic signs and symptoms of RSD in the right upper limb observed four weeks after she had had a typical herpes zoster involving the dermatomes. Early diagnosis and treatment with intranasal calcitonin and physiotherapy lead to progressive functional and pain improvements after one month.

  2. Predictive factors of herpes zoster HIV-infected patients: another adverse effect of crack cocaine.

    Science.gov (United States)

    Nacher, Mathieu; Basurko, Celia; Adenis, Antoine; Gaubert-Marechal, Emilie; Mosnier, Emilie; Edouard, Sophie; Vantilcke, Vincent; Sivapregassam, Sindou; Tressières, Benoit; Cabié, André; Couppié, Pierre

    2013-01-01

    A retrospective cohort study was conducted on 1541 HIV-infected patients to determine variables associated with the incidence of herpes zoster. A single failure Cox model showed that herpes zoster incidence increased following the first 6 months of antiretroviral treatment adjusted hazard ratio (AHR)=5 (95%CI=2.6-9.2), P60 years age group AHR=2 (95%CI=1-4), P=0.04; in patients in the top CD8 quartile AHR=2.1 (95%CI=1.3-3.6), PHerpes zoster incidence increased in patients with CD4 countsherpes zoster incidence. The present study is the first to suggest that crack cocaine is associated with an increased incidence of herpes zoster. The neurological or immunological effects of crack are discussed.

  3. Salivary Varicella Zoster Virus in Astronauts and in Patients of Herpes Zoster

    Science.gov (United States)

    Mehta, Satish; Pierson, Duane L.

    2010-01-01

    Spaceflight is a uniquely stressful environment with astronauts experiencing a variety of stressors including: isolation and confinement, psychosocial, noise, sleep deprivation, anxiety, variable gravitational forces, and increased radiation. These stressors are manifested through the HPA and SAM axes resulting in increased stress hormones. Diminished T-lymphocyte functions lead to reactivation of latent herpes viruses in astronauts during spaceflight. Herpes simplex virus reactivated with symptoms during spaceflight whereas Epstein-Barr virus (EBV), cytomegalovirus (CMV), and varicella zoster virus (VZV) reactivate and are shed without symptoms. EBV and VZV are shed in saliva and CMV in the urine. The levels of EBV shed in astronauts increased 10-fold during the flight; CMV and VZV are not typically shed in low stressed individuals, but both were shed in astronauts during spaceflight. All herpesviruses were detected by polymerase chain reaction (PCR) assay. Culturing revealed that VZV shed in saliva was infectious virus. The PCR technology was extended to test saliva of 54 shingles patients. All shingles patients shed VZV in their saliva, and the levels followed the course of the disease. Viremia was also found to be common during shingles. The technology may be used before zoster lesions appear allowing for prevention of disease. The technology may be used for rapid detection of VZV in doctors? offices. These studies demonstrated the value of applying technologies designed for astronauts to people on Earth.

  4. Cost-effectiveness of vaccination of the elderly against herpes zoster in The Netherlands

    NARCIS (Netherlands)

    de Boer, Pieter T; Pouwels, Koen B; Cox, Juul M; Hak, Eelko; Wilschut, Jan C; Postma, Maarten J

    2013-01-01

    BACKGROUND: Each year a substantial number of Dutch elderly suffers from herpes zoster (HZ), caused by the reactivation of the varicella zoster virus (VZV). A potential complication of HZ is postherpetic neuralgia (PHN) which results in a prolonged loss of quality of life. A large randomized clinica

  5. Herpes zoster pain, postherpetic neuralgia, and quality of life in the elderly.

    Science.gov (United States)

    Pickering, Gisèle; Leplege, Alain

    2011-01-01

    Herpes zoster pain and postherpetic neuralgia (PHN) particularly affect older persons. This literature review presents how quality of life is evaluated and the consequences of shingles and PHN on the quality of life of older persons. Although more than 150 articles have been published on herpes zoster and its consequences, specific studies focusing on the older population are needed, in several domains like epidemiology, preventive medicine, neuropsychology, and pharmacology. © 2010 The Authors. Pain Practice © 2010 World Institute of Pain.

  6. Herpes Zoster Lesions on Reconstructed Breast Skin: Rare Objective Proof of Reinervation.

    Science.gov (United States)

    Weitgasser, Laurenz; Valina, Stephan Wolfgang; Schoeller, Thomas; Ehebruster, Gudrun

    2017-01-01

    Blazed up Herpes zoster lesions have been described in very few patients after free and pedicled flap transfer for reconstructive purpose. Although sensory recovery after flap reconstructions has been studied extensively most studies addressed subjective perceptions of sensation. Objective investigations of spontaneous reinervation of free and pedicled flaps are rare. We would like to present a witnessed herpes zoster infection of a latissimus dorsi skin flap 2 years after breast reconstruction.

  7. Unusual oral complications of herpes zoster infection: report of a case and review of literature.

    Science.gov (United States)

    Jain, Manoj Kumar; Manjunath, K S; Jagadish, S N

    2010-11-01

    A case of herpes zoster infection with unusual oral complications involving the mandibular division of the trigeminal nerve is presented. The post-herpetic complications of osteonecrosis, spontaneous exfoliation of teeth, and subsequent pathologic fracture of mandible in the absence of concurrent predisposing factors in a 65-year-old man are demonstrated. Forty-one cases with osteonecrosis and spontaneous exfoliation of teeth previously presented in the literature are reviewed. This is the first report of pathologic fracture after herpes zoster infection.

  8. Occurrence of herpes zoster varicella infections after completion of treatment for Hodgkin's disease

    Energy Technology Data Exchange (ETDEWEB)

    Pauw, B.E. de; Janssen, J.Th.P.; Vaissier, P.; Haanen, C. (Katholieke Univ. Nijmegen (Netherlands). Dept. of Internal Medicine)

    1983-01-01

    Retrospective analysis of 210 cases of patients with Hodgkin's disease revealed an overall incidence of herpes zoster varicella of 9.5 per cent. Patients with the mixed cellular histological subtype showed a significantly increased (p < 0.05) risk as compared with the total population. More than 90 per cent of the herpes zoster varicella infections occurred after termination of treatment; a combination of radiotherapy with chemotherapy proved to be a predisposing factor.

  9. The Short- and Long-Term Risk of Stroke after Herpes Zoster: A Meta-Analysis

    Science.gov (United States)

    Liu, Xuechun; Guan, Yeming; Hou, Liang; Huang, Haili; Liu, Hongjuan; Li, Chuanwen; Zhu, Yingying; Tao, Xingyong; Wang, Qingsong

    2016-01-01

    Background Accumulating evidence indicates that stroke risk may be increased following herpes zoster. The aim of this study is to perform a meta-analysis of current literature to systematically analyze and quantitatively estimate the short and long-term effects of herpes zoster on the risk of stroke. Methods Embase, PubMed and Cochrane library databases were searched for relevant studies up to March 2016. Studies were selected for analysis based on certain inclusion and exclusion criteria. Relative risks with 95% confidence interval (CI) were extracted to assess the association between herpes zoster and stroke. Results A total of 8 articles were included in our analysis. The present meta-analysis showed that the risks of stroke after herpes zoster were 2.36 (95% CI: 2.17–2.56) for first 2 weeks, 1.56 (95% CI: 1.46–1.66) for first month, 1.17 (95% CI: 1.13–1.22) for first year, and 1.09 (95% CI: 1.02–1.16) for more than 1 year, respectively. Conclusion The results of our study demonstrated that herpes zoster was associated with a higher risk of stroke, but the risks decreased along with the time after herpes zoster. PMID:27768762

  10. Herpes Zoster as a Predictor of HIV Infection in Taiwan: A Population-Based Study.

    Science.gov (United States)

    Lee, Yuan-Ti; Nfor, Oswald Ndi; Tantoh, Disline Manli; Huang, Jing-Yang; Ku, Wen-Yuan; Hsu, Shu-Yi; Ko, Pei-Chieh; Hung, Hung-Chang; Jan, Cheng-Feng; Liaw, Yung-Po

    2015-01-01

    This study aimed to investigate the association between herpes zoster (HZ) and human immunodeficiency virus (HIV). Data were retrieved from the Longitudinal Health Insurance Databases (LHID 2005 and 2010), Taiwan. The International Classification of Diseases, 9th Revision, Clinical Modification [ICD-9-CM] codes were used to identify Hz from 2001-2004. Identification of HIV infection was from 2005-2010. The hazard ratios of HIV among herpes zoster infected and non-herpes zoster infected patients were estimated using multiple Cox proportional hazard model. In general, 19685 participants were identified with Hz. The HIV incidence rates (per 104 person-months) in herpes zoster infected and non-infected patients were 0.191(95% CI 0.130-0.280) and 0.079 (95% CI 0.074-0.084), respectively while the hazard ratio (HR) of HIV among infected individuals was 3.518 (95% CI 2.375-5.211). This study concludes that herpes zoster could be considered as a predictor of HIV infection especially among Asian populations, hence it is vital to test herpes zoster infected individuals for HIV antibodies.

  11. Cost-effectiveness of vaccination against herpes zoster.

    Science.gov (United States)

    de Boer, Pieter T; Wilschut, Jan C; Postma, Maarten J

    2014-01-01

    Herpes zoster (HZ) is a common disease among elderly, which may develop into a severe pain syndrome labeled postherpetic neuralgia (PHN). A live-attenuated varicella zoster virus vaccine has been shown to be effective in reducing the incidence and burden of illness of HZ and PHN, providing the opportunity to prevent significant health-related and financial consequences of HZ. In this review, we summarize the available literature on cost-effectiveness of HZ vaccination and discuss critical parameters for cost-effectiveness results. A search in PubMed and EMBASE was performed to identify full cost-effectiveness studies published before April 2013. Fourteen cost-effectiveness studies were included, all performed in western countries. All studies evaluated cost-effectiveness among elderly above 50 years and used costs per quality-adjusted life year (QALY) gained as primary outcome. The vast majority of studies showed vaccination of 60- to 75-year-old individuals to be cost-effective, when duration of vaccine efficacy was longer than 10 years. Duration of vaccine efficacy, vaccine price, HZ incidence, HZ incidence and discount rates were influential to the incremental cost-effectiveness ratio (ICER). HZ vaccination may be a worthwhile intervention from a cost-effectiveness point of view. More extensive reporting on methodology and more detailed results of sensitivity analyses would be desirable to address uncertainty and to guarantee optimal comparability between studies, for example regarding model structure, discounting, vaccine characteristics and loss of quality of life due to HZ and PHN.

  12. Clinical Observation on Therapeutic Effect of Ji De Sheng She Yao Tablet on 16 Cases with AIDS Complicated by Herpes Zoster

    Institute of Scientific and Technical Information of China (English)

    2001-01-01

    @@The Ji De Sheng She Yao tablet (季德胜蛇药片)is a drug for snake-bites and insect bites. According to recent reports, this drug has been used to treat herpes zoster, hepatitis B, parotitis, nephrotic syndrome, acute conjunctivitis, recurrent aphtha, urticaria, etc.1 with good therapeutic effects. More than half of the AIDS patients suffered from herpes zoster. The area of skin lesion in AIDS patients is larger than that of the patients without AIDS and the pain lasts longer. Many cases have keloids and depigmentation for months, even severe pain till their death. Routine therapeutic methods are not satisfactory in therapeutic effects. The expert group of traditional Chinese medicine for cooperative research on AIDS used Ji De Sheng She Yao tablets (季德胜蛇药片) to treat AIDS complicated by herpes zoster for the first time and the results are reported as follows.

  13. Relationship between prior knowledge about herpes zoster and the period from onset of the eruption to consultation in patients with herpes zoster.

    Science.gov (United States)

    Miyachi, Motoko; Imafuku, Shinichi

    2016-10-01

    Herpes zoster (HZ) is a common internal infection caused by latent varicella zoster virus. Emergence of antiviral chemotherapy has changed the treatment of HZ dramatically, but the effects of such therapy are documented only in patients who started treatment within 72 h of HZ onset of the eruption. There have been few studies addressing the question of factors that determine early attendance of patients at a clinic. We questioned 256 patients with acute HZ about: (i) date from onset of the eruption to first clinic visit; and (ii) their prior knowledge of HZ. We found a tendency that patients who already knew about HZ had consulted dermatology clinics earlier (P < 0.05). People most commonly obtained information about the disease from friends and family members who had previously had HZ, but not from the Internet or other mass media. Our results indicate that patient education is important for early attendance at dermatology clinics, which in turn, should result in the improved outcome of antiviral chemotherapy and prevention of postherpetic neuralgia. © 2016 Japanese Dermatological Association.

  14. Varicella-zoster virus-specific enzyme-linked immunospot assay responses and zoster-associated pain in herpes zoster subjects.

    Science.gov (United States)

    Tyring, Stephen K; Stek, Jon E; Smith, Jeffrey G; Xu, Jin; Pagnoni, Marco; Chan, Ivan S F; Silber, Jeffrey L; Parrino, Janie; Levin, Myron J

    2012-09-01

    Varicella-zoster virus (VZV)-specific cell-mediated immunity (CMI) responses were compared over time following an episode of herpes zoster (HZ) with those of age-, race-, and gender-matched healthy controls (HC) without HZ, using a validated gamma interferon (IFN-γ) enzyme-linked immunospot (ELISPOT) assay. The zoster brief-pain inventory (ZBPI) was used to assess zoster-associated pain. HZ patients (n = 140) had significantly higher IFN-γ ELISPOT responses to VZV antigen than did HC (n = 140). ELISPOT geometric mean count (GMC) responses (with 95% confidence intervals [CI]) for subjects who presented within 72 h were as follows: for HZ patients ≥ 60 years of age, at day 0 the GMC was 110 and at week 2 the GMC was 235; for HZ patients 21 to 59 years of age, at day 0 the GMC was 111 and at week 2 the GMC was 198; for HC ≥ 60 years of age, at day 0 the GMC was 19 and at week 2 the GMC was 18; and for HC 21 to 59 years of age, at day 0 the GMC was 59 and at week 2 the GMC was 56. The mean pain score (95% CI) across age groups at 1 week postrash (n = 106) was 6.0 (5.5, 6.5) and at 2 weeks postrash (n = 119) was 3.5 (2.9, 4.0). The percentage of HZ patients with substantial pain (score ≥ 3) at 6 weeks postrash increased with age from 8% for patients 21 to 49 years of age to 16% for patients 50 to 59 years of age to 22% for patients ≥ 60 years of age. The VZV-specific CMI response was substantially boosted by an episode of HZ, as measured by ELISPOT results. Older adults had lower VZV-specific cellular immunity than younger subjects at baseline, but the boosting effect of HZ was substantial for all age groups. HZ patients experienced considerable zoster-associated acute (1 to 2 weeks after rash) pain across age groups, while chronic pain increased with age.

  15. Hospital admissions for herpes zoster in Portugal between 2000 and 2010.

    Science.gov (United States)

    Mesquita, Margarida; Froes, Filipe

    2013-01-01

    Introdução e Objectivos: O aumento da incidência de herpes zoster e da nevralgia pós-herpética estão associados ao envelhecimento da população. Estas patologias podem ser francamente debilitantes e ter um grande impacto na qualidade de vida dos doentes. Numa população envelhecida como a portuguesa, é esperado que o impacto do herpes zoster e da post-herpetic neuralgia aumentem. No entanto, não existe no país nenhum sistema específico de monitorização da doença e não foram encontrados dados epidemiológicos portugueses nas últimas décadas. A vacina contra o herpes zoster, já recomendada noutros países europeus, ainda não se encontra disponível em Portugal. Conhecer o impacto do herpes zoster é importante para fundamentar medidas de saúde pública relacionadas com a vacinação.Material e Métodos: Procedeu-se a uma análise retrospetiva da base de dados da Administração Central dos Sistemas de Saúde com a informação clínica codificada dos internamentos hospitalares de todos os indivíduos com o diagnóstico principal de herpes zoster (ICD-9-CM 053) e que tiveram alta entre 2000 e 2010.Resultados: Em Portugal, entre 2000 e 2010, ocorreram 1 706 internamentos hospitalares com o diagnóstico principal de herpes zoster. A maioria dos doentes era idosa. Do total de internados, 10,6% tinham formas potencialmente graves de imunocompromisso. A doença predominante de herpes zoster sem complicações, seguido de herpes zoster do sistema nervoso e oftálmico. A duração média dos internamentos foi de 9,3 dias, aumentando com a idade. A letalidade intra-hospitalar foi de 1%. Considerando o período de 2000-2009 e apenas a população adulta, a média anual da incidência dos internamentos hospitalares com o diagnóstico principal deherpes zoster foi de 1,9 por 100 000 habitantes, aumentando com a idade.Conclusão: Este estudo confirma que, em Portugal, as formas graves de herpes zoster estão relacionadas com a idade e associadas a

  16. Seroepidemiology of Rubella, Cytomegalovirus, Herpes simplex & Varicella zoster virus in college women of Bushehr.

    Directory of Open Access Journals (Sweden)

    Afshin Barazesh

    2014-01-01

    Full Text Available Abstract Background: Acute viral infections such as cytomegalovirus, Rubella, Herpes simplex and varicella zoster virus in pregnant women can cause congenital infection with increased risk of developing congenital anomalies and morbidity. We aimed to identify young women susceptible to these viral infections in Bushehr. Materials and Methods: In 2009, 180 female were randomly selected from high schools and college students who were been assisted in marriage consulting clinics. In this cross sectional study, IgG antibodies against varicella zoster virus (VZV, Herpes simplex virus I,II (HSV I,II , Rubella & cytomegalovirus (CMV were determined by indirect enzyme immunoassay (ELISA technique. Results: Mean age of the participants was 18.72 years old. %99.4 and %95 of sera were positive for cytomegalovirus & Rubella respectively and also Antibodies against VZV & HSV were detected in %74.5 & %69.4 of samples. There were no significant correlation between antibody seropositivity and education level, living places (rural or urban and occupation. (P<0/05. Conclusion: Although, The findings of this study indicated that high prevalence rate of VZV &HSV 1,2 in child bearing age women, but 1/3 -1/4 of them, are still susceptible to these infections, so routine screening of these viruses is suggested in antenatal care.

  17. The Shozu Herpes Zoster (SHEZ) Study: Rationale, Design, and Description of a Prospective Cohort Study

    Science.gov (United States)

    Takao, Yukiko; Miyazaki, Yoshiyuki; Onishi, Fumitake; Kumihashi, Hideaki; Gomi, Yasuyuki; Ishikawa, Toyokazu; Okuno, Yoshinobu; Mori, Yasuko; Asada, Hideo; Yamanishi, Koichi; Iso, Hiroyasu

    2012-01-01

    Background The incidence and risk factors for herpes zoster have been studied in cross-sectional and cohort studies, although most such studies have been conducted in Western countries. Evidence from Asian populations is limited, and no cohort study has been conducted in Asia. We are conducting a 3-year prospective cohort study in Shozu County in Kagawa Prefecture, Japan to determine the incidence and predictive and immunologic factors for herpes zoster among Japanese. Methods The participants are followed for 3 years, and a telephone survey is conducted every 4 weeks. The participants were assigned to 1 of 3 studies. Participants in study A gave information on past history of herpes zoster and completed health questionnaires. Study B participants additionally underwent varicella-zoster virus (VZV) skin testing, and study C participants additionally underwent blood testing. If the participants develop herpes zoster, we evaluate clinical symptoms, measure cell-mediated immunity and humoral immunity using venous blood sampling, photograph skin areas with rash, conduct virus identification testing by polymerase chain reaction (PCR) and virus isolation from crust sampling, and evaluate postherpetic pain. Results We recruited 12 522 participants aged 50 years or older in Shozu County from December 2009 through November 2010. The participation rate was 65.7% of the target population. Conclusions The present study is likely to provide valuable data on the incidence and predictive and immunologic factors for herpes zoster in a defined community-based population of Japanese. PMID:22343323

  18. Evaluation of Chosen Cytokine Levels among Patients with Herpes Zoster as Ability to Provide Immune Response.

    Directory of Open Access Journals (Sweden)

    Agata Zajkowska

    Full Text Available Herpes zoster is a viral disease caused by the reactivation of varicella-zoster virus (VZV which remained latent in the cranial nerve or dorsal root ganglia. Cell-mediated immunity is known to decline with age as part of immunosenescence and can lead to the reactivation of VZV. Whereas herpes zoster is usually mild in healthy young persons, older patients are at increased risk for complications. In the present study we investigated the serum cytokine profile (IL-17, IL-23, IL-21, IL-4, IL-12, representing cellular and humoral immunity and assessed the level of VZV IgG antibodies in patients with herpes zoster.We investigated the serum concentrations of IL-17, IL-23, IL-21, IL-4, IL-12 and the level of VZV IgG antibodies in 23 patients with herpes zoster who did not develop superinfection. The control group was represented by 21 individuals in similar age with no inflammatory and infectious diseases. Cytokine and antibodies levels were measured by ELISA method. Statistical analysis was performed using the ROC curve (receiver operating characteristic, t-test, Welch's t-test, and nonparametric tests with STATISTICA 10 software.In patients with herpes zoster, the serum level of IL-17, IL-23, IL-21, IL-4 and IL-12 as well as VZV IgG antibodies titer were statistically significantly increased compared to control group.Our results confirm the broad activation of the immune system involving humoral and cell-mediated immunity.

  19. Providers' lack of knowledge about herpes zoster in HIV-infected patients is among barriers to herpes zoster vaccination.

    Science.gov (United States)

    Aziz, M; Kessler, H; Huhn, G

    2013-06-01

    Identification of perceptions about herpes zoster (HZ) disease, vaccine effectiveness and safety, and vaccine recommendations may impact immunization practices of physicians for HIV-infected patients. A survey was used to quantify knowledge of HZ as well as determine physician immunization perceptions and practices. There were 272/1700 respondents (16%). Correct answers for the incidence of varicella zoster virus (VZV) infection in adults and incidence of HZ in HIV-infected patients were recorded by 14% and 10% of providers, respectively. Providers reported poor knowledge of the incidence of disease recurrence in HIV-infected patients (41% correct), potency of HZ vaccine (47.5% correct) and mechanism of protection against reactivation of VZV (66% correct). Most (88%) agreed that HZ was a serious disease, and 73% believed that the burden of disease made vaccination important. A majority (75%) did not vaccinate HIV patients with HZ vaccine regardless of antiretroviral therapy status. Barriers to administration included safety concerns, concern that vaccine would not prevent HZ, risk of HZ dissemination, reimbursement issues and lack of Infectious Diseases Society of America (IDSA) guidelines. Only 38% of providers agreed that CDC guidelines were clear and 50% believed that clinical trials were needed prior to use of HZ vaccine in HIV-infected patients. Education about HZ is needed among HIV providers. Providers perceived vaccination as important, but data on vaccine safety and clear guidance from the CDC on this issue are lacking.

  20. Concurrent Reactivation of Herpes Simplex and Varicella Zoster Viruses Confirmed by the Loop-Mediated Isothermal Amplification Assay

    Directory of Open Access Journals (Sweden)

    Tsukane Kobayashi

    2014-01-01

    Full Text Available Concurrent reactivation of herpes simplex and varicella zoster viruses is rare. Here, we describe the case of an elderly patient with herpes labialis and herpes zoster manifesting as a right-side facial eruption with vesicles and crusting. The loop-mediated isothermal amplification (LAMP assay demonstrated the presence of both herpes simplex virus type 1 and varicella zoster virus in swab samples taken from the face, which was confirmed by real-time PCR, suggesting concurrent reactivation of both viruses. The use of the LAMP assay in the present case indicates its usefulness in the diagnosis of atypical herpes infections.

  1. 自拟带状疱疹止痛液治疗带状疱疹%Since the quasi liquid treatment of herpes zoster herpes zoster pain

    Institute of Scientific and Technical Information of China (English)

    李红

    2015-01-01

    objective to study the matching ribbon spore rash analgesic liquid clinical curative effect for the treatment of herpes zoster.Methods select to our hospital patients with herpes zoster, imposing from herpes zoster pain, observe its clinical effect after using.results of herpes seven appears to apply to parts which have very good anti-infiammation, detumescence and hygroscopic raw muscle, analgesic effect, quickly eliminate pathological symptom such as acid, hemp, swollen and painful.the clinical practice the effective rate was 100%.conclusion from herpes zoster pain liquid for the treatment of herpes zoster has significant curative effect, can be widely used in clinical.%目的:研究自拟带状孢疹止痛液治疗带状疱疹的临床疗效。方法选取来我院就诊的带状疱疹患者,对其施以自拟带状疱疹止痛液,观察其使用后的临床效果。结果七药合用外敷于起疱疹的部位可起到很好的抗炎、消肿、收湿生肌、止痛的效果,迅速消除酸、麻、肿、痛等病理症状。经临床实践其有效率为100%。结论自拟带状疱疹止痛液对于带状疱疹的治疗有显著疗效,可在临床当中广泛应用。

  2. Herpes zoster: Epidemiología y clínica Clinical and epidemiological aspects of Herpes zoster

    Directory of Open Access Journals (Sweden)

    Claudia Vujacich

    2008-04-01

    Full Text Available El herpes zoster (HZ constituye una enfermedad de distribución mundial; sin embargo, existen es casos datos comunicados sobre la misma en países de Latinoamérica. Con el objetivo de evaluar aspectos clínicos y epidemiológicos de esta enfermedad en nuestra población, realizamos un análisis retrospectivo de historias clínicas de un centro privado de referencia en enfermedades infecciosas en Buenos Aires, Argentina (período: 2000-2005. Se realizó un análisis estadístico univariado para evaluar los factores asociados a neuralgia posherpética en este grupo de pacientes. Sobre un total de 302 casos evaluables, el 62% correspondieron a mujeres. La mediana de edad fue de 57 años. El 16.1% de los pacientes presentó condiciones predisponentes al desarrollo de zoster. Las localizaciones más frecuentes fueron la torácica, oftálmica y lumbosacra. El 7.75% presentó compromiso de más de dos metámeras. El 94% de los pacientes recibió medicación antiviral, siendo el aciclovir la droga más utilizada. El 94% recibió alguna medicación coadyuvante (antiinflamatorios no esteroideos, antineuríticos, corticoides. La complicación más frecuente fue la neuralgia posherpética (12% y se encontró estadísticamente asociada a edad mayor de 50 años.Herpes zoster (HZ is a public health problem worldwide. Although, there is paucity of data of this disease from South American countries. The objective of this study was to evaluate clinical and epidemiological aspects of HZ in a population of patients from South America. We underwent a retrospective analysis of clinical charts of an infectious diseases reference center (period: 2000-2005. Univariate analysis was performed to assess variables related to post herpetic neuralgia (PHN. From a total of 302 cases, 62% were in women. The median age was 57 years; 16.1% of the patients had a predisposing condition for the development of HZ. Most frequent dermatomes involved were: thoracic, ophthalmic and

  3. Association between recent herpes zoster but not herpes simplex infection and subsequent risk of malignancy in women: a retrospective cohort study.

    Science.gov (United States)

    Buntinx, F; Bartholomeeusen, S; Belmans, A; Mathei, C; Opdenakker, G; Sweldens, K; Truyers, C; Van Ranst, M

    2014-05-01

    The association between herpes zoster and subsequent cancer risk is still unclear. Consequently, doubts remain regarding the need for investigation of herpes patients for co-existing or subsequent malignancy. This is a retrospective cohort study comparing cancer risk in patients after herpes zoster and age-/sex-matched non-herpes zoster patients, in a primary care-based continuous morbidity database. We tested for interaction by gender, age, diabetes, HRT use or antiviral therapy. Analyses were repeated for patients with and without herpes simplex. The hazard ratio (HR) comparing cancer risk in herpes zoster vs. control patients was significant in all women, women aged > 65 years and subgroups of breast and colorectal cancer (HRs 1·60, 1·82, 2·14, 2·19, respectively). For men, a significant association was found for haematological cancers (HR 2·92). No associations were found with herpes simplex. No interaction was identified with antiviral therapy, diabetes or HRT treatment. We concluded that there was a moderate significant association between herpes zoster and subsequent cancer risk in women aged > 65 years, without any influence of antiviral therapy. No association was found with herpes simplex. There is insufficient reason for extensively testing older patients with herpes zoster or herpes simplex for the presence of occult cancer.

  4. Acupuncture plus moxibustion for herpes zoster: A systematic review and meta-analysis of randomized controlled trials.

    Science.gov (United States)

    Coyle, Meaghan E; Liang, Haiying; Wang, Kaiyi; Zhang, Anthony Lin; Guo, Xinfeng; Lu, Chuanjian; Xue, Charlie C

    2017-03-24

    Herpes zoster is an acute inflammatory condition which can have a significant impact on quality of life. Antiviral therapies are effective, but do not meet patients' expectations of symptomatic relief. Acupuncture and moxibustion have been used for herpes zoster; this systematic review evaluated their efficacy and safety. Nine English and Chinese databases were searched from their inceptions to March 2016. Randomized controlled trials evaluating the combination of acupuncture plus moxibustion in adult herpes zoster were included. Outcomes included pain intensity and duration, quality of life and adverse events. Meta-analysis was performed using RevMan software (version 5.3). Nine studies (945 participants) were included. Studies were of low to moderate methodological quality based on risk of bias assessment. Pain intensity (visual analogue scale) was lower among those who received acupuncture plus moxibustion compared with pharmacotherapy (one study; MD -8.25 mm, 95% CI -12.36 to -4.14). The clinical significance of this result is yet to be established. Some benefits were seen for other pain and cutaneous outcomes, and global improvement in symptoms. Mild adverse events were reported in the intervention groups. Acupuncture plus moxibustion may improve pain and cutaneous outcomes, although current evidence is limited by the number of studies and methodological shortcomings.

  5. Herpes zoster recurrences more frequent than previously reported.

    Science.gov (United States)

    Yawn, Barbara P; Wollan, Peter C; Kurland, Marge J; St Sauver, Jennifer L; Saddier, Patricia

    2011-02-01

    To present population-based estimates of herpes zoster (HZ) recurrence rates among adults. To identify recurrent cases of HZ, we reviewed the medical records (through December 31, 2007) of all Olmsted County, Minnesota, residents aged 22 years or older who had an incident case of HZ between January 1, 1996, and December 31, 2001. Kaplan-Meier curves and Cox regression models were used to describe recurrences by age, immune status, and presence of prolonged pain at the time of the incident HZ episode. Of the 1669 persons with a medically documented episode of HZ, 95 had 105 recurrences (8 persons with >1 recurrence) by December 31, 2007, an average follow-up of 7.3 years. The Kaplan-Meier estimate of the recurrence rate at 8 years was 6.2%. With a maximum follow-up of 12 years, the time between HZ episodes in the same person varied from 96 days to 10 years. Recurrences were significantly more likely in persons with zoster-associated pain of 30 days or longer at the initial episode (hazard ratio, 2.80; 95% confidence interval, 1.84-4.27; P<.001) and in immunocompromised individuals (hazard ratio, 2.35; 95% confidence interval, 1.35-4.08; P=.006). Women and anyone aged 50 years or older at the index episode also had a greater likelihood of recurrence. Rates of HZ recurrence appear to be comparable to rates of first HZ occurrence in immunocompetent individuals, suggesting that recurrence is sufficiently common to warrant investigation of vaccine prevention in this group.

  6. Herpes Zoster--Eye Complications: Rates and Trends

    Science.gov (United States)

    Yawn, Barbara P.; Wollan, Peter M.; St Sauver, Jennifer L.; Butterfield, Linda C.

    2013-01-01

    Purpose To provide population based data on the risk, types and outcomes of eye involvement in herpes zoster (HZ). Methods A cohort study based on medical record review of patients diagnosed with HZ between January 1, 1980 and December 31, 2007. HZ was confirmed by typical rash and symptoms or laboratory testing and eye involvement was confirmed by ophthalmologists’ evaluation. Information was collected on all eye diagnoses, all HZ eye related visits, treatments, procedures and outcomes. Results Of the 2035 individuals with HZ in any dermatome, 184 patients (9.0%) had eye involvement. Mean age of the 184 was 62.6 with 5 cases in patients <21. Overall, 6.5% were immune suppressed at the time of the eye complications. The rate of increase of HZ eye involvement was 23% by decade from 1980 to 2007. Common eye complications were keratitis (76.2%), uveitis/iritis (46.6%) and conjunctivitis (35.4%). Recurrent keratitis and recurrent iritis/uveitis occurred in 6.9% and 7.4% respectively. Outcomes included six (3.3%) patients with new vision decrements to 20/200 or worse. Two individuals had successful corneal transplants. Another six (3.3%) individuals had lid ptosis that affected vision including one elderly woman with a permanent unilateral tarsorrhaphy. Severe HZ eye pain was reported to be directly responsible for one unsuccessful suicide attempt. No one developed ARN. A mean of 10.8 HZ eye visits per HZ patient with eye involvement were reported over a mean of 308 days. Conclusion Eye complications are common, result in significant health care utilization and in permanent vision decrement in about 6.6% of individuals with HZ eye involvement. Most health care utilization and long term adverse outcomes were in patients in whom administration of HZ prevention with the zoster vaccine would be possible. PMID:23664666

  7. Varicella and Herpes Zoster in Madrid, based on the Sentinel General Practitioner Network: 1997–2004

    Directory of Open Access Journals (Sweden)

    Gutiérrez-Rodríguez Ángeles

    2007-06-01

    Full Text Available Abstract Background Varicella (chickenpox is the primary disease caused by varicella-zoster virus. It is extremely contagious and is frequent in children. Indeed, in the absence of vaccination, a high proportion of the population is liable to contract it. Herpes zoster -more frequent among adults- is caused by reactivation of the latent virus. The objective of this study is to describe the status of and time trend for varicella and herpes zoster in the Madrid Autonomous Region prior to the introduction of the vaccine to the general population. Methods Data source: individualised varicella and herpes zoster case records kept by the Madrid Autonomous Region Sentinel General Practitioner Network for the period 1997–2004. Cumulative incidences, crude and standardised incidence rates, and age-specific rates of varicella and herpes zoster were calculated for each year. Kendall's Tau-b correlation coefficient was calculated to evaluate whether incidence displayed a time trend. Spectral density in the time series of weekly incidences was estimated using a periodogram. Results Standardised annual varicella incidence rates ranged from 742.5 (95% CI: 687.2 – 797.7 to 1239.6 (95% CI: 1164.5 – 1313.4 cases per 100 000 person-years. Most cases affected children, though complications were more frequent in adults. Varicella incidence displayed an annual periodicity but no trend over time. Most herpes zoster cases occurred at advanced ages, with incidence registering a rising annual trend but no seasonality factor. Conclusion In the absence of vaccination, no significant changes in varicella incidence were in evidence recent years, though these were observed in the incidence of herpes zoster. Sentinel general practitioner networks are a valid instrument for surveillance of diseases such as varicella. Further varicella vaccination-coverage and vaccine-efficacy studies are called for.

  8. Incidence of herpes zoster in Japanese patients with rheumatoid arthritis from 2005 to 2010.

    Science.gov (United States)

    Nakajima, Ayako; Urano, Wako; Inoue, Eisuke; Taniguchi, Atsuo; Momohara, Shigeki; Yamanaka, Hisashi

    2015-07-01

    To clarify the incidence and the risks of herpes zoster infection in Japanese patients with rheumatoid arthritis (RA). By using a self-report of occurrence of herpes zoster in patients with RA in a large observational cohort study from 2005 to 2010, the standardized incidence rate was calculated. A Cox model was used to analyze risk factors for occurrence of herpes zoster. A total of 7,986 patients (female 83.1%) accumulated 30,140 patient-years of observation, and 366 events were confirmed. The standardized incidence rate per 1,000 patient-years was 9.1 (95% confidence interval (CI) 6.2-12.9) in total, 7.8 (3.6-14.8) in men, and 10.3 (6.8-15.0) in women. The risk factors for herpes zoster were age [/10 years: Hazard ratio (HR) 1.268, 95% CI 1.153-1.393, p herpes zoster in Japanese RA patients, and is a benchmark for future studies.

  9. [Data mining analysis of professor Li Fa-zhi AIDS herpes zoster medical record].

    Science.gov (United States)

    Wang, Dan-Ni; Li, Zhen; Xu, Li-Ran; Guo, Hui-Jun

    2013-08-01

    Analysis of professor Li Fa-zhi in the treatment of AIDS drug laws of herpes zoster and postherpetic neuralgia, provide reference for the use of Chinese medicine treatment of AIDS, herpes zoster and postherpetic neuralgia. By using the method of analyzing the complex network of Weishi county, Henan in 2007 October to 2011 July during an interview with professor Li Fa-zhi treatment of AIDS of herpes zoster and postherpetic neuralgia patients, patients are input structured clinical information collection system, into the analysis of the data, carries on the research analysis theory of traditional Chinese medicine compatibility system algorithm and complex network analysis the use of complex networks. The use of multi-dimensional query analysis of AIDS drugs, the core of herpes zoster and postherpetic neuralgia treated in this study are Scutellariae Radix, Glucyrrhizae Radix, Carthame Flos, Plantaginis Semen, Trichosamthis Fructus, Angelicae Sinensis Radix, Gentianae Radix; core prescription for Longdan Xiegan decoction and Trichosanthes red liquorice decoction. Professor Li Fa-zhi treatment of AIDS, herpes zoster and postherpetic neuralgia by clearing heat and removing dampness and activating blood circulation to.

  10. Functional decline and herpes zoster in older people: an interplay of multiple factors.

    Science.gov (United States)

    2015-12-01

    Herpes zoster is a frequent painful infectious disease whose incidence and severity increase with age. In older people, there is a strong bidirectional link between herpes zoster and functional decline, which refers to a decrement in ability to perform activities of daily living due to ageing and disabilities. However, the exact nature of such link remains poorly established. Based on the opinion from a multidisciplinary group of experts, we here propose a new model to account for the interplay between infection, somatic/psychiatric comorbidity, coping skills, polypharmacy, and age, which may account for the functional decline related to herpes zoster in older patients. This model integrates the risk of decompensation of underlying disease; the risk of pain becoming chronic (e.g. postherpetic neuralgia); the risk of herpes zoster non-pain complications; the detrimental impact of herpes zoster on quality of life, functioning, and mood; the therapeutic difficulties due to multimorbidity, polypharmacy, and ageing; and the role of stressful life events in the infection itself and comorbid depression. This model underlines the importance of early treatment, strengthening coping, and vaccine prevention.

  11. A suspected dental cellulitis leading to diagnosis of both herpes zoster ophthalmicus and HIV

    Directory of Open Access Journals (Sweden)

    Grace E. Parkins, BDS, FDS.RCPS (Glas., FWACS, FGCS

    2015-03-01

    Full Text Available Herpes zoster ophthalmicus and HIV are serious health problems. We report a case of a 37-year-old woman who presented to the Korle-Bu Teaching Hospital with dyspnea and facial cellulitis, and a diagnosis 5 days prior of dental cellulitis made at a district hospital. Investigations revealed that the facial cellulitis was secondary to herpes zoster infection involving the ophthalmic division of the left trigeminal nerve. The patient responded well to oral acyclovir but developed postherpetic neuralgia. During the course of treatment, she was also diagnosed to be HIV-1 positive and was referred for further management. This case represents a unique report in which the patient presented to the hospital with symptoms of cellulitis suggestive of underlying dental infection but was later diagnosed with both herpes zoster ophthalmicus and an underlying HIV infection. Atypical presentations of herpes zoster can occur in HIV/AIDS. Signs of herpes zoster infection with cellulitis should alert the clinician that the patient may have a possible underlying immunosuppressive disease. The population must be educated regarding the importance of early presentation and careful compliance with treatment as well as regular follow-ups.

  12. Herpes Zoster Vaccine Effectiveness against Incident Herpes Zoster and Post-herpetic Neuralgia in an Older US Population: A Cohort Study

    Science.gov (United States)

    Langan, Sinéad M.; Smeeth, Liam; Margolis, David J.; Thomas, Sara L.

    2013-01-01

    Background Herpes zoster is common and has serious consequences, notably post-herpetic neuralgia (PHN). Vaccine efficacy against incident zoster and PHN has been demonstrated in clinical trials, but effectiveness has not been studied in unselected general populations unrestricted by region, full health insurance coverage, or immune status. Our objective was to assess zoster vaccine effectiveness (VE) against incident zoster and PHN in a general population-based setting. Methods and Findings A cohort study of 766,330 fully eligible individuals aged ≥65 years was undertaken in a 5% random sample of Medicare who received and did not receive zoster vaccination between 1st January 2007 and 31st December 2009. Incidence rates and hazard ratios for zoster and PHN were determined in vaccinated and unvaccinated individuals. Analyses were adjusted for age, gender, race, low income, immunosuppression, and important comorbidities associated with zoster, and then stratified by immunosuppression status. Adjusted hazard ratios were estimated using time-updated Cox proportional hazards models. Vaccine uptake was low (3.9%) particularly among black people (0.3%) and those with evidence of low income (0.6%). 13,112 US Medicare beneficiaries developed incident zoster; the overall zoster incidence rate was 10.0 (9.8–10.2) per 1,000 person-years in the unvaccinated group and 5.4 (95% CI 4.6–6.4) per 1,000 person-years in vaccinees, giving an adjusted VE against incident zoster of 0.48 (95% CI 0.39–0.56). In immunosuppressed individuals, VE against zoster was 0.37 (95% CI 0.06–0.58). VE against PHN was 0.59 (95% CI 0.21–0.79). Conclusions Vaccine uptake was low with variation in specific patient groups. In a general population cohort of older individuals, zoster vaccination was associated with reduction in incident zoster, including among those with immunosuppression. Importantly, this study demonstrates that zoster vaccination is associated with a reduction in PHN. Please

  13. Safety of herpes zoster vaccination among inflammatory bowel disease patients being treated with anti-TNF medications.

    Science.gov (United States)

    Khan, N; Shah, Y; Trivedi, C; Lewis, J D

    2017-10-01

    The risk of herpes zoster (HZ) is elevated in inflammatory bowel disease (IBD) patients treated with anti-TNF medications. While it is optimal to give herpes zoster vaccine prior to initiation of therapy clinical circumstances may not always allow this. To determine the safety of giving herpes zoster vaccine while patients are on anti-TNF therapy. We conducted a retrospective cohort study involving IBD patients who were followed in the Veterans Affairs (VA) healthcare system between 2001 and 2016. Patients who received herpes zoster vaccine while on anti-TNF medication were identified through vaccination codes and confirmed through individual chart review. Our outcome of interest was development of HZ between 0 and 42 days after herpes zoster vaccine administration. Fifty-six thousand four hundred and seventeen patients with IBD were followed in the VA healthcare system. A total of 59 individuals were on anti-TNF medication when they were given herpes zoster vaccine, and amongst them, 12 (20%) were also taking a thiopurine. Median age at the time of herpes zoster vaccine was 64.9 years and 95% of patients had a Charlson Comorbidity Index of ≥2. Median number of encounters within 42 days after receiving herpes zoster vaccine was two. No case of HZ was found within 0-42 days of HZV administration. Our data suggest that co-administering the herpes zoster vaccine to patients who are taking anti-TNF medications is relatively safe. This study significantly expands the evidence supporting the use of herpes zoster vaccine in this population, having included an elderly group of patients with a high Charlson Comorbidity Index who are likely at a much higher risk of developing HZ. © 2017 John Wiley & Sons Ltd.

  14. Association of Herpes Zoster and Type 1 Diabetes Mellitus.

    Directory of Open Access Journals (Sweden)

    Hsin-Hung Chen

    Full Text Available The purpose of our study was to determine the association of type 1 diabetes mellitus (T1DM and the risk of herpes zoster (HZ.In this cohort study, we selected 4736 patients with T1DM registered in the Catastrophic Illness Patient Database who received insulin therapy before 2003 and 18944 participants without DM who were selected by frequency matched based on sex and age. Cox proportional hazard regression analysis was used to measure the hazard ratios (HRs of HZ in the T1DM group compared with that in the non-T1DM group.Cox proportional hazard regression analysis showed that the adjusted HR of HZ was 2.38 times higher for patients in the T1DM group (95% CI = 1.77-3.19 than for those in the non-T1DM group. According to diabetes severity, mild and serious T1DM patients were associated with a higher risk of HZ (adjusted HR = 2.26, 95% CI = 1.67-3.05; and adjusted HR = 5.08, 95% CI = 2.66-9.71, respectively than subjects without T1DM.Patients with T1DM are at a higher risk of HZ than those without T1DM.

  15. Evaluation of the economic burden of Herpes Zoster (HZ) infection.

    Science.gov (United States)

    Panatto, Donatella; Bragazzi, Nicola Luigi; Rizzitelli, Emanuela; Bonanni, Paolo; Boccalini, Sara; Icardi, Giancarlo; Gasparini, Roberto; Amicizia, Daniela

    2015-01-01

    The main objective of this systematic review was to evaluate the economic burden of Herpes Zoster (HZ) infection.   The review was conducted in accordance with the standards of the "Preferred Reporting Items for Systematic Reviews and Meta-Analyses" guidelines. The following databases were accessed: ISI/Web of Knowledge (WoS), MEDLINE/PubMed, Scopus, ProQuest, the Cochrane Library and EconLit. Specific literature on health economics was also manually inspected. Thirty-three studies were included. The quality of the studies assessed in accordance with the Consolidated Health Economic Evaluation Reporting Standards checklist was good. All studies evaluated direct costs, apart from one which dealt only with indirect costs. Indirect costs were evaluated by 12 studies. The economic burden of HZ has increased over time. HZ management and drug prescriptions generate the highest direct costs. While increasing age, co-morbidities and drug treatment were found to predict higher direct costs, being employed was correlated with higher indirect costs, and thus with the onset age of the disease. Despite some differences among the selected studies, particularly with regard to indirect costs, all concur that HZ is a widespread disease which has a heavy social and economic burden.

  16. Herpes zoster vaccination in the elderly subjects: improving awareness and uptake

    Directory of Open Access Journals (Sweden)

    Stefanati A

    2015-10-01

    Full Text Available Armando Stefanati, Nicoletta Valente, Silvia Lupi, Sara Previato, Matilde Giordani, Giovanni Gabutti Department of Medical Sciences, University of Ferrara, Ferrara, Italy Abstract: Herpes zoster (HZ is a common disease in adults and older subjects solely related to the reactivation of latent varicella zoster virus in ganglia. The incidence of the disease increases with aging and the decline of varicella zoster virus-specific cell-mediated immunity. HZ has a significant impact on the quality of life of subjects during the acute phase. Besides, pain can persist even for a long time becoming chronic. The chronic pain following HZ is called postherpetic neuralgia, and it is a debilitating long-lasting condition, characterized by metameric pain, allodynia, and hyperalgesia. Therapeutic options against HZ and postherpetic neuralgia are often suboptimal and the impact of the disease and its complications on daily living activities is significant, especially in older subjects. Nowadays, a preventive approach to the disease is possible; as a matter of fact, a high-antigen content live vaccine is available. This vaccine has a good profile in terms of immunogenicity, efficacy, effectiveness, and safety and its use may prevent both HZ and postherpetic neuralgia. Nevertheless, the evaluation of the issues raised in countries that introduced this immunization show that both provider and patient barriers could have prevented a more robust uptake of HZ vaccination. In the USA, HZ immunization storage was expensive, reimbursement was cumbersome, and supply shortages may have limited promotion by the interests of the manufacturer and provider. The doctors did not actively recommend HZ vaccination; on the other hand, subjects were mostly unaware of the HZ vaccine. Several demographic factors, including sex and educational level, could have negatively affected the coverage rates; besides, the clinicians who treat adults focus less on vaccination than those taking

  17. Expression of varicella-zoster virus and herpes simplex virus in normal human trigeminal ganglia

    Energy Technology Data Exchange (ETDEWEB)

    Vafai, A.; Wellish, M.; Devlin, M.; Gilden, D.H. (Univ. of Colorado School of Medicine, Denver (USA)); Murray, R.S. (Univ. of Colorado School of Medicine, Denver (USA) Veterans Administration Medical Center, Denver, CO (USA))

    1988-04-01

    Lysates of radiolabeled explants from four human trigeminal ganglia were immunoprecipitated with antibodies to varicella-zoster virus (VZV) and to herpes simplex virus. Both herpes simplex virus- and VZV-specific proteins were detected in lysates of all four ganglia. Absence of reactivity in ganglion explants with monoclonal antibodies suggested that herpes simplex virus and VZV were not reactivated during the culture period. In situ hybridization studies demonstrated the presence of RNA transcripts from the VZV immediate early gene 63. This approach to the detection of herpes simplex virus and VZV expression in human ganglia should facilitate analysis of viral RNA and proteins in human sensory ganglia.

  18. Herpes Zoster Induced Osteomyelitis in the Immunocompromised Patients: A 10-year Multicenter Study

    Directory of Open Access Journals (Sweden)

    Reza Tabrizi

    2014-09-01

    Full Text Available Statement of the Problem: Alveolar bone necrosis induced by Herpes zoster infection is considered as a rare manifestation of osteomyelitis and few case reports are presented in the literature. Purpose: The aim of this study was to evaluate mandibular osteomyelitis caused by herpes zoster in the immunocompromised patients with histopathologically documented osteomyelitis in the mandible and herpes zoster infection. Materials and Method: 30 patients were recruited in this cross-sectional study. 19 patients were completely edentulous, 4 patients were partially edentulous and 7 with complete dentition. In all cases, specimens were analyzed using a conventional polymerase chain reaction (PCR test for varicella zoster virus. Results: 16 patients underwent dialysis, 9 patients received chemotherapy treat-ments and 5 patients had transplantation (four kidneys and one liver. Histopa-thological assessment demonstrated a nonspecific bone necrosis exhibiting an eosinophilic, homogeneous non-vital bone tissue with peripheral resorption sur-rounded by reactive connective tissue. PCR test was positive in 21 cases. Conclusion: This study demonstrated that the frequency of osteomyelitis induced by herpes zoster could be more than the records provided by previous studies. Histopathological findings might be nonspecific in such patients. PCR test was not positive for all HZ induced osteomyelitis patients.

  19. Herpes Zoster of the Third Division of the Trigeminal Nerve. A Clinical Pathologic Conference.

    Science.gov (United States)

    Doan, Karen; Stoler, Kenneth; Logan, Keri

    2015-11-01

    Herpes zoster of the trigeminal nerve is a disease that often challenges dentists and dental specialists trying to make the proper diagnosis, as many ulcerative and vesiculobullous diseases of the mouth have a similar clinical appearance. We report a clinical case in which a 27-year-old patient sought care for this vesicular lesion. Included are the differential diagnosis and treatment modalities that we used to diagnose the disease. A clinical pathologic conference is provided to highlight the appropriate courses of action in the management of herpes zoster.

  20. Frecuencia de infección por VIH en pacientes con episodio agudo de herpes zoster.

    OpenAIRE

    LAZARTE HERAUD, Susana; BRAVO PUCCIO, Francisco; SAMALVIDES CUBA, Frine; Del Solar Chacaltana, Manuel; GUERRA AMAYA, Oscar; VERDONCK BOSTEELS, Kristien; SOLARI SERPA, Lely; GOTUZZO HERENCIA, Eduardo

    2012-01-01

    Objetivo: Evaluar la frecuencia de infección por VIH en pacientes que consultan por episodio agudo de herpes zoster. Material y Métodos: Se incluyeron a todos los pacientes entre 18 y 49 años, atendidos entre setiembre del 2001 y enero del 2003 en el Departamento de Enfermedades Infecciosas, Tropicales y Dermatológicas del Hospital Nacional Cayetano Heredia, por un cuadro agudo de herpes zoster, diagnosticado clínicamente. Los criterios de inclusión fueron: status VIH desconocido tanto del pa...

  1. Localized linear IgA dermatosis induced by UV light-treatment for herpes zoster.

    Science.gov (United States)

    He, Chundi; Xu, Honghui; Xiao, Ting; Geng, Long; Chen, Hong-Duo

    2007-05-01

    We report a case of localized linear IgA dermatosis (LID). The patient suffered from herpes zoster on the right waist and received three localized ultraviolet (UV) light treatments. One month later he presented with bullae on the same site. Direct immunofluorescence showed deposition of linear IgA and weak C3 along the basement membrane zone. Indirect immunofluorescence on the salt-split human skin demonstrated that IgA antibodies were bound to the epidermal side. To our knowledge, this is the first case of localized LID induced by UV light treatment for herpes zoster. It is also the third case of LID induced by UV light.

  2. The impact of herpes zoster and post-herpetic neuralgia on quality-of-life

    Directory of Open Access Journals (Sweden)

    Schmader Kenneth E

    2010-06-01

    Full Text Available Abstract Background The potentially serious nature of herpes zoster (HZ and the long-term complication post-herpetic neuralgia (PHN are often underestimated. One in four people will contract herpes zoster in their lifetime, with this risk rising markedly after the age of 50 years, and affecting one in two in elderly individuals. Pain is the predominant symptom in all phases of HZ disease, being reported by up to 90% of patients. In the acute phase, pain is usually moderate or severe, with patients ranking HZ pain as more intense than post-surgical or labour pains. Up to 20% of patients with HZ develop PHN, which is moderate-to-severe chronic pain persisting for months or years after the acute phase. We review the available data on the effect of HZ and PHN on patients' quality-of-life. Discussion Findings show that HZ, and particularly PHN, have a major impact on patients' lives across all four health domains - physical, psychological, functional and social. There is a clear correlation between increasing severity of pain and greater interference with daily activities. Non-pain complications such as HZ ophthalmicus can increase the risk of permanent physical impairment. Some elderly individuals may experience a permanent loss of independence after an acute episode of HZ. Current challenges in the management of HZ and PHN are highlighted, including the difficulty in administering antiviral agents before pain becomes established and the limited efficacy of pain treatments in many patients. We discuss the clinical rationale for the HZ vaccine and evidence demonstrating that the vaccine reduces the burden of the disease. The Shingles Prevention Study, conducted among >38,000 people aged ≥60 years old, showed that the HZ vaccine significantly reduces the burden of illness and the incidence of both HZ and PHN. In the entire study population, zoster vaccination reduced the severity of interference of HZ and PHN with activities of daily living by two

  3. Evidence-based interventional pain medicine according to clinical diagnoses. 17. Herpes zoster and post-herpetic neuralgia.

    Science.gov (United States)

    van Wijck, Albert J M; Wallace, Mark; Mekhail, Nagy; van Kleef, Maarten

    2011-01-01

    Herpes zoster infection is caused by a reactivation of the latent varicella zoster virus that causes chicken pox. It appears predominantly in older adults whose immunity for the virus has waned. The natural course of the disease is usually favorable, and the symptoms disappear spontaneously within a few weeks. Some patients, however, have prolonged pain: post-herpetic neuralgia. The diagnosis of acute zoster infection is made on the clinical signs including the appearance of rash. Post-herpetic neuralgia is described as sharp, burning, aching, or shooting constantly present in the dermatome that corresponds with the earlier rash. The objectives of treating herpes zoster are: (1) acute pain reduction; (2) promotion of recovery of epidermal defects and prevention of secondary infections; and (3) reduction or prevention of post-herpetic neuralgia. The objective of the treatment of post-herpetic neuralgia is primarily pain alleviation and improvement of the quality of life. Early treatment of the infection and the pain is believed to reduce the risk for post-herpetic neuralgia. This persistent pain syndrome is difficult to treat. Antiepileptic drugs and tricyclic antidepressants are the first choice. Interventional treatments, such as epidural injections of corticosteroids and local anesthetic drugs, have an effect on the acute pain but are of limited use in preventing post-herpetic neuralgia. When conservative treatment fails in providing satisfactory relief of post-herpetic neuralgia, a sympathetic block may be considered (2 C+); if this treatment provides unsatisfactory results, spinal cord stimulation may be considered, in a study context (2 C+).

  4. A cross-sectional study of the knowledge, attitude, and practice of patients aged 50 years or above towards herpes zoster in an out-patient setting.

    Science.gov (United States)

    Lam, A Cy; Chan, M Y; Chou, H Y; Ho, S Y; Li, H L; Lo, C Y; Shek, K F; To, S Y; Yam, K K; Yeung, I

    2017-08-01

    There has been limited research on the knowledge of and attitudes about herpes zoster in the Hong Kong population. This study aimed to investigate the knowledge, attitude, and practice of patients aged 50 years or above towards herpes zoster and its vaccination. This was a cross-sectional study in the format of a structured questionnaire interview carried out in Sai Ying Pun Jockey Club General Outpatient Clinic in Hong Kong. Knowledge of herpes zoster and its vaccination was assessed, and patient attitudes to and concerns about the disease were evaluated. Factors that affected a decision about vaccination against herpes zoster were investigated. A total of 408 Hong Kong citizens aged 50 years or above were interviewed. Multiple regression analysis revealed that number of correct responses regarding knowledge about herpes zoster was positively correlated with educational attainment (B=0.313, P=0.026) and history of herpes zoster (B=0.408, P=0.038), and negatively correlated with age (B= -0.042, Pherpes zoster. Misconceptions about herpes zoster were notable in this study. More health education is needed to improve the understanding and heighten awareness of herpes zoster among the general public. Although the majority of participants indicated that herpes zoster would have a significant impact on their health, a relatively smaller proportion was actually worried about getting the disease. Further studies on this topic should be encouraged to gauge the awareness and knowledge of herpes zoster among broader age-groups.

  5. MR imaging in Bell's palsy and herpes zoster opticus: correlation with clinical findings

    Energy Technology Data Exchange (ETDEWEB)

    Kwon, Jung Ho; Mo, Jong Hyun; Moon, Sung Hee; Lee, Sang Sun; Park, Yang Hee; Lee, Kyung Hee [National Police Hospital, Seoul (Korea, Republic of); Choi, Ik Joon [Sejong General Hospital, Seoul (Korea, Republic of)

    1998-09-01

    To evaluate the MRI findings of acute facial nerve paralysis in Bell's palsy and herpes zoster opticus, and to correlate these with the clinical findings. We retrowspectively reviewed the MRI findings in six cases of BEll's palsy(BP) and two of herpes zoster oticus(HZO), and compared them with the findings for 30 normal facial nerves. This nerve was considered abnormal when its signal intensity was greater than that of brain parenchyma or the contralateral normal side on Gd-enhanced T1-weighted axial and coronal MR images. We analysed the location and degree of contrast enhancement, interval change, and clinical progression in correlation with House-Brackmann(HB) grade and electroneuronography (ENoG) findings. Fifteen of 30 normal facial nerves(50%) seen on Gd-enhanced MRI were mildly enhanced in the geniculate ganglion, the proximal tympanic, and the proximal mastoid segment of the facial nerve. No enhancement of the internal auditory canal(IAC) or labyrinthine segment of the facial nerve was noted, however. In BP and HZO, Gd-enhanced MR images revealed fair to marked enhancement for more than two segments from the internal auditory canal to the mastoid segment of the facial nerve. During follow-up MRI, enhancement of the facial nerve varied in location and signal intensity, though gradually decreased in intensity approximately eight weeks after the onset of facial nerve palsy. No correlation between clinical HB grade, ENoG, and follow up MRI findings was noted. Except in the internal auditory canal and labyrinthine segment, normal facial nevemay show mild and relatively symmetrical enhancement. In BP and HZO, the facial nerve showed diffuse enhancement from the IAC to the mastoid segment.=20.

  6. STUDY OF HERPES ZOSTER IN HIV PATIENTS IN RELATION TO CD4 COUNT

    Directory of Open Access Journals (Sweden)

    Nivedita Devi

    2015-09-01

    Full Text Available AIMS AND OBJECTIVES: 1. To study herpes zoster in HIV positive patients in relation to CD4 count. 2. To study the various clinical presentations, common sites, and demographic characteristics of herpes zoster in HIV. MATERIALS AND METHODS: A study was conducted on 94 HIV patients with a clinical diagnosis herpes zoster attending DVL OPD of Government General Hospital, Kakinada. Severity of rash was graded depending on the number of lesions as mild (50.Assessment of intensity of pain was done using visual analog scale (VAS, a numerical rating scale marked from 0 to 10 in increasing order of severity. The relation of CD4 count and herpes zoster and complications of zoster were recorded. RESULTS : The maximum incidence of herpes zoster was found in the sexually active age group with higher incidence in males53.1% and ur ban people 55.3%. Patients with severe rash were 57.4% moderate rash 31.9% and mild rash 10.6%. At the time of presentation, majority 51.06% had vesicular rash. The most common symptom was pricking pain followed by burning sensation and stabbing pain. Most of the patients had thoracic dermatome involvement in 51, cer vical in 18, trigeminal nerve in 16and lumbar in 9. Ophthalmic branch the relation of CD4 count and is involved in 7, maxillary in 5 and mandibular in 4. Majority 18 (19.14% were in the CD4 ra nge 200 - 249, 15 between CD4 150 - 199 and 11 between CD4 350 - 399. Complications noted were post herpetic neuralgia, secondary bacterial infection, scarring, conjuntivis, facial palasy and keratitis. Multidermatomal involvement is seen in 15.95%.

  7. Evaluation of Chosen Cytokine Levels among Patients with Herpes Zoster as Ability to Provide Immune Response

    Science.gov (United States)

    Zajkowska, Agata; Garkowski, Adam; Świerzbińska, Renata; Kułakowska, Alina; Król, Monika Emilia; Ptaszyńska-Sarosiek, Iwona; Nowicka-Ciełuszecka, Anna; Pancewicz, Sławomir; Czupryna, Piotr; Moniuszko, Anna; Zajkowska, Joanna

    2016-01-01

    Aim and Background Herpes zoster is a viral disease caused by the reactivation of varicella–zoster virus (VZV) which remained latent in the cranial nerve or dorsal root ganglia. Cell-mediated immunity is known to decline with age as part of immunosenescence and can lead to the reactivation of VZV. Whereas herpes zoster is usually mild in healthy young persons, older patients are at increased risk for complications. In the present study we investigated the serum cytokine profile (IL-17, IL-23, IL-21, IL-4, IL-12), representing cellular and humoral immunity and assessed the level of VZV IgG antibodies in patients with herpes zoster. Methods We investigated the serum concentrations of IL-17, IL-23, IL-21, IL-4, IL-12 and the level of VZV IgG antibodies in 23 patients with herpes zoster who did not develop superinfection. The control group was represented by 21 individuals in similar age with no inflammatory and infectious diseases. Cytokine and antibodies levels were measured by ELISA method. Statistical analysis was performed using the ROC curve (receiver operating characteristic), t-test, Welch’s t-test, and nonparametric tests with STATISTICA 10 software. Results In patients with herpes zoster, the serum level of IL-17, IL-23, IL-21, IL-4 and IL-12 as well as VZV IgG antibodies titer were statistically significantly increased compared to control group. Conclusion Our results confirm the broad activation of the immune system involving humoral and cell-mediated immunity. PMID:26934574

  8. Predictive values of prurigo nodularis and herpes zoster for HIV infection and immunosuppression requiring HAART in French Guiana.

    Science.gov (United States)

    Magand, Florence; Nacher, Mathieu; Cazorla, Céline; Cambazard, Frederic; Marie, Dominique Sainte; Couppié, Pierre

    2011-07-01

    Prurigo nodularis and herpes zoster frequently lead to the diagnosis of HIV in tropical areas. The WHO has established a clinical definition of AIDS for undeveloped countries. Prurigo and herpes zoster are both classified as stage 2. The main objective of this study was to compare the level of immunosuppression of patients diagnosed as HIV-positive after consulting for prurigo nodularis or herpes zoster in French Guiana. A retrospective study was conducted including patients consulting at the Department of Dermatology, Cayenne Hospital (French Guiana) for prurigo nodularis or herpes zoster between 1989 and 2007 for which the systematic HIV test was positive. Demographic data and CD4 counts of both groups were compared. Analysis of 346 patients consulting for herpes zoster (n=192) or prurigo nodularis (n=154) led to the discovery of 129 HIV infections. The positive predictive value (PPV) for HIV positivity was 38.5% for herpes zoster and 36% for prurigo nodularis. The median lymphocyte count was 302/mm(3) in herpes zoster and 87/mm(3) in prurigo nodularis (Pimmunosuppression. This questions the pertinence of the WHO clinical classification of AIDS. In the absence of CD4 count, the present results suggest that for patients with prurigo nodularis, antiretrovirals should be initiated without delay.

  9. Burden of herpes zoster requiring hospitalization in Spain during a seven-year period (1998-2004).

    Science.gov (United States)

    Gil, Angel; Gil, Ruth; Alvaro, Alejendro; San Martín, María; González, Antonio

    2009-05-07

    A thorough epidemiological surveillance and a good understanding of the burden of diseases associated to VZV are crucial to asses any potential impact of a prevention strategy. A population-based retrospective epidemiological study to estimate the burden of herpes zoster requiring hospitalization in Spain was conducted. This study was conducted by using data from the national surveillance system for hospital data, Conjunto Mínimo Básico de Datos (CMBD). Records of all patients admitted to hospital with a diagnosis of herpes zoster (ICD-9-MC codes 053.0-053.9) during a 7-year period (1998-2004) were selected. A total of 23,584 hospitalizations with a primary or secondary diagnosis of herpes zoster in patients > or = 30 years of age were identified during the study period. Annually there were 13.4 hospitalizations for herpes zoster per 100,000 population in patients > or = 30 years of age. The rate increases with age reaching a maximum in persons > or = 80 years of age (54.3 admissions per 100,000 population >80 years of age). The mean cost of a hospitalization for herpes zoster in adult patients was 3,720 euro. The estimated annual cost of hospitalizations for herpes zoster in patients > or = 30 years of age in Spain was 12,731,954 euro. Herpes zoster imposes an important burden of hospitalizations and result in large cost expenses to the Spanish National Health System, especially in population older than 50 years of age.

  10. A comparison of herpes simplex virus type 1 and varicella-zoster virus latency and reactivation

    OpenAIRE

    2015-01-01

    Herpes simplex virus type 1 (HSV-1; human herpesvirus 1) and varicella-zoster virus (VZV; human herpesvirus 3) are human neurotropic alphaherpesviruses that cause lifelong infections in ganglia. Following primary infection and establishment of latency, HSV-1 reactivation typically results in herpes labialis (cold sores), but can occur frequently elsewhere on the body at the site of primary infection (e.g. whitlow), particularly at the genitals. Rarely, HSV-1 reactivation can cause encephaliti...

  11. Unusual formation of keloids after each episode of recurrent herpes zoster in an HIV positive patient

    Directory of Open Access Journals (Sweden)

    Koley Sankha

    2009-01-01

    Full Text Available Herpes Zoster (HZ lesions are well known to heal with keloids. As immunity plays an important role in the development of abnormal scars and keloids, the latter is unusual in HIV where immunity is low. We report a rare case of recurrent HZ in an HIV-positive male where the lesions have healed with formation of keloids in both episodes. Within 50 days of last episode, he had an attack of herpes progenitalis.

  12. Perspectives on optimal control of varicella and herpes zoster by mass routine varicella vaccination.

    Science.gov (United States)

    Betta, Monica; Laurino, Marco; Pugliese, Andrea; Guzzetta, Giorgio; Landi, Alberto; Manfredi, Piero

    2016-03-16

    Herpes zoster arises from reactivation of the varicella-zoster virus (VZV), causing varicella in children. As reactivation occurs when cell-mediated immunity (CMI) declines, and there is evidence that re-exposure to VZV boosts CMI, mass varicella immunization might increase the zoster burden, at least for some decades. Fear of this natural zoster boom is the main reason for the paralysis of varicella immunization in Europe. We apply optimal control to a realistically parametrized age-structured model for VZV transmission and reactivation to investigate whether feasible varicella immunization paths that are optimal in controlling both varicella and zoster exist. We analyse the optimality system numerically focusing on the role of the cost functional, of the relative zoster-varicella cost and of the planning horizon length. We show that optimal programmes will mostly be unfeasible for public health owing to their complex temporal profiles. This complexity is the consequence of the intrinsically antagonistic nature of varicella immunization programmes when aiming to control both varicella and zoster. However, we show that gradually increasing-hence feasible-vaccination schedules can perform better than routine programmes with constant vaccine uptake. Finally, we show the optimal profiles of feasible programmes targeting mitigation of the post-immunization natural zoster boom with priority.

  13. Acyclovir Prophylaxis Reduces the Incidence of Herpes Zoster Among HIV-Infected Individuals: Results of a Randomized Clinical Trial.

    Science.gov (United States)

    Barnabas, Ruanne V; Baeten, Jared M; Lingappa, Jairam R; Thomas, Katherine K; Hughes, James P; Mugo, Nelly R; Delany-Moretlwe, Sinead; Gray, Glenda; Rees, Helen; Mujugira, Andrew; Ronald, Allan; Stevens, Wendy; Kapiga, Saidi; Wald, Anna; Celum, Connie

    2016-02-15

    Human immunodeficiency virus (HIV)-infected persons have higher rates of herpes zoster than HIV-uninfected individuals. We assessed whether twice daily treatment with 400 mg of oral acyclovir reduces the incidence of herpes zoster in a randomized, double-blind, placebo-controlled trial among 3408 persons coinfected with HIV and herpes simplex virus type 2. During 5175 person-years of follow-up, 26 cases of herpes zoster occurred among those assigned acyclovir, compared with 69 cases among those assigned placebo (rates, 1.00 and 2.68/100 person-years, respectively), a relative decrease of 62% (hazard ratio, 0.38; 95% confidence interval, .24-.67; P herpes zoster incidence among HIV-infected persons.

  14. 颈部带状疱疹及带状疱疹后神经痛%Herpes Zoster on the Neck and Neuralgia after Herpes Zoster

    Institute of Scientific and Technical Information of China (English)

    李全成

    2006-01-01

    急性带状疱疹(Acute herpes zoster)是由水痘——带状疱疹病毒(Varicella zoster virus,VZV)感染所致的一种疾病.患者的特征性表现为沿感染神经分布区的局限性疼痛及相应区域内出现节段性、排列成束状簇集水疱的特异性皮肤损害。在急性带状疱疹的病程中,大多数患者的疼痛十分剧烈,故有效地镇痛是治疗该病的重要措施之一。如果患者得不到及时治疗或治疗不当,部分患者,尤其是老年人,疱疹消失后疼痛仍然存在,进而形成带状疱疹后神经痛。

  15. Herpes zoster is associated with herpes simplex and other infections in under 60 year-olds.

    Science.gov (United States)

    Ogunjimi, Benson; Buntinx, Frank; Bartholomeeusen, Stephaan; Terpstra, Ita; De Haes, Inke; Willem, Lander; Elli, Steven; Bilcke, Joke; Van Damme, Pierre; Coenen, Samuel; Beutels, Philippe

    2015-02-01

    We assessed the association between herpes zoster (HZ) and herpes simplex (HS) occurrence whilst controlling for risk factors of HZ. Using a Belgian general practitioner network, a retrospective cohort study with 3736 HZ patients and 14,076 age-gender-practice matched controls was performed, covering over 1.5 million patient-years. Multiple logistic regression was used with HZ as outcome and several diagnoses (malignancy, depression, diabetes mellitus, auto-immune diseases, asthma, multiple sclerosis, HIV, fractures), medications (systemic corticosteroids, biologicals, vaccination), HS and other infections as variables. HS was significantly associated with HZ for all analysed time intervals (up to five years) post HZ (OR of 3.51 [2.09 5.88] 95%CI one year post HZ) and to a lesser extent for time ranges pre HZ. Registration of other infections was significantly associated with HZ in all time intervals pre and post HZ (OR up to 1.37). Malignancy up to five years pre HZ, depression up to one year pre or post HZ, fractures up to two years pre HZ, asthma, auto-immune diseases, and immunosuppressive medication one year pre or post HZ were also associated with HZ. HZ and HS occurrences are significantly associated and potentially share a common susceptibility beyond the known risk factors. Copyright © 2014 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

  16. Patient perspective on herpes zoster and its complications: an observational prospective study in patients aged over 50 years in general practice.

    Science.gov (United States)

    Bouhassira, Didier; Chassany, Olivier; Gaillat, Jacques; Hanslik, Thomas; Launay, Odile; Mann, Claude; Rabaud, Christian; Rogeaux, Olivier; Strady, Christophe

    2012-02-01

    Understanding the effect of herpes zoster and zoster-related pain should inform care to improve health-related quality of life in elderly patients. A 12-month, longitudinal, prospective, multicenter observational study conducted in primary care in France enrolled patients aged ≥ 50 years with acute eruptive herpes zoster. Patient-reported zoster-related pain was assessed by validated questionnaires (Douleur Neuropathique en 4 Questions [DN4], Zoster Brief Pain Inventory [ZBPI], and Neuropathic Pain Symptom Inventory [NPSI]) on days 0 and 15, and at months 1, 3, 6, 9, and 12. Health-related quality of life was assessed by the 12-item short-form health survey (SF-12) and the Hospital Anxiety and Depression scale on day 0 and at months 3, 6, and 12. Of 1358 patients included, 1032 completed follow-up. Mean ± standard deviation age was 67.7 ± 10.7 (range, 50-95) years; 62.2% were women. Most patients (94.1%) were prescribed antiviral drugs. The prevalence of zoster-related pain on day 0 and at months 3, 6, 9, and 12 was 79.6%, 11.6%, 8.5%, 7.4%, and 6.0%, respectively. Patients with persistent pain had lower scores on the physical and mental component summaries of the SF-12 and the ZBPI interference score than those without pain. By logistic regression analysis, main predictive factors on day 0 for postherpetic neuralgia at month 3 were age, male sex, ZBPI interference score, Physical Component Summary score of the SF-12, and neuropathic quality of pain (DN4 score ≥ 4). Despite early diagnosis and treatment with antiviral agents, many patients with herpes zoster experience persistent pain and marked long-term reduction in health-related quality of life.

  17. Three cases of herpes zoster radiculitis in MS patients treated with natalizumab.

    Science.gov (United States)

    Yamout, Bassem I; Abou Zeid, Nuhad; Taha, Ali J; Zeineddine, Maya M; Khoury, Samia J

    2016-09-01

    Natalizumab was the first FDA-approved monoclonal antibody for the treatment of multiple sclerosis (MS). We report on 3 natalizumab-treated patients who developed herpes zoster infections. In addition to progressive multifocal leukoencephelopathy, other opportunistic infections have been rarely reported during Natalizumab treatment. We believe that clinicians need heightened awareness of these infections in view of the risks of serious complications.

  18. Determinants of non-compliance with herpes zoster vaccination in the community-dwelling elderly

    NARCIS (Netherlands)

    Opstelten, Wim; van Essen, Gerrit A; Hak, Eelko

    2009-01-01

    As part of a series of studies on vaccine acceptance, we assessed determinants of compliance of the community-dwelling elderly with herpes zoster (HZ) vaccination in an existing influenza vaccination program. General practitioners (GPs) sent out a questionnaire to 1778 patients aged > or =65 years,

  19. Treatment of 48 Cases of Herpes Zoster by Puncturing Nerve Stem

    Institute of Scientific and Technical Information of China (English)

    倪夕朗; 洪珏

    2008-01-01

    @@ Herpes zoster is a viral disorder involving both nerve and skin simultaneously, with the duration of about 2 to 3 weeks. The author treated 48 cases by puncturing nerve stem in recent years and obtained good therapeutic results. Now it is reported as follows.

  20. Vitamin D is closely linked to the clinical courses of herpes zoster: From pathogenesis to complications.

    Science.gov (United States)

    Chao, Chia-Ter; Chiang, Chih-Kang; Huang, Jenq-Wen; Hung, Kuan-Yu

    2015-10-01

    Vitamin D is renowned for its pleiotropic effects, including but not limited to bone integrity, and it has assumed an important role in the current research era. As vitamin D receptors are present in a variety of human tissues, particularly immune cells, the immunomodulatory potential of vitamin D cannot be overemphasized. Herpes zoster, which presents as grouped cutaneous vesicles over dermatomes or visceral/central nervous system infection in its severe form, has a higher incidence in immune-suppressed patients. Considering the importance of vitamin D in host immunity, we hypothesize that vitamin D acts as an effect-modifier for the entire herpes zoster spectrum with regard to disease susceptibility, manifestation, efficacy of pharmacologic management, and emergent complications during treatment. Moreover, the possibility exists that vitamin D might affect the course of postherpetic neuralgia. In line with this theory, we comprehensively searched the existing herpes zoster literature and provided important insight into the relationship between the disease courses of herpes zoster and vitamin D.

  1. [Analysis on clinical features and treatment of herpes zoster patients hospitalized in real world].

    Science.gov (United States)

    Yuan, Ling-Lian; Wang, Lian-Xin; Xie, Yan-Ming; Yang, Wei; Yang, Zhi-Xin; Zhuang, Yan; Zhang, Yun-Bi

    2014-09-01

    From the hospital information system (HIS) of 20 national grade III-A general hospitals, 2 960 cases of herpes zoster as the research object, analyzes the relations between the general information, syndrome of traditional Chinese medicine (TCM), western medicine combined diseases, the relationship between the solar term and the incidence of herpes zoster, and the combined use of Chinese and western medicine. Among the patients with 46-65 year old has the highest percentage of diseased; admission to general outpatient clinic is the most; the most common medical payment is medicare; combined disease such as hypertension, diabetes and coronary heart disease is more common; early treatment effect of herpes zoster is better than the sequelae; summer and autumn solar term patients is hospitalized more, TCM syndrome is damp heat of liver fire; about drugs, western medicine is the most commonly used vitamin B1 and mecobalamin, traditional Chinese medicine is the most frequently used Danhong injection, combination therapy with promoting blood circulation drugs and neurotrophic drugs. Thus, herpes zoster, more common in elderly patients, with no obvious relationship between solar term, should be early diagnosis and early treatment, often with combination of Chinese traditional and western medicine treatment.

  2. Do herpes zoster patients receive antivirals?: a national survey in general practice.

    NARCIS (Netherlands)

    Opstelten, W.; Essen, G.A. van; Moons, K.G.M.; Wijck, A.J.M. van; Schellevis, F.G.; Kalkman, C.J.; Verheij, T.J.M.

    2005-01-01

    BACKGROUND: The main complications of herpes zoster (HZ) are postherpetic neuralgia and, in case of HZ ophthalmicus, eye disorders. Antiviral treatment may modify the course of disease and reduce the risk of complications. OBJECTIVE: To assess which doctors' and patients' characteristics were relate

  3. Effect of acyclovir and steroid in a young immunocompetent male with herpes zoster myelitis

    DEFF Research Database (Denmark)

    El-Safadi, Louay; Arngrim, Nanna; Amin, Faisal Mohammad

    2014-01-01

    Herpes zoster myelitis is a rare condition, usually seen in aged and immunocompromised patients. Due to atypical presen-tations it can be hard to diagnose. Intraspinal lesions on magnetic resonance imaging (MRI) support the diagnosis. We present a 39-year-old otherwise healthy male with symptoms...

  4. Oro-Facial Herpes Zoster: A Case Report With A Detailed Review Of Literature

    Directory of Open Access Journals (Sweden)

    Satyaranjan Mishra

    2013-01-01

    Full Text Available Herpes zoster or shingles is a reactivation of the Varicella zoster virus that entered the cutaneous nerve endings during an earlier episode of chicken pox, travelled to the dorsal root ganglia, and remained in a latent form. Nerves most commonly involved are C3, T5, L1, L2 and first division of trigeminal nerve. The condition is characterized by occurrence of multiple, painful, unilateral vesicles and ulceration which shows a typical single dermatome involvement. The infection usually affects elderly individuals, and if present in the younger age group, immune-compromised status such as HIV/AIDS may be suspected. In this case report we present a patient with herpes zoster involving the maxillary and mandibular divisions of the trigeminal nerve, with unilateral vesicles over the left side of lower and middle 1/3rd of face along the trigeminal nerve tract, with intraoral involvement of buccal mucosa, labial mucosa and the palate of the same side.

  5. Treatment of 60 Cases of Senile Herpes Zoster by Encircled Acupuncture plus Valaciclovir

    Institute of Scientific and Technical Information of China (English)

    HE Ying-dan; FANG Rui-hua; KUAI Le

    2007-01-01

    To observe the clinical therapeutic effect and safety of local encircled acupuncture plus valaciclovir in treating senile herpes zoster.Methods:Sixty senile patients with herpes zoster were divided into two groups.In acupuncture and medicine group,the patients were treated by encircled acupuncture plus valaciclovir.The needle was inserted about 0.8 cun away from herpes and to form an angle of 15°with the skin around the skin lesion.During treatment,valaciclovir was taken orally 300 mg every time,twice every day for successive 10 days.In westem medicine group,valaciclovir was taken orally 300 mg every time,twice every day for successive 10 days.Results:The time of stopping herpes,relieving pain andscabbing in acupuncture and medicine group was significantly lower than that in western group.Conclusion:Local encircled acupuncture plus valaciclovir in treating senile herpes zoster got effects quickly and could effectively shorten the course of disease and reduce the incidence rateofresidual neuralgia.

  6. Diagnosis and management of herpes zoster by the family and community physician

    Directory of Open Access Journals (Sweden)

    Pedro Alexandre Barreto Coelho

    2014-08-01

    Full Text Available The herpes virus that causes varicella (chickenpox persists in a latent form in the nervous system and can reactivate and propagate through nerve roots, manifesting years later through painful skin lesions, a condition called herpes zoster. The diagnosis is primarily clinical, but it is important to make a differential diagnosis with impetigo, contact dermatitis, dermatitis herpetiformis and also herpes simplex itself. After the diagnosis is confirmed, treatment should be initiated within the first 72 hours after onset of the rash and it is based upon antiviral therapy. Valacyclovir and famciclovir are more effective when compared to acyclovir. The most common complication of herpes zoster is post-herpetic neuralgia, usually managed with tricyclic antidepressants, anticonvulsants, topical lidocaine or capsaicin. Recently, a live attenuated vaccine against herpes zoster was introduced in Brazil, with the same components as the vaccine against varicella, but in a greater concentration. However, it still has a high cost and is not available in the public health system.

  7. Is peptic ulcer disease a risk factor of postherpetic neuralgia in patients with herpes zoster?

    Science.gov (United States)

    Chen, Jen-Yin; Chang, Chia-Yu; Lan, Kuo-Mao; Sheu, Ming-Jen; Lu, Chin-Li; Hu, Miao-Lin

    2013-11-01

    Postherpetic neuralgia is the most common complication of herpes zoster which is caused by a reactivation of latent varicella zoster virus. The pathogenesis of postherpetic neuralgia may involve peripheral and central mechanisms. Reported risk factors for postherpetic neuralgia include female gender, old age, diminished cell-mediated immunity and nutritional deficiencies. Based on our clinical observation which revealed that peptic ulcer disease (PUD) is one of the common comorbidities in patients with postherpetic neuralgia, we hypothesize that herpes zoster patients with PUD may be at a greater risk for the development of postherpetic neuralgia due to their impaired cellular immunity and depressed nutritional status. Major causes of PUD include Helicobacter pylori infection and usage of ulcerogenic medications. Patients with H. pylori infection may develop T cell dysfunctions and nutritional deficiencies including vitamin C, iron, cobalamin, carotenes and alpha-tocopherol. Ulcerogenic medications such as nonsteroidal anti-inflammatory drugs and steroids have been found not only to be ulcerogenic but also immunosuppressive to T cells. In addition, usage of steroids and nonsteroidal anti-inflammatory drugs may cause deficiencies of alpha-tocopherol, carotenes, cobalamin, iron, zinc and vitamin C. Vitamin C, carotenes and alpha-tocopherol are anti-inflammatory and the major oxidant scavengers in the aqua phase and biomembranes. Deficiencies of these nutrients may induce dysregulated inflammation and oxidative damage leading to neuropathic pain in patients with herpes zoster. Furthermore, nutrient deficiencies including zinc, iron, cobalamin and vitamin C are associated with dysregulation of Ca(v)3.2 T-channels and N-methyl-D-aspartate receptors, upregulation of nitric oxide synthase, the increase of nitric oxide formation and dysfunction of central norepinephrine inhibitory pain pathway. Prospective cohort studies are suggested to test the hypothesis. We further

  8. A comparison of herpes simplex virus type 1 and varicella-zoster virus latency and reactivation

    Science.gov (United States)

    Kennedy, Peter G. E.; Rovnak, Joel; Badani, Hussain

    2015-01-01

    Herpes simplex virus type 1 (HSV-1; human herpesvirus 1) and varicella-zoster virus (VZV; human herpesvirus 3) are human neurotropic alphaherpesviruses that cause lifelong infections in ganglia. Following primary infection and establishment of latency, HSV-1 reactivation typically results in herpes labialis (cold sores), but can occur frequently elsewhere on the body at the site of primary infection (e.g. whitlow), particularly at the genitals. Rarely, HSV-1 reactivation can cause encephalitis; however, a third of the cases of HSV-1 encephalitis are associated with HSV-1 primary infection. Primary VZV infection causes varicella (chickenpox) following which latent virus may reactivate decades later to produce herpes zoster (shingles), as well as an increasingly recognized number of subacute, acute and chronic neurological conditions. Following primary infection, both viruses establish a latent infection in neuronal cells in human peripheral ganglia. However, the detailed mechanisms of viral latency and reactivation have yet to be unravelled. In both cases latent viral DNA exists in an ‘end-less’ state where the ends of the virus genome are joined to form structures consistent with unit length episomes and concatemers, from which viral gene transcription is restricted. In latently infected ganglia, the most abundantly detected HSV-1 RNAs are the spliced products originating from the primary latency associated transcript (LAT). This primary LAT is an 8.3 kb unstable transcript from which two stable (1.5 and 2.0 kb) introns are spliced. Transcripts mapping to 12 VZV genes have been detected in human ganglia removed at autopsy; however, it is difficult to ascribe these as transcripts present during latent infection as early-stage virus reactivation may have transpired in the post-mortem time period in the ganglia. Nonetheless, low-level transcription of VZV ORF63 has been repeatedly detected in multiple ganglia removed as close to death as possible. There is

  9. Characteristics of hearing loss in patients with herpes zoster oticus.

    Science.gov (United States)

    Kim, Chang-Hee; Choi, Hyerang; Shin, Jung Eun

    2016-11-01

    Patients with herpes zoster oticus (HZO) may commonly show symptoms associated with 7th and 8th cranial nerve (CN VII and CN VIII) dysfunction. The aim of this study is to investigate the characteristics of hearing loss in patients with HZO and discuss possible mechanisms.Ninety-five HZO patients who showed at least one of the symptoms of CN VII and CN VIII dysfunction between January 2007 and October 2014 were included in this study. Hearing loss was defined when the mean thresholds of pure tone audiometry (PTA) in speech frequency (0.5 kHz + 1 kHz + 2 kHz/3) or isolated high frequency (4 kHz + 8 kHz/2) were greater than 10 dB in the affected ear compared with the healthy ear, and a total of 72 patients were classified as the hearing loss group.The difference of mean PTA thresholds between affected and healthy ears was significantly greater in the high frequency range than in low range (20.0 ± 11.5 dB vs. 12.9 ± 15.7 dB, P = 0.0026) in patients with hearing loss (n = 72). The difference between affected and healthy ear was significantly greater in patients with vertigo (n = 34) than those without vertigo (n = 38) in both the high (P = 0.033) and low (P = 0.024) frequency ranges. In contrast, the differences between affected and healthy ears were not significantly different between patients with facial palsy (n = 50) and those without facial palsy (n = 22) in both the high (P = 0.921) and low (P = 0.382) frequency ranges.In patients with HZO, hearing loss is more severe in the high frequency range than in the low frequency range. Hearing impairment is more severe in patients with vertigo than in those without vertigo in both the high and low frequency ranges, even though the degree of hearing impairment is not significantly different between patients with and without facial palsy. These findings indicate that the mechanisms of viral spread from CN VII to CN VIII may differ between

  10. The relationship between T lymphocyte subsets changes and the zoster associated pain in aged patients with acute herpes zoster%老年带状疱疹患者急性期T细胞亚群变化及其与疱疹相关性疼痛的关系

    Institute of Scientific and Technical Information of China (English)

    安尔丹; 肖旺频; 周宗立; 孙丽

    2011-01-01

    目的 检测老年带状疱疹患者急性期外周血T细胞亚群水平,观察患者急性期机体细胞免疫状态与带状疱疹急性期疼痛(AHP)和后遗神经痛(PHN)的关系。 方法 选择急性期老年带状疱疹患者60例,根据AHP视觉模拟评分(visual analogue scales,VAS)分为轻中度AHP组:VAS评分≤6分,重度AHP组:VAS评分>6分;再根据随访结果是否发生带状疱疹后PHN分为非PHN组和PHN组。选取年龄、性别相匹配的门诊健康体检者25例作为对照组。记录患者AHP最严重时VAS评分,采用流式细胞测定技术测定急性期外周血T细胞亚群CD3+、CD4+和CD8+百分比及计算CD4 +/CD8+比值。 结果 各组年龄、性别差异无统计学意义(P>0.05);轻中度AHP组、重度AHP组、非PHN组和PHN组CD3+、CD4+、CD8+表达与对照组比较均降低(P<0.05),重度AHP组CD4+表达低于轻中度AHP组(P<0.05) ;CD4 +/CD8+比值轻中度AHP组、非PHN组均高于对照组(P<0.05),重度AHP组低于轻中度AHP组(P<0.05),PHN组低于非PHN组(P<0.05);PHN组AHP VAS评分高于非PHN组(P<0.05)。 结论 老年带状疱疹患者急性期普遍存在细胞免疫功能低下,表现为T细胞亚群百分比降低;重度AHP患者细胞免疫状态更低。PHN患者在疱疹急性期存在更严重的局部损害和更低下免疫应答。%Objective To study T lymphocyte subsets levels in acute zoster patients and investigate its relation to the zoster associated pain.Methods According to the visual analogue scales(VAS) in the acuter phase, 60 patients with herpes zoster were divided into two groups: group A (VAS≤6) and group B (VAS>6). According to the follow-up results, patients were divided into another two groups: group C (PHN not developed) and group D (PHN developed). 25 healthy volunteers with a similar age and gender range as the patients were recruited as control group. T lymphocyte subsets were detected by fluorescence-activated cell sorter

  11. Lymphopaenia, anti-Ro/anti-RNP autoantibodies, renal involvement and cyclophosphamide use correlate with increased risk of herpes zoster in patients with systemic lupus erythematosus.

    Science.gov (United States)

    Hu, Stephen Chu-Sung; Lin, Chi-Ling; Lu, Yi-Wei; Chen, Gwo-Shing; Yu, Hsin-Su; Wu, Ching-Shuang; Lan, Cheng-Che E

    2013-05-01

    Herpes zoster occurs with increased frequency in patients with systemic lupus erythematosus (SLE). The aim of this study was to identify and evaluate clinical and laboratory risk factors associated with development of herpes zoster in patients with SLE. A retrospective case-control study was performed in a population of patients with SLE. Patients were identified as cases if their first episode of herpes zoster occurred after diagnosis of SLE. Patients with SLE who never developed herpes zoster were enrolled as controls. Medical charts and laboratory data for both cases and control patients were comprehensively reviewed. A total of 65 cases and 105 controls were included. Risk factors associated with the development of herpes zoster in patients with SLE were found to be lymphopaenia, anti-Ro antibodies, anti-RNP antibodies, neuropsychiatric manifestations, renal involvement and cyclophosphamide use. Therefore, the presence of certain disease manifestations in patients with SLE represents risk factors for the development of herpes zoster.

  12. Herpes Zoster and Postherpetic Neuralgia: Past, Present and Future

    Directory of Open Access Journals (Sweden)

    Gary J Bennett

    2009-01-01

    Full Text Available OBJECTIVES: The history behind the current understanding of the varicella-zoster virus and its relationship to the pain conditions caused by shingles and postherpetic neuralgia are reviewed. The framework for the current conceptualization is Hope-Simpson’s latency hypothesis. Data from recent work in virology, neuroanatomy and epidemiology are reviewed, as is work using varicella-zoster virus-infected animals. The recent data largely confirm Hope-Simpson’s hypothesis and extend it significantly.

  13. Frecuencia de infección por VIH en pacientes con episodio agudo de herpes zoster

    Directory of Open Access Journals (Sweden)

    Susana Lazarte Heraud

    2005-01-01

    Full Text Available Objetivo: Evaluar la frecuencia de infección por VIH en pacientes que consultan por episodio agudo de herpes zoster. Material y Métodos: Se incluyeron a todos los pacientes entre 18 y 49 años, atendidos entre setiembre del 2001 y enero del 2003 en el Departamento de Enfermedades Infecciosas, Tropicales y Dermatológicas del Hospital Nacional Cayetano Heredia, por un cuadro agudo de herpes zoster, diagnosticado clínicamente. Los criterios de inclusión fueron: status VIH desconocido tanto del paciente como de su pareja; que no presentaran alguna complicación neurológica o presentación atípica de zoster y que no tuvieran signos ni síntomas compatibles con infección por VIH (muguet oral, diarrea crónica, síndrome de desgaste, etc.. Previa firma de consentimiento informado, se tomó muestra de sangre para prueba de ELISA para VIH1. A todos los pacientes con resultado positivo se les realizó western blot. Resultados: Veintiún pacientes cumplieron los criterios del estudio, 14 varones y 7 mujeres. Cinco pacientes (23,8% fueron VIH positivos. De éstos, 4 fueron varones (4/14 y 1 mujer (1/7. No se encontró diferencias significativas en cuanto a la conducta sexual de riesgo. Conclusiones: Se encuentra un porcentaje elevado de infección por VIH en adultos jóvenes que consultan en un hospital general por un cuadro agudo de herpes zoster, sin ningún otro signo ni síntoma de inmunosupresión, independientemente de conductas sexuales de riesgo. Nuestro hallazgo justifica un despistaje de VIH en adultos jóvenes con herpes zoster.

  14. Evaluation of sorivudine (BV-araU) versus acyclovir in the treatment of acute localized herpes zoster in human immunodeficiency virus-infected adults

    NARCIS (Netherlands)

    Bodsworth, NJ; Boag, F; Burdge, D; Genereux, M; Borleffs, JCC; Evans, BA; Modai, J; Colebunders, R; Thomas, M; DeHertogh, D; Pacelli, L; Thomis, J; Knight, E.L.; McNulty, AM; Delaney, C; VanHove, D; Sacks, S; Gage, L; McLeod, A; DiazMitoma, F; Fong, J; MacFadden, D; Martel, A; Rachlis, A; Salit, [No Value; Shafran, S; Szabo, J; Toma, E; Deschenes, L; Gill, J; Lalonde, R; Kaufhold, R; Molina, JM; Dellamonica, P; Rozenbaum, W; Kolsters, FP; Meenhorst, PL; Danner, S; Sprenger, HG; EllisPegler, RB; Moragas, J; Moyle, G; Colman, J; Parnell, A; McLean, KA; Holmes, DA; Kitchen, C.M.R.; Linde, A; Dahl, H; Dwyer, D

    1997-01-01

    The clinical efficacy and safety of sorivudine as treatment for acute cutaneous tester in human immunodeficiency virus-infected adults was compared with that of acyclovir in a double-blinded randomized study, A total of 125 patients with laboratory-confirmed tester rash present for less than or equa

  15. 针灸治疗带状疱疹的临床研究进展%Research Progress of Acupuncture in the Treatment of Herpes Zoster

    Institute of Scientific and Technical Information of China (English)

    张莉莉; 孙忠人; 仇立波

    2015-01-01

    带状疱疹是由水痘-带状疱疹病毒引起的急性感染性皮肤病,中医称之为“蛇丹”、“蜘蛛疮”、“火带疮”、“缠腰火丹”等,神经痛为本病特征之一。近年来,针灸治疗带状疱疹的经验越来越丰富,疗效明显优于西药,且副作用小。现将临床上针灸治疗带状疱疹的方法做一总结,为治疗此病选择更有效的方法提供参考。%Herpes zoster is an acute infectious skin disease caused by the varicella zoster virus.In traditional Chinese medicine it is called“Snake Dan”,“Spider chuang”,“Huo Dai Chuang”,“Chan Yao Huo Dan”and so on.Nerve pain is one of the characteristics.In recent years, the experience of acupuncture treatment for her-pes zoster has been becoming richer and richer.The therapeutic effect is better than western medicine.What’ s more,acupuncture has lower side effects.This article makes a summary of using acupuncture in the treatment of herpes zoster to provide a more effective method for treating herpes zoster.

  16. The short- and long-term risk of stroke after herpes zoster - a nationwide population-based cohort study.

    Directory of Open Access Journals (Sweden)

    Nandini Sreenivasan

    Full Text Available BACKGROUND AND OBJECTIVE: Varicella zoster virus (VZV is known to cause VZV vasculopathy, which may be associated with stroke. A recent study found an increased risk of stroke within one year of herpes zoster. We aimed to investigate the short and long-term effects of herpes zoster on the risk of stroke. METHODS: Using Danish national registers, we constructed a cohort consisting of all Danish adults ≥18 years old between 1995 and 2008 (n = 4.6 million; person-years of follow-up = 52.9 million. Individual-level information on prescriptions for herpes zoster antiviral treatment and diagnoses of stroke was obtained from national registers. We compared the risk of stroke in persons who had received the specific dosage of acyclovir for herpes zoster with persons who had never received antiviral treatment by Poisson regression. RESULTS: During follow-up, 2.5% received treatment for herpes zoster and 5.0% were diagnosed with stroke. Individuals who had received medication had a 127% (95% CI 83-182% increased risk the first two weeks, 17% (CI 9-24% between two weeks and one year, and 5% (2-9% after the first year. The increased risk was greatest in the youngest age group (<40. To control for healthcare-seeking behaviour, we conducted parallel analyses investigating the risk of selected fractures after herpes zoster and found no similar increased risks. CONCLUSIONS: This large nationwide cohort study found an increased risk of stroke after treatment for herpes zoster. Although the short-term risk was particularly high, we cannot rule out the possibility of a small but important long-term risk.

  17. Efficacy observation on treating 32 cases of herpes zoster with the fire needle therapy%火针疗法治疗带状疱疹32例疗效观察

    Institute of Scientific and Technical Information of China (English)

    谢祖艺; 杨作卿; 曾庆萍; 鲁莉燕; 黄伟福

    2013-01-01

    带状疱疹是一种急性疱疹性皮肤病。西医暂无特效疗法,火针疗法治疗带状疱疹简单、实用、疗效好、易操作。采用火针疗法治疗32例带状疱疹,临床疗效满意,值得推广。%Herpes zoster is an acute skin disease. Little effects in modern medicine therapy, fire needle therapy for herpes zoster is simple, practical, effective, and easy to operate. Using fire needle therapy to treat 32 cases of herpes zoster, the clinical results are satisfactory, worthy of promotion.

  18. Experimental studies on the prevention and treatment of chickenpox and herpes zoster with measles vaccine.

    Science.gov (United States)

    Li, W H; Ming, Z L; Chen, Q; Li, Y

    1989-05-01

    In 151 chickenpox patients treated with live attenuated measles vaccine, the cure rate was 100%. In 145 cases of herpes zoster, the effective rate was 100% (completely cured in 91.7% and improved in 8.3%). In the treated group, the time needed for the subsidence of fever and skin rash and the duration of the disease were markedly shorter than those in the control group (P less than 0.01). It is particularly effective for alleviating pain, preventing and relieving postherpetic neuralgia in patients with zoster. The application of measles vaccine to the patients in the chickenpox incubation period might prevent the development of the disease, and decrease the incidence and death rate of varicella zoster virus infection in highly susceptible patients. The mechanism of its anti-viral action and production of interferon in the body is discussed.

  19. Herpes Zoster Involving the Second Division of the Trigeminal Nerve: Case Report and Literature Review.

    Science.gov (United States)

    Paquin, Rebecca; Susin, Lisiane F; Welch, Garrett; Barnes, Jonathan B; Stevens, Mark R; Tay, Franklin R

    2017-09-01

    Herpes zoster along the maxillary division of the trigeminal nerve is a rare condition that is caused by reactivation of the varicella zoster virus that resides within the trigeminal ganglion after the primary infection of chickenpox. The disease may be manifested as a toothache during its prodromal stage. The active stage of the disease is characterized by the appearance of a vesicular rash. Postherpetic neuralgia is a common complication of herpes zoster after resolution of the facial and intraoral symptoms. There is increasing evidence for herpes zoster patients to develop stroke later in life. The present case reports the development of herpes zoster maxillaris in a 71-year-old man whose maxillary right canine was diagnosed as pulpal necrosis and symptomatic apical periodontitis and was subsequently treated endodontically by cleaning and shaping and filling the canal space with gutta-percha and an epoxy resin-based sealer. The patient presented 3 days later with midfacial ulceration, desquamation, and crusting as well as intraoral ulceration along the course of the V2 dermatome. After successful treatment with antiviral medication, postherpetic neuralgia developed within the next 2 months. Complete resolution of the neuralgia occurred at the 4-month recall with negligible facial scarring. Herpes zoster may mimic odontogenic pain during the prodromal stage of the disease. Reactivation of the virus has also been implicated in the pathogenesis of pulpal pathoses. These paradoxical facets are of interest to the endodontist and should be considered in the differential diagnosis of the disease. Published by Elsevier Inc.

  20. [Neurologic complications of herpes zoster. A retrospective study in 100 patients].

    Science.gov (United States)

    Sánchez-Guerra, M; Infante, J; Pascual, J; Berciano, J; Polo, J

    2001-03-01

    The neurologic complications associated with herpes zoster are infrequent except for postherpetic neuralgia. The aim of this study was to review the clinical profile and the distribution of these complications in a retrospective series of patients. A retrospective analysis of the last 100 patients admitted with the diagnosis of herpes zoster with neurologic complications to our center from 1992 to 1999 by the Departments of Internal Medicine and Neurology was performed. The characteristics of the complications other than postherpetic neuralgia are reported. Aside from the 88 patients with postherpetic neuralgia, the 12 remaining patients presented other complications: seven different peripheral neuropathies, including three with Ramsay-Hunt syndrome, two meningitis, one encephalitis and one myelitis. In addition, one patient had ophthalmic herpes zoster with cerebral vasculopathy as ipsilateral Wallenberg's syndrome. Nine patients (75%) were males, four (25%) were under the age of 20 years and seven older than 60 years and only three were immunodepressed. The CSF was abnormal in six out of the eight patients in whom it was studied with lymphocytic pleocytosis being shown on analysis without qualitative or quantitative alteration in intrathecal synthesis of IgG. In the immunosuppressed patients the serology in the CSF of the varicela zoster virus was negative. All patients demonstrated regressive evolution following treatment with acyclovir. Neurologic complications other than postherpetic neuralgia occurred in 12% of the patients of this series, there was male predominance and peripheral neuropathies were the most frequent complications. Serology of the varicela zoster virus in immunosuppressed patients may be negative. In this series the prognosis was mainly satisfactory.

  1. Herpes Zoster oftálmico e posterior acidente vascular cerebral: relato de caso

    Directory of Open Access Journals (Sweden)

    Carlos A. M. Guerreiro

    1984-12-01

    Full Text Available Um caso de acidente vascular cerebral (AVC 14 semanas após a instalação de herpes zoster oftálmico (HZO é apresentado. A tomografia computadorizada craniana documentou comprometimento em território de artéria cerebral média ipsilateral ao HZO. O diagnóstico de probabilidade é o de arterite por herpes zoster com posterior trombose. Os autores reviram a literatura e enfatizam o longo intervalo entre o HZO e a instalação da hemiplegia. Citam as novas drogas antivirais que tornam esta causa de AVC potencialmente passível de ser prevenida.

  2. Comparative efficacy of phenytoin, steroid and carbamazepine in herpes zoster and post herpetic neuralgia

    Directory of Open Access Journals (Sweden)

    Agarwal S

    1991-01-01

    Full Text Available Three hundred patients of different ages were sequentially assigned three therapy groups (100 in each group viz. phenytoin, steroid (prednisolone and carbamazepine. Effect of these drugs on herpes zoster neuralgia and in prevention of post herpetic neuralgia was studied. Phenytoin was found to be superior to both steroid and carbamazepine in relieving the pain of herpes zoster and in reducing the incidence of post herpetic neuralgia. Only 16.1% of the patients in phenytoin treated group developed post herpetic neuralgia lasting for 2-4 weeks while 22.7% and 29.6% of the steroid and carbamazepine treated patients respectively developed post herpetic neuralgia and that too lasting for longer duration. No patient under 40 years developed post herpetic neuralgia.

  3. The diagnosis and treatment of herpes zoster%带状疱疹的诊治

    Institute of Scientific and Technical Information of China (English)

    张先雷; 孟胜利

    2016-01-01

    带状疱疹,又名盘腰缠,其发病率较高,有些患者症状不典型,确诊有一定的难度,给患者的后续诊治造成困难。本文简要介绍带状疱疹的诊治,为临床提供探讨。%Herpes zoster is the scientiifc name for Pan Yao Chan.Its incidence rate is high.The symptoms of some patients are not typical.Diagnosis has certain dififculty,which causes dififculties in the follow up diagnosis and treatment of patients.In this article,the author briefly introduces the diagnosis and treatment of herpes zoster,to provide discuss for clinic.

  4. The effect and mechanism analysis of valaciclovir on herpes zoster in elderly patients

    Institute of Scientific and Technical Information of China (English)

    Yu-Hua Chen

    2015-01-01

    Objective: To explore the effect and mechanism of valaciclovir on herpes zoster in elderly patients. Methods: 80 cases patients received valaciclovir treatments in our hospital were analyzed in this part. The expression of TNF-α, NF-κB, CD4 and CD8 were detected by Western Blotting. Results: The content of TNF-α, NF-κB, CD4 and CD8 was increased greatly in patients after drug treatments with statistical differences. Conclusion: Up-regulated expression of TNF-α, NF-κB, CD4 and CD8 is involved in the pathogenesis of herpes zoster and valaciclovir therapy mainly through normalizing those abnormal expressions of proteins.

  5. Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective

    Science.gov (United States)

    Johnson, Robert W.; Alvarez-Pasquin, Marie-José; Bijl, Marc; Franco, Elisabetta; Gaillat, Jacques; Clara, João G.; Labetoulle, Marc; Michel, Jean-Pierre; Naldi, Luigi; Sanmarti, Luis S.; Weinke, Thomas

    2015-01-01

    Herpes zoster (HZ) is primarily a disease of nerve tissue but the acute and longer-term manifestations require multidisciplinary knowledge and involvement in their management. Complications may be dermatological (e.g. secondary bacterial infection), neurological (e.g. long-term pain, segmental paresis, stroke), ophthalmological (e.g. keratitis, iridocyclitis, secondary glaucoma) or visceral (e.g. pneumonia, hepatitis). The age-related increased incidence of HZ and its complications is thought to be a result of the decline in cell-mediated immunity (immunosenescence), higher incidence of comorbidities with age and social-environmental changes. Individuals who are immunocompromised as a result of disease or therapy are also at increased risk, independent of age. HZ and its complications (particularly postherpetic neuralgia) create a significant burden for the patient, carers, healthcare systems and employers. Prevention and treatment of HZ complications remain a therapeutic challenge despite recent advances. This is an overview of the multidisciplinary implications and management of HZ in which the potential contribution of vaccination to reducing the incidence HZ and its complications are also discussed. PMID:26478818

  6. Herpes zoster as a marker of occult cancer

    DEFF Research Database (Denmark)

    Schmidt, S A J; Mor, A; Schønheyder, H C;

    2016-01-01

    : Through February 18, 2016, we searched PubMed, EMBASE and references of relevant papers for studies on zoster and risk of any cancer. One author screened retrieved papers by title and abstract; included papers were reviewed by two authors for eligibility, data extraction, and potential biases. Despite...

  7. Incidence and predictors of herpes zoster among antiretroviral therapy-naïve patients initiating HIV treatment in Johannesburg, South Africa

    Science.gov (United States)

    Maskew, Mhairi; Ajayi, Toyin; Berhanu, Rebecca; Majuba, Pappie; Sanne, Ian; Fox, Matthew P.

    2014-01-01

    Summary Objectives To describe the characteristics of HIV-infected patients experiencing herpes zoster after antiretroviral therapy (ART) initiation and to describe the incidence and predictors of a herpes zoster diagnosis. Methods Adult patients initiating ART from April 2004 to September 2011 at the Themba Lethu Clinic in Johannesburg, South Africa were included. Patients were followed from ART initiation until the date of first herpes zoster diagnosis, or death, transfer, loss to follow-up, or dataset closure. Herpes zoster is described using incidence rates (IR) and predictors of herpes zoster are presented as subdistribution hazard ratios (sHR) and 95% confidence intervals (95% CI). Results Fifteen thousand and twenty-five patients were included; 62% were female, the median age was 36.6 years, and the median baseline CD4 count was 98 cells/mm3. Three hundred and forty patients (2.3%) experienced herpes zoster in a median of 26.1 weeks after ART initiation. Most (71.5%) occurred within 1 year of initiation, for a 1-year IR of 18.1/1000 person-years. In an adjusted model, patients with low CD4 counts (herpes zoster (sHR: 1.53, 95% CI: 0.97–2.28) were at increased risk of incident herpes zoster. Conclusions While only 2% of patients were diagnosed with herpes zoster in this cohort, patients with low CD4 counts and those with prior episodes of herpes zoster were at higher risk for a herpes zoster diagnosis. PMID:24680820

  8. A case of herpes zoster ophthalmicus preceded one week by diplopia and ophthalmalgia.

    Science.gov (United States)

    Ota, Tomohiro; Yamazaki, Mineo; Toda, Yusuke; Ozawa, Akiko; Kimura, Kazumi

    2017-04-28

    A 66-year-old man presented with headache and ophthalmalgia. Diplopia developed, and he was hospitalized. The left eye had abducent paralysis and proptosis. We diagnosed him with Tolosa-Hunt syndrome and administered methylprednisolone at 1 g/day for 3 days. However, the patient did not respond to treatment. No abnormality was found on his MRI or cerebrospinal fluid examination. Tests showed his serum immunoglobulin G4 and antineutrophil cytoplasmic antibody titers were within normal limits. He also had untreated diabetes mellitus (HbA1c 9.2). One week after first presenting with symptoms, herpes zoster appeared on the patient's dorsum nasi, followed by keratitis and a corneal ulcer. Herpes zoster ophthalmicus with ophthalmoplegia was diagnosed. We began treatment with acyclovir (15 mg/kg) and prednisolone (1 mg/kg, decreased gradually). Ophthalmalgia and the eruption improved immediately. The eye movement disorder improved gradually over several months. It is rare that diplopia appears prior to cingulate eruption of herpes zoster ophthalmicus. We speculated that onset of the eruption was inhibited by strong steroid therapy and untreated diabetes mellitus.

  9. Varicella and herpes zoster vaccines: WHO position paper, June 2014--Recommendations.

    Science.gov (United States)

    2016-01-04

    This article presents the World Health Organization's (WHO) recommendations for the use of varicella and herpes zoster vaccination from the WHO position paper on varicella and herpes zoster vaccines - June 2014, published in the Weekly Epidemiological Record [1]. This position paper summarizes the WHO position on the use of varicella and herpes zoster vaccines. The current document replaces the position paper on the use of varicella vaccines published in 1998 [2]. Footnotes to this paper provide a number of core references. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO's current position on the use of vaccines in the global context. This paper reflects the recommendations of WHO's Strategic Advisory Group of Experts (SAGE) on immunization. These recommendations were discussed by SAGE at its April 2014 meeting. Evidence presented at the meeting can be accessed at http://www.who.int/immunization/sage/previous/en/index.html.

  10. Herpes zoster and the risk of ischemic and hemorrhagic stroke: A systematic review and meta-analysis.

    Science.gov (United States)

    Lian, Ying; Zhu, Yun; Tang, Fang; Yang, Bing; Duan, Ruisheng

    2017-01-01

    Herpes zoster infection and stroke are highly prevalent in the general population; however, reports have presented inconsistent findings regarding the relationship between herpes zoster infection and stroke. In this meta-analysis, we aimed to clarify this association. The PubMed and Embase databases were searched for studies published from their inception to January 2016. Two investigators independently extracted the data. The pooled relative risk (RR) was calculated using a random effects model. A total of 8 studies met the inclusion criteria. During the first 1 month after herpes zoster infection, the pooled RRs for ischemic stroke and hemorrhagic stroke were 1.55 (95% CI, 1.46-1.65) and 1.70 (95% CI, 0.73-3.96), respectively, and within 3 months after infection, the corresponding RRs were 1.17 (95% CI, 1.12-1.23) and 2.05 (95% CI, 1.17-3.60), respectively. At 1 year and more than 1 year after herpes zoster infection, a significant relationship was not observed between herpes zoster infection and the incidence of ischemic and hemorrhagic stroke. Publication bias was not observed. The accumulated evidence generated from this systematic review indicates that an increased risk for ischemic stroke occurred in the short term after herpes zoster infection, whereas a significant relationship was not observed in the long term after infection. With respect to hemorrhagic stroke, the association was not significant. With respect to hemorrhagic stroke, the association between was not significant except within 3 months after a herpes zoster infection.

  11. Burden of herpes zoster requiring hospitalization in Spain during a seven-year period (1998–2004

    Directory of Open Access Journals (Sweden)

    San Martín María

    2009-05-01

    Full Text Available Abstract Background A thorough epidemiological surveillance and a good understanding of the burden of diseases associated to VZV are crucial to asses any potential impact of a prevention strategy. A population-based retrospective epidemiological study to estimate the burden of herpes zoster requiring hospitalization in Spain was conducted. Methods This study was conducted by using data from the national surveillance system for hospital data, Conjunto Mínimo Básico de Datos (CMBD. Records of all patients admitted to hospital with a diagnosis of herpes zoster (ICD-9-MC codes 053.0–053.9 during a 7-year period (1998–2004 were selected. Results A total of 23,584 hospitalizations with a primary or secondary diagnosis of herpes zoster in patients ≥ 30 years of age were identified during the study period. Annually there were 13.4 hospitalizations for herpes zoster per 100,000 population in patients ≥ 30 years of age. The rate increases with age reaching a maximum in persons ≥ 80 years of age (54.3 admissions per 100,000 population >80 years of age. The mean cost of a hospitalization for herpes zoster in adult patients was 3,720 €. The estimated annual cost of hospitalizations for herpes zoster in patients ≥ 30 years of age in Spain was 12,731,954 €. Conclusion Herpes zoster imposes an important burden of hospitalizations and result in large cost expenses to the Spanish National Health System, especially in population older than 50 years of age

  12. Burden of herpes zoster requiring hospitalization in Spain during a seven-year period (1998–2004)

    Science.gov (United States)

    2009-01-01

    Background A thorough epidemiological surveillance and a good understanding of the burden of diseases associated to VZV are crucial to asses any potential impact of a prevention strategy. A population-based retrospective epidemiological study to estimate the burden of herpes zoster requiring hospitalization in Spain was conducted. Methods This study was conducted by using data from the national surveillance system for hospital data, Conjunto Mínimo Básico de Datos (CMBD). Records of all patients admitted to hospital with a diagnosis of herpes zoster (ICD-9-MC codes 053.0–053.9) during a 7-year period (1998–2004) were selected. Results A total of 23,584 hospitalizations with a primary or secondary diagnosis of herpes zoster in patients ≥ 30 years of age were identified during the study period. Annually there were 13.4 hospitalizations for herpes zoster per 100,000 population in patients ≥ 30 years of age. The rate increases with age reaching a maximum in persons ≥ 80 years of age (54.3 admissions per 100,000 population >80 years of age). The mean cost of a hospitalization for herpes zoster in adult patients was 3,720 €. The estimated annual cost of hospitalizations for herpes zoster in patients ≥ 30 years of age in Spain was 12,731,954 €. Conclusion Herpes zoster imposes an important burden of hospitalizations and result in large cost expenses to the Spanish National Health System, especially in population older than 50 years of age PMID:19422687

  13. Herpes zoster and the risk of ischemic and hemorrhagic stroke: A systematic review and meta-analysis

    Science.gov (United States)

    Tang, Fang; Yang, Bing; Duan, Ruisheng

    2017-01-01

    Background Herpes zoster infection and stroke are highly prevalent in the general population; however, reports have presented inconsistent findings regarding the relationship between herpes zoster infection and stroke. In this meta-analysis, we aimed to clarify this association. Material and methods The PubMed and Embase databases were searched for studies published from their inception to January 2016. Two investigators independently extracted the data. The pooled relative risk (RR) was calculated using a random effects model. Results A total of 8 studies met the inclusion criteria. During the first 1 month after herpes zoster infection, the pooled RRs for ischemic stroke and hemorrhagic stroke were 1.55 (95% CI, 1.46–1.65) and 1.70 (95% CI, 0.73–3.96), respectively, and within 3 months after infection, the corresponding RRs were 1.17 (95% CI, 1.12–1.23) and 2.05 (95% CI, 1.17–3.60), respectively. At 1 year and more than 1 year after herpes zoster infection, a significant relationship was not observed between herpes zoster infection and the incidence of ischemic and hemorrhagic stroke. Publication bias was not observed. Conclusion The accumulated evidence generated from this systematic review indicates that an increased risk for ischemic stroke occurred in the short term after herpes zoster infection, whereas a significant relationship was not observed in the long term after infection. With respect to hemorrhagic stroke, the association was not significant. With respect to hemorrhagic stroke, the association between was not significant except within 3 months after a herpes zoster infection. PMID:28178287

  14. A COMPARATIVE STUDY TO EVALUATE THE EFFICACY AND SAFETY OF VALACYCLOVIR AND FAMCYCLOVIR IN THE MANAGEMENT OF HERPES ZOSTER IN A TERTIARY CARE HOSPITAL IN PUDUCHERRY

    Directory of Open Access Journals (Sweden)

    Indradev

    2014-05-01

    Full Text Available OBJECTIVE: The objective of this study was to compare the efficacy and safety of Valacyclovir and Famcyclovir in the management of Acute Herpes Zoster. MATERIALS AND METHODS: Relevant data were taken from 162 patients with herpes zoster who presented within 72 hours of onset of rash and were randomized into 2 groups of 81 each. The 1st group received Valacyclovir 1gm thrice a day for 7 days while those in the 2nd group received Famcyclovir 500 mg thrice a day for 7 days respectively and evaluated at the end of each week upto 6 weeks period and examined for full crusting of lesions, complete healing of the lesion and loss of acute pain (visual analogue scale scores for pain. Safety assessment was based on adverse effects. RESULTS: The intent to treat analysis (162 Pts showed that valacyclovir for 7 days significantly accelerated the resolution of pain in Herpes zoster pts (P=0.00014 compared with famcyclovir; median pain duration were 21 and 22 days respectively. There was no difference between treatments in time taken for healing of lesions. Adverse effects like nausea, vomiting, diarrhoea and headache were commonly reported in both groups. Valacyclovir was found to be statistically superior over Famcyclovir in terms of G.I adverse effects. Compliance was also better with Valacyclovir. CONCLUSION: Oral Valacyclovir administered three times daily for 7 days during acute zoster infection offers significant benefit by providing a well-tolerated, cost effective and accelerated rate of resolution of pain and maintains the favorable safety profile compared to oral Famcyclovir.

  15. Longitudinal risk of herpes zoster in patients with non-Hodgkin lymphoma receiving chemotherapy: A nationwide population-based study.

    Science.gov (United States)

    Cho, Shih-Feng; Wu, Wan-Hsuan; Yang, Yi-Hsin; Liu, Yi-Chang; Hsiao, Hui-Hua; Chang, Chao-Sung

    2015-09-22

    This study investigated the incidence of and risk factors for herpes zoster in patients with non-Hodgkin lymphoma (NHL) who were receiving anti-lymphoma treatment. The overall incidence density of herpes zoster was 12.21% (472/3865); 11.79% (258/2188) of the patients received conventional chemotherapy and 12.76% (214/1677) of the patients received rituximab-containing chemotherapy. For the patients who received conventional chemotherapy, the risk factors included female gender, multiple courses of chemotherapy and autologous hematopoietic stem cell transplantation. For the patients who received rituximab-containing chemotherapy, the risk factors included female gender, diabetes mellitus, multiple courses of chemotherapy, autologous hematopoietic stem cell transplantation and higher accumulated rituximab dose. The majority of the herpes zoster episodes occurred within the first two years after the diagnosis of NHL. After adjusting for the propensity score matching, rituximab-containing chemotherapy was not associated with a higher overall incidence density of herpes zoster (P = 0.155). However, the addition of rituximab to conventional chemotherapy increased the short-term risk of herpes zoster with adjusted odd ratios of 1.38 (95% confidence intervals (CI) = 1.05-1.81, P = 0.021) and 1.37 (95% CI = 1.08-1.73, P = 0.010) during the 1-year and 2-year follow-up periods, respectively.

  16. 浅谈肝郁与带状疱疹%Brief analysis on liver depression and herpes zoster

    Institute of Scientific and Technical Information of China (English)

    龙雄初; 龙枚飞; 李晓玲; 赵社海; 马洪仕

    2012-01-01

    通过对带状疱疹多年的诊治,结合目前该病的发病特点,从肝郁与人体正气(免疫力)、肝郁与带状疱疹的发病两个方面分析,结合现代医学探讨肝郁与带状疱疹的关系.笔者认为长时间的肝郁损伤人体正气,带状疱疹正是由于机体正气不足,免疫力下降,病毒被激活、繁殖而发病.肝郁是带状疱疹发病的重要因素.%According to years of treatment experience on herpes zoster,combined with its current onset characteristics as well as modem medicine,the authors probed into the relation between liver depression and herpes zoster on the following two aspects:one was liver depression and healthy qi (immunity) ; the other was liver depression and the incidence of herpes zoster.We considered that long-term liver depression impairs healthy qi.Then herpes zoster appears because detriment of healthy qi leading to decreased immunity,reactivation and reproduction of virus.Liver depression is a significant factor for the onset of herpes zoster.

  17. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults.

    Science.gov (United States)

    Lal, Himal; Cunningham, Anthony L; Godeaux, Olivier; Chlibek, Roman; Diez-Domingo, Javier; Hwang, Shinn-Jang; Levin, Myron J; McElhaney, Janet E; Poder, Airi; Puig-Barberà, Joan; Vesikari, Timo; Watanabe, Daisuke; Weckx, Lily; Zahaf, Toufik; Heineman, Thomas C

    2015-05-28

    In previous phase 1-2 clinical trials involving older adults, a subunit vaccine containing varicella-zoster virus glycoprotein E and the AS01B adjuvant system (called HZ/su) had a clinically acceptable safety profile and elicited a robust immune response. We conducted a randomized, placebo-controlled, phase 3 study in 18 countries to evaluate the efficacy and safety of HZ/su in older adults (≥50 years of age), stratified according to age group (50 to 59, 60 to 69, and ≥70 years). Participants received two intramuscular doses of the vaccine or placebo 2 months apart. The primary objective was to assess the efficacy of the vaccine, as compared with placebo, in reducing the risk of herpes zoster in older adults. A total of 15,411 participants who could be evaluated received either the vaccine (7698 participants) or placebo (7713 participants). During a mean follow-up of 3.2 years, herpes zoster was confirmed in 6 participants in the vaccine group and in 210 participants in the placebo group (incidence rate, 0.3 vs. 9.1 per 1000 person-years) in the modified vaccinated cohort. Overall vaccine efficacy against herpes zoster was 97.2% (95% confidence interval [CI], 93.7 to 99.0; P<0.001). Vaccine efficacy was between 96.6% and 97.9% for all age groups. Solicited reports of injection-site and systemic reactions within 7 days after vaccination were more frequent in the vaccine group. There were solicited or unsolicited reports of grade 3 symptoms in 17.0% of vaccine recipients and 3.2% of placebo recipients. The proportions of participants who had serious adverse events or potential immune-mediated diseases or who died were similar in the two groups. The HZ/su vaccine significantly reduced the risk of herpes zoster in adults who were 50 years of age or older. Vaccine efficacy in adults who were 70 years of age or older was similar to that in the other two age groups. (Funded by GlaxoSmithKline Biologicals; ZOE-50 ClinicalTrials.gov number, NCT01165177.).

  18. Herpes zoster em pacientes com lúpus eritematoso sistêmico juvenil Herpes zoster in patients with juvenile systemic lupus erythematosus

    Directory of Open Access Journals (Sweden)

    Paula da Silva Neves

    2007-04-01

    Full Text Available Infecção pelo vírus varicela zoster (VVZ em pacientes com lúpus eritematoso sistêmico juvenil (LESJ tem sido pouco descrita. Durante um período de 12 anos, ocorreram 195 internações em 77 pacientes com LESJ e estas foram acompanhadas pela Unidade de Reumatologia Pediátrica do Instituto da Criança do Hospital das Clínicas da Universidade de São Paulo. Onze pacientes (14%, dez do sexo feminino, apresentaram 14 internações (7,1% pelo VVZ. Nesses pacientes, a média de idade foi de 16 anos e 5 meses e a média do tempo de duração do LESJ até a primeira infecção devido ao VVZ foi de 4 anos. Todos os episódios das infecções estavam associados com atividade da doença, que se apresentaram como lesões vesicobolhosas seguindo trajeto nervoso. As regiões do tórax e membros foram mais comumente afetadas. Todos haviam utilizado prednisona e quatro usaram ciclofosfamida EV. Todos receberam aciclovir EV por 7 a 10 dias. Nenhum paciente apresentou neuralgia pós-herpética, infecção bacteriana secundária ou evoluiu para óbito. Entretanto, uma paciente em uso de aciclovir apresentou amaurose aguda por vasculite necrosante retiniana bilateral associado ao VVZ, necessitando de duas aplicações de ganciclovir intravítreo e gamaglobulina EV (2 g/kg/dose, com recuperação parcial da acuidade visual. Assim sendo, infecção por VVZ em pacientes com LESJ foi infreqüente, habitualmente associada à atividade da doença e à corticoterapia. Essa infecção foi controlada com aciclovir, e os pacientes raramente apresentaram complicações.Varicella zoster virus (VZV infection in patients with juvenile systemic lupus erythematosus (JSLE has been rarely described. 195 hospitalizations of 77 JSLE patients occurred in a period of 12 years and were followed at the Pediatric Rheumatology Unity of the Instituto da Criança - Hospital das Clínicas - Universidade de São Paulo. Eleven patients (14%, 10 female, had 14 hospitalizations (7.1% due to

  19. Association of cigarette smoking with a past history and incidence of herpes zoster in the general Japanese population: the SHEZ Study.

    Science.gov (United States)

    Ban, J; Takao, Y; Okuno, Y; Mori, Y; Asada, H; Yamanishi, K; Iso, H

    2017-04-01

    Few studies have examined the impact of cigarette smoking on the risk for herpes zoster. The Shozu Herpes Zoster (SHEZ) Study is a community-based prospective cohort study over 3 years in Japan aiming to clarify the incidence and predictive and immunological factors for herpes zoster. We investigated the associations of smoking status with past history and incidence of herpes zoster. A total of 12 351 participants provided valid information on smoking status and past history of herpes zoster at baseline survey. Smoking status was classified into three categories (current, former, never smoker), and if currently smoking, the number of cigarettes consumed per day was recorded. The participants were under the active surveillance for first-ever incident herpes zoster for 3 years. We used a logistic regression model for the cross-sectional study on the association between smoking status and past history of herpes zoster, and a Cox proportional hazards regression model for the cohort study on the association with risk of incidence. The multivariable adjusted odd ratios (95% CI) of past history of herpes zoster for current vs. never smokers were 0·67 (0·54-0·80) for total subjects, 0·72 (0·56-0·93) for men and 0·65 (0·44-0·96) for women. The multivariable adjusted hazard ratios (95% CI) of incident herpes zoster for current vs. never smokers were 0·52 (0·33-0·81) for total subjects, 0·49 (0·29-0·83) for men and 0·52 (0·19-1·39) for women. Smoking status was inversely associated with the prevalence and incidence of herpes zoster in the general population of men and women aged ⩾50 years.

  20. Vaccination against herpes zoster in developed countries: state of the evidence.

    Science.gov (United States)

    Drolet, Mélanie; Oxman, Michael N; Levin, Myron J; Schmader, Kenneth E; Johnson, Robert W; Patrick, David; Mansi, James A; Brisson, Marc

    2013-05-01

    Although progress has been made in the treatment of herpes zoster (HZ) and postherpetic neuralgia (PHN), available therapeutic options are only partially effective. Given evidence that a live-attenuated varicella-zoster-virus vaccine is effective at reducing the incidence of HZ, PHN and the burden of illness, policymakers and clinicians are being asked to make recommendations regarding the use of the zoster vaccine. In this report, we summarize the evidence regarding the: (1) burden of illness; (2) vaccine efficacy and safety; and (3) cost-effectiveness of vaccination, to assist evidence-based policy making and guide clinicians in their recommendations. First, there is general agreement that the overall burden of illness associated with HZ and PHN is substantial. Second, the safety and efficacy of the zoster vaccine at reducing the burden of illness due to HZ and the incidence of PHN have been clearly demonstrated in large placebo-controlled trials. However, uncertainty remains about the vaccine's duration of protection. Third, vaccination against HZ is likely to be cost-effective when the vaccine is given at approximately 65 y of age, if vaccine duration is longer than 10 y.

  1. MRI diagnosis of muscle denervation from herpes zoster with discordant distribution of the skin rash

    Energy Technology Data Exchange (ETDEWEB)

    Gupta, Amit; Sundaram, Murali [Cleveland Clinic, Section of Musculoskeletal Radiology, Imaging Institute, Cleveland, OH (United States); Winalski, Carl S. [Cleveland Clinic, Section of Musculoskeletal Radiology, Imaging Institute, Cleveland, OH (United States); Cleveland Clinic, Department of Biomedical Engineering, Lerner Research Institute, Cleveland, OH (United States)

    2014-10-15

    Herpes zoster is a common disorder characterized by a painful rash along a dermatome caused by reactivation of the varicella zoster virus (VZV). Muscle denervation injury from motor involvement is an uncommon phenomenon. Discordant distribution of the skin rash and motor nerve involvement, presenting as a skin rash in one body part and muscle weakness or pain from nerve involvement in another body part is an even more uncommonly reported finding. We present an unusual case of muscle denervation injury resulting from motor involvement of a peripheral nerve by VZV diagnosed by magnetic resonance imaging with cutaneous manifestations in a different dermatomal distribution. To the best of our knowledge, there has been no similar case reported in the English radiology literature. We suggest that whenever a radiologist notices MRI findings suggesting denervation injury and a cause not readily identified, VZV-related denervation injury should be included in the differential diagnosis, especially in an older immunocompromised patient. (orig.)

  2. 带状疱疹急性期临床症状与皮损区病理性改变的相关性研究%Study on relationship between clinical symptoms and pathological changes in skin lesions of patients with herpes zoster in acute phase

    Institute of Scientific and Technical Information of China (English)

    高月; 季凤清; 李彦平; 孙海梅; 张乐辉

    2013-01-01

    Objective To observe the relationship between clinical symptoms and pathological changes in skin lesions of patients with herpes zoster in acute phase, and the effect of early application of anti - inflammatory and immune therapy for skin lesions on the course of disease. Methods There were two stages in this study. In the first stage, skin tissues under herpes or in pain locations of 3 patients with definite diagnosis of herpes zoster were taken and prepared for conventional slices with HE staining and S -100 staining. Abnormal lymphocytes infiltration and nerve ending lesions in these sections were observed. In the second stage, 36 patients with herpes zoster in acute phase were randomly assigned to two groups. Patients in nerve block group ( n = 18 ) receiving subcutaneous block by injection of solution ( 10 ~ 15 ml in volume ) containing 0.3% li-docaine, 0. 5mg cobamamide and 40 mg methylprednisolone into skin where the most severe skin lesions or the most intense pain occurred from proximal to distal part according to the nerve distribution. Patients in medicine group ( n = 18 ) receiving conventional therapy by taking oral antiviral agents, vitamin B12, analgesics, and applying topical agents in skin lesions. The difference in duration of healing of skin lesions and reduction of pain intensity in the acute phase between these two different therapeutic methods was observed. Results Epidermal atrophy and partial basal cells liquidation were found in skin lesions. A moderate number of lymphoidocytes and plasmocytes were peripherally infiltrated the dO ermis and blood vessels. Mild edema was found in the superficial layer of dermis. Injured peripheral nerve, damaged axons, and infiltration of a small number of lymphocytes were observed in immunohistochemical staining sections. Patients with the same skin lesions had shorter time for incrustation in nerve block group than that of medicine group ( P 〈 0.05 ). Pain intensity of patients in nerve block group was

  3. [Case of spinal epidural abscess after continuous epidural block to manage the pain of herpes zoster].

    Science.gov (United States)

    Miyamoto, Tatsuhito; Nakatani, Toshihiko; Narai, Yasuhiro; Sakakibara, Manabu; Hashimoto, Tatsuya; Saito, Youji

    2014-03-01

    A woman in her 90's received continuous epidural block for the pain of herpes zoster. Four days after epidural catheterization, she was found with cellutitis. Fourteen days after epidural catheterization, spinal epidural abscess was pointed out on MRI. Since there were no neurological symptoms, we performed conservative medical management with antibiotics. She recovered without sequela When the symptoms of cellutitis appeared after epidural block (even if there are neither neurological symptoms nor infectious signs), there is a possibility of progressing into spinal epidural abscess.

  4. Herpes Zoster with Post Herpetic Neuralgia Involving the Right Maxillary Branch of Trigeminal Nerve: A Case Report and Review of Literature

    Science.gov (United States)

    Subramanian, Kailasam; Sankari, S Leena; Potluri, Venkata Lakshmi Aparna; Prabakaran, Akila

    2017-01-01

    Herpes Zoster (HZ) is an acute, self-limiting, neuro cutaneous viral infection caused by the reactivation of the Varicella Zoster Virus (VZV) that remains latent in the dorsal root ganglion. About 50% of occurrence is seen in older age groups and immunocompromised patients. Less than 5% occur in children. HZ is characterized by the unilateral pain, burning and tingling sensation followed by the vesicular eruptions limited to the single dermatome that are innervated by the single cranial ganglion, sometimes it leads to Post Herpetic Neuralgia (PHN). We report a case of a HZ in a 22-year-old young female patient involving the right maxillary branch of the trigeminal nerve along with PHN. PMID:28274075

  5. Burden of herpes zoster and postherpetic neuralgia in Japanese adults 60 years of age or older: Results from an observational, prospective, physician practice-based cohort study.

    Science.gov (United States)

    Sato, Keiko; Adachi, Koichi; Nakamura, Hiroyuki; Asano, Kazuhiro; Watanabe, Akihiro; Adachi, Riri; Kiuchi, Mariko; Kobayashi, Keiju; Matsuki, Taizo; Kaise, Toshihiko; Gopala, Kusuma; Holl, Katsiaryna

    2017-04-01

    Approximately one in three persons will develop herpes zoster during their lifetime, and it can lead to serious complications such as postherpetic neuralgia. However, evidence on burden of herpes zoster and postherpetic neuralgia in Japan is limited. This prospective, observational, multicenter, physician practice-based cohort study was conducted in Kushiro, Hokkaido, Japan (Clinicaltrials.gov identifier NCT01873365) to assess the incidence and hospitalization rates of herpes zoster, and the proportion, clinical burden and risk factors for postherpetic neuralgia in adults aged 60 years or more. Within the study area, 800 subjects developed herpes zoster and 412 were eligible for the study. Herpes zoster incidence was 10.2/1000 person-years and higher among women and older subjects. Subjects with herpes zoster required on average 5.7 outpatient consultations. Herpes zoster-associated hospitalization rate was 3.4% (27/800). The proportion of postherpetic neuralgia and other complications was 9.2% (38/412) and 26.5% (109/412), respectively. Statistically significant association with the development of postherpetic neuralgia was male sex (odds ratio [OR], 2.51; 95% confidence interval [CI], 1.17-5.38), age of 70-74 years (OR, 3.51; 95% CI, 1.09-11.3), immunosuppressive therapy (OR, 6.44; 95% CI, 1.26-32.9), severe herpes zoster pain at first consultation (OR, 3.08; 95% CI, 1.10-8.62) and rash on upper arms (vs no rash on upper arms; OR, 3.46; 95% CI, 1.10-10.9). Considerable herpes zoster and postherpetic neuralgia burden exists among elderly in Japan, and there may be predictive factors at the first visit which could be indicative of the risk of developing postherpetic neuralgia. © 2016 The Authors. The Journal of Dermatology published by John Wiley & Sons Australia, Ltd on behalf of Japanese Dermatological Association.

  6. Dental complications of herpes zoster: Two case reports and review of literature

    Directory of Open Access Journals (Sweden)

    Swati Gupta

    2015-01-01

    Full Text Available Herpes zoster (HZ (shingles results due to reactivation of varicella-zoster virus. Unusual dental complications like osteonecrosis, exfoliation of teeth, periodontitis, and calcified and devitalized pulps, periapical lesions, and resorption of roots as well as developmental anomalies such as irregular short roots and missing teeth may arise secondary to involvement of 2 nd or 3 rd division of trigeminal nerve by HZ. Such cases pose both a diagnostic as well as a therapeutic challenge. We report two such rare dental complications of HZ-spontaneous tooth exfoliation and osteonecrosis of the maxilla in a 70-year-old female patient; and multiple periapical pathoses affecting right half of the mandibular teeth in a 45-year-old female patient. Both the patients did not have any associated systemic illness. The aim of this paper was to compare the present cases with all the 46 cases of osteonecrosis and 6 cases of multiple periapical pathoses secondary to trigeminal zoster reported in literature till date The article also throws light that the occurrence of such dental complications of HZ is not entirely dependent on the immune status of the host.

  7. Study on the clinical efficacy of transversal abdominal plane blockade in treatment of acute herpes zoster on abdomen%腹横肌平面阻滞治疗腹部急性带状疱疹的临床观察

    Institute of Scientific and Technical Information of China (English)

    刘永彬; 万磊; 罗克金

    2016-01-01

    目的:观察腹横肌平面阻滞治疗急性期下腹部带状疱疹的临床疗效。方法28例急性带状疱疹患者随机分为肋间神经阻滞组(IC 组,n =14)和腹横肌平面阻滞组(TP 组,n =14),分别接受 T10、T11、T12椎旁肋间神经阻滞(1次/周,共4次)和患侧腹横肌平面阻滞(1次/周,共4次)。观察两组的阻滞平面范围评分值、结痂时间、4周后通常痛视觉模拟评分和爆发痛视觉模拟评分。结果 TP 组阻滞平面评分值明显高于 IC 组( P <0.05)。TP 组皮肤结痂时间明显短于 IC 组( P <0.05)。TP 组疼痛视觉模拟评分值明显低于 IC 组( P <0.05)。结论腹横肌平面阻滞可以有效控制急性期下腹部带状疱疹所致皮神经疼痛,同时有助于带状疱疹皮损区的愈合。%Objective To observe the efficacy of transversal abdominal plane blockade in treatment of patients with acute herpes zoster in lower abdomen. Methods Twenty - eight patients with acute herpes zoster in lower abdomen were randomly assigned into group IC(n = 14),pa-tients in this group received paravertebral intercostal nerve blockade at T10 ,T11 and T12(once a week and four times as one course)and patients in group TP( n = 14)received transversal abdominal plane blockade( once a week and four times as one course). Scales of blockade level (SBL),time for forming scab(TFB),visual analogue scales(VAS)of common pain and visual analogue scales(VAS)of burst pain after four weeks were observed and recorded. Results Scales of blockade level(SBL)in group TP were higher than those of group IC( P < 0. 05). The duration for forming scab in patients of group TP was shorter than that of patients in group IC( P < 0. 05). Visual analogue scales(VAS)of com-mon pain and burst pain in patients of group TP were lower than those of patients in group IC( P < 0. 05). Conclusion Transversal abdominal plane blockade is effective in alleviating cutaneous nerve pain

  8. Distribution of health effects and cost-effectiveness of varicella vaccination are shaped by the impact on Herpes Zoster.

    NARCIS (Netherlands)

    Lier, A. van; Lugner, A.K.; Opstelten, W.; Jochemsen, P.; Wallinga, J.; Schellevis, F.; Sanders, E.; Melker, H. de; Boven, M. van

    2015-01-01

    Background: Herpes zoster (HZ) is a painful disease affecting a considerable part of the elderly. Programmatic HZ vaccination of elderly people may considerably reduce HZ morbidity and its related costs, but the extent of these effects is unknown. In this article, the potential effects and cost-effe

  9. Longitudinal study on oral shedding of herpes simplex virus 1 and varicella-zoster virus in individuals infected with HIV

    NARCIS (Netherlands)

    M. van Velzen (Monique); W.J.D. Ouwendijk (Werner ); S. Selke (Stacy); S.D. Pas (Suzan); F.B. van Loenen (Freek); A.D.M.E. Osterhaus (Albert); A. Wald (Anna); G.M.G.M. Verjans (George)

    2013-01-01

    textabstractPrimary herpes simplex virus 1 (HSV-1) and varicella-zoster virus (VZV) infection leads to a life-long latent infection of ganglia innervating the oral mucosa. HSV-1 and VZV reactivation is more common in immunocompromised individuals and may result in viral shedding in saliva. We determ

  10. Detection of varicella-zoster virus and herpes simplex virus by the polymerase chain reaction with degenerate primers

    NARCIS (Netherlands)

    Jacobs, J.J.L.; Folkers, E.; Vreeswijk, J.

    1999-01-01

    Varicella-zoster virus (VZV) and herpes simplex virus (HSV) are human pathogens of significance involved in multiple diseases with either typical or atypical clinical features. In neonates and immunocompromised patients these alphaherpesviruses may cause life-threatening diseases such as

  11. 带状疱疹202例临床分析%Clinical analysis of 202 cases of herpes zoster

    Institute of Scientific and Technical Information of China (English)

    张源; 王青; 张腾

    2016-01-01

    目的:探究带状疱疹患者的临床特点及高危因素。方法:回顾性分析带状疱疹患者202例的临床资料。结果:73例患者发病年龄≥65岁。皮损位于肋间神经分布区域90例。误诊率12%。结论:带状疱疹在中老年人中发病率较高,最易累及肋间神经,心脑血管病是带状疱疹发病的高危因素。%Objective:To explore the clinical characteristics and high risk factors of patients with herpes zoster.Methods:The clinical data of 202 cases of patients with herpes zoster were analyzed retrospectively.Results:73 cases of patients were over 65 years old.90 cases had lesions in the distribution area of intercostal nerve.The misdiagnosis rate was 12%.Conclusion:Herpes zoster had higher incidence in the elderly and affected the intercostal nerve most easily,the cerebrovascular disease was high risk factors for the onset of herpes zoster.

  12. Detection of varicella-zoster virus and herpes simplex virus by the polymerase chain reaction with degenerate primers

    NARCIS (Netherlands)

    Jacobs, J.J.L.; Folkers, E.; Vreeswijk, J.

    1999-01-01

    Varicella-zoster virus (VZV) and herpes simplex virus (HSV) are human pathogens of significance involved in multiple diseases with either typical or atypical clinical features. In neonates and immunocompromised patients these alphaherpesviruses may cause life-threatening diseases such as encephaliti

  13. Health care utilization and cost burden of herpes zoster in a community population.

    Science.gov (United States)

    Yawn, Barbara P; Itzler, Robbin F; Wollan, Peter C; Pellissier, James M; Sy, Lina S; Saddier, Patricia

    2009-09-01

    To conduct a population-based study to assess health care utilization (HCU) and costs associated with herpes zoster (HZ) and its complications, including postherpetic neuralgia (PHN) and nonpain complications, in adults aged 22 years and older. Medical record data on HCU were abstracted for all confirmed new cases of HZ from January 1, 1996, through December 31, 2001, among residents of Olmsted County, Minnesota. Herpes zoster-related costs were estimated by applying the Medicare Payment Fee Schedule to health care encounters and mean wholesale prices to medications. All costs were adjusted to 2006 US dollars using the medical care component of the Consumer Price Index. The HCU and cost of the 1669 incident HZ cases varied, depending on the complications involved. From 3 weeks before to 1 year after initial diagnosis, there were a mean of 1.8 outpatient visits and 3.1 prescribed medications at a cost of $720 for cases without PHN or nonpain complications compared with 7.5 outpatient visits and 14.7 prescribed medications at a cost of $3998 when complications, PHN, or nonpain complications were present. The annual medical care cost of treating incident HZ cases in the United States, extrapolated from the results of this study in Olmsted County, is estimated at $1.1 billion. Most of the costs are for the care of immunocompetent adults with HZ, especially among those 50 years and older.

  14. OBSERVATION ON THE THERAPEUTIC EFFECT OF PLUM-BLOSSOM NEEDLE TAPPING PLUS MEDICATION FOR HERPES ZOSTER

    Institute of Scientific and Technical Information of China (English)

    WANG Li-kang; YIN Li-li

    2005-01-01

    Objective: To observe the therapeutic effect of plum-blossom needle tapping combined with intravenous drip of Acyclovir for herpes zoster. Methods: A total of 40 herpes zoster patients were randomized into acupuncture plus medication group (n=21) and medication group (n=19) which were treated respectively with topical plum-blossom needle tapping in the focus region combined with intravenous drip of Acyclovir (250 mg+250 mL normal saline, twice daily) and simple intravenous drip of Acyclovir. Results: After treatment, of the 21 and 19 cases in acupuncture plus medication and medication groups, 18 (85.7%) and 10 (52.6%) were cured, 3 (14.3%) and 7 (36.8%) had marked improvement, 0 (0) and 2 (10.5%) failed, with the effective rates being 100.0% and 89.5% respectively. The cure duration of acupuncture plus medication and medication groups were (2.5±1.0) days and (4.0±2.3) days separately. The therapeutic effect of the former group was significantly superior to that of the later group (P<0.05) and the duration of cure of acupuncture plus medication group was evidently shorter than that of medication group (P<0.05). Conclusion: The therapeutic effect of plum-blossom needle tapping plus Acyclovir is significantly superior to that of simple Acyclovir in relieving pain, promoting scabbing, and shortening the therapeutic duration.

  15. The Evaluation Clinical and Demographic Characteristics of 115 Patients Diagnosed with Herpes Zoster in Eeastern Turkey

    Directory of Open Access Journals (Sweden)

    Hatice Uce Özkol

    2013-12-01

    Full Text Available Objective: The aim of this study was to investigate the clinical and demographic characteristics of patients diagnosed with herpes zoster and to explore the similarities and differences with other epidemiological studies from Turkey and the world. Methods: We retrospectively reviewed the records of 115 patients diagnosed with herpes zoster in the Yuzuncu Yıl University Medical Faculty Dermatology Department between January 2007 and December 2010. Results: The mean age of the patients was 42.21±23.88 years. 115 patients, -47 female (40.9%, 68 male (59.1%- aged between 2 and 93 years were assessed. Pediatric age group, 20 (17.4%, adult age group, 95 (82.6% patients, respectively. The incidence of HZ was found to be 0.43%. HZ was observed winter rarely (13.04%. Is mostly seen in the months of March (17.39% The affected dermatome were thorasic (49 patient, 42.6%, servical (21 patient, 18.3%, ophtalmic (22 patient, 19.1%, lomber (16 patient, 13.9%, sacral (7 patient, 6.1% respectively. Complications developed in 13% of patients. Conclusion: We observed that our findings were more or less similar to the findings of the literature data. Cases of HZ in our study was very rare during the winter season. Multi-center studies are needed to the emergence of clinical and epidemiological characteristics of HZ in Turkey.

  16. Herpes zoster in psoriasis patients undergoing treatment with biological agents: prevalence, impact, and management challenges

    Directory of Open Access Journals (Sweden)

    el Hayderi L

    2016-10-01

    Full Text Available Lara el Hayderi, Fany Colson, Bita Dezfoulian, Arjen F Nikkels Department of Dermatology, CHU du Sart Tilman, University Hospital of Liège, Liège, Belgium Abstract: As TNF-α is a major factor in the immune defense against herpes zoster (HZ; an increased incidence and severity of HZ cases were suspected in patients undergoing treatment with TNF antagonists. Several studies and clinical experience provided evidence that the incidence of HZ increases by twofold to threefold in this patient category. The number of severe cases of HZ, with multisegmental, disseminated cutaneous, and/or systemic involvement, is also increased. Concerning psoriasis patients under biologicals, the clinician should be more alert for an eventual HZ event, in particular during the first year of biological treatment, and be aware of the possibility of more severe HZ cases. HZ may also undergo an age-shift toward younger patients. Rapid identification of risk factors for severe HZ, such as severe prodromal pains and/or the presence of satellite lesions, is recommended. The treatment recommendations of HZ in this patient group are identical to the recently published guidelines for the management of HZ. The live attenuated viral vaccine OKA/Merck strain anti-HZ vaccination is recommended before initiating biological treatment in psoriasis patients. The new adjuvanted anti-HZ vaccine will probably also benefit patients while on biological treatment. Keywords: herpes zoster, TNF antagonists, anti-IL17, anti-IL12/23, psoriasis, aciclovir

  17. Vaccine-strain herpes zoster found in the trigeminal nerve area in a healthy child: A case report.

    Science.gov (United States)

    Iwasaki, Sayaka; Motokura, Kouji; Honda, Yoshitaka; Mikami, Masamitsu; Hata, Daisuke; Hata, Atsuko

    2016-12-01

    A previously healthy 2-year-old girl, vaccinated for varicella at 17 months, was admitted because of left-sided facial herpes zoster caused by vaccine-strain varicella-zoster virus (VZV). She recovered fully with no complication after intravenous treatment using acyclovir. Earlier reports have described that herpes zoster (HZ) rashes caused by vaccine-strain VZV tend to occur on the dermis corresponding to the skin area where the varicella vaccine was received. However, rashes appeared on this girl only in the trigeminal nerve area, which is unrelated to the vaccinated site. Results underscore the importance of distinguishing vaccine-strain VZV from wild-type VZV whenever encountering HZ cases after vaccination, even in immunocompetent children, irrespective of the skin lesion site. Monitoring vaccine-strain HZ incidence rates is expected to elucidate many aspects of varicella vaccine safety.

  18. The management of oral candidosis in diabetic patient with maxillary Herpes Zoster

    Directory of Open Access Journals (Sweden)

    Kus Harijanti

    2008-09-01

    Full Text Available Background: Oral candidosis is an infection caused by mainly Candida albicans. Candida species are common normal flora in the oral cavity and have been reported to be present in 40% to 60% of the population. Candida is predominantly an opportunistic infectious agent. Infection frequency has increased because of the presence of both local and systemic risk factors. The elderly age and diabetes mellitus may decrease the amount of saliva (xerostomia and potentially increase the risk of colonization and secondary infection by Candida. Herpes Zoster (HZ is a manifestation of the reactivation of latent varicella zoster virus. It is characterized by unilateral, painful, vesicular rash with a dermatomal distribution. The clinical manifestations of this disease can erupt to the skin and mucous membrane. If maxillary nerve is involved, the lesion can appear on unilateral facial skin and oral mucous membrane. Purpose: The purpose of this paper is to report and discuss the difficulties in managing the oral candidosis in elderly patient (57 year old male who suffered from maxillary Herpes Zoster and diabetes mellitus. Case management: At first, the patient was treated with 2% chlorhexidine gluconate and mycostatin oral suspension as topical antimycotic and reffered to dermathology clinic for viral infection treatment, however the oral candidosis did not improved. Subsequently, ketokonazole tablet was given three times daily for three weeks and regulated blood glucose level. In systemic antifungi (ketokonazole treatment the oral candidosis disappeared. Conclusion: In this case, it is conclude that the management of oral candidosis are adequate, antiviral, blood glucose level regulating and systemic antifungal therapy.

  19. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction.

    Science.gov (United States)

    Yawn, Barbara P; Saddier, Patricia; Wollan, Peter C; St Sauver, Jennifer L; Kurland, Marge J; Sy, Lina S

    2007-11-01

    To establish accurate, up-to-date, baseline epidemiological data for herpes zoster (HZ) before the introduction of the recently licensed HZ vaccine. Using data from January 1, 1996, to October 15, 2005, we conducted a population-based study of adult residents (Greater than or equal to 22 years) of Olmsted County, MN, to determine (by medical record review) the incidence of HZ and the rate of HZ-related complications. Incidence rates were determined by age and sex and adjusted to the US population. A total of 1669 adult residents with a confirmed diagnosis of HZ were identified between January 1, 1996, and December 31, 2001. Most (92%) of these patients were immunocompetent and 60% were women. When adjusted to the US adult population, the incidence of HZ was 3.6 per 1000 person-years (95% confidence interval, 3.4-3.7), with a temporal increase from 3.2 to 4.1 per 1000 person-years from 1996 to 2001. The incidence of HZ and the rate of HZ-associated complications increased with age, with 68% of cases occurring in those aged 50 years and older. Postherpetic neuralgia occurred in 18% of adult patients with HZ and in 33% of those aged 79 years and older. Overall, 10% of all patients with HZ experienced 1 or more nonpain complications. Our population-based data suggest that HZ primarily affects immunocompetent adults older than 50 years; 1 in 4 experiences some type of HZ-related complication.

  20. The intention of Dutch general practitioners to offer vaccination against pneumococcal disease, herpes zoster and pertussis to people aged 60 years and older

    NARCIS (Netherlands)

    Lehmann, Birthe A.; Eilers, Renske; Mollema, Liesbeth; Ferreira, Jose; de Melker, Hester E.

    2017-01-01

    Background: Increasing life expectancy results in a larger proportion of older people susceptible to vaccine preventable diseases (VPDs). In the Netherlands, influenza vaccination is routinely offered to people aged 60 years and older. Vaccination against pneumococcal disease, herpes zoster and

  1. 从1例带状疱疹性前庭神经元炎误诊引发的思考%Considerations on 1 cases of herpes zoster misdiagnosed

    Institute of Scientific and Technical Information of China (English)

    刘丽萍

    2014-01-01

    Herpes zoster is caused by the varicella-zoster virus invading peripheral nerves, which causes acute inflammatory skin disease,often encroachs intercostals nerve,and usually happens at the waist.It is rare that herpes zoster vestibular neuronitis occurs surrounding the pinna.In this paper, we will do a simple analysis for one misdiagnosed case of herpes zoster vestibular neuronitis,in the hope for the diagnosis and treatment of the disease in the clinical work.%带状疱疹是由水痘-带状疱疹病毒侵入周围神经后引起的急性炎性皮肤病,常侵犯肋间神经,好发于腰部。发生于耳郭周围的带状疱疹致前庭神经元炎者较少见。本文就1例带状疱疹性前庭神经元炎误诊病例做一简单分析,以期望在临床工作中针对该病的诊断以及治疗有所帮助。

  2. Current and future effects of varicella and herpes zoster vaccination in Germany - insights from a mathematical model in a country with universal varicella vaccination

    NARCIS (Netherlands)

    Horn, Johannes; Karch, André; Damm, Oliver; Kretzschmar, Mirjam; Siedler, Anette; Ultsch, Bernhard; Weidemann, Felix; Wichmann, Ole; Hengel, Hartmut; Greiner, Wolfgang; Mikolajczyk, Rafael T

    2016-01-01

    Varicella zoster virus (VZV) is primarily known for causing varicella in childhood, but can reactivate again as herpes zoster (HZ) after a period of latency, mainly in persons older than 50 years. Universal varicella vaccination was introduced in Germany in 2004, while HZ vaccination has not been re

  3. Current and future effects of varicella and herpes zoster vaccination in Germany - insights from a mathematical model in a country with universal varicella vaccination

    NARCIS (Netherlands)

    Horn, Johannes; Karch, André; Damm, Oliver; Kretzschmar, Mirjam; Siedler, Anette; Ultsch, Bernhard; Weidemann, Felix; Wichmann, Ole; Hengel, Hartmut; Greiner, Wolfgang; Mikolajczyk, Rafael T

    2016-01-01

    Varicella zoster virus (VZV) is primarily known for causing varicella in childhood, but can reactivate again as herpes zoster (HZ) after a period of latency, mainly in persons older than 50 years. Universal varicella vaccination was introduced in Germany in 2004, while HZ vaccination has not been

  4. Evaluation of microRNA Expression in Patients with Herpes Zoster

    Directory of Open Access Journals (Sweden)

    Xihan Li

    2016-12-01

    Full Text Available Reactivated varicella-zoster virus (VZV, which lies latent in the dorsal root ganglions and cranial nerves before its reactivation, is capable of causing herpes zoster (HZ, but the specific mechanism of virus reactivation and latency remains unknown. It was proposed that circulating microRNAs (miRNAs in body fluids could potentially indicate infection. However, the connection between herpes zoster and circulating miRNAs has not been demonstrated. In this study, 41 HZ patients without superinfection were selected. The serum miRNA levels were analyzed by TaqMan low density array (TLDA and confirmed individually by quantitative reverse transcription PCR (RT-qPCR analysis. Thirty-five age-matched subjects without any infectious diseases or inflammation were selected as controls. The results showed that the serum miRNA expression profiles in 41 HZ patients were different from those of control subjects. Specifically, 18 miRNAs were up-regulated and 126 were down-regulated more than two-fold in HZ patients compared with controls. The subsequent confirmation of these results by qRT-PCR, as well as receiver operating characteristic (ROC curve analysis, revealed that six kinds of miRNAs, including miR-190b, miR-571, miR-1276, miR-1303, miR-943, and miR-661, exhibited statistically significant enhanced expression levels (more than four-fold in HZ patients, compared with those of healthy controls and herpes simplex virus (HSV patients. Subsequently, it is proposed that these circulating miRNAs are capable of regulating numerous pathways and some may even participate in the inflammatory response or nervous system activity. This study has initially demonstrated that the serum miRNA expression profiles in HZ patients were different from those of uninfected individuals. Additionally, these findings also suggest that six of the altered miRNA could be potentially used as biomarkers to test for latent HZ infection.

  5. 耳部无疱疹的带状疱疹性面瘫%Zoster sine herpete-Facial paralysis without herpes caused by herpes zoster virus

    Institute of Scientific and Technical Information of China (English)

    赵琨; 李健东; 赵亮; 于春刚; 李杨; 王杰

    2016-01-01

    疱疹顿挫型面瘫同亨特综合征一样,由水痘-带状疱疹病毒(varicella-zoster virus VZV)感染面神经所致,多为潜伏在膝状神经节的VZV病毒再次复活感染。表现为急性周围性面瘫,耳、舌、咽等部位的剧烈疼痛,伴有眩晕、听力下降等症状,但不出现疱疹,所以在临床中常常被误诊为贝尔面瘫。而其不论是病因、发病机制还是治疗及愈后方面与贝尔面瘫都不同,临床中常常耽误治疗,影响患者的愈后。本文就疱疹顿挫性面瘫在临床特征、发病机制、诊断、治疗及愈后等方面的进展做一综述,以引起耳鼻咽喉科医师对此类疾病的关注。%Zoster sine herpete (ZSH) facial palsy is caused by the varicella-zoster virus (VZV), similar to Ramsay Hunt syndrome. Latent VZV infection is reactivated in the geniculate ganglion, causing acute peripheral facial palsy, severe pain in the ear, tongue, pharynx and other regions of head and neck. Vertigo and hearing loss can be part of the process. However, facial palsies caused by VZV are not always accompanied by vesicular eruption, and these cases are referred to as zoster sine herpete (ZSH). Distinguishing ZSH from Bell palsy is difficult, and ZSH is often clinically diagnosed as Bell pal-sy. However, the etiology, pathogenesis, treatment and prognosis are quite different. So facial palsy in ZSH is often misdiag-nosed and adequate treatment delayed, leading to poor prognosis. In this paper, we elaborate on the clinical features, patho-genesis, diagnosis, treatment and prognosis of ZSH associated facial palsy, in order to bring it to the attention of Otorhinolar-yngologist.

  6. Coexistent granulomatous vasculitis and leukaemia cutis in a patient with resolving herpes zoster.

    Science.gov (United States)

    Elgoweini, M; Blessing, K; Jackson, R; Duthie, F; Burden, A D

    2011-10-01

    An 80-year-old man presented with a 6-month history of indurated tender purple papules. These had coalesced to form plaques with some central scarring and a dermatomal distribution on the left arm, immediately following herpes zoster (HZ) infection at this site. The patient had a 5-year history of small lymphocytic lymphoma (SLL), which was being managed conservatively under a 'watch and wait' protocol. On histological examination of a skin biopsy, marked interstitial granulomas and prominent granulomatous vasculitis were seen, supporting the clinical impression of a post-HZ granulomatous reaction. In addition, there was a dense monoclonal small B-cell lymphocytic infiltrate indicating koebnerization by SLL (a finding that has not been reported previously with concurrent postherpetic granulomatous vasculitis). Although benign pseudolymphomas occur in postherpetic cases, this case shows that even in association with benign vasculitic features true lymphomas can occur. Furthermore, this case highlights the importance of immunocytochemistry, molecular studies and clinicopathological correlation.

  7. Preventing and managing herpes zoster: key actions to foster healthy aging.

    Science.gov (United States)

    Maggi, Stefania; Gabutti, Giovanni; Franco, Elisabetta; Bonanni, Paolo; Conversano, Michele; Ferro, Antonio; Lazzari, Marzia; Rossi, Alessandro; Scotti, Silvestro; Vitale, Francesco; Volpi, Antonio; Greco, Donato

    2015-02-01

    Population aging is the demographic phenomenon characterizing all countries in the world, and it is challenging the national infrastructures, in particular health systems. However, aging itself is not associated with increased medical spending, but disability and comorbidity that affect older individuals are the actual drivers for health expenditures. Therefore, if people age in better health, medical spending may be significantly reduced. Preventative interventions proved to be effective in reducing/preventing disease and disability and often found to be cost effective, include diet and exercise interventions, medications, routine disease screenings, and immunizations. Vaccination can protect older citizens against life-threatening diseases, such as influenza, pneumococcal infections, tetanus, and against diseases which adversely impact their quality of life, such as herpes zoster (HZ). Including HZ vaccination in its citizens' lifetime immunization calendar can reinforce Europe's commitment toward active, healthy aging. This paper outlines the consensus statement of a group of Italian experts on HZ.

  8. The risk of herpes zoster during biological therapy for psoriasis and other inflammatory conditions.

    Science.gov (United States)

    Adelzadeh, L; Jourabchi, N; Wu, J J

    2014-07-01

    Recent advances in biological therapies have proved highly effective in treating psoriasis and other inflammatory conditions, including psoriatic arthritis, rheumatoid arthritis, inflammatory bowel disease and ankylosing spondylitis. However, adverse effects related to their immunosuppression have been observed, including an increased propensity to viral infections. This review evaluates the evidence of herpes zoster (HZ) risk from biologics based on clinical reports, cohort studies and randomized controlled studies. The risk of HZ associated with these agents remains controversial, especially when comparing their risk with non-biological therapy used to treat the same inflammatory conditions. This review specifically assesses the risk of the TNF inhibitors etanercept, adalimumab and infliximab, as well as interleukin-12/23 inhibitor ustekinumab. We found multiple cohort studies, randomized controlled trials and case reports that suggest infliximab increases risk of HZ, whereas adalimumab, etanercept and ustekinumab HZ risk remain controversial. Nevertheless, HZ vaccination should be considered prior to initiation of biological therapy, particularly infliximab.

  9. Advances in the understanding of the pathogenesis and epidemiology of herpes zoster

    Science.gov (United States)

    Gershon, Anne A.; Gershon, Michael D.; Breuer, Judith; Levin, Myron J.; Oaklander, Anne Louise; Griffiths, Paul D.

    2017-01-01

    SUMMARY The primary varicella zoster virus (VZV) infection results in chickenpox (varicella), which is transmitted via the airborne route. VZV is highly infectious, but in the USA the incidence of varicella has been reduced by 76–87% as a result of the varicella vaccine. The virus establishes latency in the dorsal root ganglia during varicella and, when reactivated, travels along the sensory nerve axons to cause shingles (herpes zoster [HZ]). There are over 1 million cases of HZ in the USA each year, with an estimated lifetime attack rate of 30%. The incidence of HZ, which causes significant morbidity, increases with age and reaches approximately 10 cases per 1,000 patient-years by age 80. Cell-mediated immunity (CMI) is known to decline with age as part of immunosenescence, and decreased CMI is associated with reactivation of VZV. This article provides an overview of our emerging understanding of the epidemiology and pathogenesis of varicella and HZ, in addition to exploring the current theories on latency and reactivation. Understanding the risk factors for developing HZ and the complications associated with infection, particularly in older people, is important for prompt diagnosis and management of HZ in primary care, and they are therefore also reviewed. PMID:20510263

  10. Herpes zoster in elderly adults in a community hospital in Buenos Aires. June 2013-May 2014

    Directory of Open Access Journals (Sweden)

    Miriam Rozenek

    2017-02-01

    Full Text Available Herpes zoster (HZ is caused by reactivation of the varicella zoster virus. Its main risk factor is increasing age and comorbidities. There are limited data on the characteristics of HZ in South America, especially in the elderly. We analyzed epidemiological and clinical characteristics of 340 patients over 60 years assisted for HZ, between June 2013 and May 2014. The average age was 74 years (60-100, 62% (210 had thoracic location; 75% (255 of the initial consultations were held in guards; 68% (143 had pain and vesicles, and 4% (14 only pain at baseline. Pain persisted after finishing the episode in 41% (139. The diagnosis was made between 1 and 3 days from the beginning of the episode in 53% (180 patients. Average number of visits per episode was 3.6 (1-24. Antiviral treatment was supplied to 91% (309; however it was inadequate in dose or time in 49.1% (167 cases. Pain treatment was indicated in 66% (224. Most frequently used drugs (alone or in combination were non-steroidal painkillers (43%, 146, pregabalin (30%, 102, opiates (24%, 82, and steroids (12%, 41; 9% (31 presented comorbidities; 27% (126 experienced pain after the ending of the episode, with an average duration of 138.7 days. In general, diagnosis was done late, making it difficult to use antivirals correctly. The presence of pain was more frequent than reported in other publications, however there are few data in this age group

  11. Cost-effectiveness of vaccination against herpes zoster and postherpetic neuralgia: a critical review.

    Science.gov (United States)

    Kawai, Kosuke; Preaud, Emmanuelle; Baron-Papillon, Florence; Largeron, Nathalie; Acosta, Camilo J

    2014-03-26

    The objective of this study was to systematically review cost-effectiveness studies of vaccination against herpes zoster (HZ) and postherpetic neuralgia (PHN). We searched MEDLINE and EMBASE databases for eligible studies published prior to November 2013. We extracted information regarding model structure, model input parameters, and study results. We compared the results across studies by projecting the health and economic impacts of vaccinating one million adults over their lifetimes. We identified 15 cost-effectiveness studies performed in North America and Europe. Results ranged from approximately US$10,000 to more than US$100,000 per quality-adjusted life years (QALY) gained. Most studies in Europe concluded that zoster vaccination is likely to be cost-effective. Differences in results among studies are largely due to differing assumptions regarding duration of vaccine protection and a loss in quality of life associated with HZ and to a larger extent, PHN. Moreover, vaccine efficacy against PHN, age at vaccination, and vaccine cost strongly influenced the results in sensitivity analyses. Most studies included in this review shows that vaccination against HZ is likely to be cost-effective. Future research addressing key model parameters and cost-effectiveness studies in other parts of the world are needed. Copyright © 2014 Elsevier Ltd. All rights reserved.

  12. Genetic variation in the HLA region is associated with susceptibility to herpes zoster

    Science.gov (United States)

    Crosslin, D R; Carrell, D S; Burt, A; Kim, D S; Underwood, J G; Hanna, D S; Comstock, B A; Baldwin, E; de Andrade, M; Kullo, I J; Tromp, G; Kuivaniemi, H; Borthwick, K M; McCarty, C A; Peissig, P L; Doheny, K F; Pugh, E; Kho, A; Pacheco, J; Hayes, M G; Ritchie, M D; Verma, S S; Armstrong, G; Stallings, S; Denny, J C; Carroll, R J; Crawford, D C; Crane, P K; Mukherjee, S; Bottinger, E; Li, R; Keating, B; Mirel, D B; Carlson, C S; Harley, J B; Larson, E B; Jarvik, G P

    2015-01-01

    Herpes zoster, commonly referred to as shingles, is caused by the varicella zoster virus (VZV). VZV initially manifests as chicken pox, most commonly in childhood, can remain asymptomatically latent in nerve tissues for many years and often re-emerges as shingles. Although reactivation may be related to immune suppression, aging and female sex, most inter-individual variability in re-emergence risk has not been explained to date. We performed a genome-wide association analyses in 22 981 participants (2280 shingles cases) from the electronic Medical Records and Genomics Network. Using Cox survival and logistic regression, we identified a genomic region in the combined and European ancestry groups that has an age of onset effect reaching genome-wide significance (P>1.0 × 10−8). This region tags the non-coding gene HCP5 (HLA Complex P5) in the major histocompatibility complex. This gene is an endogenous retrovirus and likely influences viral activity through regulatory functions. Variants in this genetic region are known to be associated with delay in development of AIDS in people infected by HIV. Our study provides further suggestion that this region may have a critical role in viral suppression and could potentially harbor a clinically actionable variant for the shingles vaccine. PMID:25297839

  13. Clinical Characteristics and Outcomes in a Population With Disseminated Herpes Zoster: A Retrospective Cohort Study.

    Science.gov (United States)

    Bollea-Garlatti, M L; Bollea-Garlatti, L A; Vacas, A S; Torre, A C; Kowalczuk, A M; Galimberti, R L; Ferreyro, B L

    2017-03-01

    Shingles is the cutaneous expression of the reactivation of latent varicella zoster virus infection in sensory ganglia. It presents as vesicles in the corresponding dermatome. The condition is called disseminated herpes zoster (DHZ) when more than 2 contiguous dermatomes are affected, more than 20 vesicles are observed outside the initial dermatome, or involvement is systemic. DHZ is rare and most frequently occurs in immunocompromised patients. To describe the epidemiology, predisposing factors, clinical presentation, laboratory findings, and clinical course of patients with DHZ, and to compare the findings in immunocompromised and immunocompetent patients. We analyzed a retrospective case series of adults hospitalized between February 2010 and October 2015. Forty-one patients with virologically confirmed manifestations of DHZ were included. Stress as a trigger factor was detected in 39% and immunodepression in 58.5%. Immunocompromised patients were younger than the immunocompetent patients (mean ages, 60.5 vs 82 years, P.01). Six patients died; there was no difference in mortality between the 2 groups. This study provides evidence on the relationship between DHZ, the presence of underlying immunodepression, and complications. Immunosenescence may play an important role in the onset of this disease in older immunocompetent patients. Copyright © 2016 AEDV. Publicado por Elsevier España, S.L.U. All rights reserved.

  14. [Varicella and herpes zoster. Part 1: virology, epidemiology, clinical picture, laboratory diagnostics].

    Science.gov (United States)

    Wittek, Miriam; Doerr, Hans Wilhelm; Allwinn, Regina

    2010-05-01

    Varicella-zoster virus (VZV), known as one of the eight human herpesviridae, shows a ubiquitous distribution and is the cause for acute exanthema in childhood (chickenpox). VZV is highly infectious, spread by respiratory droplets and direct contact with fluid in vesicles. As a characteristic of the alpha-herpesviridae, VZV establishes latency in the nucleus of the paraspinal cells. Reactivation of VZV (zoster) is possible in all infected persons, but becomes more common with increasing age and a decline of VZV-specific cell-mediated immunity. Immunocompromised patients and older people (> 50 years) have an increased risk for a severe course of disease. The postherpetic neuralgia (PHN), as one of the most common and feared complications, is defined as a neuropathic pain (burning character), which persists for > 6 weeks after onset of disease and needs adequate antiviral and pain treatment.

  15. An update on the treatment and prevention of herpes zoster and postherpetic neuralgia%带状疱疹及其后遗神经痛治疗与预防

    Institute of Scientific and Technical Information of China (English)

    方丽; 吴贤杰

    2009-01-01

    带状疱疹及带状疱疹后遗神经痛是皮肤科引起神经性疼痛的常见原因,其治疗和预防是常见临床问题.抗病毒药物能够降低疱疹严重程度、缩短疱疹持续时间,但对带状疱疹后遗神经痛的作用尚不明确.糖皮质激素、三环类抗抑郁药、抗惊厥剂、镇痛药等均能减轻带状疱疹相关疼痛.抗惊厥剂、麻醉性镇痛药、三环类抗抑郁药及局部用利多卡因贴剂和辣椒素软膏均对带状疱疹后遗神经痛有效.接种水痘一带状疱疹疫苗对带状疱疹及带状疱疹后遗神经痛的发病率有重要影响.%Herpes zoster and postherpetic neuralgia(PHN)are common causes of neuropathic pain,their treatment and prevention ale usually troublesome.Antiviml drugs have been consistently found to effectively reduce the severity and duration of herpes zoster.However,there iS no convincing evidence that antiviral agents could reduce the risk of PHN.It is reported that the acute pain of herpes zoster can be relieved by corticosteroids,tricyclic antidepressants,anticonvulsants and analgesics,and PHN can be alleviated by anticonvulsants,narcotic analgesics.tricyclic antidepressants,lidocaine patch 5%and capsaicin ointment.Prophylactic vaccination with herpes zoster vaccine may have a beneficial effect on the incidence of herpes zosterand PHN.

  16. 带状疱疹89例临床分析%Clinical analysis of 89 patients with herpes zoster

    Institute of Scientific and Technical Information of China (English)

    徐勇梅

    2015-01-01

    Objective:To analyze the clinical characteristics of patients with herpes zoster. Methods:The retrospective studyof 89 patients withherpes zoster from Nov. 2013 to Oct. 2014 was conducted.Results:All patients received aciclovir and cobamamide. Among them, 66(74.16%) patients were cured in 2 to 8 weeks, and post-herpetic neuralgia was found in 6(6.74%) patients aged above 65 years. There were 32.58%(29/89) of the patients infected with virues of herpes zoster in winter.The herpes zoster was commonly seen in the chest of 32 patients(35.96%) and the patients over 50 years were susceptible to herpes zoster. Conclusion: The awareness of herpes zoster should be increased in patients as to early diagnosis and treatment.%目的:探讨带状疱疹的临床特点。方法:收集2013年11月至2014年10月门诊带状疱疹患者89例,回顾性分析患者的临床资料。结果:89例患者均采用阿昔洛韦联合腺苷钴胺治疗,其中66例(74.16%)在2~8周痊愈,后遗神经痛6例(6.74%),均为65岁以上患者。带状疱疹以冬季发病居多为32.58%(29/89),胸部发病最多见为35.96%(32/89),50岁以上患者较多占82.02%(73/89)。结论:应提高患者对带状疱疹的认知度,做到早就诊、早治疗。

  17. Most Common Dermatologic Topics Published in Five High-Impact General Medical Journals, 1970–2012: Melanoma, Psoriasis, Herpes Simplex, Herpes Zoster, and Acne

    Science.gov (United States)

    Choi, Young M; Namavar, Aram A; Wu, Jashin J

    2014-01-01

    Context: General practitioners frequently encounter skin diseases and are accustomed to diagnosing the most common dermatologic conditions. Objective: We sought to determine the most common dermatologic topics published in five high-impact general medical journals (New England Journal of Medicine, The Lancet, the Journal of the American Medical Association, British Medical Journal (now The BMJ), and Annals of Internal Medicine). Design: We conducted an independent search of the Thomson Reuters’ Science Citation Index for common dermatologic topics, limited to the period 1970 to 2012. Main Outcome Measure: Total number of publications dealing with each dermatologic topic considered. Results: The five most common dermatologic topics published were melanoma, psoriasis, herpes simplex, herpes zoster, and acne. Melanoma and psoriasis were the top two dermatologic topics published in each journal except for Annals of Internal Medicine. Conclusions: Internists frequently diagnose herpes simplex, herpes zoster, and acne, which are also common dermatologic topics published. Although internists infrequently diagnose melanoma and psoriasis, they are major topics for general medical journals because of their increased community awareness, major advancements in therapeutic research, and their nondermatologic manifestations. PMID:25662523

  18. Most common dermatologic topics published in five high-impact general medical journals, 1970-2012: melanoma, psoriasis, herpes simplex, herpes zoster, and acne.

    Science.gov (United States)

    Choi, Young M; Namavar, Aram A; Wu, Jashin J

    2014-01-01

    General practitioners frequently encounter skin diseases and are accustomed to diagnosing the most common dermatologic conditions. We sought to determine the most common dermatologic topics published in five high-impact general medical journals (New England Journal of Medicine, The Lancet, the Journal of the American Medical Association, British Medical Journal (now The BMJ), and Annals of Internal Medicine). We conducted an independent search of the Thomson Reuters’ Science Citation Index for common dermatologic topics, limited to the period 1970 to 2012. Total number of publications dealing with each dermatologic topic considered. The five most common dermatologic topics published were melanoma, psoriasis, herpes simplex, herpes zoster, and acne. Melanoma and psoriasis were the top two dermatologic topics published in each journal except for Annals of Internal Medicine. Internists frequently diagnose herpes simplex, herpes zoster, and acne, which are also common dermatologic topics published. Although internists infrequently diagnose melanoma and psoriasis, they are major topics for general medical journals because of their increased community awareness, major advancements in therapeutic research, and their nondermatologic manifestations.

  19. Clinical analysis of 616 herpes zoster cases%616例带状疱疹临床分析

    Institute of Scientific and Technical Information of China (English)

    王江涛

    2015-01-01

    目的:探讨带状疱疹的临床特点和发病规律,为带状疱疹的治疗提供参考依据。方法回顾性分析皮肤科门诊治疗的616例带状疱疹患者的临床资料。结果616例患者中,男370例,女246例,男性发病数是女性的1.5倍。带状疱疹发病时间以一、二季度较高,占401例(65.1%);发病年龄以中老年居多,占303例(49.2%)。结论带状疱疹患者中男性居多,发病率随年龄增大而增加,中老年患者病情重,容易导致后遗神经痛。早期规范治疗,可明显缩短病程及减少后遗神经痛的发生。%Objective To investigate clinical characteristics and occurrence regularity of herpes zoster, in order to provide reference for treating herpes zoster. Methods Clinical data of 616 herpes zoster patients in department of dermatology were retrospectively analyzed. Results Among 616 patients, there were 370 male and 246 female. Male had morbidity number as 1.5 times of female. The first and second quarters had higher occurrence of herpes zoster, accounting for 401 cases (65.1%). Middle-aged and elderly people accounted mostly as 303 cases (49.2%). Conclusion The majority of herpes zoster patients are male, and their morbidity increased with age. Middle-aged and elderly people had severe status, which can lead to postherpetic neuralgia. Early standard treatment can obviously shorten course of disease and reduce incidence of postherpetic neuralgia.

  20. Benefit and Risk of Tofacitinib in the Treatment of Rheumatoid Arthritis: A Focus on Herpes Zoster.

    Science.gov (United States)

    Yamaoka, Kunihiro

    2016-09-01

    The biologics have revolutionized the treatment of rheumatoid arthritis (RA). However, there are still patients that are difficult to control and a cure is still not achievable. Tofacitinib, a Janus kinase (JAK) inhibitor is an orally available, new-in-class, disease-modifying anti-rheumatic drug with similar efficacy to biologics. JAK is activated by multiple cytokines involved in the pathology of RA, and affects non-immune and immune cells, mainly the lymphocytes. Besides its anti-rheumatic effect, the recent focus has been on adverse events. As with other biologics, serious infections have been observed especially with patients with lymphopenia, consistent with the mechanism of action. The major difference in adverse events from other disease-modifying anti-rheumatic drugs is the prominent increase in the occurrence of herpes zoster; it is increased worldwide, especially in Asia. There are other concerns such as malignancies and hyperlipidemia that may cause cardiovascular events that deserve further attention. The first JAK inhibitor for RA is demonstrating great benefit along with some risk, providing insights into the post-biologic era.

  1. Management and Prevention of Herpes Zoster in the Immunocompromised Inflammatory Bowel Disease Patient: A Clinical Quandary.

    Science.gov (United States)

    Côté-Daigneault, Justin; Peerani, Farhad; MacMahon, Eithne; Delaporte, Emmanuel; Rahier, Jean-François; Colombel, Jean-Frédéric

    2016-10-01

    Crohn's disease (CD) and ulcerative colitis (UC), the 2 main clinical phenotypes of inflammatory bowel disease (IBD), are diseases that result from a dysregulated immune response to gut microbiota in genetically susceptible hosts. This aberrant immune response may intrinsically predispose IBD patients to infectious complications. Moreover, immunosuppressive medications used to treat IBD including corticosteroids, thiopurines, methotrexate, calcineurin inhibitors, anti-tumor necrosis factor (anti-TNF) agents and other biologics, further increase patients' susceptibility to opportunistic infections. Herpes zoster (HZ), also known as shingles, is an opportunistic viral reactivation often observed in IBD patients with several case reports demonstrating complicated or disseminated disease in those on immunosuppression. While HZ vaccination is recommended in all immunocompetent adults aged ≥60 years, as a live virus vaccine, it is currently contraindicated in IBD patients on anti-TNF therapy and in other significantly immunocompromised patient groups. While caution is still warranted in these circumstances, recent clinical data has emerged which has prompted us to review and examine the universal approach to HZ vaccination in the immunosuppressed IBD population. In the following narrative review, we will discuss and provide an overview of the clinical manifestations, incidence, management and prevention of HZ in the IBD patient.

  2. Survey on public awareness, attitudes, and barriers for herpes zoster vaccination in South Korea.

    Science.gov (United States)

    Yang, Tae Un; Cheong, Hee Jin; Song, Joon Young; Noh, Ji Yun; Kim, Woo Joo

    2015-01-01

    A cross-sectional study was performed to assess current public awareness of herpes zoster (HZ) and its vaccine, determine the factors that influence people's intention regarding HZ vaccination, and investigate the barriers for vaccination by changing decisions with sequential questions regarding knowledge, cost, and physician's recommendation in the Department of Infectious Diseases, Korea University Guro Hospital, in South Korea, between August 23 and September 15 of 2013. Among 603 subjects who completed the survey, 85.7% and 43.6% subjects were aware of HZ and HZ vaccination, respectively. Women, younger age group, those with higher income or higher education levels were more likely to be aware of HZ. Overall, 85.8% of subjects aware of HZ were willing to be vaccinated or vaccinate their parents. The main obstacles for the increased acceptance toward vaccination were the high cost and low perceived risk, which decreased acceptance to 60.2%. However, physician's recommendation reversed 69.5% of the refusal to accept HZ vaccine. These results indicate that expanding public education and physician's recommendations are important factors aimed at increasing HZ vaccine coverage rate.

  3. Active herpes zoster infection with cutaneous manifestation and adenopathy on FDG PET/CT

    Directory of Open Access Journals (Sweden)

    Antoine Wadih, MD

    2015-10-01

    Full Text Available We report a patient with history of Hodgkin lymphoma. Six months after treatment, 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography and/or computed tomography ([18F] FDG PET/CT scan showed abnormal uptake in right axillary lymph nodes concerning for recurrence. In addition, PET/CT showed a new hypermetabolic skin lesion overlying the right scapula. Clinical evaluation was consistent with shingles, and the patient was treated with valacyclovir. Subsequent PET/CT scan was normal with no evidence of lymphoma. Although there have been reported cases of abnormal FDG in nodes or in skin due to herpes zoster, our case is unique in the literature in that the PET/CT demonstrates abnormalities involving both the skin and associated lymph nodes. The possibility of false positive uptake, not because of recurrent malignancy, must always be considered when abnormal FDG uptake is noted in the follow-up of oncology patients. Careful review of the scan and correlation with clinical findings can avoid false positive interpretation and facilitate patient management.

  4. The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS during a period of increasing varicella vaccine coverage, 1998–2003

    Directory of Open Access Journals (Sweden)

    Clements Karen M

    2005-06-01

    Full Text Available Abstract Background The authors sought to monitor the impact of widespread varicella vaccination on the epidemiology of varicella and herpes zoster. While varicella incidence would be expected to decrease, mathematical models predict an initial increase in herpes zoster incidence if re-exposure to varicella protects against reactivation of the varicella zoster virus. Methods In 1998–2003, as varicella vaccine uptake increased, incidence of varicella and herpes zoster in Massachusetts was monitored using the random-digit-dial Behavioral Risk Factor Surveillance System. Results Between 1998 and 2003, varicella incidence declined from 16.5/1,000 to 3.5/1,000 (79% overall with ≥66% decreases for all age groups except adults (27% decrease. Age-standardized estimates of overall herpes zoster occurrence increased from 2.77/1,000 to 5.25/1,000 (90% in the period 1999–2003, and the trend in both crude and adjusted rates was highly significant (p Conclusion As varicella vaccine coverage in children increased, the incidence of varicella decreased and the occurrence of herpes zoster increased. If the observed increase in herpes zoster incidence is real, widespread vaccination of children is only one of several possible explanations. Further studies are needed to understand secular trends in herpes zoster before and after use of varicella vaccine in the United States and other countries.

  5. The effect of valtrex on T cell subset and IL2, IL6 and IL10 level in patients with herpes zoster

    Institute of Scientific and Technical Information of China (English)

    Gui-E Wang; Jian Chen; Ling Chen

    2015-01-01

    Objective:To explore the effects of valtrex on T cell subset and IL2, IL6 and IL10 level in patients with herpes zoster.Methods: 120 patients with herpes zoster in our hospital were analyzed. The serum T cell subset and IL2, IL6 and IL10 were detected by Western Blotting. Healthy volunteers were enrolled as control group.Results: The CD4+ level was increased significantly while the CD8+ decreased significantly, and the ratio of the two increased too (P all<0.01). The IL6 and IL10 levels were increased significantly (P<0.01). But no significant change in IL2 level was observed.Conclusion:Valtrex is effective on herpes zoster by regulating T cell subset, IL6 and IL10 levels.

  6. Research Progress of Pricking and Cupping Treatment of Herpes Zoster%刺络拔罐治疗带状疱疹研究进展

    Institute of Scientific and Technical Information of China (English)

    邢菁; 付于

    2012-01-01

    Herpes zoster is a common skin disease, which always happens in spring and autumn in the elderly patients and seriously affects the quality of life. This paper summarizes the research progress of cupping treatment of herpes zoster in recent years, including a preliminary understanding of herpes zoster.%带状疱疹是临床上常见皮肤病,以春、秋季多见,好发于中老年人,严重影响患者的生活质量.文章总结了近年来刺络拔罐治疗带状疱疹的研究进展,并包含笔者对带状疱疹的初步认识.

  7. Integrated Approach to Understanding the Treatment of Herpes Zoster%综合方法治疗带状疱疹的体会

    Institute of Scientific and Technical Information of China (English)

    李如意

    2011-01-01

    目的:了解综合方法治疗带状疱疹的现状和进展.方法:通过对目前已知的综合方法治疗带状疱疹的治疗原则和方案,进行阐述与分析.结果:传统的单一疗法存在局限性.讨论:综合方法治疗是今后带状疱疹的趋势.%Objective: To understand the integrated approach to the treatment status and progress of herpes zoster.Methods: The currently known method of treatment of herpes zoster integrated treatment principles and programs, described and analyzed. Results: The limitations of a single therapy. Discussion: an integrated approach to treatment is the future trend of herpes zoster.

  8. Clinical Misdiagnosis of Herpes Zoster and the Countermeasures%带状疱疹临床误诊分析及对策

    Institute of Scientific and Technical Information of China (English)

    杜策

    2016-01-01

    Objective To analyze the causes of herpes zoster misdiagnosis and to put forward the countermeasures to reduce the oc-currence of misdiagnosis. Methods The clinical data of 117 cases with herpes zoster were collected and analyzed. Results Herpes zos-ter misdiagnosis occurred in almost every department, department of internal medicine, department of surgery and department of rehabil-itation had the higher occurrence;herpes zoster on chest, abdomen, head, face and neck was often misdiagnosed;the misdiagnosis of her-pes zoster occurred more in the middle-age and elderly. Conclusions Different causes lead to the misdiagnosis of herpes zoster;more at-tention should be paid and certain countermeasures should be taken to reduce the occurrence of misdiagnosis.%目的:分析带状疱疹误诊原因,并提出减少误诊的对策。方法收集我院皮肤科确诊为带状疱疹117例患者的临床资料,进行分析、总结。结果带状疱疹误诊见于临床各科,尤以内科、外科、康复科等科室所占比例较高;误诊部位以胸腹部、头面颈部居多;误诊年龄以中老年患者居多。结论带状疱疹误诊原因较多,应该多方面加以重视,并采取相应对策,减少误诊的出现。

  9. 恶性肿瘤伴发泛发性带状疱疹的治疗%Treatment for malignant tumors complicated with disseminated herpes zoster

    Institute of Scientific and Technical Information of China (English)

    付艳; 毕益明; 陈秀芳; 陈兴秀; 江志勇; 郑东星; 王淑燕

    2012-01-01

    Objective To explore the treatment for malignant tumors complicated with disseminated herpes zoster, and then compare with malignant tumors complicated with unilateral herpes zoster.Methods The data on 9 patients with malignant tumors and complicated with disseminated herpes zoster who had been treated from January 2000 to July 2011 were retrospectively analyzed,and so were the data on the 28 patients complicated with unilateral herpes zoster herpes zoster who had been treated during the same time.Results There was a significant difference in the CD4/CD8 rate between the patients with disseminated herpes zoster and those with unilateral herpes zoster ( 44.44% vs.10.71% or 4/9 vs.3/28,P < 0.05 ).Time to scar formation differed significantly between the patients with disseminated herpes and those with unilateral herpes zoster ( [7.44 ± 1.926]d vs.[3.89 ± 0.598]d,P<0.01 ).Conclusions The immune function is weaker in malignant tumor patients complicated with disseminated herpes zoster than in those with local herpes zoster.Time to scar formation is also longer in the patients with disseminated herpes zoster.%目的 对恶性肿瘤伴发的泛发性带状疱疹的治疗进行探讨,并与恶性肿瘤伴发的局限于单侧的带状疱疹进行统计学分析.方法 回顾分析我院自2000年1月至2011年7月住院期间共收治9例泛发性带状疱疹病人,同期收治恶性肿瘤伴发局限性带状疱疹28例,并对其进行统计学分析.结果 恶性肿瘤伴发泛发性带状疱疹患者CD4/CD8降低比例为44.44%(4/9),恶性肿瘤伴有单纯性带状疱疹患者CD4/CD8降低比例为10.71%(3/28);二者比较有统计学意义(P<0.05).恶性肿瘤伴发泛发性带状疱疹患者结痂时间平均为(7.44±1.92)天,恶性肿瘤伴发单纯性带状疱疹患者结痂时间平均为(3.89±0.598)天,二者比较有显著统计学差异(P<0.01).结论 恶性肿瘤伴发泛发性带状疱疹患者免疫功能低于恶性肿瘤伴发单纯

  10. Nursing of Hospitalized Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease Complicated by Wound Infection after Herpes Zoster%慢性阻塞性肺疾病急性加重期住院患者并发带状疱疹感染后创面的护理

    Institute of Scientific and Technical Information of China (English)

    刘映兰

    2013-01-01

    Summarizing 1 case of chronic obstructive pulmonary diseases acute exacerbation(AECOPD) patients complicated with wound infection after herpes zoster.In AECOPD patients with long duration and application fight infection in patients with long-term hospitalization and glucocorticoid treatment leads to the body resistance was poor,the wound area was large,serious infection,difficult to healing,healing in humid environment theory,under the guidance of the wet sex therapy,using metronidazole injection plus gentamycin local wet apply affected part and ribavirin injection,prescribed antibiotics and asthma, eliminating phlegm to bluff and pain relief support treatment,combined with regular skin care,made the patient’s psychological nursing and health education, continuous and effective nursing wounds,and is accelerate the healing.%  总结1例慢性阻塞性肺疾病急性加重期(AECOPD)患者并发带状疱疹后创面感染的护理。由于年老体弱同时伴有多种并发症,最突出的症状为缺氧。缺氧导致皮肤神经营养不良,抵抗力下降造成多种致病菌感染。且患者长期住院应用抗感染、糖皮质激素等治疗导致身体抵抗力差,伤口面积大,感染严重,难愈合等特点,在湿润环境愈合理论的指导下,采用了湿性疗法,选用甲硝唑注射液加庆大霉素和利巴韦林注射液局部湿敷患处,遵医嘱全身使用抗生素、抗病毒、平喘、化痰、强心、利尿和止痛等对证支持治疗,结合常规皮肤护理、做好患者的心理护理和健康教育,使创面得到连续有效的护理,加快了愈合速度。

  11. Treatment of Abdominal Segmental Hernia, Constipation, and Pain Following Herpes Zoster with Paravertebral Block.

    Science.gov (United States)

    Kim, Saeyoung; Jeon, Younghoon

    2015-01-01

    Herpes zoster (HZ) most commonly occurs in elderly patients and involves sensory neurons resulting in pain and sensory changes. Clinically significant motor deficits and visceral neuropathies are thought to be relatively rare. A 72-year-old man presented with abdominal segmental hernia, constipation, and pain following HZ in the left T9-10 dermatome. Sixteen days before presentation, he had developed a painful herpetic rash in the left upper abdominal quadrant. Approximately 10 days after the onset of the rash, constipation occurred and was managed with daily oral medication with bisacodyl 5 mg. In addition, 14 days after the onset of HZ, the patient noticed a protrusion of the left upper abdominal wall. Abdominal x-ray, ultrasound of the abdomen, and electrolyte analysis showed no abnormalities. General physical examination revealed a reducible bulge in his left upper quadrant and superficial abdominal reflexes were diminished in the affected region. Electromyographic testing revealed denervational changes limited to the left thoracic paraspinal muscles and supraumbilical muscles, corresponding to the affected dermatomes. He was prescribed with 500 mg of famciclovir 3 times a day for 7 days, and pregabalin 75 mg twice a day and acetaminophen 650 mg 3 times a day for 14 days. However, his pain was rated at an intensity of 5 on the numerical analogue scale from 0 (no pain) to 10 (worst pain imaginable). A paravertebral block was performed at T9-10 with a mixture of 0.5% lidocaine 3 mL and triamcinolone 40 mg. One day after the procedure, the abdominal pain disappeared. In addition, 5 days after the intervention, the abdominal protrusion and constipation were resolved. He currently remains symptom free at a 6 month follow-up.

  12. The temporal impact of aging on the burden of herpes zoster.

    Science.gov (United States)

    Varghese, Lijoy; Standaert, Baudouin; Olivieri, Antonio; Curran, Desmond

    2017-01-23

    The risk of Herpes Zoster (HZ) increases with age and various studies have also demonstrated an increasing HZ incidence globally. Simultaneously, the global trend of an aging population has placed a greater burden on the healthcare system. This study aims to estimate the potential burden of HZ over time accounting for the increasing trends of both HZ incidence and global aging. A recent systematic review on HZ incidence identified studies that evaluated the temporal effects of HZ incidence. Data from the identified studies were extracted to estimate the trend of HZ incidence in the ≥65-year-old age cohort. The incidence rates were estimated up to the year 2030 using two scenarios: a linear extrapolation and a last observation carried forward. Three countries were chosen to perform the analysis on: Australia, Japan and the United States. The incidence data from the three countries showed an average annual increase between 2.35 and 3.74% over the time period of the studies selected. The elderly population for the US, Japan and Australia are expected to increase by 55, 10 and 53% respectively by the year 2030 compared to the levels in 2015. Under the first scenario between 2001 and 2030, the number of annual incident cases of HZ in those aged ≥65 years is expected to increase by +343% (293,785 to 1,303,328), +176% (158,616 to 437,867) and +376% (18,105 to 86,268) in the US, Japan and Australia respectively while those for the second scenario are +150%, +83% and +223% respectively. In the US alone, the estimated annual cost of HZ-related cases in the ≥65 age cohort is approximately 4.74 Billion US$ in 2030. The increasing incidence of HZ coupled with the demographic trends (i.e., aging population and greater life expectancy) in many countries are likely to imply a rising economic burden of HZ on already constrained healthcare budgets.

  13. Incidence and time trends of Herpes zoster in rheumatoid arthritis: a population-based cohort study

    Science.gov (United States)

    Veetil, Bharath Manu Akkara; Myasoedova, Elena; Matteson, Eric L.; Gabriel, Sherine E.; Green, Abigail B.; Crowson, Cynthia S.

    2012-01-01

    Objective To determine the incidence, time trends, risk factors and severity of herpes zoster (HZ) in a population-based incidence cohort of patients with rheumatoid arthritis (RA) compared to a group of individuals without RA from the same population. Methods All residents of Olmsted County, MN who first fulfilled 1987 American College of Rheumatology criteria for RA between 1/1/1980 and 12/31/2007 and a cohort of similar residents without RA were assembled and followed by retrospective chart review until death, migration, or 12/31/2008. Results There was no difference in the presence of HZ prior to RA incidence/index date between the cohorts (p=0.85). During follow-up 84 patients with RA (rate: 12.1 per 1000 person-years) and 44 subjects without RA (rate: 5.4 per 1000 person-years) developed HZ. Patients with RA were more likely to develop HZ than those without RA (hazard ratio: 2.4; 95% confidence interval: 1.7, 3.5). Patients diagnosed with RA in 1995–2007 had a higher likelihood of developing HZ than those diagnosed in 1980–1994. Erosive disease, previous joint surgery, use of hydroxychloroquine and corticosteroids were significantly associated with the development of HZ in RA, while the use of methotrexate or biologic agents was not. Complications of HZ occurred at a similar rate in both cohorts. Conclusion The incidence of HZ is increased in RA and has risen in recent years. The increasing incidence of HZ in more recent years is also noted in the general population. RA disease severity is associated with development of HZ. PMID:23281295

  14. Increasing Incidence of Herpes Zoster Over a 60-year Period From a Population-based Study.

    Science.gov (United States)

    Kawai, Kosuke; Yawn, Barbara P; Wollan, Peter; Harpaz, Rafael

    2016-07-15

    Temporal increases in the incidence of herpes zoster (HZ) have been reported but studies have examined short study periods, and the cause of the increase remains unknown. We examined the long-term trend of HZ. A population-based cohort study was conducted in Olmsted County, Minnesota, using data from 1945-1960 and 1980-2007. Medical records review of possible cases was performed to confirm incident cases of HZ, the patient's immune status, and prescribing of antivirals for HZ. We examined the relative change in the temporal trend in the incidence rates before and after the introduction of the varicella vaccination program. Of the 8017 patients with HZ, 58.7% were females and 6.6% were immunocompromised. The age- and sex-adjusted incidence rate of HZ increased from 0.76 per 1000 person-years (PY) (95% confidence interval [CI], .63-.89) in 1945-1949 to 3.15 per 1000 PY (95% CI, 3.04-3.26) in 2000-2007. The rate of increase across the time period was 2.5% per year after adjusting for age and sex (adjusted incidence rate ratio, 1.025 [95% CI, 1.023-1.026]; P 4-fold over the last 6 decades. This increase is unlikely to be due to the introduction of varicella vaccination, antiviral therapy, or change in the prevalence of immunocompromised individuals. © The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.

  15. Improvement in Herpes Zoster Vaccination in Patients with Rheumatoid Arthritis: A Quality Improvement Project.

    Science.gov (United States)

    Sheth, Heena; Moreland, Larry; Peterson, Hilary; Aggarwal, Rohit

    2017-01-01

    To improve herpes zoster (HZ) vaccination rates in high-risk patients with rheumatoid arthritis (RA) being treated with immunosuppressive therapy. This quality improvement project was based on the pre- and post-intervention design. The project targeted all patients with RA over the age of 60 years while being treated with immunosuppressive therapy (not with biologics) seen in 13 rheumatology outpatient clinics. The study period was from July 2012 to June 2013 for the pre-intervention and February 2014 to January 2015 for the post-intervention phase. The electronic best practice alert (BPA) for HZ vaccination was developed; it appeared on electronic medical records during registration and medication reconciliation of the eligible patient by the medical assistant. The BPA was designed to electronically identify patient eligibility and to enable the physician to order the vaccine or to document refusal or deferral reason. Education regarding vaccine guidelines, BPA, vaccination process, and feedback were crucial components of the project interventions. The vaccination rates were compared using the chi-square test. We evaluated 1823 and 1554 eligible patients with RA during the pre-intervention and post-intervention phases, respectively. The HZ vaccination rates, reported as patients vaccinated among all eligible patients, improved significantly from the pre-intervention period of 10.1% (184/1823) to 51.7% (804/1554) during the intervention phase (p Electronic identification of vaccine eligibility and BPA significantly improved HZ vaccination rates. The process required minimal modification of clinic work flow and did not burden the physician's time, and has the potential for self-sustainability and generalizability.

  16. Clinical Analysis on 18 Cases of Child Herpes Zoster and Review the Literature%儿童带状疱疹18例及文献复习

    Institute of Scientific and Technical Information of China (English)

    杨珊; 迪丽努尔·阿布都热依木; 普雄明

    2013-01-01

    目的 探讨儿童带状疱疹的临床特征.方法 回顾性分析2008年1月-2011年12月本科收治的18例儿童带状疱疹的临床资料并进行文献复习.结果 儿童带状疱疹有轻微的前驱症状,皮疹少且散在分布,神经痛轻微,病程短(2 ~7d),且不发生后遗神经痛.结论 儿童带状疱疹临床少见、症状轻微,发病诱因以感染常见.%Objective To discuss the clinical features of children herpes zoster. Methods The pathogenesis,symptoms, experiences and treatments of eighteen children with herpes zoster were analysised. Results The children herpes zoster had minor precursory symptoms. The skin rash on children was few and scattered, neuralgia was slight in children, and course in children was short(2 ~7d). No PHN happened in children. Conclusion Children herpes zoster is rare in the clinic,clinical symptoms is minor. Infection was the common predisposing factor.

  17. AIDS病人眼部带状疱疹病毒感染病例分析%Herpes zoster virus infection case analyses the AIDS eye part

    Institute of Scientific and Technical Information of China (English)

    王寅威

    2008-01-01

    Objective Discuss the ponderance,prognosis,treatment and prophylaxis that the AIDS patient eye part herpes zoster virus opportunistic infection.Method Herpes zoster opportunistic infection case carries out retrospect nature analysis on the AIDS eye part friendship hospital ophthalmology outpatient service makes a definite diagnosis.Result The AIDS eye part herpes zoster virus opportunistic infection inflammation is grave,the pole curing difficulty,the prognosis is bad.Conclusion The herpes zoster opportunistic infection the AIDS disease eye part duplicating each other in taking precautions against and early phase discovers,cures AIDS,ocular infection by to treat long ago being nice%目的 探讨AIDS病人眼部带状疱疹病毒机会性感染的严重性、预后、治疗以及预防.方法 医院眼科门诊确诊的AIDS眼部带状疱疹机会性感染病例行回顾性分析.结果 AIDS眼部带状疱疹病毒机会性感染炎症严重,治疗困难,预后极差.结论 AIDS病眼部带状疱疹性机会性感染重在预防和早期发现,治疗AIDS眼部感染以早治疗为佳.

  18. Alterations of electroencephalogram in patients with headache after herpes zoster virus infection%带状疱疹后头痛的脑电图改变

    Institute of Scientific and Technical Information of China (English)

    徐心耕; 陈慧娟; 高琳; 张建

    2015-01-01

    Objective To investigate alerations in electroencephalogram in patients with headache post infection of herpes zoster virus. Methods A retrospective analysis of electroencephalogram of 58 patiens with headache was carried out.Results In patients with headache post herpes zoster virus infection, abnormal rate of electroencephalogram was 87%. While in group without history of herpes zoster virus infection, the abnormal rate of electroencephalogram was 12%.Conclusion Patients with headache post herpes zoster virus infection had higher rates of abnormality in electroencephalogram.%目的:探讨带状疱疹病毒感染后头痛患者脑电图异常。方法:对58例头痛患者的脑电图进行回顾性分析。结果:带状疱疹病毒感染后头痛组脑电图异常率87%,无疱疹病毒感染的患者脑电图异常率12%。结论:带状疱疹病毒感染后头痛患者脑电图异常发生率高。

  19. Rehabilitation of shoulder paresis caused by herpes zoster according to the International Classification of Functioning, Disability and Health A case report

    Institute of Scientific and Technical Information of China (English)

    Qiang Gao; Yonghong Yang; Chengqi He; Shaxin Liu

    2011-01-01

    We describe the case of a 73-year-old man with left shoulder paresis caused by a herpes zoster infection of the left C5 dermatomes. The patient had been affected by pain for 10 days, a skin rash on his left shoulder and back for 5 days, and weakness of his left shoulder for 2 days before admission. Electromyography revealed denervation discharges from the left supraspinatus, infraspinatus and deltoid muscles, which was compatible with radiculopathy showing after zoster infection. The patient was examined in accordance with the International Classification of Functioning, Disability and Health, and treated with range-of-movement and strengthening exercises as well as activities of daily living and social participation. At 14 months after the onset of the condition, muscle strength had returned to normal. Electromyography revealed that motor unit action potentials were largely normal. These results indicate that the rehabilitation of paresis caused by herpes zoster can obtain positive results with suitable movement training.

  20. Clinical Analysis of 50 Cases of Child Herpes Zoster%儿童带状疱疹50例临床分析

    Institute of Scientific and Technical Information of China (English)

    杨凤琼; 谢雪冰; 邓骥

    2011-01-01

    Objective To discuss the clinical features of children herpes zoster. Methods Fifty children with herpes zoster were compared with 50 cases of adults herpes zoster on their symptoms, experiences and treatments.Result The children herpes zoster had minor precursory symptoms(24% ). The skin rash on children was few and scattered while on adlut heavy. Neuralgia was slight in children but obvious in adult. and course in children was (7.5 ± 1. 8 d) and in adult was ( 18 ±2.5 d) respectively. No PHN happened in children but about 56% in adult patients. Discussion The incidence rate of children herpes zoster is low, and most of them have inducement.%目的 探讨儿童带状疱疹的临床特征.方法 分析50例儿童带状疱疹的诱因、症状、体征及治疗,并与同期50例成人带状疱疹患者临床资料相对照.结果 儿童带状疱疹有轻微前驱症状(24%),皮疹少且散在.神经痛轻微,病程短(7.5±1.8 d),且不发生后遗神经痛;而成人带状疱疹则皮疹重,神经痛明显,病程长(18±2.5d),有后遗神经痛(56%).讨论相对于成年人,儿童带状疱疹发病率低,发病多有诱因.

  1. The humanistic, economic and societal burden of herpes zoster in Europe: a critical review.

    Science.gov (United States)

    Gater, Adam; Uhart, Mathieu; McCool, Rachael; Préaud, Emmanuelle

    2015-02-27

    Herpes zoster (HZ) or "shingles" is common in persons aged 50 years or over. HZ is characterised by a painful dermatological rash which typically resolves in approximately one month. Persistent pain for months or years after rash onset, however, is a common complication of HZ; referred to as post-herpetic neuralgia (PHN). Both HZ and PHN have a significant impact on patients' lives, with considerable implications for healthcare systems and wider society. The aim of the present review is to provide comprehensive documentation and critical appraisal of published data concerning the humanistic, economic and societal burden of HZ in Europe. Systematic literature searches were conducted in Medline, EMBASE, PsycINFO, EconLit, HEED and CRD databases. Searches were conducted in July 2014 and restricted to articles published in the past 20 years. Articles were selected for full review by two independent researchers in accordance with predefined eligibility criteria. From a review of 1619 abstracts, 53 eligible articles, were identified which reported data concerning healthcare resource use (n = 38), direct costs (n = 20), indirect costs (n = 16), total costs (n = 10) and impact on health-related quality of life (HRQoL) (n = 21). Findings highlight that PHN is associated with greater impairments in HRQoL and higher costs of management than HZ. For both HZ and PHN, pain severity is a significant predictor of impact on individuals, healthcare systems and society. While the incidence of HZ and PHN increase with age, age does not appear to be a key driver of overall costs for HZ and PHN. Specifically, while direct costs (e.g. GP, specialists, medications, hospitalisations) tend to be higher for older patients, indirect costs (e.g. work time missed) are higher for younger patients. Available evidence highlights that HZ and PHN result in significant humanistic and economic burden for patients, healthcare systems and wider societies. A tendency to focus upon healthcare resource use

  2. Herpes zoster and risk of cancer in the elderly US population

    Science.gov (United States)

    Mahale, Parag; Yanik, Elizabeth L.; Engels, Eric A.

    2015-01-01

    Background Herpes zoster (HZ) arises in older people due to age-related decline in immunity. We assessed whether HZ, as a marker of immune suppression, is associated with increased cancer risk. Methods We conducted a case-control study in US adults aged ≥ 65 years using the SEER-Medicare linked database. Cases (n=1,108,986) were people with first cancers identified in cancer registries (1992-2005). Controls (n=100,000) were cancer-free individuals frequency-matched to cases on age, sex, and year of selection. We identified HZ diagnosis using Medicare claims. Logistic regression models were constructed to determine adjusted associations between cancer and HZ. Results HZ prevalence was modestly higher in cases than controls (1.4% vs. 1.2%). We identified significant associations between HZ and oral cavity/pharyngeal (adjusted odds ratio [aOR]=1.21), colon (aOR=1.10), lung (aOR=1.11), and non-melanoma skin (aOR=1.46) cancers; myeloma (aOR=1.38); diffuse large B cell lymphoma (aOR=1.30); lymphoplasmacytic lymphoma (aOR=1.99); and chronic lymphocytic leukemia/small lymphocytic lymphoma (aOR=1.55). Among solid cancers, HZ was mostly associated with regional and/or distant stage tumors. Associations were strongest when HZ was diagnosed 13-35 months before cancer diagnosis/selection; they were significant for some cancers in the 36-59-month period, and 60+ months for lymphoplasmacytic lymphoma (OR=1.99). Conclusion HZ is associated with modestly increased risk of a few cancers, particularly hematological malignancies. Associations were strongest at short latency intervals for many cancers, and for regional/distant stages among solid cancers, perhaps reflecting reverse causality. Impact Age-related immune decline does not play a major role in cancer development in older people, but it may be important for some lymphomas. PMID:26578536

  3. Rapid quantitative PCR assays for the simultaneous detection of herpes simplex virus, varicella zoster virus, cytomegalovirus, Epstein-Barr virus, and human herpesvirus 6 DNA in blood and other clinical specimens

    NARCIS (Netherlands)

    Engelmann, I.; Petzold, D. R.; Kosinska, A.; Hepkema, B. G.; Schulz, T. F.; Heim, A.

    Rapid diagnosis of human herpesvirus primary infections or reactivations is facilitated by quantitative PCRs. Quantitative PCR assays with a standard thermal cycling profile permitting simultaneous detection of herpes simplex virus (HSV), varicella zoster virus (VZV), cytomegalovirus (CMV),

  4. 针刺放血结合云南白药外敷治疗急性期带状疱疹30例%Clinical Observation on the Treatment of Acute Herpes Zoster by Bloodletting plus Cupping and Yunnan Baiyao External Application

    Institute of Scientific and Technical Information of China (English)

    马广昊

    2015-01-01

    Objective:To investigate the clinical efficacy of bloodletting -cupping combined with Yunnan Baiyao therapy on herpes zoster.Methods:Sixty patients with herpes zoster were randomly allocated into two groups.The treatment group with 30 patients were received pricking bloodletting therapy plus cupping and Yun-nan Baiyao,and the control group with 30 patients were received acupuncture treatment.10 days after the treat-ment, the VAS score was recorded for a comparison of the therapeutic effects.Results:At the end of treatment, the total efficacy rate was 73.33%in the treatment group, which was higher than 36.67%in the control group (P<0.05).Conclusion:Compared with acupuncture, bloodletting therapy plus cupping combined with Yun-nan Baiyao has a better therapeutic effect on herpes zoste than traditional acupuncture therapies.%目的:观察放血结合云南白药外敷治疗带状疱疹的临床疗效。方法:将60例带状疱疹患者随机分为两组,治疗组30例采用梅花针叩刺放血结合云南白药治疗,对照组30例采用常规针灸疗法治疗,治疗1个疗程后观察疼痛缓解率及疗效并进行 VAS 评分,进行疗效对比。结果:治疗组痊愈率为73.33%,对照组痊愈率为36.67%,两组比较差异有统计学意义( P<0.05)。结论:放血疗法结合云南白药外敷治疗带状疱疹优于传统针刺疗法。

  5. 中西医结合治疗带状疱疹性角膜炎%Herpes Zoster Keratitis was Treated by Traditional Chinese Medicine and Western Medicine

    Institute of Scientific and Technical Information of China (English)

    何静

    2012-01-01

    Herpes zoster keratitis is a kind of unilateral skin and eye disease caused by neurotropic virus (the varicella-zoster virus) . Herpes zoster kertitis usually is treated with antiviral agent and antiviral drops. Now we treat herpes zoster kertitis with "Longdan Xiegan Decoction" to improve immunity and detoxicate. It is quite effective for shortening duration of disease and consolidating curative effect.%带状疱疹性角膜炎是嗜神经病毒(水痘一带状疱疹病毒)引起的不越过中线的单侧皮肤、眼部疾患,3/4的病例角膜被侵犯.通常用西药抗病毒药口服,抗病毒眼药局部治疗.辅以中药龙胆泻肝汤加减治疗后能提高全身抵抗力,固本排毒,对缩短痛程,巩固疗效是非常有益的.

  6. 清热解毒法治疗带状疱疹43例%Antipyretic and Antidotil Therapy to Treat 43 Cases of Herpes Zoster

    Institute of Scientific and Technical Information of China (English)

    王瑾

    2001-01-01

    Objective: To observe the clinical effect of antipyretic and antidotal on herpes zoster disease. Methods: To adapt both oral and external antipyretic and antidotil herb to treating 43 cases of herps zoster patients. Results: Using antipyretic and antidotal herb can shorten the course of herps zoster. Conclusion: Both oral and external antipyretic and antidotil herb could inhibit either herpes' virus or caricella virus.%目的:观察和验证清热解毒类中药对带状疱疹的临床功效。方法:对43例带状疱疹患者均采用中药清热解毒内治外用。结果:清热解毒法治疗能缩短带状疱疹病程,控制临床症状。结论:清热解毒法内外综合治疗对水豆-带状疱疹病毒有杀灭,抑制作用。

  7. A genome-wide comparative evolutionary analysis of herpes simplex virus type 1 and varicella zoster virus.

    Directory of Open Access Journals (Sweden)

    Peter Norberg

    Full Text Available Herpes simplex virus type 1 (HSV-1 and varicella zoster virus (VZV are closely related viruses causing lifelong infections. They are typically associated with mucocutaneous or skin lesions, but may also cause severe neurological or ophthalmic diseases, possibly due to viral- and/or host-genetic factors. Although these viruses are well characterized, genome-wide evolutionary studies have hitherto only been presented for VZV. Here, we present a genome-wide study on HSV-1. We also compared the evolutionary characteristics of HSV-1 with those for VZV. We demonstrate that, in contrast to VZV for which only a few ancient recombination events have been suggested, all HSV-1 genomes contain mosaic patterns of segments with different evolutionary origins. Thus, recombination seems to occur extremely frequent for HSV-1. We conclude by proposing a timescale for HSV-1 evolution, and by discussing putative underlying mechanisms for why these otherwise biologically similar viruses have such striking evolutionary differences.

  8. Zosteriform lichen planus after herpes zoster: report of a new case of Wolf's isotopic phenomenon and literature review.

    Science.gov (United States)

    Lora, Viviana; Cota, Carlo; Kanitakis, Jean

    2014-11-15

    The Wolf's isotopic phenomenon corresponds to the occurrence of a skin disease at a body site affected previously by a different, already healed dermatosis. We report a 74-year-old man who presented with a zosteriform eruption consisting of erythematous-scaly, slightly pruritic papules on the right flank some weeks after herpes zoster (HZ) had healed on the same area. Histologic examination showed typical changes of lichen planus, confirming the diagnosis of post-HZ zosteriform lichen planus (ZLP). The lesions regressed with topical steroid treatment. Zosteriform lichen planus (ZLP) is one example of Wolf's isotopic phenomenon appearing after HZ. So far, only 17 cases have been reported in the literature. The precise pathogenesis of ZLP is not well known, although persisting viral proteins could be responsible for the hypersensitivity reaction. We review and discuss the salient clinicopathologic features of this rare entity based on a thorough literature review.

  9. 184例带状疱疹的诊疗体会%Experience in Diagnosis and Treatment of 184 Cases of Herpes Zoster

    Institute of Scientific and Technical Information of China (English)

    李冰皓

    2016-01-01

    目的:探讨带状疱疹的治疗要点。方法选取本院2013年至今收治的184例带状疱疹患者作为观察对象,分析带状疱疹的治疗原则及各期的治疗方法。结果经过内外兼治的方法184例患者均达到了理想的效果,其中痊愈142例,显效36例,有效6例。结论对带状疱疹必须要抗病毒和恢复受损的神经同时治疗,尽量做到早期用药。配合红蓝光照射治疗更能够有效修复受损的神经组织,改善患者的疼痛症状,值得在临床中推广应用。%Objective To study the treatment of herpes zoster. Methods 184 cases of herpes zoster treated in our hospital from 2013 to the present were selected as the observation object, Analysis of herpes zoster treatment principles and the various stages of treatment. Results After internal and external treatment, 184 cases achieved satisfactory results, Among them, 142 cases were cured, 36 cases were markedly effective, and 6 cases were effective. Conclusion Herpes zoster must be treated with antiviral and recovery of damaged nerve simultaneously, try to do early use of drugs. Combined with red and blue light irradiation treatment can effectively repair the damaged nerve tissue, improve the pain symptoms of patients, it is worth in clinical application.

  10. MEBO治疗带状疱疹23例疗效观察%The Efficacy of MEBO in Treating 23 Cases of Herpes Zoster

    Institute of Scientific and Technical Information of China (English)

    唐广立; 王洪昌

    2001-01-01

    Objective:To find out a new method for treating herpes zoster. Method:23 cases of herpes zoster were treated with MEBO(MEBO grou)and 22cases were treated with conventional method (control group).Result: All the cases healed. In MEBOgroup, the wound healing time was shorter than that in the control group(P<0.01).Con-clusion:MEBO is effective for treating herpes zoster. It is easy to use and its efficacy is satifactory%目的:探讨带状疱疹新的治疗方法.方法:治疗组23例局部采用MEBO暴露或包扎治法,对照组22例采用传统疗法.结果:两组病人均治愈,治疗组中22例疼痛缓解,而对照组只有14例缓解(P<0.05).XFK YWX :治疗带状疱效果确切,简单易行,值行推广.

  11. 针灸联合中药治疗带状疱疹%Treating herpes zoster by acupuncture and moxibusion plusTCM medicine

    Institute of Scientific and Technical Information of China (English)

    于永娜; 李玲; 贾丽华

    2015-01-01

    目的:探讨带状疱疹的治疗疗效。方法:选取120例带状疱疹患者进行针灸联合中药的治疗。结果:120例患者治疗后,102例治愈,占85%,10例显效,占10%,8例未愈,占5%。结论:针灸联合中药治疗带状疱疹有显著的疗效。%Objective: To study clinical efficacy of acupuncture and moxibusion plus TCM medicine on herpes zoster. Methods: 120 cases with herpes zoster were selected, and received acupuncture and moxibusion plus TCM medicine. Results: In 120 cases, 102 cases were cured (85%), 10 cases were markedly improved (10%), 8 cases were ineffective (5%). Conclusion: Acupuncture and moxibusion plus TCM medicine showed remarkable efficacy on herpes zoster.

  12. Herpes zoster-associeret morbiditet hos børn i kemoterapi for akut lymfoblastaer leukaemi

    DEFF Research Database (Denmark)

    Sørensen, Gitte Vrelits; Helgestad, Jon; Rosthøj, Steen

    2009-01-01

    receiving chemotherapy. All eruptions were treated with acyclovir, in eight cases intravenously, and in six cases chemotherapy was interrupted. Cutaneous dissemination occurred in two cases, visceral dissemination in none. One child had postherpetic trigeminal neuralgia for two months. The eruption rate......, treatment and course of zoster eruptions were registered in a cohort of 67 children with newly diagnosed ALL. Of these, 45 had had varicella at the time of diagnosis and 15 contracted varicella or were vaccinated during the course of therapy. RESULTS: Eleven children had a total of 17 eruptions while...... was higher among small children than among school-aged children (0.22 vs. 0.13 per year of chemotherapy) and was related to the intensity of chemotherapy (0.30 per year of consolidation treatment vs. 0.13 for maintenance therapy). Three children on prolonged intensive chemotherapy had recurrent zoster...

  13. Perspectives on the impact of varicella immunization on herpes zoster. A model-based evaluation from three European countries.

    Directory of Open Access Journals (Sweden)

    Piero Poletti

    Full Text Available The introduction of mass vaccination against Varicella-Zoster-Virus (VZV is being delayed in many European countries because of, among other factors, the possibility of a large increase in Herpes Zoster (HZ incidence in the first decades after the initiation of vaccination, due to the expected decline of the boosting of Cell Mediated Immunity caused by the reduced varicella circulation. A multi-country model of VZV transmission and reactivation, is used to evaluate the possible impact of varicella vaccination on HZ epidemiology in Italy, Finland and the UK. Despite the large uncertainty surrounding HZ and vaccine-related parameters, surprisingly robust medium-term predictions are provided, indicating that an increase in HZ incidence is likely to occur in countries where the incidence rate is lower in absence of immunization, possibly due to a higher force of boosting (e.g. Finland, whereas increases in HZ incidence might be minor where the force of boosting is milder (e.g. the UK. Moreover, a convergence of HZ post vaccination incidence levels in the examined countries is predicted despite different initial degrees of success of immunization policies. Unlike previous model-based evaluations, our investigation shows that after varicella immunization an increase of HZ incidence is not a certain fact, rather depends on the presence or absence of factors promoting a strong boosting intensity and which might or not be heavily affected by changes in varicella circulation due to mass immunization. These findings might explain the opposed empirical evidences observed about the increases of HZ in sites where mass varicella vaccination is ongoing.

  14. Clinical Analysis of 12 HIV-infected Patients with Herpes Zoster%HIV感染并发带状疱疹12例临床分析

    Institute of Scientific and Technical Information of China (English)

    张更建; 张信江; 罗显华; 董泽令; 黄健; 陈龙庆; 王磊

    2013-01-01

    Objective To explore the clinical characteristics of HIV-infected patients with herpes zoster. Methods A retrospective analysis was performed on patients diagnosed as HIV infection with herpes zoster from November 2008 to October 2011 in our hospital. Results There were 12 HIV-infected patients with herpes zoster, male nine cases, female three cases, aged 25 to 58 years, average 35 years old. Eight cases were farmers, one was worker, two cases were individual and the other one was company staff. All the patients had neuropathic pain syndromes, five cases of them paining obviously. Patients were all with the two nerve branches innervating the area except one . 11 cases were cured, the other one was better. There were two cases of HIV patients diagnosed in the first year, four cases in the second year and six cases in the third year. The incidence of HIV increased with year. Conclusion HIV infection complicated with herpes zoster easily. Herpes zoster should be recognized as a marker condition indicating the necessity of screening for HIV. Obviously neuropathic pain and larger scale of rash always occurred in the HIV patients with herpes zoster. The common treatment of HIV patients with herpes zoster were using medicine with antivirus, nerve nutrition, diminishing inflammation acetanilide and enhancing immunologic function, but not glucocorticoid. The treatment alleviated the symptom effectively.%目的 探讨HIV感染者并发带状疱疹的临床特点.方法 回顾性分析2008年11月-2011年10月本科收治的12例HIV感染并发带状疱疹患者的临床资料.结果 男9例,女3例;年龄25~58岁,大于50岁1例.农民8例,工人1例,个体2例,职员1例.11例皮损分布≥2个神经分支支配区,均出现神经痛症状,其中5例疼痛明显.临床治愈11例,好转1例.三年间检出HIV感染并发带状疱疹者分别为2例、4例和6例.结论 HIV感染者易并发带状疱疹,带状疱疹可为HIV感染的首要症状.HIV感染并发带状

  15. Herpes zoster como primeira manifestação de infeção por vírus varicela-zoster numa criança saudável

    OpenAIRE

    Catarina Carrusca; Raquel Machado; Carolina Albuquerque; Florbela Cunha

    2016-01-01

    O herpes zoster (HZ) resulta da reativação do vírus varicela- -zoster (VVZ). A incidência aumenta com a idade, sendo raro em crianças saudáveis. Descrevemos um caso de HZ oftálmico numa menina de 29 meses, previamente saudável. Apresentava febre e erupção cutânea vesicular dolorosa no território oftálmico do nervo trigémio. Sem história de varicela ou vacinação anti-varicela prévias. Teve contacto intrafamiliar com varicela aos dois meses de idade. A pesquisa do vírus nas...

  16. Prevention of herpes zoster and its complications: from the clinic to the real-life experience with the vaccine.

    Science.gov (United States)

    Giovanni, Gabutti; Nicoletta, Valente; Parvanè, Kuhdari; Silvia, Lupi; Armando, Stefanati

    2016-12-01

    The erpes zoster is an acute viral illness characterized by a vesicular rash of unilateral distribution, which can eventually cause severe complications, such as post-herpetic neuralgia, ophthalmic zoster, stroke or other neurological complications. In Europe, an incidence of between 2.0 and 4.6 cases per 1000 person-years is estimated, with an increase after 50 years of age. Currently, the therapeutic options for are only partially effective in limiting the acute phase, while the management of complications is frequently complex and not satisfactory. The overall burden of the disease and the elevated costs associated with diagnosis and clinical and therapeutic management led to the development of a new preventive approach through a live attenuated virus vaccine. The vaccine now available decreases the incidence of the disease, post-herpetic neuralgia and the burden of illness. Moreover, the vaccine is safe and well tolerated and it seems to confer long-term protection. Based on the clinical results and evidence provided by the Health Technology Assessment, several countries introduced immunization although with different recommendations and methods of funding.

  17. Predictors of postherpetic neuralgia in patients with herpes zoster: a pooled analysis of prospective cohort studies from North and Latin America and Asia

    Directory of Open Access Journals (Sweden)

    Kosuke Kawai

    2015-05-01

    Conclusions: In addition to older age and severe acute pain, this study suggests that impaired physical and social functioning from acute zoster pain may play a role in the development of PHN in this prospective cohort study of HZ patients from North and Latin America and Asia.

  18. 三氧化二砷治疗血液病后合并带状疱疹的临床研究%Clinical analysis of hematologic disorders complicated with herpes zoster after treating with arsenic trioxide

    Institute of Scientific and Technical Information of China (English)

    张旗; 慕俐君; 王晓波; 李莉; 康志杰; 闫金松

    2011-01-01

    Objective To explore the increasing risk of herpes zoster and its possible mechanisms for hematologic disorders treated with arsenic trioxide (ATO). Methods The cases were divided into study group (with ATO) and control group (without ATO). The incidence rate of herpes zoster was compared between the two groups, and then the average cycles of chemotherapy were compared between the patients complicated with herpes zoster or not in study group. Results The rate of herpes zoster was significantly higher in study group than that in control group (χ2 =4.492, P =0.034). The rates of herpes zoster were 23.95 % (23/96) in study group and 7.89 % (3/38) in control groups. Patients in study group with herpes zoster had received 7.60 cycles and those without herpes zoster 7.72 cycles of chemotherapy on average (Z=0.976, P=0.296).Conclusion The risk of herpes zoster complication in hematologic disorders was increased after ATO treatment which probably activated varicella-zoster virus.%目的 分析三氧化二砷(ATO)治疗血液病后合并带状疱疹感染患者的临床特征及其可能的发生机制.方法 将研究对象分为研究组(应用ATO)和对照组(未应用ATO),观察两组带状疱疹发病率,以及研究组中发生带状疱疹和未发生带状疱疹患者的平均化疗次数.结果 研究组带状疱疹发病率为23.95%(23/96),发生带状疱疹者平均化疗7.60次,未发生带状疱疹者平均化疗7.72次(Z=0.976,P=0.296);对照组带状疱疹发病率7.89%(3/38),两组间带状疱疹发病率差异有统计学意义(χ2=4.492,P=0.034).结论 ATO治疗血液疾病可以增加带状疱疹的发病率,可能与其激活水痘-带状疱疹病毒有关.

  19. Treatment of herpes zoster with Clinacanthus nutans (bi phaya yaw) extract.

    Science.gov (United States)

    Sangkitporn, S; Chaiwat, S; Balachandra, K; Na-Ayudhaya, T D; Bunjob, M; Jayavasu, C

    1995-11-01

    A randomized, placebo-controlled trial of the efficacy of topical formulation of Clinacanthus nutans (Bi Phaya Yaw) extract was carried out in 51 patients with varicella-zoster virus infection. The study medication was applied five times daily for 7-14 days until the lesions were healed. The number of patients with lesion crusting within 3 days and with lesion healing within 7 days and 10 days were significantly greater in the C. nutans extract-treated group than the placebo group (p nutans extract-treated group than in the placebo group. There were no side effects of the study medication.

  20. Clinical Manifestations of Herpes Zoster, Its Comorbidities, and Its Complications in North of Iran from 2007 to 2013

    Directory of Open Access Journals (Sweden)

    Farhang Babamahmoodi

    2015-01-01

    Full Text Available Background. Herpes zoster infection is a painful worldwide disease. Inappropriate and delayed treatment causes prolongation of the disease with debilitating symptoms and postherpetic neuralgia. Method. A cross-sectional study evaluated shingles cases admitted in a teaching hospital with one-year followup in north of Iran from 2007 to 2013. Results. From 132 patients, 60.4% were male. Head and neck involvement occurred in 78 people (59.1%, thoracoabdominal region in 37 cases (28%, and extremities in 16 cases (12.1%, and one case (0.8% got multisites involvement. 54 cases (40.9% had predisposing factors including diabetes mellitus in 26 cases (19.7%, malignancy in 15 (11.4%, immunosuppressive medication in 7 (5.03%, HIV infection in 3 (2.3%, radiotherapy in 2 (1.5%, and tuberculosis in one patient (0.8%. The most common symptoms were pain (95.5%, weakness (56%, fever (31.1%, headache (30.3%, ocular complaints (27.3%, itching (24.2%, and dizziness (5.3%. 21 cases (15.9% had bacterial superinfection on blistering areas and overall 18 cases (13.6% had opium addiction. 4 cases (3.03% died during admission because of comorbidities. Postherpetic neuralgia was reported in 56 patients (42.5% after three months and seven cases (5% in one-year followup. Conclusion. Shortening interval between skin lesion manifestation and starting medication can accelerate lesion improvement and decrease disease course, extension, and complication.

  1. Gentiana scabra Bunge. Formula for Herpes Zoster: Biological Actions of Key Herbs and Systematic Review of Efficacy and Safety.

    Science.gov (United States)

    Wang, Kaiyi; Coyle, Meaghan E; Mansu, Suzi; Zhang, Anthony Lin; Xue, Charlie Changli

    2017-01-12

    This study reviewed the biological action of key herbs and evaluated systematically the efficacy and safety of oral Gentiana formula for herpes zoster (HZ). Experimental studies relevant to HZ were identified in PubMed. Randomized controlled trials using Gentiana formula for HZ were identified from nine English and Chinese databases. The primary outcome was evaluation of pain. Potential risk of bias was assessed. Meta-analysis was conducted using mean difference or risk ratio with 95% confidence intervals. Key herbs Gentiana scabra Bunge, Gentiana triflora Pall, Scutellaria baicalensis Georgi, and Gardenia jasminoides Ellis have shown antiinflammatory actions through inhibition of inflammatory cytokines and pro-inflammatory enzymes. Twenty-six clinical studies, involving 2955 participants, were included. Modified Gentiana formula resolved pain earlier than pharmacotherapy when used alone or combined with topical Chinese herbal medicine. Incidence of postherpetic neuralgia was lower (risk ratio 0.14, 95% confidence interval 0.03 to 0.74) with modified Gentiana formula plus topical Chinese herbal medicine. Mild adverse events were reported. Antiinflammatory actions of key herbs of Gentiana formula may explain clinical benefit in hastening pain relief and decreasing postherpetic neuralgia. Few adverse events were reported. Findings were limited by study quality and diversity in intervention and comparator dosage. Copyright © 2017 John Wiley & Sons, Ltd.

  2. 带状疱疹并发眼外肌麻痹11例临床分析%Analysis of 11 cases of herpes zoster complicated by extraocular muscles paralysis

    Institute of Scientific and Technical Information of China (English)

    杨晓鸥

    2012-01-01

    11例带状疱疹并发眼外肌麻痹患者均表现为眼睑及周围皮肤带状疱疹,疹后14天~2个月出现复视、斜视,持续4周~2个月.早期眼部外用、严重者系统应用糖皮质激素治疗可防止眼部后遗症的发生.%Eleven cases of herpes zoster complicated by extraocular muscles paralysis were reported. All cases presented herpes zoster of eyelids and nearby skin. Ten days to two months after the onset of herpes zoster, diplopia and esotropia occurred and lasted for 4 weeks to 2 months. Early application of glucocorticoids can prevent the occurrence of ocular sequelae.

  3. 带状疱疹愈合部位发生银屑病-Wolf's同位反应1例%Wolf's Isotopic Response: A Case of Psoriasis on the Site of Healed Herpes Zoster

    Institute of Scientific and Technical Information of China (English)

    胡晓莉; 瞿子伟; 范娟

    2012-01-01

    患者男,38岁.6周前左胸及背部出现带状疱疹皮损,2周后治愈.20d前,皮损愈合处出现簇集分布的鳞屑性红斑丘疹.皮损组织病理符合银屑病,提示为带状疱疹Wolf's同位反应.%A 38-year-old male presented with a 20-day Cluster of erythematous-desquamative lesions at the site of healed herpes zoster on his left chest-back region. He had been treated 6 weeks previously for herpes zoster of the same region. The lesions healed completely within 2 weeks. Based on histological findings, the patient had psoriasis.The clinical picture suggests Wolf's isotopic response on the site of healed herpes zoster.

  4. Herpes zoster as a cause of viral meningitis in immunocompetent patients.

    Science.gov (United States)

    Kangath, Raghesh Varot; Lindeman, Tracey Einem; Brust, Karen

    2013-01-09

    A 30-year-old Caucasian woman, without significant medical history or immunosuppression, presented with a 7-day history of severe headache and neck pain. The patient was presumed to have tension headache versus migraine, but was admitted because her symptoms did not resolve. A lumbar puncture was performed showing lymphocytic pleocytosis suggestive of aseptic meningitis and the patient was started on broad-spectrum antibiotics and acyclovir. After admission, a rash was discovered on her left lumbar region with vesicles on top of an erythematous base. Varicella PCR was conducted on the patient's cerebrospinal fluid which was positive. Upon further history, patient was found to have previous varicella infection as a child, but no prior episodes of dermatomal zoster. Therefore, this patient was found to have aseptic meningitis and cutaneous manifestation of disseminated varicella-zoster despite immunocompetence. Antibacterial treatment was discontinued and she was continued on acyclovir for 7 days with transition to valacyclovir for 2 additional weeks with good treatment response and symptom resolution.

  5. Acute retinal necrosis results in low vision in a young patient with a history of herpes simplex virus encephalitis.

    Science.gov (United States)

    Shahi, Sanjeet K

    2016-08-31

    Acute retinal necrosis (ARN), secondary to herpes simplex encephalitis, is a rare syndrome that can present in healthy individuals, as well as immuno-compromised patients. Most cases are caused by a secondary infection from the herpes virus family, with varicella zoster virus being the leading cause of this syndrome. Potential symptoms include blurry vision, floaters, ocular pain and photophobia. Ocular findings may consist of severe uveitis, retinal vasculitis, retinal necrosis, papillitis and retinal detachment. Clinical manifestations of this disease may include increased intraocular pressure, optic disc oedema, optic neuropathy and sheathed retinal arterioles. A complete work up is essential to rule out cytomegalovirus retinitis, herpes simplex encephalitis, herpes virus, syphilis, posterior uveitis and other conditions. Depending on the severity of the disease, the treatment options consist of anticoagulation therapy, cycloplegia, intravenous acyclovir, systemic steroids, prophylactic laser photocoagulation and pars plana vitrectomy with silicon oil for retinal detachment. An extensive history and clinical examination is crucial in making the correct diagnosis. Also, it is very important to be aware of low vision needs and refer the patients, if expressing any sort of functional issues with completing daily living skills, especially reading. In this article, we report one case of unilateral ARN 20 years after herpetic encephalitis.

  6. Herpes

    Science.gov (United States)

    ... AACC products and services. Advertising & Sponsorship: Policy | Opportunities Herpes Testing Share this page: Was this page helpful? Also known as: Herpes Culture; Herpes Simplex Viral Culture; HSV DNA; HSV ...

  7. Incidence and clinical features of herpes simplex viruses (1 and 2) and varicella-zoster virus infections in an adult Korean population with aseptic meningitis or encephalitis.

    Science.gov (United States)

    Choi, Rihwa; Kim, Gyeong-Moon; Jo, Ik Joon; Sim, Min Seob; Song, Keun Jeong; Kim, Byoung Joon; Na, Duk L; Huh, Hee Jae; Kim, Jong-Won; Ki, Chang-Seok; Lee, Nam Yong

    2014-06-01

    Since there are limited data on the incidence and clinical findings of central nervous system (CNS) infection by three α-herpesviruses including human herpes simplex virus 1 (HSV-1), HSV-2 and varicella-zoster virus (VZV) in Korea, a retrospective analysis of clinical data and polymerase chain reaction (PCR) results was performed in patients who presented with suspicion of acute viral meningitis and/or encephalitis at the emergency department of a tertiary referral hospital in Seoul, Korea. During the 3-year study period, a total of 224 cerebrospinal fluid (CSF) samples from 224 patients were examined. Among the 224 patients, 135 (60.3%) patients were identified as having aseptic meningitis (n = 70, 51.9%), encephalitis (n = 41, 30.4%) or meningoencephalitis (n = 24, 17.8%) at discharge. Twenty-four (17.8%) patients were identified as having VZV meningitis (n = 16, 11.9%), VZV meningoencephalitis (n = 2, 1.5%), HSV-2 meningitis (n = 4, 3.0%), or HSV-1 encephalitis (n = 2, 1.5%). Of the 24 patients infected with the three herpesviruses, immunocompromised patients accounted for 33.3% (n = 8). Skin rashes were observed in half (n = 9) of the patients with VZV, and none with HSV-1 or HSV-2. One patient with VZV meningitis and four patients with brain parenchymal involvement had neurologic sequelae. In conclusion, three herpesviruses are important causative agents of CNS infectious disease with significant morbidity in adults, regardless of the immunologic status. Therefore, CSF should be examined for HSV-1, HSV-2, and VZV using sensitive diagnostic methods in all cases of adult patients with clinical manifestations of CNS disease in order to identify the correct etiology and to determine appropriate therapy.

  8. Herpes Zoster Associated Hospital Admissions in Italy: Review of the Hospital Discharge Forms

    Directory of Open Access Journals (Sweden)

    Giovanni Gabutti

    2009-09-01

    Full Text Available In Italy a specific surveillance system for zoster does not exist, and thus updated and complete epidemiological data are lacking. The objective of this study was to retrospectively review the national hospital discharge forms database for the period 1999-2005 using the code ICD9-CM053. In the period 1999-2005, 35,328 hospital admissions have been registered with annual means of 4,503 hospitalizations and 543 day-hospital admissions. The great part of hospitalizations (61.9% involved subjects older than 65 years; the mean duration of stay was 8 days. These data, even if restricted to hospitalizations registered at national level, confirm the epidemiological impact of shingles and of its complications.

  9. 火针刀技术治疗带状疱疹临床观察%Clinical Observation of Cauterized Needle-knife Treatment of Herpes Zoster

    Institute of Scientific and Technical Information of China (English)

    唐胜修; 王小莲; 刘辛; 韦春华

    2011-01-01

    Objective :To observe the effect of cauterized needle-knife treatment of herpes zoster. Methods :44 cases of herpes zoster patients were divided into 2 groups according with random number table method,24 cases of cauterized needle-knife group ( group 1 ) and 20 cases of western medicine ( group 2). After the 2 groups were treated respectively, add up the whole scab time and changes in pain intensity of the 2 groups respectively, then make statistical comparison. Results: After treatments, the whole scab time of group 1 was significantly lower then that of group 2 (P < 0. 05), the pain score of group 1 was significantly lower than that of group 2 (P < 0.05). Conclusion: the herpes zoster treatment efficacy of cauterized needle-knife was superior to that of westem medicine.%目的:观察火针刀技术治疗带状疱疹的疗效.方法:带状疱疹患者44例,以随机数字表法分为两组,其中火针刀组24例,以火针刀治疗,西药组20例,以西药治疗,直至疱疹皮损处全部结痂为止.分别统计每组患者结痂所需时间及治疗前后疼痛程度评分,并加以比较.结果:火针刀组结痂所需时间明显少于西药组的时间(P<0.05),火针刀组治疗后疼痛评分明显少于西药组评分(P<0.05).结论:火针刀技术治疗带状疱疹疗效优于西药组.

  10. Serum cytokines, T lymphocyte subsets and STAT3 function in patients with herpes zoster as well as the intervention effect of mouse nerve growth factor

    Institute of Scientific and Technical Information of China (English)

    Yun Xu; Ling-Ling Tan; Kai Wang; Juan-Juan Zhang; Li-Jing Zhang

    2016-01-01

    Objective:To assess the levels of serum cytokines, T lymphocyte subsets and STAT3 in patients with herpes zoster as well as the intervention effect of mouse nerve growth factor. Methods:A total of 102 patients with herpes zoster were selected as observation group and received mouse nerve growth factor intervention, and 100 cases of normal people who received physical examination in our hospital during the same period as the healthy control group. The levels of serum Th1/Th2 cytokines, IgG subclass and complements and T lymphocyte subsets as well as STAT3 function of observation group before and after treatment and healthy control group were detected.Results: Serum IL-2 andγ-IFN levels of observation group after treatment were higher than those before treatment while IL-4, IL-5, IL-10 and TNF-α levels were lower than those before treatment (P<0.05); serum IgG1, IgG3, IgG4, C3 and C4 values of observation group after treatment were higher than those before treatment while IgG2 value was lower than that before treatment (P<0.05); CD3, CD4 and CD4/CD8 levels of observation group after treatment were higher than those before treatment while CD8 level was lower than that before treatment (P<0.05); STAT3, p-STAT3 and JAK2 expression levels of observation group after treatment were lower than those before treatment (P<0.05).Conclusions:There are abnormal immune system and STAT3 signaling pathway function in patients with herpes zoster, and mouse nerve growth factor intervention can restore multisystem balance and accelerate disease rehabilitation, and has positive clinical significance.

  11. Herpes zoster como primeira manifestação de infeção por vírus varicela-zoster numa criança saudável

    Directory of Open Access Journals (Sweden)

    Catarina Carrusca

    2016-03-01

    Full Text Available O herpes zoster (HZ resulta da reativação do vírus varicela-zoster (VVZ. A incidência aumenta com a idade, sendo raro em crianças saudáveis. Descrevemos um caso de HZ oftálmico numa menina de 29 meses, previamente saudável. Apresentava febre e erupção cutânea vesicular dolorosa no território oftálmico do nervo trigémio. Sem história de varicela ou vacinação anti-varicela prévias. Teve contacto intrafamiliar com varicela aos dois meses de idade. A pesquisa do vírus nas vesículas por polimerase chain reaction foi positiva. Os títulos de IgG e IgM anti-vírus varicela-zoster foram inicialmente negativos, tendo ocorrido seroconversão oito semanas depois. Medicada com aciclovir endovenoso, recuperou sem sequelas. O HZ pode ocorrer em crianças previamente saudáveis, sem evidência de varicela anterior e com serologia para VVZ negativa. Tal pode ser explicado pela imaturidade do sistema imunológico, assim como pela transferência transplacentária de anticorpos maternos, aquando da infeção primária precoce.

  12. Influence of systemic immune and cytokine responses during the acute phase of zoster on the development of postherpetic neuralgia

    Institute of Scientific and Technical Information of China (English)

    Sheng-mei ZHU; Yong-min LIU; Er-dan AN; Qing-lian CHEN

    2009-01-01

    Postherpetic neuralgia (PHN) is a severe sequela of herpes zoster (HZ). Until now, only age and pain severity were considered predisposing factors for the development of PHN. We evaluated 49 patients with acute phase HZ, 10 of whom developed PHN (Group A) and 39 of whom did not develop PHN (Group B). Twenty-five healthy volunteers similar in age and gender distribution to the study group were recruited as controls (Group C). Numbers of serum CD3+ (pan-T lymphocytes), CD4+ (helper/inducer), and CD8+ (suppressor/cytotoxic) lymphocytes were decreased significantly in Groups A and B relative to the control group, but there were no statistical differences between Groups A and B. Interleukin (IL)-1β IL-6, tumor necrosis factor (TNF)-α, IL-8, and IL-10 were significantly elevated in Groups A and B relative to Group C. IL-6 was significantly higher in Group A than in Group B, and was significantly positively correlated with pain severity scored on a visual analog scale. Therefore, we suggest that the inflammatory response, especially that of IL-6, in the acute phase of HZ may be associated with hyperalgesia and the development of PHN.

  13. [Delirium during oral therapy of herpes zoster with acyclovir. Case report and brief review of central nervous system side-effects of acyclovir].

    Science.gov (United States)

    Braun, J S; Apel, I; Schäffer, S; Schumacher, M; Berger, M

    1998-11-01

    In differential diagnosis of a delir also adverse effects of medicaments have to be taken into account beside other causes. We report a case of an agitated delir with nocturnal disturbance of consciousness, confusion, restlessness and sleeplessness. This delir existed exclusively during the therapy of a cutaneous herpes zoster with zovirax-pills which can only be explained by a causal connection--after exclusion of other causes. As a so far undescribed predisposition for neurotoxicity of oral therapy with acyclovir signs of vascular encephalopathy were found in the patient's cranial magnetic resonance imaging. The central nervous side effects of acyclovir were summarized shortly.

  14. Hemicellulose dressing for skin lesions caused by herpes zoster in a patient with leukemia-an alternative dressing.

    Science.gov (United States)

    Chacon, Julieta; Ferreira, Lydia

    2009-01-01

     Herpes zoster is a painful disease that can develop in immunosuppressed children. Prolonged immunosuppression in leukemia patients can substantially delay healing of herpetic lesions. The purpose of this report was to evaluate the use of hemicellulose dressings as an alternative treatment for extensive herpetic lesions in an immunosuppressed child with leukemia. The hemicellulose dressing was applied to the lesions on the second day after debridement. After 36 days, the lesions were completely healed. The hemicellulose dressing was an effective resource for promoting complete epithelial healing.

  15. [Viral infection of herpes simplex, Epstein-Barr, varicela zoster, human papilloma, cytomegalovirus, or adenovirus are not related to sinonasal adenocarcinomas].

    Science.gov (United States)

    Pérez Escuredo, Jhudit; Llorente, José Luis; Melón, Santiago; de Oña, María; García Martínez, Jorge; Alvarez Marcos, César; Hermsen, Mario

    2007-01-01

    Several types of virus have been implicated in the development of head and neck tumors. However, until now sinonasal adenocarcinomas (ACN) have not been studied. The aim of this study is to screen a series of ACN for the presence of a number of viruses known to play a role in cancer. Viral DNA sequences of herpes simplex virus, Epstein-Barr, varicela zoster, human papilloma, cytomegalovirus, and adenovirus were analysed by PCR in 37 primary ACN. Three tumors (8.1%) were positive for Epstein-Barr virus and 1 case (2.7%) for cytomegalovirus. Viral infections do not seem to play a role in the etiology of ACN.

  16. 蛇串疮辨证施护55例体会%Experience of Nursing Based on Syndrome Differentiation for 55 Cases of Herpes Zoster

    Institute of Scientific and Technical Information of China (English)

    徐琳

    2012-01-01

    蛇串疮是疼痛性疱疹性皮肤病,文章从一般护理常规、辨证施护、皮肤护理、疼痛护理、情志护理及饮食护理等方面较详细阐述了蛇串疮的辨证施护体会,提示多方面联合进行中医护理可提高临床疗效.%Herpes zoster is a skin disease characterized by pain and herpes. The nursing experience was explained from many aspects, including nursing routine, nursing based on syndrome differentiation, skin nursing, pain nursing, emotion nursing and diet nursing. It is proved that TCM combined with western medicine can improve the effect.

  17. Cantharidin patches and intravenous administration of vitamin C in the concomitant treatment of herpes zoster:a case report%斑蝥素贴剂结合维生素C静脉注射辅助治疗带状疱疹1例

    Institute of Scientific and Technical Information of China (English)

    Martin Schencking; Karin Kraft

    2011-01-01

    @@ The diagnosis and therapy for herpes zoster (HZ) are frequently associated with consultation of a general practitioner and with hospital care.Although there are several serious complications of zoster such as ophthalmic, splanchnic, cerebral,and motor conditions, the most common and feared in immunocompetent adults is postherpetic neuralgia (PHN).Its definition is controversial.Recent data support the distinction between acute herpetic neuralgia (within 30 d of rash onset),subacute herpetic neuralgia (30 to 120 d after rash onset), and postherpetic neuralgia (defined as pain lasting at least 120 d from rash onset)[1-3].PHN is classified as a neuropathic pain that is associated with mechanical allodynia where normally innocuous tactile stimuli are perceived as painful[2].In actual studies it is reported that the incidence of HZ is 3.2 to 4.1 in 1 000 person-years[4, 5].

  18. A case control study on family history as a risk factor for herpes zoster and associated outcomes, Beijing, China.

    Science.gov (United States)

    Suo, Luodan; Lu, Li; Li, Juan; Sun, Mu; Wang, Haihong; Peng, Xinhui; Yang, Fan; Pang, Xinghuo; Marin, Mona; Wang, Chengbin

    2017-05-09

    Hospital-based case control studies have found family history of herpes zoster (HZ) was associated with risk of HZ, but the role of family history is not fully examined for other HZ-associated outcomes such as recurrent HZ, occurrence of postherpetic neuralgia (PHN), and HZ with different pain severities. We conducted a population-based matched case control study. HZ cases that occurred during December 1, 2011 to November 30, 2012 were identified by face-to-face interview with all residents of eight selected communities/villages from three districts of Beijing, China. Medical records were reviewed for those who sought healthcare for HZ. For each case-patient, three, age-matched controls (±5 years) without HZ were enrolled from the same community/village of the matched case. Data on family history of HZ were collected by interview and only defined among first-degree relatives. A total of 227 case-patients and 678 matched controls were enrolled. Case-patients were more likely to report a family history of HZ [odds ratio (OR) =2.4, P = 0.002]. Compared with controls, association of family history decreased from HZ with PHN to HZ without PHN (OR = 6.0 and 2.3, respectively; P = 0.002 for trend), from recurrent HZ to primary HZ (OR = 9.4 and 2.2, respectively; P = 0.005 for trend), and from HZ with moderate or severe pain to HZ with mild or no pain (OR = 3.2 and 0.8, respectively; P < 0.001 for trend). Family history of HZ was associated with HZ occurrence and was more likely in HZ case-patients with PHN, recurrences, and painful HZ.

  19. Measuring the burden of herpes zoster and post herpetic neuralgia within primary care in rural Crete, Greece

    Directory of Open Access Journals (Sweden)

    Lionis Christos D

    2011-12-01

    Full Text Available Abstract Background Research has indicated that general practitioners (GPs have good clinical judgment in regards to diagnosing and managing herpes zoster (HZ within clinical practice in a country with limited resources for primary care and general practice. The objective of the current study was to assess the burden of HZ and post herpetic neuralgia (PHN within rural general practices in Crete, Greece. Methods The current study took place within a rural setting in Crete, Greece during the period of November 2007 to November 2009 within the catchment area in which the Cretan Rural Practice-based Research Network is operating. In total 19 GP's from 14 health care units in rural Crete were invited to participate, covering a total turnover patient population of approximately 25, 000 subjects. For the purpose of this study an electronic record database was constructed and used as the main tool for monitoring HZ and PHN incidence. Stress related data was also collected with the use of the Short Anxiety Screening Test (SAST. Results The crude incidence rate of HZ was 1.4/1000 patients/year throughout the entire network of health centers and satellite practices, while among satellite practices alone it was calculated at 1.3/1000 patients/year. Additionally, the standardised incidence density within satellite practices was calculated at 1.6/1000 patients/year. In regards to the stress associated with HZ and PHN, the latter were found to have lower levels of anxiety, as assessed through the SAST score (17.4 ± 3.9 vs. 21.1 ± 5.7; p = 0.029. Conclusions The implementation of an electronic surveillance system was feasible so as to measure the burden of HZ and PHN within the rural general practice setting in Crete.

  20. Longitudinal study on oral shedding of herpes simplex virus 1 and varicella-zoster virus in individuals infected with HIV.

    Science.gov (United States)

    van Velzen, Monique; Ouwendijk, Werner J D; Selke, Stacy; Pas, Suzan D; van Loenen, Freek B; Osterhaus, Albert D M E; Wald, Anna; Verjans, Georges M G M

    2013-09-01

    Primary herpes simplex virus 1 (HSV-1) and varicella-zoster virus (VZV) infection leads to a life-long latent infection of ganglia innervating the oral mucosa. HSV-1 and VZV reactivation is more common in immunocompromised individuals and may result in viral shedding in saliva. We determined the kinetics and quantity of oral HSV-1 and VZV shedding in HSV-1 and VZV seropositive individuals infected with HIV and to assess whether HSV-1 shedding involves reactivation of the same strain intra-individually. HSV-1 and VZV shedding was determined by real-time PCR of sequential daily oral swabs (n = 715) collected for a median period of 31 days from 22 individuals infected with HIV. HSV-1 was genotyped by sequencing the viral thymidine kinase gene. Herpesvirus shedding was detected in 18 of 22 participants. Shedding of HSV-1 occurred frequently, on 14.3% of days, whereas solely VZV shedding was very rare. Two participants shed VZV. The median HSV-1 load was higher compared to VZV. HSV-1 DNA positive swabs clustered into 34 shedding episodes with a median duration of 2 days. The prevalence, duration and viral load of herpesvirus shedding did not correlate with CD4 counts and HIV load. The genotypes of the HSV-1 viruses shed were identical between and within shedding episodes of the same person, but were different between individuals. One-third of the individuals shed an HSV-1 strain potentially refractory to acyclovir therapy. Compared to HSV-1, oral VZV shedding is rare in individuals infected with HIV. Recurrent oral HSV-1 shedding is likely due to reactivation of the same latent HSV-1 strain.

  1. The diagnostic significance of enzyme linked immuno-sorbent assay for herpes simplex, varicella zoster and cytomegalovirus retinitis.

    Directory of Open Access Journals (Sweden)

    Madhavan Hajib

    2003-01-01

    Full Text Available Purpose: To evaluate the diagnostic usefulness of enzyme linked immuno-sorbent assay (ELISA in single serum samples to associate herpes simplex virus (HSV, varicella zoster virus (VZV or cytomegalovirus (CMV with viral retinitis as against polymerase chain reaction (PCR on intraocular specimens. It was also designed to study the seroprevalence in normal healthy individuals, and the genomic prevalence of HSV, VZV and CMV in patients without an active viral inflammatory process. Methods: PCR for the detection of HSV, VZV and CMV genomes was done on 33 and 90 intraocular fluids from viral retinal patients and non-viral controls respectively. ELISA was done on 30 and 100 serum samples from viral retinitis patients and normal healthy controls respectively. Results: PCR did not detect HSV, VZV and CMV genomes except one, in which VZV-DNA was detected. ELISA showed prevalence rates of 28%, 83% and 90% for antibodies against HSV, VZV and CMV respectively in the normal population. In the 30 viral retinitis patients, PCR detected HSV-DNA in 2 (6.7%, VZV-DNA in 7 (23.3% and CMV-DNA in 6 (20.0% patients, while ELISA detected antibodies against HSV, VZV and CMV in 13 (43.3%, 24 (80.0% and 23 (76.7% patients respectively. ELISA was of value in indirect diagnosis only in 6 (20.0% as compared to 15 (50.0% of 30 patients by PCR, this difference was statistically significant (McNemar test, P value = 0.005. Conclusion: Serology by ELISA is no longer a useful diagnostic tool to associate HSV, VZV and CMV viruses with viral retinitis.

  2. Early and reliable detection of herpes simplex virus type 1 and varicella zoster virus DNAs in oral fluid of patients with idiopathic peripheral facial nerve palsy: Decision support regarding antiviral treatment?

    Science.gov (United States)

    Lackner, Andreas; Kessler, Harald H; Walch, Christian; Quasthoff, Stefan; Raggam, Reinhard B

    2010-09-01

    Idiopathic peripheral facial nerve palsy has been associated with the reactivation of herpes simplex virus type 1 (HSV-1) or varicella zoster virus (VZV). In recent studies, detection rates were found to vary strongly which may be caused by the use of different oral fluid collection devices in combination with molecular assays lacking standardization. In this single-center pilot study, liquid phase-based and absorption-based oral fluid collection was compared. Samples were collected with both systems from 10 patients with acute idiopathic peripheral facial nerve palsy, 10 with herpes labialis or with Ramsay Hunt syndrome, and 10 healthy controls. Commercially available IVD/CE-labeled molecular assays based on fully automated DNA extraction and real-time PCR were employed. With the liquid phase-based oral fluid collection system, three patients with idiopathic peripheral facial nerve palsy tested positive for HSV-1 DNA and another two tested positive for VZV DNA. All patients with herpes labialis tested positive for HSV-1 DNA and all patients with Ramsay Hunt syndrome tested positive for VZV DNA. With the absorption-based oral fluid collection system, detections rates and viral loads were found to be significantly lower when compared to those obtained with the liquid phase-based collection system. Collection of oral fluid with a liquid phase-based system and the use of automated and standardized molecular methods allow early and reliable detection of HSV-1 and VZV DNAs in patients with acute idiopathic peripheral facial nerve palsy and may provide a valuable decision support regarding start of antiviral treatment at the first clinical visit.

  3. Distrofia simpática reflexa pós herpes zoster

    OpenAIRE

    Minami,Catia Susana Harumi; Costa,Mônica Duarte; Antônio,Silvio Figueira; Chahade,Wiliam Habib

    2004-01-01

    A distrofia simpática reflexa (DSR) é uma síndrome dolorosa pouco entendida que consiste na presença de múltiplos sinais e sintomas incluindo dor, edema, alterações cutâneas distróficas e disfunção autonômica envolvendo uma ou mais extremidades. Nem sempre a DSR pós-herpes zóster é facilmente reconhecida. Poucos relatos dessa complicação foram publicados, o que torna interessante esta descrição. Apresentamos o caso de uma mulher branca, de 65 anos de idade cujos sinais e sintomas característi...

  4. Gerstmann's syndrome following an acute herpes simplex encephalitis.

    Science.gov (United States)

    Ilchevsky, S; Boev, I; Kazakova, T

    1998-01-01

    The authors present a rare clinical case of a woman who developed Gerstmann's syndrome following an acute Herpes simplex viral encephalitis. Clinical observation and laboratory evaluation were performed during the acute phase of the disease. After that the follow-up continued for one-year period. The localization of the pathologic process was determined by computerized tomography, conducted periodically. The characteristics of the clinical picture are interpreted in the context of the contemporary concepts of the topical diagnosis of Gerstmann's syndrome. The possibility of a sudden onset of acute Herpes simplex viral encephalitis without a preceding febrile-intoxication syndrome is worth noting. Conclusions are drawn stressing the need of an early etiologic treatment and the importance of the rehabilitation activities during the convalescence period.

  5. Research status and development trends of herpes zoster vaccine%带状疱疹疫苗的研究现状及发展趋势

    Institute of Scientific and Technical Information of China (English)

    张勇; 赫宝双; 赵海波

    2012-01-01

    Original infection of varicella-zoster virus can induce varicella and then herpes when the virus is activated again. In recent years, with the progress of aging of domestic population, the incidence rate of herpes is increasing apparently, and there is no apparent therapeutic effect to treat post-herpetic neuralgia caused by herpes with antiviral drugs. Therefore, the prevention and therapy of herpes has been attached more and more importance for it has become an important public hygiene issue. The prevention of herpes with vaccine has been accepted by the society widely. In this article, we summarized the causative agent of herpes and the current situation of research and development of vaccine research.%水痘-带状疱疹病毒原发感染为水痘,再度被激活则引起带状疱疹(HZ).近年来,随着国内人口结构的老龄化趋势日益加重,HZ的发病率有明显上升的趋势,且引起的后遗神经痛使用抗病毒药物治疗无明显疗效.HZ的防治现已成为重要的公共卫生问题.采用疫苗预防HZ已经越来越被社会所接受.本文就该病原体及其疫苗方面的研究现状及进展作一综述.

  6. 针灸治疗带状疱疹临床研究概况%The general situation ofAcupuncture treatment of herpes zoster in clinical research work

    Institute of Scientific and Technical Information of China (English)

    张爱珍

    2013-01-01

      介绍针灸治疗带状疱疹临床研究的进展及相关情况,对未来发展进行展望。%  This article describes the clinical studies progress and related information of acupuncture treatment of herpes zoster, future development prospects.

  7. 1例肾移植术后并发带状疱疹患者的药学监护体会%Experience on pharmaceutical care in a renal transplantion recipient with herpes zoster

    Institute of Scientific and Technical Information of China (English)

    吉小丽; 戴映; 宋洪涛

    2015-01-01

    Objective To report experience on pharmaceutical care in a renal transplantation recipient with herpes zoster . Methods The methods and measures of pharmaceutical care of a renal transplantation recipient with herpes zoster were retro‐spectively summarized .Results A safety ,effectiveness ,rationality of medication were significantly increased by pharmaceuti‐cal care in renal transplantation patient′s with herpes zoster and the patient′s quality of life was improved .Conclusion Pharma‐ceutical care was necessary and valuable to renal transplantation recipients with herpes zoster .%目的:报告肾移植术后并发带状疱疹患者的药学监护经验和体会。方法回顾性总结1例肾移植术后并发带状疱疹患者的药学监护方法和措施。结果通过药学监护,明显提高了肾移植术后并发带状疱疹患者用药的安全、有效、合理,改善了患者的生活质量。结论对肾移植术后患者实施药学监护非常有必要。

  8. 犀角地黄汤加减配合雄黄散治疗带状疱疹%Xijiaodihuang Decoction with Realgar Powder in Treating Herpes Zoster

    Institute of Scientific and Technical Information of China (English)

    林春华

    2013-01-01

    目的:探讨犀角地黄汤加减配合雄黄散治疗带状疱疹的疗效。方法回顾性分析2009~2012年应用犀角地黄汤加减内服配合雄黄散外敷治疗带状疱疹30例临床资料。结果29例治愈,治愈时间4~10 d,平均7 d。结论内外合治,疗效显著。%Objective: To investigate the curative ef ect of Xijiao Dihuang Decoction Combined with realgar powder in the treatment of herpes zoster. Methods:retrospective analysis of 2009 to 2012 of Xijiaodihuang decoction combined with realgar powder on the treatment of herpes zoster clinical data of 30 cases. Results: 29 cases were cured, the cure time short 4 days, the longest 10 days, an average of 7 days. Conclusion:internal and external treatment, curative ef ect.

  9. Facial herpes zoster infection precipitated by surgical manipulation of the trigeminal nerve during exploration of the posterior fossa: a case report

    Directory of Open Access Journals (Sweden)

    Mansour Nassir

    2009-09-01

    Full Text Available Abstract Introduction We present a case of herpes zoster infection (shingles precipitated by surgical manipulation of the trigeminal nerve root during an attempted microvascular decompression procedure. The pathogenesis of this phenomenon, as well as the importance and role of prophylactic acyclovir in its management, are discussed. Case presentation A 54-year-old Caucasian man with a classical long-standing left-sided V2 and V3 division primary trigeminal neuralgia refractory to medical management, underwent posterior fossa exploration for microvascular decompression via a standard retromastoid craniectomy. The patient had immediate and complete relief from pain. Three days after the operation, he developed severely painful vesicles with V2 and V3 dermatomal distribution. Rather than the classical paroxysmal, lancinating type of trigeminal neuralgia, the pain experienced by the patient was of a constant burning nature. A clinical diagnosis of herpes zoster (shingles was made after smear confirmation from microbiological testing. The patient was commenced on antiviral treatment with acyclovir. His vesicular rash and pain gradually subsided over the next two weeks. He remains asymptomatic one year later. Conclusions Postoperative shingles precipitated by trigeminal nerve manipulation during surgery for trigeminal neuralgia can be a distressing and demoralizing experience for the patient. A careful preoperative history, early recognition, and prompt antiviral therapy is necessary.

  10. Clinical Analysis of 87 Cases Inpatients with Herpes Zoster in General Hospital%住院患者发生带状疱疹87例临床分析

    Institute of Scientific and Technical Information of China (English)

    孙晓燕; 张美芳; 马小萍; 党倩丽

    2012-01-01

    Objective To investigate the risk facters of inpatients with herpes zoster during hosipitalitation in general hospital. Methods Eighty-seven cases of inpatients with herpes zoster were analyzed by a retrospective way from January 2007 to January 2010. Results Eighty-seven patients were infected herpes zoster during hosipitalitation in 86 975 inpatients (0. 10% ). Fifty-four patients were infected herpes zoster during hosipitalitation in 44 913 inpatients who were more than 50 years old (0.12% ). Thirty-three patients were infected herpes zoster in 42 062 inpatients who were less than 50 years old (0.08% ). Eighty-seven patients with herpes zoster during hosipitalitation were suffered with another disease, in which 33 patients with cardiovascular disease, 18 patients with cancer, 10 patients with diabetes mellitus. Conclusion Over 50 age, with Cardiovascular disease, cancer and diabetes mellitus were risk factors of inpatient with herpes zoster during hosipitalitation%目的 探讨住院患者发生带状疱疹的危险因素.方法 对2007年1月-2010年1月本院住院患者住院期间87例发生带状疱疹患者的临床资料进行回顾性分析.结果 86 975例住院患者中,住院期间发生带状疱疹87例(0.10%),其中50岁以上住院患者44 913例,发生带状疱疹54例(0.12%);年龄<50岁的住院患者42 062例,共发生带状疱疹33例(发生率0.08%);87例带状疱疹患者所患基础疾病包括:心脑血管病(34例)、恶性肿瘤(18例)和糖尿病(10例).结论 年龄> 50岁、伴有心脑血管疾病、糖尿病和恶性肿瘤等是住院患者发生带状疱疹的高危险因素.

  11. 30 Cases Clinical Analysis of Diabetes Combining Recurrent Herpes Zoster%糖尿病合并复发性带状疱疹18例临床分析

    Institute of Scientific and Technical Information of China (English)

    张翠松

    2013-01-01

    Objective:To analyse the occurrence and treatment of diabetes combining recurrent herpes zoster.Methods:Information of 18 patients with diabetes combining recurrent herpes zoster was collected,and the occurrence and treatment of clinical was analyzed.Results:Out of 30 cases,28 patients experienced recurrence once and 2 cases twice.All the patients recovered through joint treatment.Conclusion:Diabetes combining with recurrent herpes zoster is not rare,the recurrent understanding of herpes zoster should be improved.Joint treatment by antiviral,nutrition nerve treatment is needed to prevent herpes zoster.%  目的:分析糖尿病合并复发性带状疱疹的发病特点与治疗体会。方法:收集18例糖尿病合并复发性带状疱疹患者的临床资料,并对其发病特点与治疗情况进行临床分析。结果:18例患者16例复发1次,2例复发2次,经过联合治疗患者均恢复正常。结论:糖尿病合并复发性带状疱疹并不少见,应提高对复发性带状疱疹的认识,治疗上应降糖联合抗病毒、营养神经治疗,防止带状疱疹后遗神经痛的发生。

  12. Price of pain: population-based cohort burden of disease analysis of medication cost of herpes zoster and postherpetic neuralgia

    Directory of Open Access Journals (Sweden)

    Friesen KJ

    2016-08-01

    Full Text Available Kevin J Friesen,1 Jamie Falk,1 Silvia Alessi-Severini,1 Dan Chateau,2 Shawn Bugden1 1College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada; 2Department of Community Health Sciences, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada Background: Pain is a main symptom of herpes zoster (HZ, and postherpetic neuralgia (PHN is a frequent complication occurring in 5% to 15% of cases, causing moderate to severe neuropathic pain. A population-based observational study was conducted to evaluate the treatment patterns and economic burden of prescription drug treatment of HZ and PHN pain in the province of Manitoba (Canada over a period of 15 years. Methods: Administrative health care data, including medical and hospital separation records, were examined to identify episodes of HZ using International Classification of Diseases-9/10 codes between April 1, 1997 and March 31, 2014. Episodes of PHN were identified using medical and prescription claims. Incident use of analgesic, antidepressant, or anticonvulsant drugs was used to determine prescription pain costs. Results: The age-adjusted incidence of HZ increased from 4.7 episodes/1,000 person-years in 1997/98 to 5.7/1,000 person-years in 2013/14. PHN occurred in 9.2% of HZ cases, a rate that did not change over the study period (P=0.57. The annual cost to treat HZ pain rose by 174% from 1997/98, reaching CAD $332,981 in 2011/12, 82.8% (95% confidence interval [CI] 81.2%, 84.3% of which was related to PHN. The per episode cost of HZ rose by 111% from $31.59 (95% CI $25.35, $37.84 to $66.81 (95% CI $56.84, $76.78 and by 94% for PHN from $292 (95% CI $225, $358 to $566 (95% CI $478, $655. These increases were driven by increasing use of anticonvulsants, primarily gabapentin, which accounted for 57% of the increase in cost. Conclusion: There has been an increase in the incidence of HZ and PHN and in the average cost associated with the

  13. Analysis of the Effect of Nursing Intervention on 150 Cases of Patients with Herpes Zoster in Outpatient Department%150例门诊带状疱疹患者护理干预效果分析

    Institute of Scientific and Technical Information of China (English)

    吴丽环

    2016-01-01

    Objective To explore the effect of nursing intervention on 150 patients with herpes zoster patients. Methods The research and clinic from November 2013 to November 2015 a total of 150 patients with herpes zoster outpatient treated patients, all patients were randomly divided into two groups, which were control group and observation group, 75 cases of herpes zoster patients with herpes zoster outpatient clinic, two groups of patients were used in different types of nursing in-tervention. The control group of patients with herpes zoster outpatient take routine nursing, the observation group of patients with herpes zoster outpatient based on routine nursing methods on strengthening the implementation of nursing, nursing ef-fect, compared with the control group and the observation group of patients with herpes zoster outpatient for different nursing methods after the cessation time, pain time, time and healing time of herpes scab. Results In the observation group of pa-tients with herpes zoster outpatient nursing total efficiency was significantly higher than that of the control group of patients with herpes zoster outpatient and observation, symptoms of herpes zoster patients in outpatient group was significantly better than the control group of patients with herpes zoster outpatient, the card party t examination and comparison of two groups of herpes zoster patients nursing efficacy and disease situation obtains the p value of less than 0.05, the difference has sta-tistical significance. Conclusion The patients with herpes zoster outpatient in the base of routine nursing practice of inten-sive care, can effectively improve patients with herpes zoster disease cure rate, to a great extent help patients relieve pain pain, reduce the treatment time of patients, with good effect of nursing, therefore, is worth the clinical promotion.%目的:探讨护理干预对门诊带状疱疹患者150例的疗效。方法选取并研究该中心门诊于2013年11月—2015年11月

  14. Detection of Vero Cells Infected with Herpes Simplex Types 1 and 2 and Varicella Zoster Viruses Using Raman Spectroscopy and Advanced Statistical Methods

    Science.gov (United States)

    Huleihel, Mahmoud; Shufan, Elad; Zeiri, Leila; Salman, Ahmad

    2016-01-01

    Of the eight members of the herpes family of viruses, HSV1, HSV2, and varicella zoster are the most common and are mainly involved in cutaneous disorders. These viruses usually are not life-threatening, but in some cases they might cause serious infections to the eyes and the brain that can lead to blindness and possibly death. An effective drug (acyclovir and its derivatives) is available against these viruses. Therefore, early detection and identification of these viral infections is highly important for an effective treatment. Raman spectroscopy, which has been widely used in the past years in medicine and biology, was used as a powerful spectroscopic tool for the detection and identification of these viral infections in cell culture, due to its sensitivity, rapidity and reliability. Our results showed that it was possible to differentiate, with a 97% identification success rate, the uninfected Vero cells that served as a control, from the Vero cells that were infected with HSV-1, HSV-2, and VZV. For that, linear discriminant analysis (LDA) was performed on the Raman spectra after principal component analysis (PCA) with a leave one out (LOO) approach. Raman spectroscopy in tandem with PCA and LDA enable to differentiate among the different herpes viral infections of Vero cells in time span of few minutes with high accuracy rate. Understanding cell molecular changes due to herpes viral infections using Raman spectroscopy may help in early detection and effective treatment. PMID:27078266

  15. Detection of Vero Cells Infected with Herpes Simplex Types 1 and 2 and Varicella Zoster Viruses Using Raman Spectroscopy and Advanced Statistical Methods.

    Science.gov (United States)

    Huleihel, Mahmoud; Shufan, Elad; Zeiri, Leila; Salman, Ahmad

    2016-01-01

    Of the eight members of the herpes family of viruses, HSV1, HSV2, and varicella zoster are the most common and are mainly involved in cutaneous disorders. These viruses usually are not life-threatening, but in some cases they might cause serious infections to the eyes and the brain that can lead to blindness and possibly death. An effective drug (acyclovir and its derivatives) is available against these viruses. Therefore, early detection and identification of these viral infections is highly important for an effective treatment. Raman spectroscopy, which has been widely used in the past years in medicine and biology, was used as a powerful spectroscopic tool for the detection and identification of these viral infections in cell culture, due to its sensitivity, rapidity and reliability. Our results showed that it was possible to differentiate, with a 97% identification success rate, the uninfected Vero cells that served as a control, from the Vero cells that were infected with HSV-1, HSV-2, and VZV. For that, linear discriminant analysis (LDA) was performed on the Raman spectra after principal component analysis (PCA) with a leave one out (LOO) approach. Raman spectroscopy in tandem with PCA and LDA enable to differentiate among the different herpes viral infections of Vero cells in time span of few minutes with high accuracy rate. Understanding cell molecular changes due to herpes viral infections using Raman spectroscopy may help in early detection and effective treatment.

  16. Varicella Zoster Virus Promoter Sequences

    Science.gov (United States)

    1994-01-01

    71:2999-3003 . Dumas AM. Geelen JLMC. Maris W, and van der Noordaa J . 1980. Infectivity and molecular weight of varicella-zoster virus DNA. J. Gen...zusammenhang der 164 varizelen mit gewissenfallen von herpes zoster. weinklin. Wchschr. 22,1323-1327. Vonsover A, Leventon- Kriss S, Langer A, Smetana Z

  17. 带状疱疹分期针灸治疗体会%Acupuncture Therapy of Herpes Zoster on Different Stages

    Institute of Scientific and Technical Information of China (English)

    刘福华

    2012-01-01

    针灸治疗带状疱疹的疗效确切、方法多样,但缺乏对不同时期采用何种针灸方法对提高本病疗效的认识,文章就不同时期带状疱疹针灸治疗做以初步探讨,以期为临床选用方便、合理、有效治疗方案提供参考.%Acupuncture treatment of herpes zoster has definite effect, and methods are various, but the lack of different time.a of the types of acupuncture and moxibustion methods to improve the curative effect of understanding, the author according to different period shingles provide different acupuncture treatment to make the preliminary discussion, so as that convenient, reasonable and effective treatment can be chosen in clinical for reference.

  18. Association between work time loss and quality of life in patients with Herpes Zoster: a pooled analysis of the MASTER studies.

    Science.gov (United States)

    Rampakakis, Emmanouil; Stutz, Melissa; Kawai, Kosuke; Tsai, Tsen-Fang; Cheong, Hee Jin; Dhitavat, Jittima; Ortiz-Covarrubias, Alejandro; Cashat-Cruz, Miguel; Monsanto, Homero; Johnson, Kelly D; Sampalis, John S; Acosta, Camilo J

    2017-01-18

    Herpes zoster (HZ) has a significant negative effect on the productive work life of individuals, and has been shown to be responsible for cases of absenteeism, presenteeism and decreased work effectiveness. The aim of this study was to evaluate health utility scores and associated predictors in an actively employed population of Herpes Zoster (HZ) patients with and without work time loss (WTL). This was a pooled analysis of the prospective, observational MASTER cohort studies, conducted in 8 countries across North America, Latin America and Asia. A total of 428 HZ patients engaged in full or part time work were included. WTL, defined as missing ≥ 1 partial or full work day, and work effectiveness, reported on a scale of 0-100%, were evaluated with the Work and Productivity Questionnaire (WPQ). The Pearson product-moment correlation was used to assess the correlation between work effectiveness and HRQoL. Mixed models with repeated measures assessed the relationship between HZ-related WTL over a 6-month follow-up period, and HRQoL, as evaluated by the EQ-5D. Additional predictors of HRQoL were also identified. Overall, 57.7% of respondents reported WTL. Mean (SD) percent work effectiveness of patients in the WTL group was significantly lower compared to non-WTL (NWTL) patients at baseline [50.3 (31.6) vs. 71.4 (27.8); p work effectiveness was negatively associated with HRQoL overall (p work and productive life of actively employed individuals. In turn, HZ-related reductions in work effectiveness and work time are associated with a negative effect on HRQoL.

  19. Parsonage-Turner Syndrome rather than Zoster Neuritis

    Directory of Open Access Journals (Sweden)

    Karim Gariani

    2011-07-01

    Full Text Available We report the case of an 86-year-old man with acute left shoulder pain, followed by left limb monoparesis and a herpetic rash on the left upper limb and thoracic region. This situation presented a diagnostic challenge because of the simultaneity of symptoms attributable to Parsonage-Turner syndrome and herpes zoster neuropathy. A detailed clinical history, physical examination and electroneuromyography were essential to distinguish the neurological structures involved and to ascertain the diagnosis.

  20. Synergistic activity of amenamevir (ASP2151) with nucleoside analogs against herpes simplex virus types 1 and 2 and varicella-zoster virus.

    Science.gov (United States)

    Chono, Koji; Katsumata, Kiyomitsu; Suzuki, Hiroshi; Shiraki, Kimiyasu

    2013-02-01

    ASP2151 (amenamevir) is a helicase-primase complex inhibitor with antiviral activity against herpes simplex virus HSV-1, HSV-2, and varicella-zoster virus (VZV). To assess combination therapy of ASP2151 with existing antiherpes agents against HSV-1, HSV-2, and VZV, we conducted in vitro and in vivo studies of two-drug combinations. The combination activity effect of ASP2151 with nucleoside analogs acyclovir (ACV), penciclovir (PCV), or vidarabine (VDB) was tested via plaque-reduction assay and MTS assay, and the data were analyzed using isobolograms and response surface modeling. In vivo combination therapy of ASP2151 with valaciclovir (VACV) was studied in an HSV-1-infected zosteriform spread mouse model. The antiviral activity of ASP2151 combined with ACV and PCV against ACV-susceptible HSV-1, HSV-2, and VZV showed a statistically significant synergistic effect (P<0.05). ASP2151 with VDB was observed to have additive effects against ACV-susceptible HSV-2 and synergistic effects against VZV. In the mouse model of zosteriform spread, the inhibition of disease progression via combination therapy was more potent than that of either drugs as monotherapy (P<0.05). These results indicate that the combination therapies of ASP2151 with ACV and PCV have synergistic antiherpes effects against HSV and VZV infections and may be feasible in case of severe disease, such as herpes encephalitis or in patients with immunosuppression.

  1. Recurrent zosteriform herpes simplex

    Directory of Open Access Journals (Sweden)

    Inamadar Arun

    1992-01-01

    Full Text Available A 25-year-old man had recurrent zosteriform herpes simplex for past 6 years. The attacks were precipitated by prolonged exposure to sunlight. Pain was mild and lesions used to subside each time in about 7 days. Clinical features which help in differentiating recurrent herpes simplex from recurrent herpes zoster are summarized.

  2. Shingles (Herpes Zoster)

    Science.gov (United States)

    ... Boards study tools Online Learning Center Meetings and events Make a difference Career planning Media Relations Toolkit AAD apps Academy meeting Chronic urticaria—for members Chronic urticaria—for public Dermatology World Dialogues in Dermatology JAAD Mohs AUC ...

  3. Analysis of the combined effect of local UV and acyclovir on herpes zoster%局部紫外线联合阿昔洛韦治疗带状疱疹的疗效观察

    Institute of Scientific and Technical Information of China (English)

    李智忠

    2010-01-01

    目的 观察局部紫外线照射联合阿昔洛韦治疗带状疱疹的临床疗效.方法 138例带状疱疹患者分为2组.治疗组用阿昔洛韦口服治疗加局部紫外线照射;对照组单用阿昔洛韦治疗带状疱疹.结果 治疗组有效率(97.92%)明显高于对照组(P<0.05),带状疱疹后遗神经痛发生率亦比对照组明显降低.结论 局部紫外线联合阿昔洛韦治疗带状疱疹起效快,疗程短,疗效显著,且能防止后神经痛的发生.%Objective To understand partial response of herpes zoster to ultraviolet radiation,and find other methods of herpes zoster treatment.Methods 138 cases of herpes zoster were divided into two groups.The treatment group received oral acyclovir and local ultraviolet irradiation while the control group received acyclovir alone.Results Treatment efficacy was significantly higher in the treatment group(97.92%)compared to the control( P < 0.05),and the incidence of postherpetic neuralgia was also significantly lower in the treatment group.Conclusion Local UV combined with acyclovir treatment of herpes zoster produces fast,brief duration,significant effects,and can prevent the occurrence of postherpetic neuralgia.

  4. Effect of Xinhuang Tablets on Herpes Zoster of the Earlier Period Neuralgia%新癀片治疗带状疱疹早期神经痛的序贯试验

    Institute of Scientific and Technical Information of China (English)

    徐翔; 梁东辉; 马红利

    2011-01-01

    目的 观察新癀片治疗带状疱疹早期神经痛的疗效和安全性.方法 采用质反应开放型单向序贯试验,逐对纳入基线资料相当的带状疱疹患者,按照既定随机分配方案接受不同的治疗计划.每对患者均接受抗病毒治疗和氦氖激光治疗,其中一位患者同时予新癀片1.28g,po tid.结果 当观察到第15对符合纳入标准的病例时,实验线触及U线,表明新癀片对带状疱疹神经痛止痛有效,不良反应少.结论 新癀片治疗带状疱疹早期神经痛的疗效肯定,安全性好.%Objective:To observe the curative effect and safety of xinhuang tablets on herpes zoster of the earlier period neuralgia. Method: A sequential test of the open single-direction qualitative reaction was adopted, and patients with herpes zoster and similar characteristics at baseline were randomly divided into two groups for different therapy. Both groups received the anti-viral and He-Ne laser therapy, but the treatment group took xinhuang tablets. Result;Up to the 15 pairs observed, the experimental line met with U line. It showed that xinhuang tablets had effect with little adverse reactions on the pain of herpes zoster neuralgia. Conclusion: Xinhuang tablets were safe and effective on herpes zoster of earlier period neuralgia.

  5. Exploration on the Mechanism of Recurrent Herpes Zoster in Patients with AIDS%艾滋病患者带状疱疹反复发作的机制探讨

    Institute of Scientific and Technical Information of China (English)

    郭会军; 付涵

    2012-01-01

    Objective: To investigate the mechanisms of multiple recurrent herpes zoster in AIDS patients. Methods: Scientific research achievements made by the domestic and foreign scholars in recent years in the mechanism of multiple recurrent herpes zoster in AIDS patients were summarized and analyzed combined with clinical observations. Results: Compared with the normal people, T-lymphocyte subsets(CD3 +, CD4+, CD8 + ) and CD4 +/CD8 + ratio of the patients with herpes zoster caused by VZV decreased, amone which T-helper cells decreased significantly and the ration of T helper cells and T suppressor cell( CD4 +/CD8+) decreased significantly. Conclusion; The suscepatibility of AIDS patients to get herpes zoster are related with hypoimmunity.%目的:探讨艾滋病患者多次复发带状疱疹的机制.方法:结合临床观察,总结分析近年来国内外学者关于艾滋病患者多次复发带状疱疹机制的科研成果.结果:由水痘-带状疱疹病毒(VZV)引起的带状疱疹患者的T淋巴细胞亚群(CD3+、CD4+、CDs+)以及CD4+ /CD8+比值与正常人比较均降低,其中T辅助细胞(CD4+)明显下降,T辅助细胞与T抑制细胞的比值(CD4 +/CD8+)明显降低.结论:艾滋病患者易发生带状疱疹与免疫力低下有关.

  6. Clinical Observation of Rehabilitation Therapy in Treating Herpes Zoster Complicated by Motor Dysfunction%康复疗法治疗带状疱疹并发运动功能障碍临床观察

    Institute of Scientific and Technical Information of China (English)

    万勇; 刘洁; 周琦; 肖林; 陈启明; 陕大艳

    2014-01-01

    To observe the clinical curative effect of rehabilitation therapy in treating herpes zoster complicated by motor dys-function. Methods:5 patients with herpes zoster complicated by movement disorders were given physical therapy,movement and learn-ing,functional training such as individualized rehabilitation. Results:Patients′ muscle strength and limb function were improved marked-ly after 3 months treatment,follow-up for 1 a,with muscle strength gradually increasing. Conclusion:Individualized rehabilitation in trea-ting herpes zoster complicated by motor dysfunction can obviously improve patients′ motor function.%目的:观察康复疗法治疗带状疱疹并发的临床疗效。方法:5例带状疱疹并发肢体运动障碍患者,给予物理治疗、运动再学习,功能训练等个体化康复治疗。结果:治疗3个月后,患者肌力、肢体功能较治疗前明显好转,随访1 a,患者肌力逐步提高。结论:针对带状疱疹并发肢体运动功能障碍给予个性化康复治疗能明显提高患者运动功能。

  7. The Therapeutic Effect of Tapped Cupping with Laser Exposure Therapy in the Treatment of Herpes Zoster: An Analysis of 36 Cases%叩刺拔罐配合激光照射治疗带状疱疹36例

    Institute of Scientific and Technical Information of China (English)

    何祖书

    2011-01-01

    Objective:To observe the clinical therapeutic effect of tapped cupping with laser exposure therapy in the treatment of herpes zoster. Method:66 cases of herpes zoster were selected and divided randomly into treatment group(36 cases)and control group(30 cases). The treatment group was treated with tapped cupping and laser exposure therapy while the control was treated with laser exposure. They were treated for 7 days. Result: The effect of the treatment group was better than that in the control group (P <0. 05). Conclusion: The tapped cupping with laser exposure therapy in the treatment of herpes zoster is superior to laser exposure.%目的:观察叩刺拔罐配合激光照射治疗带状疱疹的临床疗效.方法:选取确诊带状疱疹的66例患者,随机分为治疗组36例与对照组30例.治疗组采用叩刺拔罐配合激光照射,对照组采用激光照射治疗.治疗7天观察疗效.结果:治疗组疗效明显优于对照组(P<0.05).结论:叩刺拔罐配合激光照射治疗带状疱疹疗效显著,优于单纯激光照射.

  8. Clinical curative effect observation of traditional Chinese medicine in the treatment of herpes zoster in 60 cases%中药治疗带状疱疹60例临床疗效观察

    Institute of Scientific and Technical Information of China (English)

    主父晨星

    2016-01-01

    目的:探究中药治疗带状疱疹的临床疗效。方法:60例带状疱疹患者均采用银翘苦参汤治疗,观察患者的治疗有效率以及不良反应的发生情况。结果:治疗总有效率96.7%,不良反应3例(5.0%)。结论:中药治疗带状疱疹具有较好的临床效果,并发症较少。%Objective:To explore the traditional Chinese medicine in the treatment of herpes zoster.Methods:60 patients with herpes zoster were given Yin Qiao Ku Shen decoction treatment.The treatment effective rate and occurrence of adverse reactions of patients were observed.Results:The treatment effective rate was 96.7%.The adverse reactions were 3 cases(5.0%).Conclusion:Traditional Chinese medicine in the treatment of herpes zoster has a good clinical effect.The complication is less.

  9. 针灸治疗带状疱疹及其后遗神经痛60例%Acupuncture Treating 60 Cases of Herpes Zoster and Postherpetic Neuralgia

    Institute of Scientific and Technical Information of China (English)

    陈大翠

    2014-01-01

    目的:观察针灸治疗带状疱疹及其后遗神经痛的疗效。方法:60例患者均根据其带状疱疹期和后遗症期及中医辨证分型,选择合适针法治疗,观察其临床疗效。结果:治愈58例,好转2例,治愈率为96.7%。结论:针灸具有显著的活血、通络、止痛作用,合理选择应用是治疗带状疱疹及其后遗神经痛的有效方法。%Objective:To observe the curative effect of acupuncture treating herpes zoster and postherpetic neuralgia. Methods:60 patients chose ap-propriate acupuncture treatment according to the period of herpes zoster, sequelae period and syndrome differentiation of Chinese medicine, the clini-cal effect was observed. Results: 58 cases were cured, 2 cases improved, the cured rate was 96.7%. Conclusion:Acupuncture can invigorate the blood circulation, dredge collaterals and relieve pain, which reasonably applied is an effective method for herpes zoster and postherpetic neuralgia.

  10. Nursing Experience for 38 Cases Patients with Senile Herpes Zoster%38例老年头面部带状疱疹(蛇盘疮)病人的整体护理

    Institute of Scientific and Technical Information of China (English)

    徐琳

    2011-01-01

    目的:探讨老年头面部带状疱疹护理经验,以减少并发症,提高护理质量.方法:对本院住院的38例老年性头面部带状疱疹患者的护理进行分析总结.结果:经过正确有效的治疗和综合护理,38例患者均明显好转出院,无1例出现后遗神经痛.结论:有效的治疗配合多方面的综合护理可以减轻带状疱疹患者的疼痛、减少并发症.%Objective: To observe the nursing experience for senile herpes zoster to reduce complications and improve the quality of rursing.Methods: Analyzed the nursing experience of 38 cases of senile Herpes Zoster.Results: After effective treatment and nursing, none of 38 cases of senive Herpes Zoster were postherpetic neuralgia.Conclusion: Effective treatment and nursing can reliere the pain and reduce the complications.

  11. Report of 1 case of varicose veins of lower extremities with herpes zoster and lumbar disc protrusion%下肢浅静脉曲张伴带状疱疹及腰椎间盘突出1例

    Institute of Scientific and Technical Information of China (English)

    罗在胜; 吴志宏; 张加满

    2015-01-01

    In this paper, the diagnosis and treatment of 1 case for the simple varicose veins of lower extremities with herpes zoster and lumbar disc protrusion in patients was reviewed and summarized. The causes for missing diagnosis of herpes zoster in the early period were analyzed, in order to improve the recognition and identification of three types of diseases, including simple varicose veins of lower extremities, herpes zoster and lumbar disc protrusion. This will avoid missed diagnosis and misdiagnosis in the future clinical work.%通过对1例单纯性下肢浅静脉曲张溃疡形成伴带状疱疹及腰椎间盘突出患者的诊疗过程进行回顾、总结,分析早期对带状疱疹漏诊的原因,旨在提高对单纯性下肢浅静脉曲张、带状疱疹、腰椎间盘突出三种疾病的认识及鉴别,避免在今后的临床工作中出现漏诊及误诊。

  12. Assessment and management of patients with acute red eye.

    Science.gov (United States)

    Watkinson, Sue

    2013-06-01

    This article provides an overview of the role of the nurse in the assessment and management of five ocular conditions that give rise to an acute red eye in older people. The conditions discussed are acute closed angle glaucoma, acute iritis, acute conjunctivitis, herpes zoster ophthalmicus and bacterial corneal ulcer.

  13. European consensus-based (S2k) Guideline on the Management of Herpes Zoster - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 2: Treatment.

    Science.gov (United States)

    Werner, R N; Nikkels, A F; Marinović, B; Schäfer, M; Czarnecka-Operacz, M; Agius, A M; Bata-Csörgő, Z; Breuer, J; Girolomoni, G; Gross, G E; Langan, S; Lapid-Gortzak, R; Lesser, T H; Pleyer, U; Sellner, J; Verjans, G M; Wutzler, P; Dressler, C; Erdmann, R; Rosumeck, S; Nast, A

    2017-01-01

    Herpes zoster (HZ, shingles) is a frequent medical condition which may severely impact the quality of life of affected patients. Different therapeutic approaches to treat acute HZ are available. The aim of this European project was the elaboration of a consensus-based guideline on the management of patients who present with HZ, considering different patient populations and different localizations. This interdisciplinary guideline aims at an improvement of the outcomes of the acute HZ management concerning disease duration, acute pain and quality of life of the affected patients and at a reduction in the incidence of postherpetic neuralgia (PHN) and other complications. The guideline development followed a structured and pre-defined process, considering the quality criteria for guidelines development as suggested by the AGREE II instrument. The steering group was responsible for the planning and the organization of the guideline development process (Division of Evidence-Based Medicine, dEBM). The expert panel was nominated by virtue of clinical expertise and/or scientific experience and included experts from the fields of dermatology, virology/infectiology, ophthalmology, otolaryngology, neurology and anaesthesiology. Recommendations for clinical practice were formally consented during the consensus conference, explicitly considering different relevant aspects. The guideline was approved by the commissioning societies after an extensive internal and external review process. In this second part of the guideline, therapeutic interventions have been evaluated. The expert panel formally consented recommendations for the treatment of patients with HZ (antiviral medication, pain management, local therapy), considering various clinical situations. Users of the guideline must carefully check whether the recommendations are appropriate for the context of intended application. In the setting of an international guideline, it is generally important to consider different

  14. Study on the T-helper cell 1/2 cytokine profile in blister fluid of patients with herpes zoster and its clinical significance.

    Science.gov (United States)

    Zhang, Meifang; Wu, Na; Yang, Li; Zhang, Jie; Sun, Xiaoyan; Zhong, Shiyu; Ma, Xueliang; Wang, Yili

    2011-12-01

    Herpes zoster (HZ) is a Varicella zoster virus infection disease. Previous studies have presumed the connection between development of HZ and involvement of cellular immunity in peripheral blood. However, whether cellular immunity plays a role in the local skin lesion has not been addressed. To explore the levels of T-helper cell (Th)1/Th2 type cytokine profiles in the blister fluid of the skin lesions from the patients with HZ and its role in pathogenesis, we used the cytometric bead array kit to compare the levels of cytokines (interleukin [IL]-2, tumor necrosis factor [TNF]-α, IL-10 and IL-4) in blister fluid from 46 patients with those from the suction blister fluids from 20 volunteers without any infectious disease (the control group). The results indicated that the levels of Th1 cytokines, IL-2 and TNF-α in the blister fluid from the patients' skin lesions were significantly lower than those from the control group, whereas the levels of Th2 cytokines IL-10 and IL-4 were significantly higher than those in the control group. Moreover, significant variation of the levels of Th1/Th2 cytokines (IL-2, TNF-α, IL-10 and IL-4) in the blister fluid from the HZ patients' lesions was also observed among different stages of the disease. It is concluded that a cytokine imbalance was present in the local lesions of patients with HZ during disease development. Our data suggested that the Th immunity was associated with disease activity, which may play an important role in the pathogenesis of HZ. © 2011 Japanese Dermatological Association.

  15. Herpes labialis in patients with Russell's viper bite and acute kidney injury: a single center experience.

    Science.gov (United States)

    Waikhom, Rajesh; Sapam, Ranjeeta; Patil, Krishna; Jadhav, Jaya Prada; Sircar, Dipankar; Roychowdhury, Arpita; Dasgupta, Sanjay; Pandey, Rajendra

    2011-06-01

    Snake bite is an important health hazard in tropical countries and is associated with significant morbidity and mortality. Herpes labialis is a common ailment caused by the Herpes simplex virus. There is no published data showing any association between the snake bite and development of Herpes labialis. Here, we present a series of patients who developed Herpes labialis after Russell's viper bite and had acute kidney injury. We attempted to find whether snake bite is an immunosuppressed state and whether it could have pre-disposed the patients to the development of these lesions.

  16. 早期足量抗病毒治疗带状疱疹临床疗效观察%Clinical observation on treatment of herpes zoster with high-dose antiviral therapy at early stage

    Institute of Scientific and Technical Information of China (English)

    彭光玲; 李惠

    2013-01-01

    目的:对比在治疗带状疱疹时早期足量使用阿昔洛韦类抗病毒药物与常规剂量治疗的病例在临床上的疗效.方法:以我科从2011年6月至2012年2月收治的带状疱疹患者为研究来源.以患者自愿为原则,对比分析观察组患者与对照组患者治疗结束后的临床疗效与带状疱疹后遗神经痛(postherpetic neuragia,PHN)的发生率.结果:对比观察治疗带状疱疹在疼痛缓解时间、止庖时间、皮损开始结痂时间、50%皮损结痂时间、皮损消失时间等各方面上,观察组明显短于两组对照组,差异具有统计学意义(P<0.05),但带状疱疹PHN的发生率及疼痛程度治疗后1、2、3、6月观察组与对照组其结果并无差异.对照组A与对照组B因无可比性,故未做对比.结论:对带状疱疹治疗,早期足量使用抗病毒药物其治疗效果显著,应当在临床上提倡,但对于是否可以减少带状疱疹PHN的发生及减缓其疼痛程度需要更进一步的临床研究.%Objective:To compare the clinical effect of herpes zoster(HZ) treated by routine dose and high-dose valacyclovir(VCV) classical antiviral drugs. Methods: Research source comes from the patients with herpes zoster admitted to our department from June 2011 to February 2012. Based on the principle of voluntary, patients with onset time 5 d were treated by high-dose antiviral therapy(control group B). Clinical effects and incidences of postherpetic neuralgia (PHN) of herpes zoster in the three groups at the end of treatment were compared and analyzed. Results:Pain relieving time,cessation time of new lesion,beginning time of skin lesion crusting,50% lesion crusting time and subsiding time of skin lesions were significantly shorter in observation group than in control groups (A and B) during the treatment of herpes zoster, with statistical significances (P<0.05). There was no significant difference in incidences and pain degrees of PHN of herpes zoster within the first

  17. 整体护理干预对带状疱疹患者的影响分析%Analysis of the Effects of Holistic Nursing Intervention in Patients with Herpes Zoster

    Institute of Scientific and Technical Information of China (English)

    张玉荣

    2014-01-01

    Objective To explore the effects of holistic nursing intervention in patients with herpes zoster. Methods 65 cases of herpes zoster patients in our hospital from 2011 July to 2013 October were selected,and al patients were randomly divided into nursing intervention group 33 cases and control group of 32 cases. Comparison of the clinical curative effect and the symptoms of two patients healed herpes were al observed. Results Nursing intervention group patients,the total effective rate was 93.94%,significantly higher than that in control group 81.35%, two groups,significant difference(P<0.05). A blister,pain,scar and herpes healing nursing intervention group were significantly lower than those in the control group,the two groups,the difference was statistical y significant(P<0.05). Conclusion Holistic nursing intervention on patients with herpes zoster can significantly improve the clinical efficacy,improve the clinical symptoms and the healing of herpes zoster.%目的:探讨对带状疱疹患者实施整体护理干预的影响效果。方法选取65例于2011年7月~2013年10月在本院就治的带状疱疹患者,按照随机数字表法把所有患者随机分为护理干预组33例及对照组32例。对两组患者的临床疗效及患者症状、疱疹愈合情况进行比较。结果护理干预组患者的总有效率为93.94%,明显高于对照组的81.35%,两组比较,差异显著(P<0.05)。护理干预组的止疱、止痛、结痂及疱疹愈合时间均显著低于对照组,两组比较,差异有统计学意义(P<0.05)。结论对带状疱疹患者进行整体护理干预可明显提高其临床疗效,明显改善患者的临床症状及疱疹愈合情况。

  18. 社区老年人带状疱疹综合治疗46例疗效观察%Observation of comprehensive treatment of 46 cases ofsenile people with herpes zoster in community

    Institute of Scientific and Technical Information of China (English)

    王艳红

    2013-01-01

    目的:探讨应用综合方法治疗带状疱疹的疗效。方法:选择90例≥60岁的带状疱疹病例,随机分为综合治疗组46例和局部治疗组44例。综合治疗组采用局部及全身疗法,局部治疗组仅采用单纯局部治疗。结果:综合治疗组的疱疹结痂时间、疼痛缓解程度明显优于局部治疗组、差异有统计学意义(P<0.05)。结论:应用全身抗病毒、营养神经以及局部治疗的综合方法治疗带状疱疹疗效显著。%Objective:To investigate the efficacy of application of an integrated approach to the treatment of her-pes zoster. Methods:90 patients aged 60 and over herpes zoster cases, and the cases were randomly divided into a combined therapy group of 46 patients and topical treatment group of 44 patients. The combined therapy group use topical treatment and systemic therapy,and topical treatment group use only local therapy alone.Results:The combined therapy group have much better effect than the topical treatment group in herpes scab, pain relief. The difference was statistically significant (P<0.05). Conclusion: The comprehensive method of systemic application of antiviral, neu-rotrophic and local treatment is significantly effective in treatment of herpes zoster.

  19. Clinical observation on treating 15 cases of herpes zoster in TCM%中药治疗带状疱疹15例临床疗效观察

    Institute of Scientific and Technical Information of China (English)

    吴雄鹰

    2012-01-01

      目的:探讨由中药治疗带状疱疹的临床疗效.方法:对15例带状疱疹患者采用中药外敷兼内服治疗,并与西医常规治疗对照观察.结果:中药治疗组临床治愈率(40.0%)总有效率(93.3%)均明显高于西医常规治疗组(P<0.05).结论:中药治疗带状疱疹具有实用推广价值.%  Objective:To study the clinical effect of treating herpes zoster in TCM. Methods:15 cases of patients with herpes zoster were given TCM topical and oral for treatment, and compare observe the routine modern medicine. Results:In the TCM group, the clinical cure rate of the treatment group (40.0%) of the total efficiency (93.3%) were significantly higher than than in the modern conventional treatment group (P<0.05). Conclusion:Treating zoster in TCM has practical application value.

  20. Development of a multiplex real-time PCR for the simultaneous detection of herpes simplex and varicella zoster viruses in cerebrospinal fluid and lesion swab specimens.

    Science.gov (United States)

    Wong, Anita A; Pabbaraju, Kanti; Wong, Sallene; Tellier, Raymond

    2016-03-01

    Herpes simplex viruses (HSV) and varicella zoster virus (VZV) can have very similar and wide-ranging clinical presentations. Rapid identification is necessary for timely antiviral therapy, especially with infections involving the central nervous system, neonates, and immunocompromised individuals. Detection of HSV-1, HSV-2 and VZV was combined into one real-time PCR reaction utilizing hydrolysis probes. The assay was validated on the LightCycler(®) (Roche) and Applied Biosystems 7500 Real-Time PCR System (Thermo Fisher Scientific Inc.) to detect alphaherpesviruses in cerebral spinal fluid (CSF) and lesion swab specimens, respectively. Validation data on blood and tissue samples are also presented. The multiplex assay showed excellent sensitivity, specificity and reproducibility when compared to two singleplex real-time PCR assays for CSF samples and direct fluorescent antigen/culture for lesion swab samples. Implementation of the multiplex assay has facilitated improved sensitivity and accuracy as well as reduced turn-around-times and costs. The results from a large data set of 16,622 prospective samples tested between August 16, 2012 to February 1, 2014 at the Provincial Laboratory for Public Health (Alberta, Canada) are presented here.

  1. 火针加火罐治疗带状疱疹66例临床分析%Clinical analysis on treating 66 cases of herpes zoster by fire needle combined with cupping

    Institute of Scientific and Technical Information of China (English)

    高作宏

    2013-01-01

    目的:探讨分析火针加火罐治疗带状疱疹的临床疗效。方法:回顾性分析2011年12月~2012年12月间在我社区中医科进行治疗的66例带状疱疹患者的临床记录资料。结果:治疗1周后,治疗组总有效率为97.06%,高于对照组的84.38%,具有显著性差异(P<0.05);治疗组的治愈时间和治疗费用均少于对照组,具有显著性差异(P<0.01)。结论:火针加火罐治疗带状疱疹的临床疗效显著,且操作简单,值得推广。%Objective:To investigate the clinical effect on treating herpes zoster by fire needle combined with cupping. Methods:Analysis the clinical data of 66 cases of herpes zoster patients from December 2011 to December 2012 in our community Chinese medical department. Results:A week after treatment, the total efficiency of treated group was 97.06%, higher than the 84.38%in the control group, with significant difference (P<0.05); the cure time and treatment costs were lower than the control group, with significant difference (P<0.01). Conclusion:Clinical therapeutic effect of fire needle combined with cupping therapy for herpes zoster significantly, and has the advantages of simple operation, worthy of promotion.

  2. 系统性红斑狼疮并发带状疱疹的相关危险因素分析%Analysis of related risk factors in patients with systemic lupus erythematosus complicated with herpes zoster

    Institute of Scientific and Technical Information of China (English)

    白云静; 申洪波; 陈竹; 姜德训; 安娜

    2015-01-01

    目的:探讨系统性红斑狼疮( systemic lupus erythematosus,SLE)并发带状疱疹( herpes zoster,HZ)的相关危险因素,指导临床预防和控制HZ的发生。方法选取于北京军区总医院住院的SLE并发HZ患者26例作为观察组,选取同期住院的SLE患者35例作为对照组,采用单因素分析和多因素非条件Logistic回归对两组患者进行比较分析。结果单因素分析显示:患者病程、淋巴细胞绝对值、激素治疗时间、激素冲击例数、免疫抑制剂治疗时间、1个月内环磷酰胺冲击与否以及T淋巴细胞亚群中分化簇抗原3阳性细胞(cluster of differentiation 3,CD+3)、分化簇抗原4阳性细胞(cluster of differentiation 4,CD+4)、分化簇抗原8阳性细胞(cluster of differentiation 8,CD+8)数值、CD+4/ CD+8比值等指标差异均有显著性(P<0.05)。多因素Logistic回归分析显示:激素治疗时间和激素冲击例数与并发HZ呈显著正相关,淋巴细胞绝对值与HZ呈显著负相关(P<0.05)。结论 SLE患者激素使用时间延长、激素冲击治疗以及淋巴细胞绝对值减少是HZ发生的主要危险因素;而患者的病程延长、免疫抑制剂治疗时间延长、1个月内环磷酰胺冲击治疗以及CD+3、CD+4数值下降、CD+8数值升高、CD+4/ CD+8比值下降等是次要的危险因素,临床医生应早期给予关注并积极预防HZ的发生。%Objective Exploring the related risk factors in patients with systemic lupus erythematosus complicated with herpes zoster,to prevent and control herpes zoster. Method Enrolled 26 cases of systemic lupus erythematosus patients with herpes zoster as the observation group from inpatients of Department of Rheumatism of General Hospital of Beijing Military Region,35 cases of systemic lupus erythematosus patients hospitalized in the same period as the control group. The clinical data of two groups of successively by single factor analysis and multi factor non condition-al Logistic

  3. Clinical treatment and nursing care of 50 patients with herpes zoster%50例带状疱疹患者的临床治疗及护理探讨

    Institute of Scientific and Technical Information of China (English)

    张萌萌

    2016-01-01

    Objective:To explore the treatment of herpes zoster associated with nursing care.Methods:Reviewed 50 cases of hospitalized patients experience treatment and care, the use of systemic therapy, topical and semiconductor laser treatment. Patients with different degrees and for different parts of herpes zoster,to reinforce pain care, psychological care, primary care, medication guide, diet care, health care and education rash and therapeutic effects were observed. Results:Treatment of patients with herpes zoster time is 7~13d, the average length of stay of not more than 10d, 50 patients were completely cured and no complication occurs,the treatment effect is remarkable. Conclusions:It is of great signiifcance to improve the therapeutic effect of herpes zoster by standard treatment methods,careful nursing measures and effective health education.%目的:探讨带状疱疹的治疗方法与相关护理措施。方法:回顾总结50例住院患者的治疗与护理经验,采用全身治疗、局部涂抹及半导体激光治疗方法,针对不同部位及不同程度带状疱疹的患者,进行加强疼痛护理、心理护理、基础护理、用药指导、饮食护理、皮疹护理及健康教育,并观察治疗效果。结果:带状疱疹患者的治疗时间为7~13d,平均住院日不超过10d,50例患者均完全治愈出院,且无并发症的现象发生,治疗效果显著。结论:规范正确的治疗方法、精心的护理措施及行之有效的出院健康教育对提高带状疱疹的治疗效果有重要意义。

  4. THE LESIONS OF THE NERVOUS SYSTEM CAUSED BY THE VARICELLA-ZOSTER VIRUS IN CHILDREN

    Directory of Open Access Journals (Sweden)

    I. H. Belyaletdinova

    2016-01-01

    Full Text Available To describe the spectrum of neurological complications in children with varicella and against the background of herpes zoster. The study included children at the age of 0—16 years (n = 84, who recovered from exanthematous form of the disease not longer than 21 day before the appearance  of neurological symptoms (n = 82 or presented with herpes zoster (n = 2. Results: Clinical syndromes  included acute cerebellar ataxia (n = 37, meningoencephalitis (n = 34, meningitis (n = 7, polyradiculoneuropathy (n = 4, acute disseminated encephalomyelitis (n = 1, and ischemic stroke (n = 1. The period from varicella onset to the appearance of neurological symptoms was 6 [5;8] days. We have not lethal cases. Аcute cerebellar ataxia is most common  postvaricella complication  in children.

  5. Pathogenic Relevant Factors Epidemiological Analysis of Postherpetic Neuralgia of Herpes Zoster%带状疱疹后遗神经痛发病相关因素流行病学分析

    Institute of Scientific and Technical Information of China (English)

    孔宇虹; 李元文; 杨碧莲; 蔡玲玲; 孙占学

    2014-01-01

    PHN of risk factors include:herpes zoster degree of acute pain (P=0. 002,OR=14. 507),diabetes melli-tus(P =0.007,OR =7.066)OR malignant tumors(P =0.007,OR =25.978),skin lesions type(χ2 =13. 377,P=0. 010), the precursor of pain occurred (P=0. 015,OR=5. 366), age (Z= -2. 442,P=0. 015), the lesion area (Z= -2. 203,P=0. 028). And sex, site and inducing factors and the occurrence of PHN has nothing to do. PHN reduced favorable factors include:the onset of treatment time to start ( P=0. 008, OR=9. 785) and early treatment method (χ2 =9. 535,P =0. 009). Conclusion Postherpetic neuralgia after herpes zoster occurred mostly related to the degree of acute pain, followed by the merger of diabetes, malignant tumor, early treatment, skin lesions type, precursor pain occurs, lesion area and so on, while sex, place, inducing factors was not associated with the occurrence of this disease Herpes zoster as soon as possible and Treatment with TCM independently or combined with little hormones in the early stage of PTN do good to prevent the happening of PHN.

  6. TO STUDY THE CLINICAL AND EPIDEMILOGICAL DATA OF HERPES ZOSTER AND ASSESS THE RELATION BETWEEN RISK FACTORS AND DEVELOPMENT OF POSTHERPETIC NEURALGIA (PHN

    Directory of Open Access Journals (Sweden)

    Atul

    2015-11-01

    Full Text Available BACKGROUND: Herpes zoster (HZ is a common viral disorder with characteristic rashes and pain. Postherpetic neuralgia (PHN is most common complication of HZ. There may be increased chances of PHN in the presence of various risk factors. AIM: To study the clinical and epidemiological data of HZ and assess the relation between risk factors and developement of PHN. MATERIAL AND METHODS: In this prospective study cases of HZ attending the outdoor of dermatology department were included irrespective of age and sex. Relevant demographic and clinical findings of all the cases were recorded in a predesigned performa. Cases were followed up for next 6 months for the development of any complication and recorded the same if occurred. Relevant risk factors in cases of PHN were observed, recorded and analysed. RESULTS: 123 cases were included in the study. Most common age group affected was 31-40 years, slightly more common in female sex and commonly occurred in immunocompromised cases. Most common dermatome affected was thoracic. PHN occurred in 23 (18.7% cases. About 61% of PHN cases were above the age of 50 years and it occurred in 45.45% cases of HZ with ophthalmic involvement. CONCLUSION: HZ is a common disease in the cases attending the dermatology OPD. PHN is most common complication which is more commonly associated with older age, female sex, presence of prodrome, severe rash and pain within 3 days and involvement of ophthalmic division of trigeminal nerve. But ther is no significant relation between occurrence of PHN and antiviral drug treatment.

  7. Use of lambdagt11 to isolate genes for two pseudorabies virus glycoproteins with homology to herpes simplex virus and varicella-zoster virus glycoproteins

    Energy Technology Data Exchange (ETDEWEB)

    Petrovskis, E.A.; Timmins, J.G.; Post, L.E.

    1986-10-01

    A library of pseudorabies virus (PRV) DNA fragments was constructed in the expression cloning vector lambdagt11. The library was screened with antisera which reacted with mixtures of PRV proteins to isolate recombinant bacteriophages expressing PRV proteins. By the nature of the lambdagt11 vector, the cloned proteins were expressed in Escherichia coli as ..beta..-galactosidase fusion proteins. The fusion proteins from 35 of these phages were purified and injected into mice to raise antisera. The antisera were screened by several different assays, including immunoprecipitation of (/sup 14/C)glucosamine-labeled PRV proteins. This method identified phages expressing three different PRV glycoproteins: the secreted glycoprotein, gX; gI; and a glycoprotein that had not been previously identified, which we designate gp63. The gp63 and gI genes map adjacent to each other in the small unique region of the PRV genome. The DNA sequence was determined for the region of the genome encoding gp63 and gI. It was found that gp63 has a region of homology with a herpes simplex virus type 1 (HSV-1) protein, encoded by US7, and also with varicella-zoster virus (VZV) gpIV. The gI protein sequence has a region of homology with HSV-1 gE and VZV gpI. It is concluded that PRV, HSV, and VZV all have a cluster of homologous glycoprotein genes in the small unique components of their genomes and that the organization of these genes is conserved.

  8. Vacinas em desenvolvimento: estreptococo do grupo B, herpes-zóster, HIV, malária e dengue Vaccines under development: group B streptococcus, herpes-zoster, HIV, malaria and dengue

    Directory of Open Access Journals (Sweden)

    Luiz Jacintho da Silva

    2006-07-01

    Full Text Available OBJETIVOS: As vacinas contra o estreptococo B, o herpes-zóster, o HIV, a malária e a dengue, selecionadas por critérios de comercialização iminente ou devido a problemas específicos para sua obtenção, foram objeto de uma revisão sobre o estado atual do seu desenvolvimento. FONTE DOS DADOS:Foi realizada revisão da literatura através da MEDLINE no período de 1996 a 2006, sobre a epidemiologia e imunologia das doenças, analisando tanto os maiores problemas para a obtenção de uma vacina como o estado atual dos estudos, com ênfase para os que estavam em fase mais adiantada. SÍNTESE DOS DADOS: Cada uma das cinco doenças escolhidas apresenta problemas específicos para o desenvolvimento de uma vacina. No entanto, a maioria deles já foi ou está em vias de ser resolvido, permitindo prever que uma vacina - ou vacinas - eficaz e segura estará disponível em futuro próximo. CONCLUSÕES:Apesar dos problemas enfrentados para o desenvolvimento dessas vacinas, os avanços da biologia molecular e da imunologia permitiram superar a maioria deles, abrindo a perspectiva para a obtenção de novas vacinas.OBJECTIVES: To review the current state of development of streptococcus B, herpes-zoster, HIV, malaria and dengue vaccines. These vaccines were selected both because of imminent commercial release and because of specific problems with their development. SOURCES OF DATA: A review of the literature was performed by means of a MEDLINE search, on the period 1996 to 2006, for the epidemiology and immunology of these diseases, analyzing both the greatest obstacles to creating a vaccine and the current state of research, with emphasis on studies in the most advanced stages. SUMMARY OF THE FINDINGS: Each of the five diseases chosen presents specific problems for vaccine development. Nevertheless, in the majority of cases these have been or are in sight of being resolved, allowing for the prediction that a safe and effective vaccine - or vaccines

  9. Síndrome do ápice orbitário causada por herpes zóster oftálmico: relato de caso e revisão da literatura Herpes zoster ophthalmicus and orbital apex syndrome: case report and literature review

    Directory of Open Access Journals (Sweden)

    Kenzo Hokazono

    2009-10-01

    Full Text Available OHerpes Zoster Oftálmico (HZO decorre da infecção pelo vírus da varicela-zoster que permanece latente no gânglio de Gasser até que seja reativado e comprometa a divisão oftálmica do nervo trigêmeo. HZO freqüentemente causa manifestações oftalmológicas como lesões vesiculares palpebrais, ceratoconjuntivite, esclerite, uveíte, paralisia oculomotora, miosite orbitária e neurite óptica. Raramente o acometimento do ápice da órbita pode ser a manifestação inicial desta grave afecção. Este trabalho relata um caso de síndrome do ápice orbitário associado à meningite, causado por HZO e que foi tratado com corticosteróide e aciclovir sistêmicos.Herpes Zoster ophthalmicus (HZO is caused by a varicella-zoster virus infection which remains latent in the ganglion of Gasser until it is reactivated and compromise the ophthalmic division of the trigeminal nerve. HZO commonly causes neuro-ophthalmic complications such as vesicular lesions in the eyelids, keratoconjunctivitis, sclertis, uveitis, ocular palsy, orbital miositis and optic neuritis. HZO rarely presents as an orbital apex syndrome. This paper describes a patient with of orbital apex syndrome associate and meningitis caused by HZO which was treated with systemic steroids and acyclovir.

  10. Influence of pain nursing intervention on quality of life of mid aged and old patients with herpes zoster%疼痛干预对中老年带状疱疹病人生活质量的影响

    Institute of Scientific and Technical Information of China (English)

    吴娜; 许青; 丁艳

    2015-01-01

    Objective:To probe into the influence of pain nursing intervention on quality of life of mid aged and old patients with herpes zoster.Methods:A total of 66 patients with herpes zoster were randomly divided into in-tervention group and control group.They were analyzed by using the revised facial pain scale (FPS R),self e-valuation of anxiety scale (SAS),the sleep status since the rating scale (SRSS),dermatology life quality index questionnaire (DLQI)before the pain nursing intervention,at 7 days after treatment and at a week after dis-charge.Results:After pain nursing intervention,the scores of SAS,SRSS,FPS R,DLQI in the intervention group were significantly lower than that in control group (P < 0.05).The quality of life in intervention group was better than that in control group after pain nursing intervention.Conclusion:Pain nursing intervention could effectively relieve the pain of herpes zoster patients,improve their psychological state,improve their sleep quali-ty and enhance their quality of life.%[目的]探讨疼痛干预对中老年带状疱疹病人生活质量的影响。[方法]选择66例中老年带状疱疹病人,随机分为干预组和对照组,于疼痛护理干预前、治疗7 d 后、出院1周后,采用修订版面部表情疼痛量表(FPS R)、焦虑自评量表(SAS)、睡眠状况自评量表(SRSS)、皮肤病生活质量指标调查表(DLQI),对其进行调查分析。[结果]干预后干预组 FPS R、SAS、SRSS、DLQI 评分均明显低于对照组(P <0.05),干预后干预组生活质量优于对照组。[结论]疼痛干预可有效缓解带状疱疹病人疼痛,改善心理状态,提高睡眠质量,提升生活质量。

  11. 火针刀与火针治疗带状疱疹的疗效比较%Efficacy Comparison of Herpes Zoster Treatments with Cauterized Needle-Knife and Cauterized Needle

    Institute of Scientific and Technical Information of China (English)

    唐胜修; 王小莲; 刘辛; 韦春华

    2011-01-01

    Objective: To compare the herpes zoster treatment efficacy of cauterized needle-knife and cauterized needle.Methods: 43 cases of herpes zoster patients were divided into 2 groups according with random number table method, 23 cases of cauterized needle-knife group ( group 1 ) and 20 cases of cauterized needle group ( group 2 ).After the 2 groups were treated respectively, add up the whole scab time and changes in pain intensity of the 2 groups respectively, then make statistical comparison.Results:After treatments, the whole scab time of group 1 was significantly lower than that of group 2 ( P<0.05 ), the pain score of group 1 was significantly lower than that of group 2 ( P<0.05 ), and after treatment, the pain score in group 1 was significantly less than the pre-treatment score.Conclusion: The herpes zoster treatment efficacy of cauterized needle-knife was superior to that of the cauterized needle.%目的:比较火针刀与火针治疗带状疱疹的疗效.方法:带状疱疹患者43例,按随机数字表法分为火针刀组23例和火针组20例,火针刀组以火针刀治疗,火针组以火针治疗,然后分别统计两组的全部结痂时间和疼痛强度变化,并加以比较.结果:火针刀组全部结痂时间明显少于火针组(P<0.05),治疗后火针刀组疼痛强度评分明显少于火针组(P<0.05),火针刀组治疗后疼痛强度评分明显少于治疗前评分(P<0.05).结论:火针刀治疗带状疱疹疗效优于火针治疗.

  12. 电针联合刺络拔罐治疗带状疱疹疗效观察%Observation on clinical effect of electroacupuncture plus pricking-cupping bloodletting therapy for herpes zoster

    Institute of Scientific and Technical Information of China (English)

    华宇; 李瑛; 郭清; 季玲琳; 王剑波

    2015-01-01

    目的:观察电针配合刺络拔罐治疗带状疱疹的临床疗效。方法:将43例带状疱疹患者随机分为治疗组23例和对照组20例。治疗组采用电针联合刺络拔罐治疗;对照组采用口服阿昔洛韦片(Aciclovir Tablets)、双氯芬酸钠双释放肠溶胶囊(Diclofenac Sodium Dual Release Enteric-coated Capsules)、甲钴胺分散片(Methylcobalamin Dispersible Tablets)、维生素B12治疗。结果:治疗组总有效率为87.0%,对照组为70.0%,两组总有效率差异有统计学意义(P<0.01)。结论:电针联合刺络拔罐治疗带状疱疹的临床疗效优于药物治疗。%Objective:To observe the clinical effect of electroacupuncture (EA) plus pricking-cupping bloodletting therapy for herpes zoster. Methods:A total of 43 patients with herpes zoster were randomly divided into two groups, 23 cases in the treatment group and 20 cases in the control group. The treatment group was given EA plus pricking-cupping bloodletting therapy. The control group was given oral administration of Aciclovir Tablets, Diclofenac Sodium Dual Release Enteric-coated Capsules, Methylcobalamin Dispersible Tablets, and V itamin B12. Results: The total effective rate was 87.0% in the treatment group and 70.0% in the control group, with a statistical significance in difference of the total effective rate between the two groups (P Conclusion:The clinical effect is better in the treatment of herpes zoster by EA plus pricking-cupping bloodletting therapy than by medications.

  13. Clinical observation of combination of Chinese and western medicine in treatment of herpes zoster%中西医结合治疗带状疱疹临床疗效观察

    Institute of Scientific and Technical Information of China (English)

    刘勤

    2014-01-01

    Objective To observe the therapeutic effect of combination of Chinese and Western in the treatment of her-pes zoster. Methods A total of 64 cases of herpes zoster patients in our hospital from 2012 October to 2014 January were randomly divided into treatment group and control group with 32 cases in each group.Two groups were given In-travenous ganciclovir,Mecobalamin Tablets oral and Polyinosinic injection. The treatment group was given for herpes skin needle tapping and cupping with Aciclovir ointment coating.The control group was treated with Aciclovir ointment. Two groups of patients with herpes scab and pain subsided, recovery and adverse reactions were observed in the contin-uous treatment for 10 days. Results The total effective rate of treatment group was significantly higher than the control group after treatment, the differences were statistically significant (P<0.05).The herpes subsided, scab and pain recovery time were shorter than the control group, there were statistically significant (P<0.05). Conclusion Treatment of herpes zoster with integrated traditional Chinese and western medicine curative effect, fast acting, can greatly improve the comfort of patients, enhance the quality of life, and simple and easy operation, economic benefits, it is the primary hos-pital clinical use.%目的:探讨中西医结合治疗带状疱疹的临床疗效。方法选取我院2012年10月~2014年1月收治的64例带状疱疹患者,随机分为治疗组和对照组各32例。两组均常规予更昔洛韦静滴,甲钴胺片口服,聚肌胞肌注;对于疱疹处的处理,治疗组予皮肤针叩刺后拔罐以阿昔洛韦乳膏外涂,对照组仅予阿昔洛韦乳膏外涂。连续治疗10 d,观察两组患者疱疹的消退、结痂、疼痛恢复情况以及不良反应。结果两组患者治疗后,治疗组总有效率明显高于对照组,两组比较有统计学意义(P<0.05),且治疗组患者疱疹的消退、结痂及疼痛恢复时间

  14. 蛇药片外用治疗皮肤型带状疱疹体会%Experience of snake tablet topical treated on skin type of herpes zoster

    Institute of Scientific and Technical Information of China (English)

    金旭园

    2015-01-01

    目的:探讨蛇药外用治疗带状疱疹的效果。方法:10例取季德胜蛇药片研细末加适量75%酒精,在患者水疱红斑处进行外敷治疗。结果:经过治疗和护理均获得临床治愈,无一例无效,总有效率100%。结论:采用蛇药加75%酒精外敷方法具有清热解毒、消肿止痛的功效,同时起效快,操作简便,价格便宜,使用安全,能及早减轻患者痛苦和恢复正常生活等优点,患者易于接受。%Objective:To investigate the effect of snake tablet topical treated on skin type of herpes zoster.Methods:10 paitents with skin type of herpes zoster were selected.Ji Desheng snake tablets grind into fine powder with the appropriate amount of 75%alcohol were used for external application on vesicular erythema of patients.Results:After the treatment and nursing care all the patients were cured,and the total efficiency was 100%.Conclusion:Snake tables combineded with 75% alcohol used for external application has effect of heat clearing and detoxicating,swelling and alleviate pain.It also has the adavantages of fast,simple,cheap and safe.It can alleviate the pain of patients and the advantages of early return to normal life,so the patient has good compliance.

  15. Full-Genome Sequence of a Novel Varicella-Zoster Virus Clade Isolated in Mexico

    Science.gov (United States)

    Rodríguez-Castillo, Araceli; Ortiz-Alcántara, Joanna María; Gonzalez-Durán, Elizabeth; Segura-Candelas, José Miguel; Pérez-Agüeros, Sandra Ivette; Escobar-Escamilla, Noé; Méndez-Tenorio, Alfonso; Diaz-Quiñonez, José Alberto

    2015-01-01

    Varicella-zoster virus (VZV) is a member of the Herpesviridae family, which causes varicella (chicken pox) and herpes zoster (shingles) in humans. Here, we report the complete genome sequence of varicella-zoster virus, isolated from a vesicular fluid sample, revealing the circulation of VZV clade VIII in Mexico. PMID:26159533

  16. Clinical Analysis of Eight Cases AIDS Presented with Herpes Zoster as the Initial Symptom%以带状疱疹为首发症状的艾滋病8例临床分析

    Institute of Scientific and Technical Information of China (English)

    郭强; 黎宝励

    2012-01-01

    Objective To profile characteristics and relationships of patients with AIDS combined with venereal diseases, various skin diseases, prostitution, history of multiple sex partners and has first symptom of herpes zoster. Methods Analyze clinical data of 8 patients with AIDS whose first symptom was herpes zoster, diagnosed and treated during the period from March 2011 and February 2012. Results Among the 8 patients, there are 3 males and 5 females, 7 cases were aged between 26 and 38, and ! case was aged 81 ; 5 cases were unmarried and widowed, and 3 cases were married. 8 cases were generally in a good condition, 7 cases had herpes zoster on four limbs of their body, and 1 case had herpes zoster on the face. Skin lesions were large areas of clusters of blisters, bulla and blood blister, part of which was combined with severe tingling. 2 cases had non-gonoeoc-cal urethritis (cervical) inflammation, 1 case had gonorrhea, I case had condyloma, 1 case had latent syphilis, and 1 case had combined recurrent genital herpes and advanced tuberculosis. At the same time, 1 case had combined herpes simplex and seborrheic dermatitis; and 1 case had condyloma, non-gonococcal cervicitis and latent syphilis. 8 patients have hislory of multiple sexual partners or prostitution, without history of blood transfusion and drug abuse. 7 cases were cured after treatment, while 1 case had poslherpetic neuralgia for 3 months. Conclusion Patients with herpes zoster, with lower level of education, unmarried, history of multiple sexual partners, history of prostitution, history of venereal diseases in the past and at present, or various recurrent skin diseases and tuberculosis, especially young females in service industry and people who are sexually active should have HIV screening examination to avoid missed diagnosis.%目的 探讨合并有性病、多种皮肤病、嫖娼、多性伴史与以带状疱疹为首发表现的艾滋病患者的特点和关系 方法 对2011年3月-2012年2

  17. prodromal herpes zoster mimicking odontalgia

    African Journals Online (AJOL)

    GB

    2013-03-01

    Mar 1, 2013 ... is rarely seen. During the prodromal stage, the only presenting symptom may be odontalgia, which may ... history of pain in the upper left front tooth region. 3 days back which ... day patient developed rash over his left mid face.

  18. 带状疱疹性角膜炎采用阿昔洛韦联合玻璃酸钠及氟米龙眼液治疗的临床体会%The Clinical Experience of Acyclovir Combined With Sodium Hyaluronate and Fluorometholone Eye Drops in Treatment of Herpes Zoster Keratitis

    Institute of Scientific and Technical Information of China (English)

    赵艳辉

    2015-01-01

    目的:对带状疱疹性角膜炎采用阿昔洛韦联合玻璃酸钠及氟米龙眼液治疗的临床效果进行研究分析。方法选取我院收治的带状疱疹性角膜炎患者进行临床研究。结果治疗组总有效率90.00%、畏光消失时间(8.02±3.11)min,荧光素染色阴性时间(12.13±3.02)min,同对照组患者的70.00%(、11.05±2.61)min和(15.47±2.38)min相比,P<0.05。结论阿昔洛韦联合玻璃酸钠及氟米龙眼液治疗带状疱疹性角膜炎疾病效果显著。%ObjectiveAnalysis the clinical effect of herpes zoster keratitis with acyclovir combined with sodium hyaluronate and fluorometholone eye drops in the treatment of Herpes zoster keratitis.Methods Selected patients with herpes zoster keratitis in our hospital.Results The total effective rate of treatment group reached to 90%, photophobia disappeared time (8.02 ± 3.11) min, lfuorescein staining negative time (12.13 ± 3.02) min with 70% of control patients, (11.05 ± 2.61) min and (15.47 ± 2.38) min,P<0.05.Conclusion Acyclovir combined with sodium hyaluronate and lfuorometholone eye drops in treatment of herpes zoster keratitis disease has clinically signiifcant.

  19. Safety and effectiveness of the herpes zoster vaccine to prevent postherpetic neuralgia: 2014 Update and consensus statement from the Canadian Pain Society

    Directory of Open Access Journals (Sweden)

    Canadian Pain Society Study Day participants

    2015-01-01

    Full Text Available The Canadian Pain Society (CPS hosted its first Study Day in Toronto in July 2014, attended by experts in various fields of pain management and research (listed below. The aim was to review the National Advisory Committee on Immunization guidelines and to prepare a CPS position statement concerning the use of the zoster vaccine in Canada.

  20. Varicella zoster virus reactivation during or immediately following treatment of tegumentary leishmaniasis with antimony compounds

    Directory of Open Access Journals (Sweden)

    Andrea Barbieri Barros

    2014-07-01

    Full Text Available Antimony compounds are the cornerstone treatments for tegumentary leishmaniasis. The reactivation of herpes virus is a side effect described in few reports. We conducted an observational study to describe the incidence of herpes zoster reactivation during treatment with antimony compounds. The global incidence of herpes zoster is approximately 2.5 cases per 1,000 persons per month (or 30 cases per 1,000 persons per year. The estimated incidence of herpes zoster in patients undergoing antimony therapy is higher than previously reported.

  1. Acute meningoencephalomyelitis due to varicella-zoster virus in an AIDS patient: report of a case and review of the literature

    Directory of Open Access Journals (Sweden)

    Marcelo Corti

    2011-12-01

    Full Text Available Varicella-zoster virus (VZV meningoencephalomyelitis is a rare but severe neurological complication of VZV reactivation in immunocompromised patients. We report the case of an HIV-infected individual who developed an acute and severe meningoencephalomyelitis accompanied by a disseminated cutaneous eruption due to VZV. The presence of VZV DNA in cerebrospinal fluid was confirmed by polymerase chain reaction (PCR technique. The patient started undergoing an intravenous acyclovir therapy with a mild recovery of neurological manifestations. Varicella-zoster virus should be included as a cause of acute meningoencephalomyelitis in patients with AIDS. Early diagnosis followed by specific therapy should modify the rapid and fulminant course for this kind of patients.

  2. Clinical observation of liquid nitrogen cryotherapy in the treatment of patients with herpes zoster and positive anti-HIV%液氮冷冻治疗带状疱疹合并抗-HIV阳性患者临床观察

    Institute of Scientific and Technical Information of China (English)

    徐蕾; 廖志敏

    2016-01-01

    目的:观察液氮冷冻治疗带状疱疹合并抗⁃HIV 阳性患者的临床疗效.方法:选取四川省凉山彝族自治州第二人民医院2012-03/2015-12收治的带状疱疹合并抗⁃HIV 阳性患者50例作为研究对象,将其随机分为冷冻组(n =24)和对照组(n=26),两组均予抗病毒、止痛、营养神经基础治疗,冷冻组同时给予液氮冷冻治疗,分别于治疗第7日、14日对两组患者进行疗效评估.结果:冷冻组与对照组第7日综合疗效比较,差异无统计学意义(P>0.05),冷冻组第14日综合疗效优于对照组,差异具有统计学意义(P<0.05).结论:液氮冷冻治疗带状疱疹合并抗⁃HIV 阳性患者疗效肯定,值得应用推广.%AIM: To observe the curative effect of liquid nitro⁃gen cryotherapy in the treatment of patients with herpes zoster and positive anti⁃HIV. METHODS: A total of 50 patients with herpes zoster and positive anti⁃HIV admitted into The Second Peoples Hospital of Liangshan Yi Autonomous Prefecture from March 2012 to December 2015 were selected as objects of study and randomly divided into freezing group( n = 24) and control group( n = 26), both of which received basic treatment such as antiviral, analge⁃sic, and neurotrophic treatments. The freezing group also received liquid nitrogen cryotherapy. The curative effect was evaluated on 7 and 14 days after the treatment respectively. RESULTS: For the comprehensive therapeutic effect on 7 days after the treatment, there was no statistically significant difference between the freez⁃ing group and control group (P>0.05). While the comprehensive therapeutic effect in freezing group on 14 days after the treatment was better than the control group, and the difference was statisti⁃cally significant ( P < 0. 05). CONCLUSION: Liquid nitrogen cryotherapy is an effective method for treating herpes zoster with positive anti⁃HIV patients, which is worthy of

  3. Clinical Efficacies of Helium Neon Laser Plus Pharmacotherapy in the Treatment of Herpes Zoster Patients%氦氖激光联合药物治疗带状疱疹的疗效观察

    Institute of Scientific and Technical Information of China (English)

    张碧红

    2015-01-01

    【目的】探讨氦氖激光联合药物治疗带状疱疹的临床疗效。【方法】98例带状疱疹患者随机分为两组,观察组50例和对照组48例 。两组患者均接受更昔洛韦、神经营养药和局部护理等治疗,观察组在此基础上采用氦氖激光治疗仪照射患处疼痛波及的区域,每天1次,每个部位10 min 。两组疗程均为7 d ,比较两组患者的疗效。【结果】观察组治愈39例,显效 9例,有效2例,无效 0例 ,总有效率为96.0%(48/50);对照组治愈26例,显效 9例,有效11例,无效2例,总有效率72.9%(37/48),观察组疗效优于对照组,且两组相比较差异有显著性(χ2=10.066,P < 0.01)。【结论】氦氖激光联合药物治疗带状疱疹的疗效显著,值得临床推广应用。%Objective] To explore the clinical effects of helium neon laser plus pharmacotherapy in the treatment of herpes zoster patients .[Methods] A total of 98 herpes zoster patients were divided randomly into treatment ( n = 50) and control ( n = 48) groups .Both groups received ganciclovir ,nerve cell nutrition and local wound care .Helium neon laser on each pain region for 10 min was used in treatment group but not in control group .And the therapeutic course was 7 days for both groups .[Results] In treatment group ,the out‐comes were healing ( n = 39) ,efficacious ( n = 9) ,effective ( n = 2) and ineffective ( n = 0) .And the overall effective rate was 96 .0% (48/50) .In control group ,healing ( n = 26) ,efficacious ( n = 9) ,effective ( n =11) and ineffective ( n = 2) .And the overall effective rate was 72 .9% (37/48) .The inter‐group difference was statistically significant (χ2 = 10 .066 ,P < 0 .01) .[Conclusion] Helium neon laser plus pharmacotherapy can control herpes zoster effectively so that it is worth wider popularization .

  4. Microbiology laboratory and the management of mother-child varicella-zoster virus infection

    Science.gov (United States)

    De Paschale, Massimo; Clerici, Pierangelo

    2016-01-01

    Varicella-zoster virus, which is responsible for varicella (chickenpox) and herpes zoster (shingles), is ubiquitous and causes an acute infection among children, especially those aged less than six years. As 90% of adults have had varicella in childhood, it is unusual to encounter an infected pregnant woman but, if the disease does appear, it can lead to complications for both the mother and fetus or newborn. The major maternal complications include pneumonia, which can lead to death if not treated. If the virus passes to the fetus, congenital varicella syndrome, neonatal varicella (particularly serious if maternal rash appears in the days immediately before or after childbirth) or herpes zoster in the early years of life may occur depending on the time of infection. A Microbiology laboratory can help in the diagnosis and management of mother-child infection at four main times: (1) when a pregnant woman has been exposed to varicella or herpes zoster, a prompt search for specific antibodies can determine whether she is susceptible to, or protected against infection; (2) when a pregnant woman develops clinical symptoms consistent with varicella, the diagnosis is usually clinical, but a laboratory can be crucial if the symptoms are doubtful or otherwise unclear (atypical patterns in immunocompromised subjects, patients with post-vaccination varicella, or subjects who have received immunoglobulins), or if there is a need for a differential diagnosis between varicella and other types of dermatoses with vesicle formation; (3) when a prenatal diagnosis of uterine infection is required in order to detect cases of congenital varicella syndrome after the onset of varicella in the mother; and (4) when the baby is born and it is necessary to confirm a diagnosis of varicella (and its complications), make a differential diagnosis between varicella and other diseases with similar symptoms, or confirm a causal relationship between maternal varicella and malformations in a newborn

  5. Study on clinical efficacy of resolving depression and detoxification powder (Chinese herbal medicine powder) in treatment of 146 cases of herpes zoster%从"郁"论治——应用自拟方解郁清毒散治疗带状疱疹146例临床分析

    Institute of Scientific and Technical Information of China (English)

    龙雄初; 龙枚飞; 李晓玲; 赵社海

    2012-01-01

    目的 探讨从"郁"论治带状疱疹及应用自拟方解郁清毒散治疗带状疱疹的疗效.方法 通过对带状疱疹多年来的诊治经验,结合目前带状疱疹的发病特点,应用Hamilton汉密尔顿抑郁量表(HAMD)(24项)为评定工具对带状疱疹患者进行心理调查与分析.并根据病因病机采用行气补虚、泻火解毒、通络止痛的方法,并结合现代医学药理研究成果组成的自拟方解郁清毒散治疗该病146例.结果 带状疱疹患者存在不同程度的抑郁,应用自拟方解郁清毒散治疗该病总有效率达95.89%.结论 解郁清毒散是治疗带状疱疹的有效药物,且临床应用简单、方便、价廉,能显著减少后遗神经痛的发生,亦无不良反应,值得临床推广使用.%Objective To explore the clinical effect of self - made prescription resolving depression and detoxification powder ( Jieyu Qingdu San ) originated from the theoretical concept of traditional Chinese medicine in treatment of patients with herpes zoster. Methods According to experience in treatment of herpes zoster, authors adopted the Hamilton Rating Scale for Depression ( 11AMD ) ( 24 items ) as rating system to study and analyze the psychological status of patients with herpes zoster. According to the pathogenesis, therapeutic method for moving qi ( gas ) and to nourish xu ( weakness ), purging fire to detoxify and freeing the collateral vessels to relieve pain were combined with modem pharmacological knowledge to formulate the self- made prescription for resolving depression and detoxifying powder in treatment of 146 patients with herpes zoster. Satisfactory effectiveness had been obtained. Results Most of patients with herpes zoster suffered from depression in varying degree. The clinical effect of self - made prescription resolving depression and detoxifying powder in treatment of patients with herpes zoster, is satisfactory, and its effective rate reached 95. 89% . Conclusion The application of

  6. 中药佐治老年HIV/AIDS合并带状疱疹疗效观察%Effect of traditional Chinese medicine combined with acyclovir on herpes zoster in elderly with HIV/AIDS

    Institute of Scientific and Technical Information of China (English)

    梁飞立; 苏文桂; 何艳英; 余丰; 方鹏

    2012-01-01

    Objective It is to observe the effect of traditional Chinese medicine combined with acyclovir on herpes zoster in 30 elderly patients with HIV/AIDS. Methods Sixty elderly patients with HIV/AIDS were randomly divided into two groups. Thirty patients in treatment group were treated with external application of traditional Chinese medicine combined with acyclovir; thirty patients in control group were treated with acyclovir only. Results In treatment group, 17 cases were cured and 9 cases were improved, the effective rate was 87% . In control group, 14 cases were cured and 4 cases were improved, the effective rate was 60% . There was significantly difference in effective rate between both groups. The cured time of skin lesions was ( 16.17 ± 5. 47 ) days in treatment group, and was ( 20. 50 ± 6. 35 ) days in control group, there was significant difference between both groups. Conclusion External application of traditional Chinese medicine combined with acyclovir can shorten healing time of skin lesions caused by herpes zoster in the elderly with IV/AIDS and increase cure rate.%目的 探讨中药外敷配合阿昔洛韦治疗老年HIV/AIDS合并带状疱疹的疗效.方法 60例患者随机分为2组,治疗组30例用中药外敷及阿昔洛韦静脉滴注,对照组30例单用阿昔洛韦静脉滴注.结果 治疗组治愈17 例,好转9例,未愈4例,治愈好转率87%(26/30);对照组治愈14 例,好转4例,未愈12例,治愈好转率60%(18/30);2组治愈好转率比较有显著性差异(2 =5.455,P<0.05).治疗组疱疹愈合时间(16.17±5.47)d,对照组(20.50±6.35)d,2组疱疹愈合时间比较有显著性差异(t=-2.833,P<0.05).结论 中药外敷配合阿昔洛韦治疗老年HIV/AIDS 合并带状疱疹患者能缩短疱疹愈合时间,提高治愈好转率.

  7. Clinical effect of nerve block combined with ozone treatment on Herpes Zoster%神经阻滞联合臭氧治疗带状疱疹的疗效观察

    Institute of Scientific and Technical Information of China (English)

    张玉红; 张永红; 肖春才; 彭希亮; 郑战伟; 倪文琼

    2016-01-01

    目的:观察神经阻滞联合臭氧防治带状疱疹后遗神经痛的临床疗效。方法将75例带状疱疹患者随机分为3组,A组口服加巴喷丁胶囊,300 mg/次,3次/d;B组采用神经阻滞治疗;C组采用神经阻滞联合臭氧治疗。于治疗前、治疗1周及治疗后3个月进行VAS评分检测,综合评价治疗效果。结果3组患者治疗后评分均低于治疗前(<0.05),C组疼痛缓解、痊愈时间短于A、B组(<0.05),无PHN发生。结论神经阻滞联合臭氧治疗带状疱疹是安全、有效、便捷的方法。%Objective To observe the clinical curative effect of nerve block combined with ozone treatment of postherpetic neuralgia (PHN). Methods Seventy-five patients with Herpes Zoster were randomly divided into three groups. Group A took 300 mg of Gabapentin capsules orally 3 times a day, group B was treated with nerve block, and group C was treated with nerve block combined with ozone therapy. Before treatment, 1 week and 3 months after treatment VAS score was evaluated, the treatment effect was comprehensively evaluated. Results In the three groups, VAS scores after treatment were lower than those before treatment ( < 0.05). Pain relief and recovery time of the group C was shorter than that of the groups A and B ( <0.05). No PHN occurred. Conclusions Nerve block combined with ozone is a safe, effective and convenient therapy for Herpes Zoster.

  8. Clinical Analysis of Combination of Traditional Chinese and Western Medicine Treatment Of herpes Zoster%带状疱疹中西医结合治疗的临床分析

    Institute of Scientific and Technical Information of China (English)

    宋福松

    2015-01-01

    目的:分析带状疱疹中西医结合治疗的临床疗效。方法将患者随机分为观察组与对照组,对照组使用抗病毒药物、止痛药物等西医治疗方法,观察组在西医治疗基础上使用拔火罐并且配合穴位注射等中医治疗方法,对比两组患者的临床治疗效果。结果对比两组患者的总有效率差异,观察组治疗效果明显优于对照组,存在统计学意义(P<0.05)。结论使用中西医结合治疗带状疱疹,治疗效果要优于单一使用西医治疗方法,而且不良发应发生几率低,是一项可行的治疗方法,值得进行临床推广。%Objective To analyze the clinical effect of combined traditional Chinese and Western medicine treatment of herpes zoster.Methods Patients were randomly divided into observation group and control group, the control group use of antiviral drugs,painkilers and other Western medicine treatment, the observation group in western medicine treatment on the basis of the use of cupping and acupoint injection in TCMtreatment, compared two groups of patients with clinical curative effect.ResultsThe totalefficiency differences were compared between two groups, the observation grouptreatment effect is significantly better than the control group, there was statistical significant difference (P< 0.05).Conclusion The use of traditional Chinese and Western medicine treatment of herpes zoster, treatment effect than single use of Western medicine totreatment, and adverse should occur probability is low, it is a feasible treatment method, is worthy of clinical promotion.

  9. Varicella-zoster virus-specific antibody responses in 50-59-year-old recipients of zoster vaccine.

    Science.gov (United States)

    Levin, Myron J; Schmader, Kenneth E; Gnann, John W; McNeil, Shelly A; Vesikari, Timo; Betts, Robert F; Keay, Susan; Stek, Jon E; Bundick, Nickoya D; Su, Shu-Chih; Zhao, Yanli; Li, Xiaoming; Chan, Ivan S F; Annunziato, Paula W; Parrino, Janie

    2013-11-01

    Prevaccination and 6-week postvaccination samples from the immunogenicity substudy (n = 2269) of the zoster vaccine (ZV) efficacy trial (N = 22 439) in 50-59-year-old subjects were examined for varicella-zoster virus-specific antibody responses to vaccination. The varicella-zoster virus geometric mean titer (GMT) and geometric mean fold rise were higher in ZV recipients than in placebo recipients (GMT, 660.0 vs 293.1 glycoprotein enzyme-linked immunosorbent assay units/mL [P < .001], respectively; geometric mean fold rise, 2.31 vs 1.00 [P < .025]). In each group there was a strong inverse correlation between postvaccination GMT and risk of subsequent herpes zoster. Although these data provide strong evidence that relates ZV-induced antibody and the risk of herpes zoster, a protective threshold was not determined. Clinical Trials Registration. NCT00534248.

  10. Varicella-Zoster Virus–Specific Antibody Responses in 50–59-Year-Old Recipients of Zoster Vaccine

    Science.gov (United States)

    Levin, Myron J.; Schmader, Kenneth E.; Gnann, John W.; McNeil, Shelly A.; Vesikari, Timo; Betts, Robert F.; Keay, Susan; Stek, Jon E.; Bundick, Nickoya D.; Su, Shu-Chih; Zhao, Yanli; Li, Xiaoming; Chan, Ivan S. F.; Annunziato, Paula W.; Parrino, Janie

    2013-01-01

    Prevaccination and 6-week postvaccination samples from the immunogenicity substudy (n = 2269) of the zoster vaccine (ZV) efficacy trial (N = 22 439) in 50–59-year-old subjects were examined for varicella-zoster virus–specific antibody responses to vaccination. The varicella-zoster virus geometric mean titer (GMT) and geometric mean fold rise were higher in ZV recipients than in placebo recipients (GMT, 660.0 vs 293.1 glycoprotein enzyme-linked immunosorbent assay units/mL [P < .001], respectively; geometric mean fold rise, 2.31 vs 1.00 [P < .025]). In each group there was a strong inverse correlation between postvaccination GMT and risk of subsequent herpes zoster. Although these data provide strong evidence that relates ZV-induced antibody and the risk of herpes zoster, a protective threshold was not determined. Clinical Trials Registration. NCT00534248. PMID:23908486

  11. Seroprevalence of hepatitis A virus and varicella zoster antibodies in a Javanese community (Yogyakarta, Indonesia).

    Science.gov (United States)

    Juffrie, M; Graham, R R; Tan, R I; Widjaja, S; Mulyadi, S; Weil, J; Bock, H L

    2000-03-01

    Hepatitis A virus (HAV) cause an acute inflammation of the liver. Varicella-zoster virus (VZV) cause chickenpox (varicella) and herpes zoster. Effective vaccines against hepatitis A and varicella are available for children, adolescents and adults. In order to implement an appropriate vaccination policy, a baseline to assess the potential benefits and sections of the population who would benefit most are required. We investigated seroprevalence of hepatitis A virus and varicella zoster antibodies in a Javanese community. A total of 1,103 subjects were studied. The 600 subjects aged 4 to 9 years were sampled between 23 October and 2 November, 1995. The other subjects were sampled between 12 October and 1 November, 1996. The overall prevalence of anti-HAV in cohort was 28.7%. Anti-HAV seroprevalence rates were below 30% until the age of 15 and below 40% until the age of 25. The anti-varicella seroprevalence showed only in two thirds of seropositive population at the age of 15. The results of the study have implications for vaccination strategies for both hepatitis A and varicella zoster.

  12. Clinical observation of helium-neon laser for herpes zoster in elderly patients%氦氖激光治疗老年带状疱疹的临床观察

    Institute of Scientific and Technical Information of China (English)

    石长珠; 朱应玉

    2016-01-01

    Objective:To observe the clinical efficacies of treatment of herpes zoster in elderly patients with helium-neon laser.Methods:A total of 67 pa-tients,aged over 60 years and treated on the outpatient basis in our hospital ,were recruited from August 2014 to February 2016,and randomly allocated to observational group(laser treatment,n=33) and control group(n=34).Patients in the control group received exclusive antivirus with valacyclovir hydro-chloride tablets and mecobalamin tablets as well as neurotorophic maintenance with vitamin B 1,and those in the observational group were given additional helium-neon laser treatment on the medication basis.All patients were followed up for 4 weeks.The time of crust formation and decrustation as well as daily scores on pain was maintained in the two groups,and the sequel neuralgia was observed 4 weeks after treatment.Results:The observational group had signif-icantly shorter time of crust formation and decrustation as well as lower pain scores following the 3rd day after treatment and fewer incidence of neuralgia than the control group(P<0.05).Conclusion:Helium-neon laser may lead to better clinical efficacies for herpes zoster in elderly patients ,with shorter time of crust formation and decrustation,early pain relief and less neurological sequelae.%目的:探讨氦氖激光在老年带状疱疹患者中的治疗效果。方法:选取2014年8月~2016年2月在我院皮肤性病科门诊确诊为带状疱疹且年龄≥60岁的老年患者共67例,随机分为氦氖激光组(观察组)和对照组,对照组34例仅接受盐酸伐昔洛韦分散片抗病毒、甲钴胺片及维生素B1营养神经等治疗,观察组33例在接受对照组药物治疗基础上给予氦氖激光治疗;随访4周,记录两组患者的结痂时间、脱痂时间,每日疼痛评分及4周后的后遗神经痛发生情况。结果:观察组的结痂时间、脱痂时间、治疗第3天以后每日疼痛评分以及后遗神经

  13. Characteristics on the Diagnosis and Treatment of Diabetic Facial Paralysis Patients with Herpes Zoster%糖尿病合并带状疱疹性面神经炎诊治特点探讨

    Institute of Scientific and Technical Information of China (English)

    谌剑飞; 邱明琪

    2015-01-01

    Objective To investigate the clinical characteristics on the diagnosis and treatment of diabetic facial paralysis patients with herpes zoster.Methods The clinical data in diabetic facial paralysis patients with herpes zoster were retrospectively analyzed. The clinical characteristics of diabetic patients with or without herpetic facial paralysis were compared.Results The nerve function grade and scores in diabetic patients with herpetic facial paralysis were higher than that in diabetic patients without herpetic facial paralysis (P<0.01). After treatment,the scores of nerve function were decreased in two groups (P<0.01).The cure rate and markedly effec-tive rate were 52.4% and 77.9% in diabetic patients without herpetic facial paralysis,which were higher than that in diabetic patients with herpetic facial paralysis(28.6% and 51.2%,P<0.01). Conclusion The lesions in diabetic patients with herpetic facial paralysis were more serious,which functional recovery was less than that in diabetic patients without herpetic facial paralysis.Early treatment by integrated Chinese and western medicine can improve the curative effect.%目的:探讨糖尿病带状疱疹性面神经炎临床特点,以提高对本病的诊治认识水平和疗效。方法回顾分析糖尿病带状疱疹性面神经炎患者临床诊治资料,并与无疱疹糖尿病面神经炎者进行比较。结果糖尿病带状疱疹性面神经炎者神经功能分级和评分量值,均较无疱疹性糖尿病面神经炎者为高,具有统计学意义(P<0.01);中西医结合治疗前后两组面神经功能评分量值自身比较有统计学意义(P<0.01);治愈率及愈显率分别为28.6%、51.2%与52.4%、77.9%,具有统计学意义(P<0.01)。结论糖尿病带状疱疹性面神经炎者病变较重,恢复功能较无疱疹性面神经炎者差,早期采用中西医结合治疗有助于提高疗效。

  14. 中西医结合治疗带状疱疹临床研究%Clinical Study on the Treatment of Herpes Zoster by Integration of Traditional Chinese Medicine and Western Medicine

    Institute of Scientific and Technical Information of China (English)

    张娟

    2012-01-01

    Objective:To study the clinical effects of the integration of TCM and western medicine on the treatment of Herpes Zoster. Methods: 64 patients were randomly divided into the control group and the treatment group. The control group of 32 cases was given 2 mL of intramuscular injection of antiviral poly I : C,with once per two days and oral adminstration of 25 mg indomethacin,three time a day; the treatment group of 32 cases was additionally given Chinese herbs on the basis of treatment given to the control group with the composition of Gentiana scabra Bunge 10 g, Honeysuckle flower 30 g, Radix bupleuri 10 g,Paeonia suffruticosa 10 g, Radix Paeoniae Rubra 10 g,Rehmannia root 15 g,Mongolian Dandelion 10 g,Rhizoma alismatis 10 g,Akebiaquinata 10 g,Angelica sinensis 10 g.Fruc-tus Gardeniae 10 g,Forsythia 10 g, Folium isatidis 30 g, Radix lsatidis 30 g. Anther lignum dalbergiae odoriferae 10 g and Angelica sinensis 30 g were added if there was blood stasis,one dosage a day with a treatment course of 7 days. Results:In the treatment group, 24 cases were cured,6 cases achieved excellent effects,2 were ineffective and the effective rate was 93. 7% ;in the control group,18 cases were cured, 8 achieved excellent effects, 6 were ineffective, and the effective rate was 81.3%. Effective rates of two groups had notable significance through statistics processing(P <0. 05). Conclusion: Herpes Zoster can be treated effectively by the treatment of integration of TCM and western medicine.%目的:探讨中西医结合治疗带状疱疹临床疗效.方法:64例患者随机分为对照组和治疗组.对照组32例肌肉注射抗病毒类聚肌胞针2 mL,2d1次;口服消炎痛25 mg,每日3次,治疗组32例在对照组基础上加用中药治疗.中药选用龙胆草10g,金银花30 g,柴胡10 g,牡丹皮10 g,赤芍10 g,生地黄15 g,蒲公英10 g,泽泻10 g,木通10 g,当归10 g,栀子10 g,连翘10 g,大青叶30 g,板兰根30 g.伴有瘀血者加降香10 g,当归10 g,日1

  15. [VARICELLA ZOSTER VIRUS AND DISEASES OF CENTRAL NERVOUS SYSTEM VESSELS].

    Science.gov (United States)

    Kazanova, A S; Lavrov, V F; Zverev, V V

    2015-01-01

    Systemized data on epidemiology, pathogenesis, clinical manifestation, diagnostics and therapy of VZV-vasculopathy--a disease, occurring due to damage of arteries of the central nervous system by Varicella Zoster virus, are presented in the review. A special attention in the paper is given to the effect of vaccine prophylaxis of chicken pox and herpes zoster on the frequency of development and course of VZV-vasculopathy.

  16. Low Prevalence of Varicella Zoster Virus and Herpes Simplex Virus Type 2 in Saliva from Human Immunodeficiency Virus-Infected Persons in the Era of Highly Active Antiretroviral Therapy

    Science.gov (United States)

    Wang, Chunmei C.; Yepes, Luis C.; Danaher, Robert J.; Berger, Joseph R.; Mootoor, Yunanan; Kryscio, Richard J.; Miller, Craig S.

    2009-01-01

    Objectives Human herpesviruses (HHVs), e.g. herpes simplex virus (HSV) type 1, Epstein-Barr virus and cytomegalovirus, appear in saliva at greater frequency in persons infected with human immunodeficiency virus (HIV) than healthy individuals. However, it is not known if varicella zoster virus (VZV) and HSV-2 appear simultaneously during HIV infection at greater frequency in saliva during this era of highly active antiretroviral therapy (HAART). The aim of this study was to investigate the prevalence and amounts of VZV and HSV-2 in the saliva of HIV-infected, orally asymptomatic patients. Study Design Quantitative polymerase chain reaction was used to investigate the prevalence, quantity, risk, and correlates of salivary VZV and HSV-2 from 59 HIV-seropositive individuals and 53 healthy controls in a case-control, cross-sectional study. Seventy-eight percent of the HIV-seropositive patients (46/59) were taking HAART. Results VZV DNA was detected in the saliva of 5.1% (3/59) of the HIV-positive group and in only one healthy control 1.9% (1/53; P = 0.62). The amount of VZV DNA in the expressors was low, generally less than 1,100 copies/mL with no observed difference between the HIV-positive group and the controls (P= 1.0). HSV-2 DNA was not detected in either group. In the HIV-infected group, VZV shedding occurred in those on HAART, but was not associated with oral lesions, specific CD4+ or CD8+ T-cell levels, or demographic factors. Conclusions VZV was detected at low prevalence in the saliva of HIV-infected persons whereas HSV-2 was not detected in the saliva of this cohort. HAART does not appear to diminish the risk for asymptomatic VZV shedding. PMID:20123407

  17. Kyrieleis plaques associated with Herpes Simplex Virus type 1 acute retinal necrosis

    Directory of Open Access Journals (Sweden)

    Neha Goel

    2016-04-01

    Full Text Available We report the case of a 55-year-old immunocompetent male who presented with features typical of acute retinal necrosis (ARN. Polymerase chain reaction of the aqueous tap was positive for Herpes Simplex Virus (HSV – 1. Following therapy with intravenous Acyclovir, followed by oral Acyclovir and steroids, there was marked improvement in the visual acuity and clinical picture. At one week after initiation of treatment, Kyrieleis plaques were observed in the retinal arteries. They became more prominent despite resolution of the vitritis, retinal necrosis and vasculitis and persisted till six weeks of follow-up, when fluorescein angiography was performed. The appearance of this segmental retinal periarteritis also known as Kyrieleis plaques has not been described in ARN due to HSV-1 earlier.

  18. Necrosis of nose skin after varicella zoster infection : A case report

    NARCIS (Netherlands)

    Snel, Bart Jorrit; Visconti, Giuseppe; Grabietz, Patrice D.; Werker, Paul M. N.

    Varicella zoster virus (VZV) is the causal agent of varicella (chickenpox) and herpes zoster (shingles). Primary VZV infection is a common childhood disease, but elderly patients and those having a compromised immune system are also at risk. We present the case of progressive necrosis of the nose

  19. Necrosis of nose skin after varicella zoster infection : A case report

    NARCIS (Netherlands)

    Snel, Bart Jorrit; Visconti, Giuseppe; Grabietz, Patrice D.; Werker, Paul M. N.

    2010-01-01

    Varicella zoster virus (VZV) is the causal agent of varicella (chickenpox) and herpes zoster (shingles). Primary VZV infection is a common childhood disease, but elderly patients and those having a compromised immune system are also at risk. We present the case of progressive necrosis of the nose sk

  20. Epidemiological characteristics and societal burden of varicella zoster virus in the Netherlands

    NARCIS (Netherlands)

    Pierik, Jorien G. J.; Gumbs, Pearl D.; Fortanier, Sander A. C.; Van Steenwijk, Pauline C. E.; Postma, Maarten J.

    2012-01-01

    Background: Varicella and herpes zoster are both caused by varicella zoster virus (VZV) infection or reactivation and may lead to complications associated with a (severe) societal burden. Because the epidemiology of VZV-related diseases in the Netherlands remains largely unknown or incomplete, the m

  1. Effect of acute Plasmodium falciparum malaria on reactivation and shedding of the eight human herpes viruses.

    Directory of Open Access Journals (Sweden)

    Arnaud Chêne

    Full Text Available Human herpes viruses (HHVs are widely distributed pathogens. In immuno-competent individuals their clinical outcomes are generally benign but in immuno-compromised hosts, primary infection or extensive viral reactivation can lead to critical diseases. Plasmodium falciparum malaria profoundly affects the host immune system. In this retrospective study, we evaluated the direct effect of acute P. falciparum infection on reactivation and shedding of all known human herpes viruses (HSV-1, HSV-2, VZV, EBV, CMV, HHV-6, HHV-7, HHV-8. We monitored their presence by real time PCR in plasma and saliva of Ugandan children with malaria at the day of admission to the hospital (day-0 and 14 days later (after treatment, or in children with mild infections unrelated to malaria. For each child screened in this study, at least one type of HHV was detected in the saliva. HHV-7 and HHV-6 were detected in more than 70% of the samples and CMV in approximately half. HSV-1, HSV-2, VZV and HHV-8 were detected at lower frequency. During salivary shedding the highest mean viral load was observed for HSV-1 followed by EBV, HHV-7, HHV-6, CMV and HHV-8. After anti-malarial treatment the salivary HSV-1 levels were profoundly diminished or totally cleared. Similarly, four children with malaria had high levels of circulating EBV at day-0, levels that were cleared after anti-malarial treatment confirming the association between P. falciparum infection and EBV reactivation. This study shows that acute P. falciparum infection can contribute to EBV reactivation in the blood and HSV-1 reactivation in the oral cavity. Taken together our results call for further studies investigating the potential clinical implications of HHVs reactivation in children suffering from malaria.

  2. Varicella zoster virus vaccines: potential complications and possible improvements

    Institute of Scientific and Technical Information of China (English)

    Benjamin; Silver; Hua; Zhu

    2014-01-01

    Varicella zoster virus(VZV) is the causative agent of varicella(chicken pox) and herpes zoster(shingles). After primary infection, the virus remains latent in sensory ganglia, and reactivates upon weakening of the cellular immune system due to various conditions, erupting from sensory neurons and infecting the corresponding skin tissue. The current varicella vaccine(v-Oka) is highly attenuated in the skin, yet retains its neurovirulence and may reactivate and damage sensory neurons. The reactivation is sometimes associated with postherpetic neuralgia(PHN), a severe pain along the affected sensory nerves that can linger for years, even after the herpetic rash resolves. In addition to the older population that develops a secondary infection resulting in herpes zoster, childhood breakthrough herpes zoster affects a small population of vaccinated children. There is a great need for a neuro-attenuated vaccine that would prevent not only the varicella manifestation, but, more importantly, any establishment of latency, and therefore herpes zoster. The development of a genetically-defined live-attenuated VZV vaccine that prevents neuronal and latent infection, in addition to primary varicella, is imperative for eventual eradication of VZV, and, if fully understood, has vast implications for many related herpesviruses and other viruses with similar pathogenic mechanisms.

  3. Microgravity Analogues of Herpes Virus Pathogenicity: Human Cytomegalovirus (hCMV) and Varicella Zoster (VZV) Infectivity in Human Tissue Like Assemblies (TLAs)

    Science.gov (United States)

    Goodwin, T. J.; McCarthy, M.; Albrecht, T.; Cohrs, R.

    2009-01-01

    The old adage we are our own worst enemies may perhaps be the most profound statement ever made when applied to man s desire for extraterrestrial exploration and habitation of Space. Consider the immune system protects the integrity of the entire human physiology and is comprised of two basic elements the adaptive or circulating and the innate immune system. Failure of the components of the adaptive system leads to venerability of the innate system from opportunistic microbes; viral, bacteria, and fungal, which surround us, are transported on our skin, and commonly inhabit the human physiology as normal and imunosuppressed parasites. The fine balance which is maintained for the preponderance of our normal lives, save immune disorders and disease, is deregulated in microgravity. Thus analogue systems to study these potential Risks are essential for our progress in conquering Space exploration and habitation. In this study we employed two known physiological target tissues in which the reactivation of hCMV and VZV occurs, human neural and lung systems created for the study and interaction of these herpes viruses independently and simultaneously on the innate immune system. Normal human neural and lung tissue analogues called tissue like assemblies (TLAs) were infected with low MOIs of approximately 2 x 10(exp -5) pfu hCMV or VZV and established active but prolonged low grade infections which spanned .7-1.5 months in length. These infections were characterized by the ability to continuously produce each of the viruses without expiration of the host cultures. Verification and quantification of viral replication was confirmed via RT_PCR, IHC, and confocal spectral analyses of the respective essential viral genomes. All host TLAs maintained the ability to actively proliferate throughout the entire duration of the experiments as is analogous to normal in vivo physiological conditions. These data represent a significant advance in the ability to study the triggering

  4. Microgravity Analogues of Herpes Virus Pathogenicity: Human Cytomegalovirus (hCMV) and Varicella Zoster (VZV) Infectivity in Human Tissue Like Assemblies (TLAs)

    Science.gov (United States)

    Goodwin, T. J.; McCarthy, M.; Albrecht, T.; Cohrs, R.

    2009-01-01

    The old adage we are our own worst enemies may perhaps be the most profound statement ever made when applied to man s desire for extraterrestrial exploration and habitation of Space. Consider the immune system protects the integrity of the entire human physiology and is comprised of two basic elements the adaptive or circulating and the innate immune system. Failure of the components of the adaptive system leads to venerability of the innate system from opportunistic microbes; viral, bacteria, and fungal, which surround us, are transported on our skin, and commonly inhabit the human physiology as normal and imunosuppressed parasites. The fine balance which is maintained for the preponderance of our normal lives, save immune disorders and disease, is deregulated in microgravity. Thus analogue systems to study these potential Risks are essential for our progress in conquering Space exploration and habitation. In this study we employed two known physiological target tissues in which the reactivation of hCMV and VZV occurs, human neural and lung systems created for the study and interaction of these herpes viruses independently and simultaneously on the innate immune system. Normal human neural and lung tissue analogues called tissue like assemblies (TLAs) were infected with low MOIs of approximately 2 x 10(exp -5) pfu hCMV or VZV and established active but prolonged low grade infections which spanned .7-1.5 months in length. These infections were characterized by the ability to continuously produce each of the viruses without expiration of the host cultures. Verification and quantification of viral replication was confirmed via RT_PCR, IHC, and confocal spectral analyses of the respective essential viral genomes. All host TLAs maintained the ability to actively proliferate throughout the entire duration of the experiments as is analogous to normal in vivo physiological conditions. These data represent a significant advance in the ability to study the triggering

  5. Comparison of intramuscular and subcutaneous administration of a herpes zoster live-attenuated vaccine in adults aged ≥50 years: a randomised non-inferiority clinical trial.

    Science.gov (United States)

    Diez-Domingo, Javier; Weinke, Thomas; Garcia de Lomas, Juan; Meyer, Claudius U; Bertrand, Isabelle; Eymin, Cécile; Thomas, Stéphane; Sadorge, Christine

    2015-02-04

    Zostavax(®) is a live, attenuated varicella zoster virus (VZV) vaccine developed specifically for the prevention of HZ and PHN in individuals aged ≥50 years. During the clinical development of Zostavax, which was mainly in the US, the vaccine was administrated by the subcutaneous (SC) route. In Europe, many healthcare professionals prefer administering vaccines by the intramuscular (IM) route. This was an open-label, randomised trial conducted in 354 subjects aged ≥50 years. The primary objectives were to demonstrate that IM administration is both non-inferior to SC administration in terms of 4-week post-vaccination geometric mean titres (GMTs), and elicits an acceptable geometric mean fold-rise (GMFR) of antibody titres measured by glycoprotein enzyme-linked immunosorbent assay. Pre-specified non-inferiority was set as the lower bound of the 95% confidence interval (CI) of the GMT ratio (IM/SC) being >0.67. An acceptable GMFR for the IM route was pre-specified as the lower bound of its 95% CI being >1.4. Description of the VZV immune response using the interferon-gamma enzyme-linked immunospot (IFN-γ ELISPOT) assay and of the safety were secondary objectives. Participants were randomised to IM or SC administration (1:1). The baseline demographics were comparable between groups; mean age: 62.6 years (range: 50.0-90.5). The primary immunogenicity objectives were met (per protocol analysis): GMT ratio (IM/SC): 1.05 (95% CI: 0.93-1.18); GMFR: 2.7 (2.4-3.0). VZV immune response using IFN-γ ELISPOT were comparable between groups. Frequencies of systemic adverse events were comparable between groups. Injection-site reactions were less frequent with IM than SC route: erythema (15.9% versus 52.5%), pain (25.6% versus 39.5%) and swelling (13.6% versus 37.3%), respectively. In adults aged ≥50 years, IM administration of Zostavax elicited similar immune responses to SC administration and was well tolerated, with fewer injection-site reactions than with SC

  6. STUDY REPORTS ON VARICELLA ZOSTER IN TERM PREGNANCY AND ITS OUTCOME

    Directory of Open Access Journals (Sweden)

    Pranjal

    2014-06-01

    Full Text Available Chickenpox is caused by the Varicella-Zoster virus, a member of the herpes virus family. The same virus also causes herpes zoster (shingles in adults. This infection can be widely detected in developing countries, especially for those tropical countries. It is presented with fever and vesicular lesions all over body. (1,2 Even the pregnant women can get chicken pox, and this becomes an important concern. In this specific paper, we have given the details and discussed 5 cases on chicken pox in term pregnancy and its outcome. We have also discussed the management of VZV (Varicella Zoster Virus infection in pregnancy.

  7. Herpes associated erythema multiforme

    Directory of Open Access Journals (Sweden)

    K A Kamala

    2011-01-01

    Full Text Available Erythema multiforme is an acute and a self-limiting mucocutaneous hypersensitivity reaction triggered by certain infections and medications. One of the most common predisposing factors for erythema multiforme is infection with herpes simplex virus. Herpes associated erythema multiforme (HAEM is an acute exudative dermatic and mucosal disease caused by the infecting herpes simplex virus. It has recurrence and idiorestriction, characterized by increasing of CD4+T leukomonocyte. This article reports a case of HAEM in a 9-year-old girl, with a review of relevant literature, and discusses the pathophysiology and treatment of erythema multiforme triggered by herpes simplex virus

  8. 针刺结合火罐治疗带状疱疹的临床疗效分析%Clinical analysis of the efficacy of acupuncture combined with cupping treatment of herpes zoster

    Institute of Scientific and Technical Information of China (English)

    何二代

    2015-01-01

    目的:分析带状疱疹通过针刺联合火罐治疗的临床效果。方法:研究对象来自我院在2011年1月至2014年I2月期间接诊的50例带状疱疹患者,分为对照组和观察组各25例,其中观察组采用针刺联合火罐治疗,对照组采用西药抗病毒治疗,而后对比两组患者的治疗效果差异。结果:在治疗有效率上,观察组为100%,对照组为84%;同时在治疗有效性显现时间上,观察组均快于对照组。两组比较具有统计学意义,P<0.05。结论:带状疱疹通过针刺联合火罐治疗可以有效的提升治疗有效率,同时起效快速,降低患者的不适感,提升患者生活质量。%Objective To analyze the clinical effects of herpes zoster by acupuncture combined with cupping therapy.Methods 50 patients were divided into two groups, the observation group were treated with acupuncture combined with cupping therapy, the control group with western medicine antiviral therapy, then contrast differences.ResultsThe effective rate in observation group was 100% vs 84%;at the same time show the effectiveness of the treatment, the observation group were faster than the control group.ConclusionShingles treatment by acupuncture combined with cupping therapy can effectively improve efficiency.

  9. The Role of Plasmacytoid Dendritic Cells in Innate and Adaptive Immune Responses against Alpha Herpes Virus Infections

    Directory of Open Access Journals (Sweden)

    Philipp Schuster

    2011-01-01

    Full Text Available In 1999, two independent groups identified plasmacytoid dendritic cells (PDC as major type I interferon- (IFN- producing cells in the blood. Since then, evidence is accumulating that PDC are a multifunctional cell population effectively coordinating innate and adaptive immune responses. This paper focuses on the role of different immune cells and their interactions in the surveillance of alpha herpes virus infections, summarizes current knowledge on PDC surface receptors and their role in direct cell-cell contacts, and develops a risk factor model for the clinical implications of herpes simplex and varicella zoster virus reactivation. Data from studies involving knockout mice and cell-depletion experiments as well as human studies converge into a “spider web”, in which the direct and indirect crosstalk between many cell populations tightly controls acute, latent, and recurrent alpha herpes virus infections. Notably, cells involved in innate immune regulations appear to shape adaptive immune responses more extensively than previously thought.

  10. Varicella-zoster virus reactivation from multiple ganglia: a case report

    Directory of Open Access Journals (Sweden)

    Hashemilar Mazyar

    2009-09-01

    Full Text Available Abstract Introduction Simultaneous involvements of multiple cranial nerve ganglia (geniculate ganglion and peripheral ganglia of cranial nerves VIII, IX and X by varicella-zoster virus and its subsequent activation may result in the characteristic eruptions of herpes zoster cephalicus. Coexistence of facial palsy and involvement of upper cervical dermatomes by varicella-zoster virus is quite rare. Case presentation Here, we report a 71-year-old Iranian man with involvement of multiple sensory ganglia (geniculate ganglion and upper dorsal root ganglia by varicella-zoster virus. He presented with right-sided facial weakness along with vesicular eruptions on the right side of his neck, and second and third cervical dermatomes. Conclusion The present case is an example of herpes zoster cephalicus with cervical nerve involvement. Although resembling Ramsay Hunt syndrome with presence of facial nerve paralysis and accompanying vesicles, involvement of cervical dermatomes is not a feature of the classic Ramsay Hunt syndrome.

  11. Herpes viruses, cytokines, and altered hemostasis in vital exhaustion.

    NARCIS (Netherlands)

    Ven, A.J.A.M. van der; Diest, R. van; Hamulyak, K.; Maes, M.; Bruggeman, C.A.; Appels, A.

    2003-01-01

    OBJECTIVE: Infections with herpes viruses have been implicated in the pathogenesis of atherosclerosis. We tested the hypothesis that vital exhaustion (VE) is associated with multiple herpesvirus infections, such as herpes simplex virus, varicella-zoster virus, Epstein-Barr virus, and cytomegalovirus

  12. Clinical investigation of prednisone combined with mecobalamin and indomethecin in the treatment of neuralgia following herpes zoster%强的松联合甲钴胺及吲哚美辛治疗带状疱疹后遗神经痛的疗效观察

    Institute of Scientific and Technical Information of China (English)

    潘忠泉

    2013-01-01

    Objective To observe the clinical effect of prednisone combined with mecobalamin and indomethecin in the treatment of neuralgia following herpes zoster. Methods Eighty-six patients with neuralgia following herpes zoster were randomly divided into the treatment group (n=43) and the control group (n=43). Patients in the treatment group were treated with prednisone 10 mg three times daily, mecobalamin 500 μg three times daily, and in-domethacin 25 mg two times daily for 15 days. Patients in the control group were treated with mecobalamin 500 μg three times daily and indomethacin 25 mg two times daily for 15 days. The visual analogue scale (VAS) was used to evaluate the therapeutic effects in the two groups. Results The effective rate was 83.72% in the treatment group, significantly higher than that in the control group (65.12%), P<0.05. No marked side effects were observed in the two groups. Conclusion Prednisone combined with mecobalamin and indomethecin are effective and safe for treating neuralgia following herpes zoster.%目的 评价强的松片联合甲钴胺片及吲哚美辛片治疗带状疱疹后遗神经痛的临床疗效.方法 86例带状疱疹后遗神经痛患者分为治疗组及对照组各43例,治疗组患者口服强的松片10 mg,3次/d;甲钴胺片500 μg,3 次/d,吲哚美辛片25 mg,2 次/d,疗程15 d;对照组患者口服甲钴胺片500 μg,3 次/d,吲哚美辛片25 mg,2 次/d,疗程15 d.以视觉模拟评分法(VAS)评价治疗效果.结果 治疗组患者有效率(83.72%)高于对照组(65.12%),差异有统计学意义(P<0.05),两组患者均无明显不良反应.结论 强的松联合甲钴胺及吲哚美辛治疗带状疱疹后遗神经痛有明显疗效.

  13. The clinical research of the efifcacy of Troxerotin and cerebro hydrolysate injection(TCHI) for the treatment of Neuralgia of herpes zoster%复方曲肽注射液治疗带状疱疹性神经痛的效果研究

    Institute of Scientific and Technical Information of China (English)

    田刘军; 范天仁; 尹凤婷; 周楠; 张伟丽

    2016-01-01

    目的:研究复方曲肽注射液对带状疱疹性神经痛患者的作用效果。方法选取2014年9月~2015年6月在我科住院的诊断明确的带状疱疹性神经痛患者60例,将其随机分为治疗组与对照组,各30例,对照组采用阿昔洛韦、维生素B1、维生素B12等常规治疗,治疗组加用复方曲肽注射液,疗程为2周。结果治疗组有效率83.3%,对照组有效率50%,两组比较差异有统计学意义(P<0.05)。结论复方曲肽注射液在治疗带状疱疹性神经痛方面起到显著疗效。%objective To investigate the efifcacy of troxerotin and cerebro hydrolysate injection(TCHI) in the treatment of neuralgia of herpes zoster.Methods Select September201-June2015in our hospital diagnosis of herpes zoster neuralgia clear60patients were randomly divided into treatment group and control group(30cases),30cases in treatment group were administrated with troxerotin and cerebro hydrolysate injection(TCHI),while the other 30 cases in the control group were given conventional treatment,one course lasted2week.Results The effective rates were83.3%and50%(P<0.05)in the therapeutic group and the control group,respectively.Conclusion Troxerotin and cerebro hydrolysate injection(TCHI)plays a significant effect in terms of the treatment of neuralgia of herpes zoster.

  14. The Observation about the Effect on Post-herpetic Neuralgia of Herpes Zoster by Early Intervention with Venesection Ventouse and Helium-neon Laser%刺络拔罐联合氦氖激光早期干预对带状疱疹后遗神经痛影响观察

    Institute of Scientific and Technical Information of China (English)

    夏立君; 蒋靖

    2012-01-01

    目的:刺络拔罐联合氦氖激光早期干预对带状疱疹后遗神经痛的影响观察.方法:将具有典型症状的带状疱疹患者140例随机分为两组,对照组口服伐昔洛韦胶囊、维生素B1、甲钴胺.治疗组除服用上述药外于病变处照氦氖激光并联合刺络拔罐.两组患者分别于治疗后进行临床疗效评估及治疗结束后进行3个月随访观察后遗神经痛现象.结果:治疗结束时,对照组有效率为95.7%,治疗组有效率为97.1%.两组疗效差异无显著性(P>0.05),而两者后遗神经痛率分别为21.4%、8.2%,差异有显著性(P<0.05).结论:刺络拔罐联合氦氖激光早期干预可明显减轻对带状疱疹后遗神经痛.%Objective : Observe the effect on post-herpetic neuralgia of herpes zoster by early intervention with venesection ventouse and helium-neon laser. Method: Divided the selected 140 patients of classical symptom of herpes zoster into two groups randomly: the control group used Valaciclovir, VitaminsB,, mecobalamin. While the treatment group expcet taked above-medicine, treated with venesection ventouse and helium-neon laser at the pathological change. Taked clinical curative effect evaluation after different treatment and observed the phenomenon of post-herpetic neuralgia after follow up-3weeks. Results: After the treatment, the effective rates of the control group and the treatment group were respectively 95.7%and 97.1%. There were no significant difference between two groups ( P>0.05 ) .The post-herpetic neuralgia rates of the two groups were 21.4%, 8.2%respectively, there were significant differences ( P<0.05 ). Conclusion: Venesection ventouse combined with helium-neon laser can relieve post-herpetic neuralgia of herpes zoster obviously.

  15. 带状疱疹疫苗生产中2BS细胞细胞工厂培养工艺的建立%Development of culture procedure for 2BS cell factory during production of herpes zoster vaccine

    Institute of Scientific and Technical Information of China (English)

    梁雪; 刘延威; 张宇; 石磊; 杨晓叶; 李生军; 沈红杰

    2014-01-01

    Objective To develop a culture procedure for 2BS cell factory during production of herpes zoster vaccine.Methods The 2BS cells were resuscitated (passage 28) and subcultured to passages 35 and 36,then to the ten layer cell factory at mass ratios of 1 ∶ 4 and 1 ∶ 2 respectively.The cells on each layer were added with various volumes (200,300 and 400 ml) of medium,observed for morphology by microscopy and counted.The cell factory was inoculated with varicellazoster virus at a MOI of 0.008 and prepared into live attenuated vaccine.The bulk and final product of vaccine were determined for titers.The final product was subjected to stability test at 37 ℃.The residual antibiotics and bovine albumin contents were determined by ELISA,while the endotoxin content by gel method,and the moisture content by volume titration method.Results Dense 2BS cell monolayer with high quality was prepared by subculture at a mass ratio of 1 ∶ 2 and addition of 300 ml of medium,of which the CPE reached more than 80% at time of harvest.The cells with CPE were round,most of which were in typical shape.The titers of bulk and final product of vaccine prepared with cells subcultured at a mass ratio of 1 ∶ 4 were significantly lower than those at 1 ∶ 2.However,the titer in stability test at 37 ℃ of final product of vaccine prepared with the cells subcultured at a mass ratio of 1 ∶ 4 failed to met the requirements of not less than 4.6 lgPFU/ml after storage for one week.Other indexes met the relevant requirements.Conclusion A culture procedure for 2BS cell factory during production of herpes zoster vaccine was developed,by which dense 2BS cells with even and high quality were prepared.%目的 建立带状疱疹疫苗生产中2BS细胞在细胞工厂中的培养工艺.方法 将2BS细胞复苏(28代)后,连续传代至35、36代,再分别按1∶4、1∶2比例传至10层细胞工厂中,采用不同的加液量(200、300、400 ml/层)进行培养,显微镜下观察细胞形态,并

  16. 辨证取穴配合刺络拔罐治疗带状疱疹疗效观察%Observation of curative effect of herpes zoster treated with acupuncture based on syndrome differentiation combined with pricking and cupping

    Institute of Scientific and Technical Information of China (English)

    潘华

    2011-01-01

    目的:比较辨证取穴配合刺络拔罐法与单纯刺络拔罐法治疗带状疱疹的疗效差异.方法:将86例患者随机分为观察组(43例)、对照组(43例).观察组采用辨证取穴配合局部刺络拔罐治疗,分为肝胆湿热型、脾虚湿蕴型、气虚血瘀型,穴取曲池、足三里、三阴交等;对照组采用单纯局部刺络拔罐法.两组每日1次,7天为一疗程,2个疗程后统计疗效,1月后随访.结果:观察组愈显率为93.0%(40/43),优于对照组的67.4%(29/43)(P<0.01).后遗神经痛:观察组发生率2.3%(1/43),对照组14.0%(6/43),观察组低于对照组(P<0.05).分型比较:肝胆湿热型愈显率:观察组94.7%(18/19),对照组85.7%(18/21),差异无统计学意义(P>0.05);脾虚湿蕴型愈显率:观察组93.8%(15/16),优于对照组60.0%(9/15)(P<0.05);气虚血瘀型愈显率:观察组87.5%(7/8),明显优于对照组的28.6%(2/7)(P<0.05).结论:辨证取穴配合刺络拔罐治疗带状疱疹,针对性强、疗效明显,可显著减少后遗神经痛,疗效优于单纯刺络拔罐法.%Objective To compare the differences of curative effects of herpes zoster treated with acupuncture based on syndrome differentiation combined with pricking and cupping and simple pricking and cupping. Methods Eighty-six cases were randomly divided into an observation group (43 cases) and a control group (43 cases). In observation group, acupoints selection based on syndrome differentiation I.e. Quchi( LI 11), ZusanlKST 36), Sanyinjiao ( SP 6), etc. Were selected and pricking and cupping at affected parts were applied, and the cases were classified into damp heat in liver and gallbladder, damp retention and spleen deficiency, and qi deficiency and blood stasis. In control group, all the cases were simplely treated with pricking and cupping at affected parts. The treatment was given once a day, and seven days were made one session. The curative effect was evaluated after 2 courses, and the

  17. Blindness resulting from orbital complications of ophthalmic zoster

    Science.gov (United States)

    Sosnowska, Magdalena; Zajkowska, Agata; Garkowski, Adam; Czupryna, Piotr; Pancewicz, Sławomir; Zajkowska, Joanna

    2015-01-01

    Herpes zoster ophthalmicus occurs when the latent varicella zoster virus (VZV) reactivates in the trigeminal ganglion and ophthalmic branch of the trigeminal nerve. In the elderly, there is a sharp increase in the tendency of secondary skin bacterial infections occurrence due to the deterioration of capabilities of self-care and changed sanitation. We present a case of patient who developed phlegmon of the orbit, which resulted with complete unilateral blindness. Varicella zoster virus infection in the elderly may have a severe course due to the progressive weakening of the immune system related to the age. Moreover, skin lesions around the eye socket require special care in prevention of bacterial superinfections due to the extremely high risk of life-threatening complications or disability. Neuralgia resistant to pharmacological treatment present in the course of ophthalmic zoster and difficulty in caring about skin lesions predispose to the occurrence of complications. PMID:26759550

  18. Chronic herpes simplex virus encephalitis in childhood.

    NARCIS (Netherlands)

    Leen, W.G.; Weemaes, C.M.R.; Verbeek, M.M.; Willemsen, M.A.A.P.; Rotteveel, J.J.

    2006-01-01

    Although herpes simplex virus is a major cause of acute encephalitis in childhood, chronic herpes simplex virus encephalitis has only rarely been reported. This report presents a case of chronic herpes simplex virus encephalitis in a 6-year-old female. Diagnosis was based on the detection of herpes

  19. Zoster vaccine live for the prevention of shingles in the elderly patient

    Directory of Open Access Journals (Sweden)

    Jamie Zussman

    2008-06-01

    Full Text Available Jamie Zussman, Lorraine YoungDepartment of Medicine, Dermatology Division, David Geffen School of Medicine at the University of California, Los Angeles, CaliforniaAbstract: Shingles, also known as herpes zoster, is a common disease in the elderly population that is caused by reactivation of latent varicella zoster virus. Its manifestations and complications can lead to significant short- and long-term morbidity. In 2006, the United States Food and Drug Administration approved Zoster Vaccine Live (Zostavax® for the prevention of herpes zoster in immunocompetent adults age 60 and over. The approval was based on the results of a large, multi-center clinical trial, the Shingles Prevention Study. This study showed that vaccination significantly decreased shingles incidence, burden of illness due to disease, and the development of, and severity of postherpetic neuralgia. This review offers an overview of varicella zoster virus infection and complications, a summary of the Shingles Prevention Study, and a critical analysis designed to aid the practicing physician who has questions about vaccine administration.Keywords: zoster vaccine, shingles, herpes zoster, postherpetic neuralgia, zostavax

  20. Genital Herpes

    Science.gov (United States)

    Genital herpes is a sexually transmitted disease (STD) caused by a herpes simplex virus (HSV). It can cause sores on ... also infect their babies during childbirth. Symptoms of herpes are called outbreaks. You usually get sores near ...

  1. [Vaccines against varicella-zoster virus (VZV)].

    Science.gov (United States)

    Salleras, Luis; Salleras, Montserrat; Soldevila, Nuria; Prat, Andreu; Garrido, Patricio; Domínguez, Ángela

    2015-01-01

    In Western countries, two attenuated varicella vaccines derived from the OKA strain are licensed: Varilrix® GlaxoSmithKline (OKA/RIT strain) and Varivax® Merck Sharp and Dohme (OKA/Merck strain). Currently, in Spain, varicella vaccination is only included in the Ministry of Health, Social Services and Equality official vaccination calendar for administration in adolescents who have not had the disease. Given the good results obtained in Navarra and Madrid with universal administration of the vaccine in children, it would be desirable to include the vaccine in the routine immunization schedule, with the administration of two doses at 15-18 months of age in the future. The protective efficacy of the attenuated herpes zoster vaccine was evaluated in the Shingles Prevention Study, which showed that in the short term (0-4 years) the vaccine reduced the incidence of herpes zoster by 53%, post-herpetic neuralgia by 66%, and the disease burden in immunocompetent persons aged ≥60 years by 61%. Another study demonstrated protective efficacy in persons aged 50-59 years. Over time, the protective efficacy decreases, but remains at acceptable levels, especially for post-herpetic neuralgia and the disease burden. Recently, the results of a controlled clinical trial (phase III) conducted in 18 countries to assess the protective efficacy of the inactivated subunit vaccine (glycoprotein E) adjuvanted with the adjuvant AS01B were published. The study inferred that the vaccine significantly reduced the incidence of herpes zoster in the short term (3.2 years) in people aged ≥50 years. Vaccine protection did not decrease with age at vaccination, ranging between 96.8% and 97.9% in all age groups. Copyright © 2015. Published by Elsevier España, S.L.U.

  2. Recurrent facial urticaria following herpes simplex labialis.

    Science.gov (United States)

    Zawar, Vijay; Godse, Kiran

    2012-03-01

    We describe recurrent acute right-sided facial urticaria associated with herpes labialis infection in a middle-aged female patient. Antiviral medications and antihistamines not only successfully cleared the herpes infection and urticaria but also prevented further recurrences.

  3. Recurrent facial urticaria following herpes simplex labialis

    OpenAIRE

    Vijay Zawar; Kiran Godse

    2012-01-01

    We describe recurrent acute right-sided facial urticaria associated with herpes labialis infection in a middle-aged female patient. Antiviral medications and antihistamines not only successfully cleared the herpes infection and urticaria but also prevented further recurrences.

  4. Sero-Prevalence of Antibodies against Varicella Zoster Virus in Children under Seven-Years Old in 2012 in Tehran, Iran.

    OpenAIRE

    Yasaman Vojgani; Saeed Zarei; Samira Rajaei; Leili Chamani-Tabriz; Fatemeh Ghaemimanesh; Nematallah Mohammadinia; Mahmood Jeddi-Tehrani

    2014-01-01

    Abstract Background Varicella zoster virus (VZV) is a member of herpes family viruses, which causes varicella (chickenpox) after primary infection and herpes zoster (shingles) because of latent virus reactivation from dorsal root ganglia. Generally, prevalence of varicella antibodies increases with age. We aimed to compare the prevalence of anti-VZV antibody in children under seven years old, in order to obtain a preliminarily picture of general presence of these antibodies to design an immun...

  5. Adaptive Immune Responses in a Multiple Sclerosis Patient with Acute Varicella-Zoster Virus Reactivation during Treatment with Fingolimod

    Directory of Open Access Journals (Sweden)

    Andrea Harrer

    2015-09-01

    Full Text Available Fingolimod, an oral sphingosine 1-phosphate (S1P receptor modulator, is approved for the treatment of relapsing forms of multiple sclerosis (MS. The interference with S1P signaling leads to retention particularly of chemokine receptor-7 (CCR7 expressing T cells in lymph nodes. The immunological basis of varicella zoster virus (VZV infections during fingolimod treatment is unclear. Here, we studied the dynamics of systemic and intrathecal immune responses associated with symptomatic VZV reactivation including cessation of fingolimod and initiation of antiviral therapy. Key features in peripheral blood were an about two-fold increase of VZV-specific IgG at diagnosis of VZV reactivation as compared to the previous months, a relative enrichment of effector CD4+ T cells (36% versus mean 12% in controls, and an accelerated reconstitution of absolute lymphocytes counts including a normalized CD4+/CD8+ ratio and reappearance of CCR7+ T cells. In cerebrospinal fluid (CSF the lymphocytic pleocytosis and CD4+/CD8+ ratios at diagnosis of reactivation and after nine days of fingolimod discontinuation remained unchanged. During this time CCR7+ T cells were not observed in CSF. Further research into fingolimod-associated VZV reactivation and immune reconstitution is mandatory to prevent morbidity and mortality associated with this potentially life-threatening condition.

  6. Acute Morphine Administration Reduces Cell-Mediated Immunity and Induces Reactivation of Latent Herpes Simplex Virus Type 1 in BALB/c Mice

    Institute of Scientific and Technical Information of China (English)

    Shafi Mojadadi; Abbas Jamali; Behzad Khansarinejad; Hoorieh Soleimanjahi; Taravat Bamdad

    2009-01-01

    Acute morphine administration is known to alter the course of herpes simplex virus infection. In this study, the effect of acute morphine administration on the reactivation of latent herpes was investigated in a mouse model. Because of the important role of cytolytic T lymphocyte (CTL) activity in the inhibition of herpes simplex virus type 1 (HSV-1) reactivation, the effect of acute morphine administration on CTL responses was also evaluated. Furthermore, lymphocyte proliferation and IFN-γ production were evaluated for their roles in the induction of the CTL response. The findings showed that acute morphine administration significantly reduced CTL responses, lymphocyte proliferation, and IFN-γ production. Furthermore, acute morphine administration has been shown to reactivate latent HSV-1. Previous studies have shown that cellular immune responses have important roles in the inhibition of HSV reactivation. These findings suggest that suppression of a portion of the cellular immune response after acute morphine administration may constitute one part of the mechanism that induces HSV reactivation. Cellular & Molecular Immunology.

  7. Effect of acyclovir combined with narrow-band ultraviolet-B radiation and Carnation 33 NM-B in treating immunocompromised host with herpes zoster%阿昔洛韦联合高能红光和窄谱中波紫外线治疗免疫功能下降带状疱疹患者的疗效观察

    Institute of Scientific and Technical Information of China (English)

    陈胜平; 陈锦华; 陈向齐; 吴洁; 牛高祥

    2013-01-01

      Objective To compare the effect of acyclovir combined with narrow-band ultraviolet-B radiation (NB-UVB) and Carnation 33 NM-B with that of acyclovir in the treatment of herpes zoster in immunocompromised patients. Methods Sixty-four immunocompromised patients with herpes zoster were divided into two groups, test group and control group randomly. The test group was treated with acyclovir combined with NB-UVB and the Carnation 33 NM-B;while the control group was treated with acyclovir. The efficacy was observed 14 days after treatment and the follow-up had been carried out for more than 1 months. Results The effective rate was 90.63%in the test group versus 68.75%in the control group (P=0.011). The effect of test group on vesicular scab, subside, pain relief and pain complete remission time was superior to that of the control group (P0.05). Conclusion The treatment with acyclovir combined with NB-UVB and the Carnation 33 NM-B is superior to acyclovir in immunocompromised patients with herpes zoster.%  目的比较阿昔洛韦联合高能红光和窄谱中波紫外线与单用阿昔洛韦治疗免疫功能下降带状疱疹患者的疗效,寻求一种更好的治疗方法。方法64例免疫功能下降带状疱疹患者随机分为试验组和对照组。试验组采用阿昔洛韦静脉滴注联合高能红光照射支配皮损区域的神经根体表投射部位和窄谱中波紫外线照射皮损局部,对照组单独静脉滴注阿昔洛韦,疗程均为14 d,随访1个月。结果试验组有效率为90.63%,高于对照组(68.75%)(P=0.011);试验组开始结痂时间、结痂脱落时间、疼痛开始缓解时间、疼痛基本缓解时间均低于对照组(P<0.001)。两组患者止疱时间、后遗神经痛发生率比较,差异无统计学意义(P>0.05)。结论阿昔洛韦联合高能红光和窄谱中波紫外线治疗免疫功能下降并发带状疱疹患者的疗效优于单用阿昔洛韦者。

  8. Effects of nerve block combined with antiviral drug on patients with herpes zoster pain and sleep quality%神经阻滞联合抗病毒药物对带状疱疹患者疼痛及睡眠质量影响

    Institute of Scientific and Technical Information of China (English)

    陈慧

    2015-01-01

    Objective To explore the nerve block combined with antiviral drug on patients with herpes zoster treatment effect,and provide the basis for clinical pain relief and improve the quality of sleep.Methods The 90 cases of herpes zoster patients in our hospital in the Department of Dermatology for treatment,30 cases were randomly divided into a,B,C 30 cases 30 cases,group A with simple antiviral therapy,group B with antiviral joint pain relieving antiphlogistic drug therapy,group C treated with nerve block combined with antiviral therapy,recording three groups of visual score (VAS) and sleep quality score (QS),analysis and improvement in three groups of pain and sleep quality.Results The pain scores before and after treatment,in group A had no obvious change for the better,after 2 weeks,will be obviously significant differences (t =4.329,5.424,P < 0.05),C B two groups in 1 weeks after treatment there were significant differences (P < 0.05).In sleep quality,sleep quality has not improved significantly in group A (P >0.05),after 1 weeks,the sleep quality improvement (P < 0.05) before and after treatment in the two groups of ethylene and propylene,there was significant difference (P < 0.05),ethylene propylene no obvious differences between the two groups (P > 0.05).Conclusions The nerve block combined with antiviral drug with good pain relief and improve the role of sleep in patients with herpes zoster,can be used in clinical treatment.%目的 探究神经阻滞联合抗病毒药物对带状疱疹患者治疗效果,为临床疼痛缓解和改善睡眠质量提供依据.方法 选用来我院神经内科就诊带状疱疹患者90例,随机分为甲30例、乙30例、丙30例,甲组采用单纯抗病毒治疗,乙组采用抗病毒联合镇痛消炎药治疗,丙组采用神经阻滞联合抗病毒治疗,记录三组视觉评分(VAS)和睡眠质量评分(QS),分析三组疼痛和睡眠质量改善情况.结果 疼痛评分上,甲组治疗前后未见明显好转,2

  9. Prolonged varicella-zoster virus reinfection in an adult after unrelated cord blood transplantation

    Directory of Open Access Journals (Sweden)

    Masahiro Oka

    2012-01-01

    Full Text Available Most varicella-zoster virus (VZV infections after cord blood transplantation (CBT present as localized herpes zoster. Here, we report a case of VZV reinfection in an adult patient after CBT that appeared clinically to be varicella. A 50-year-old Japanese man underwent CBT for the management of acute lymphoblastic leukemia. Seventeen months later, he developed a small number of vesicles with umbilicated centers. A skin biopsy showed an intraepidermal blister containing degenerated balloon cells. Subsequently, the skin eruption developed over his entire body. The patient was treated with intravenous acyclovir for 5 days, followed by oral valacyclovir for 9 days. It took more than 3 weeks for most of the skin lesions to scab. Serum levels of anti-VZV IgG on days 3 and 33 after the onset of the skin eruption were negative and 260 mIU/ml, respectively. Serum anti-VZV IgM on days 3 and 33 was not detected. Our patient was diagnosed with VZV reinfection.

  10. Varicella-zoster virus: pathogenesis, incidence patterns and vaccination programs.

    Science.gov (United States)

    Gabutti, Giovanni; Franchi, Michele; Maniscalco, Licia; Stefanati, Armando

    2016-06-01

    Varicella or chickenpox is a common and highly contagious exanthematic disease caused by the varicella-zoster virus (VZV) that during primary infection has the ability to establish latency. VZV reactivation, even decades after primary infection, causes herpes zoster. In healthy immunocompetent subjects, children in particular, varicella results in mild to moderate illness and for this reason, regardless its high morbidity, it is not considered a public health priority. Varicella still represents the most widespread vaccine preventable childhood infectious disease in industrialized countries; due to its relevant burden on healthcare resources several countries has introduced varicella vaccination into the recommended routine childhood national immunization schedule. Nowadays, live attenuated monovalent and combined MMRV vaccines are licensed worldwide. The use of several millions of doses has demonstrated the excellent safety and efficacy level of varicella vaccines as well as of combined MMRV vaccines. Universal vaccination adopted in many countries with a two-dose strategy has allowed to significantly reducing morbidity and mortality of this infectious disease. Anyway, an ample international debate is ongoing on the time range to be used between the two doses, and on the safety issues related to the use as first-dose of MMRV vaccine. Taking into account the availability of a zoster vaccine in subjects older than 50 years of age, it will be relevant to clarify if an impact on exogenous boosters and on the epidemiology of herpes zoster can occur after the adoption of extensive varicella immunization.

  11. Corticosteroid therapy of zoster-associated pain

    Directory of Open Access Journals (Sweden)

    Cvjetković Dejan M.

    2004-01-01

    Full Text Available Introduction Lack of exact clinical studies on effects of corticosteroids in therapy and prevention of herpes zoster-related pain, elicited many controversies in the past. The aim of our study was to estimate effects of prednisone on frequency, intensity and duration of postherpetic neuralgia. Material and methods 68 immunocompetent herpes zoster patients, 8-90 years of age (37 females and 31 males, mean age 55,7 years were enrolled for study; 30 patients were treated with acyclovir (5x800 mg daily for a 7-day period and prednisone (initial daily dose 60 mg, tapering over 14 days, and the control group of 38 patients with acyclovir only. Patients were clinically followed up for 3 months after complete resolution of skin lesions. Chi-square test was used in statistical data analysis. Results The difference regarding incidence of postherpetic neuralgia in acyclovir/prednisone group and acyclovir group (although slightly less in the former one was not significant. Duration of postherpetic neuralgia over 3 months was similar in both groups. Mild postherpetic pain was more common in the acyclovir/prednisone group (44.4% than in the acyclovir group (28.6%; however, statistical validation requires more patients to be studied. Discussion Results of our study didn’t confirm efficiency of prednisone regarding occurrence and characteristics of postherpetic neuralgia. Failure of prednisone therapy may be partly contributed to advanced age of patients and delayed onset of therapy. Conclusion Use of corticosteroids in zoster patients gives neither reliable protection from appearance of postherpetic neuralgia, nor shortens its duration. Further investigations are necessary to estimate their effects on postherpetic pain.

  12. Sex differences underlying orofacial varicella zoster associated pain in rats.

    Science.gov (United States)

    Stinson, Crystal; Deng, Mohong; Yee, Michael B; Bellinger, Larry L; Kinchington, Paul R; Kramer, Phillip R

    2017-05-17

    Most people are initially infected with varicella zoster virus (VZV) at a young age and this infection results in chickenpox. VZV then becomes latent and reactivates later in life resulting in herpes zoster (HZ) or "shingles". Often VZV infects neurons of the trigeminal ganglia to cause ocular problems, orofacial disease and occasionally a chronic pain condition termed post-herpetic neuralgia (PHN). To date, no model has been developed to study orofacial pain related to varicella zoster. Importantly, the incidence of zoster associated pain and PHN is known to be higher in women, although reasons for this sex difference remain unclear. Prior to this work, no animal model was available to study these sex-differences. Our goal was to develop an orofacial animal model for zoster associated pain which could be utilized to study the mechanisms contributing to this sex difference. To develop this model VZV was injected into the whisker pad of rats resulting in IE62 protein expression in the trigeminal ganglia; IE62 is an immediate early gene in the VZV replication program. Similar to PHN patients, rats showed retraction of neurites after VZV infection. Treatment of rats with gabapentin, an agent often used to combat PHN, ameliorated the pain response after whisker pad injection. Aversive behavior was significantly greater for up to 7 weeks in VZV injected rats over control inoculated rats. Sex differences were also seen such that ovariectomized and intact female rats given the lower dose of VZV showed a longer affective response than male rats. The phase of the estrous cycle also affected the aversive response suggesting a role for sex steroids in modulating VZV pain. These results suggest that this rat model can be utilized to study the mechanisms of 1) orofacial zoster associated pain and 2) the sex differences underlying zoster associated pain.

  13. Complications of varicella zoster.

    Science.gov (United States)

    Gücüyener, Kivilcim; Citak, Elvan Cağlar; Elli, Murat; Serdaroğlu, Ayse; Citak, Funda Erkasar

    2002-02-01

    Primary infection with varicella zoster is characterzed by a generalized vesicular rash usually without significant systemic illness. Encephalitis, pneumonitis, pancreatitis, nephritis, Reye and Guillan-Barre syndrome transvers myelitis, myocarditis have been reported before, but there is not any case having all these system to be involved during the same infection in a sequential manner ending up with multiorgan failure. We wanted to represent 21-month-old boy had a multiorgan failure due to varicella zoster infection.

  14. Herpes - oral

    Science.gov (United States)

    ... this page: //medlineplus.gov/ency/article/000606.htm Herpes - oral To use the sharing features on this page, ... 374. Read More Atopic dermatitis Cancer Fever Genital herpes Mouth ulcers Vesicles Review Date 8/14/2015 Updated ...

  15. Optimal management of genital herpes: current perspectives

    Directory of Open Access Journals (Sweden)

    Sauerbrei A

    2016-06-01

    Full Text Available Andreas Sauerbrei Institute of Virology and Antiviral Therapy, German Consulting Laboratory for Herpes Simplex Virus and Varicella-Zoster Virus, Jena University Hospital, Friedrich-Schiller University of Jena, Jena, Germany Abstract: As one of the most common sexually transmitted diseases, genital herpes is a global medical problem with significant physical and psychological morbidity. Genital herpes is caused by herpes simplex virus type 1 or type 2 and can manifest as primary and/or recurrent infection. This manuscript provides an overview about the fundamental knowledge on the virus, its epidemiology, and infection. Furthermore, the current possibilities of antiviral therapeutic interventions and laboratory diagnosis of genital herpes as well as the present situation and perspectives for the treatment by novel antivirals and prevention of disease by vaccination are presented. Since the medical management of patients with genital herpes simplex virus infection is often unsatisfactory, this review aims at all physicians and health professionals who are involved in the care of patients with genital herpes. The information provided would help to improve the counseling of affected patients and to optimize the diagnosis, treatment, and prevention of this particular disease. Keywords: herpes simplex virus, epidemiology, infection, antiviral therapy, laboratory diagnosis, prevention

  16. 梅花针配合拔罐治疗带状疱疹及后遗神经痛33例%Zoster and postherpetic neuralgia treated by percussopunctato combined with cupping therapy 33 cases

    Institute of Scientific and Technical Information of China (English)

    韩利民; 赵树林

    2003-01-01

    @@ BACKGROUND: If the zoster patients were not treated properly or failed to be cured in time, secondary infection or postherpetic neuralgia may appeared. Severe pain might exist for years although the herpes recovered completely.

  17. Pupilparalyse. En sjaelden komplikation ved øjeninfektion med Varicella zoster-virus

    DEFF Research Database (Denmark)

    Hallas, P

    2001-01-01

    Pupillary paralysis and paresis of the peripheral facial nerve on the left side was found in a 68-year-old man with concussion and herpes zoster ophthalmicus on the left eye. Post mortem examination showed no sign of intracranial hemorrhage. The cause of death was pulmonary oedema and aspiration...

  18. Acute Interstitial Nephritis Proteinuria and Herpes Simplex Virus Hepatitis in Pregnancy Mimic HELLP Syndrome (Hemolysis, Elevated Liver Enzymes, Low Platelets

    Directory of Open Access Journals (Sweden)

    Wendy M. White

    2011-12-01

    Full Text Available Elevated transaminases, hemolysis, and thrombocytopenia in pregnancy are most often caused by a preeclampsia variant—HELLP syndrome (hemolysis, elevated liver enzymes, low platelets. In atypical cases, it is important to consider other causes, such as herpes simplex virus (HSV hepatitis. Acute interstitial nephritis (AIN-induced proteinuria can make distinguishing HELLP from its mimics more difficult. A 43-year-old G4P3 gestational carrier at 28 weeks had abnormal laboratory findings consistent with HELLP, including proteinuria. However, she was normotensive and febrile, prompting an investigation into other possible causes of her signs and symptoms. She ultimately was diagnosed with disseminated HSV infection, started on definitive therapy, and allowed to continue her pregnancy to term. The proteinuria was attributed to AIN. AIN can cause proteinuria in the critically ill pregnant patient. When mimics of HELLP syndrome, such as disseminated HSV infection, are the cause of critical illness, the presence of AIN-induced proteinuria may falsely implicate a hypertensive disorder of pregnancy, resulting in iatrogenic premature delivery of the fetus and failure to initiate definitive potential lifesaving treatment.

  19. Varicella zoster meningitis complicating combined anti-tumor necrosis factor and corticosteroid therapy in Crohn's disease.

    Science.gov (United States)

    Ma, Christopher; Walters, Brennan; Fedorak, Richard N

    2013-06-01

    Opportunistic viral infections are a well-recognized complication of anti-tumor necrosis factor (TNF) therapy for inflammatory bowel disease (IBD). Cases of severe or atypical varicella zoster virus infection, both primary and latent reactivation, have been described in association with immunosuppression of Crohn's disease (CD) patients. However, central nervous system varicella zoster virus infections have been rarely described, and there are no previous reports of varicella zoster virus meningitis associated with anti-TNF therapy among the CD population. Here, we present the case of a 40-year-old male with severe ileocecal-CD who developed a reactivation of dermatomal herpes zoster after treatment with prednisone and adalimumab. The reactivation presented as debilitating varicella zoster virus meningitis, which was not completely resolved despite aggressive antiviral therapy with prolonged intravenous acyclovir and subsequent oral valacyclovir. This is the first reported case of opportunistic central nervous system varicella zoster infection complicating anti-TNF therapy in the CD population. This paper also reviews the literature on varicella zoster virus infections of immunosuppressed IBD patients and the importance of vaccination prior to initiation of anti-TNF therapy.

  20. Herpes Simplex Vaccines: Prospects of Live-attenuated HSV Vaccines to Combat Genital and Ocular infections

    Science.gov (United States)

    Stanfield, Brent; Kousoulas, Konstantin Gus

    2015-01-01

    Herpes simplex virus type-1 (HSV-1) and its closely related type-2 (HSV-2) viruses cause important clinical manifestations in humans including acute ocular disease and genital infections. These viruses establish latency in the trigeminal ganglionic and dorsal root neurons, respectively. Both viruses are widespread among humans and can frequently reactivate from latency causing disease. Currently, there are no vaccines available against herpes simplex viral infections. However, a number of promising vaccine approaches are being explored in pre-clinical investigations with few progressing to early phase clinical trials. Consensus research findings suggest that robust humoral and cellular immune responses may partially control the frequency of reactivation episodes and reduce clinical symptoms. Live-attenuated viral vaccines have long been considered as a viable option for generating robust and protective immune responses against viral pathogens. Varicella zoster virus (VZV) belongs to the same alphaherpesvirus subfamily with herpes simplex viruses. A live-attenuated VZV vaccine has been extensively used in a prophylactic and therapeutic approach to combat primary and recurrent VZV infection indicating that a similar vaccine approach may be feasible for HSVs. In this review, we summarize pre-clinical approaches to HSV vaccine development and current efforts to test certain vaccine approaches in human clinical trials. Also, we discuss the potential advantages of using a safe, live-attenuated HSV-1 vaccine strain to protect against both HSV-1 and HSV-2 infections. PMID:27114893

  1. Management of ramsay hunt syndrome in an acute palliative care setting

    Directory of Open Access Journals (Sweden)

    Shrenik Ostwal

    2015-01-01

    Full Text Available Introduction: The Ramsay Hunt syndrome is characterized by combination of herpes infection and lower motor neuron type of facial nerve palsy. The disease is caused by a reactivation of Varicella Zoster virus and can be unrepresentative since the herpetic lesions may not be always be present (zoster sine herpete and might mimic other severe neurological illnesses. Case Report: A 63-year-old man known case of carcinoma of gall bladder with liver metastases, post surgery and chemotherapy with no scope for further disease modifying treatment, was referred to palliative care unit for best supportive care. He was on regular analgesics and other supportive treatment. He presented to Palliative Medicine outpatient with 3 days history of ipsilateral facial pain of neuropathic character, otalgia, diffuse vesciculo-papular rash over ophthalmic and maxillary divisions of left trigeminal nerve distribution of face and ear, and was associated with secondary bacterial infection and unilateral facial edema. He was clinically diagnosed to have Herpes Zoster with superadded bacterial infection. He was treated with tablet Valacyclovir 500 mg four times a day, Acyclovir cream for local application, Acyclovir eye ointment for prophylactic treatment of Herpetic Keratitis, low dose of Prednisolone, oral Amoxicillin and Clindamycin for 7 days, and Pregabalin 150 mg per day. After 7 days of treatment, the rash and vesicles had completely resolved and good improvement of pain and other symptoms were noted. Conclusion: Management of acute infections and its associated complications in an acute palliative care setting improves both quality and length of life.

  2. Epidemiological characteristics and societal burden of varicella zoster virus in the Netherlands

    Directory of Open Access Journals (Sweden)

    Pierik Jorien GJ

    2012-05-01

    Full Text Available Abstract Background Varicella and herpes zoster are both caused by varicella zoster virus (VZV infection or reactivation and may lead to complications associated with a (severe societal burden. Because the epidemiology of VZV-related diseases in the Netherlands remains largely unknown or incomplete, the main objective of this study was to study the primary care incidence, associated complications and health care resource use. Methods We investigated the incidence of VZV complications in the Dutch general practitioner (GP practices and pharmacies in a retrospective population-based cohort study (2004–2008 based on longitudinal GP data including free text fields, hospital referral and discharge letters from approximately 165,000 patients. Results The average annual incidence of varicella GP-consultations was 51.5 per 10,000 (95% CI 44.4-58.7 overall; 465.5 per 10,000 for 0–1 year-olds; 610.8 per 10,000 for 1–4 year-olds; 153.5 per 10,000 for 5–9 year-olds; 8,3 per 10,000 for >10 year olds. When only ICPC coded diagnoses were analyzed the incidence was 27% lower. The proportion of complications among varicella patients was 34.9%. Most frequently complications were upper respiratory tract infections. Almost half of the varicella patients received medication. The referral rate based on GP consultations was 1.7%. The average annual incidence of herpes zoster GP-consultations was 47.5 per 10,000 (95% CI 40.6-54.4. The incidence increased with age; 32.8 per 10,000 for 65 year olds. When estimating herpes zoster incidence only on ICPC coded information, the incidence was 28% lower. The complication rate of herpes zoster was 32.9%. Post herpetic neuralgia was seen most often. Of patients diagnosed with herpes zoster 67.8% received medication. The referral rate based on GP consultations was 3.5%. Conclusions For varicella the highest incidence of GP-consultations was found in 1–4 year-olds, for herpes zoster in the >65 years olds

  3. 牛痘疫苗致炎兔皮提取物注射液联合阿昔洛韦治疗老年带状疱疹的临床观察%Clinical Observation of Extracts from Rabbit Skin Inflamed by Vaccinia Virus for Injection Combined with Acyclovir in the Treatment of Senile Herpes Zoster

    Institute of Scientific and Technical Information of China (English)

    刘国海; 张贵田; 刘庆明

    2013-01-01

    目的:观察牛痘疫苗致炎兔皮提取物注射液联合阿昔洛韦治疗老年带状疱疹的疗效和安全性.方法:将120例患者均分成治疗组和对照组,治疗组给予牛痘疫苗致炎兔皮提取物注射液、阿昔洛韦、维生素B1、维生素B12联合治疗;对照组给予阿昔洛韦、维生素B1、维生素B12常规治疗,观察两组止疱时间、止痛时间、结痂时间、痊愈时间;并于治疗前及治疗第3、7、10天进行疼痛视觉模拟评分(VAS)评价,治疗过程中观察患者不良反应发生情况.结果:治疗组的止疱时间、止痛时间、结痂时间、痊愈时间、VAS评分等方面均优于对照组(P<0.05).两组均未见明显不良反应发生.结论:牛痘疫苗致炎兔皮提取物注射液联合阿昔洛韦治疗老年带状疱疹疗效较好、安全性较高,可明显减少后遗神经痛.%OBJECTIVE: To observe therapeutic efficacy and safety of Extracts from rabbit skin inflamed by vaccinia virus for injection (analgecine) combined with acyclovir in the treatment of senile herpes zoster. METHODS: 120 patients were randomly divided into treatment group and control group; treatment group received analgecine, acyclovir, vitamin B1 and vitamin B12, and control group was given conventional treatment of acyclovir, vitamin B1 and vitamin B12. The time of response and analgesia, duration of lesion clearance and recovery time were observed in 2 groups. Pain visual analog scale (VAS) evaluation was conducted before treatment, 3, 7 and 10 days after treatment. The adverse drug reaction in the treatment were observed. RESULTS: The time of response and analgesia, duration of lesion clearance and recovery time in treatment group were better than in control group (P< 0.05). VAS scores decreased significantly. There was no significant ADR found in both groups. CONCLUSION: Analgecine combined with acyclovir is effective in the treatment of herpes zoster, and can significantly reduce postherpetic

  4. 点刺拔罐配合氦氖激光联合药物治疗早期带状疱疹的临床观察%Venesection Ventouse Coordinated with Helium-neon Laser Combined with Drugs Treat Early Herpes Zoster

    Institute of Scientific and Technical Information of China (English)

    马荣; 陈宏

    2015-01-01

    Objective]Observe the clinical effect of early herpes zoster which were treated by venesection ventouse combined with helium-neon laser and drugs. [Methods]The control group 32 cases used Famciclovir Tablet,transfer factor capsules,mecobalamin and acyclovir cream-drug for external use. While the experimental group 32 cases used Famciclovir Tablet,transfer factor capsules,mecobalamin and acyclovir cream-drug for external use. While the experimental group besides taking above-medicine, were treated with venesection ventouse and helium-neon laser at the pathological change. [Results]The control group used to cure for an average of 13 ±2.5 days. The experimental group used to cure for an average of 9.6 ±2.4 days. There were significant differences(P<0.05). [Conclusion] Early herpes zoster treated by venesection ventouse combined with helium-neon laser and drugs, can significantly shorten the duration of symptoms, alleviate suffering, and has good clinical efficacy.%[目的]观察点刺拔罐配合氦氖激光联合药物治疗早期带状疱疹的临床疗效。[方法]选取天津市长征医院2013年5月至2013年10月皮肤科门诊就诊的早期带状疱疹患者64例,按其就诊的先后顺序随机分为实验组32例和对照组32例,对照组给予口服药泛昔洛韦片、转移因子胶囊、甲钴胺片及外用药阿昔洛韦软膏;实验组32例,在对照组治疗基础上再施以点刺拔罐配合氦氖激光辅助治疗。运用统计学分析两组患者的平均治愈时间。[结果]对照组达到治愈所用的平均时间为13±2.5天,实验组达到治愈所用的平均时间为9.6±2.4天,实验组优于对照组,差异有统计学意义(P<0.05)。[结论]运用点刺拔罐配合氦氖激光联合药物治疗早期带状疱疹可以明显缩短病程、减轻病痛,有较好的临床疗效。

  5. Immune- and Nonimmune-Compartment-Specific Interferon Responses Are Critical Determinants of Herpes Simplex Virus-Induced Generalized Infections and Acute Liver Failure.

    Science.gov (United States)

    Parker, Zachary M; Pasieka, Tracy Jo; Parker, George A; Leib, David A

    2016-12-01

    The interferon (IFN) response to viral pathogens is critical for host survival. In humans and mouse models, defects in IFN responses can result in lethal herpes simplex virus 1 (HSV-1) infections, usually from encephalitis. Although rare, HSV-1 can also cause fulminant hepatic failure, which is often fatal. Although herpes simplex encephalitis has been extensively studied, HSV-1 generalized infections and subsequent acute liver failure are less well understood. We previously demonstrated that IFN-αβγR(-/-) mice are exquisitely susceptible to liver infection following corneal infection with HSV-1. In this study, we used bone marrow chimeras of IFN-αβγR(-/-) (AG129) and wild-type (WT; 129SvEv) mice to probe the underlying IFN-dependent mechanisms that control HSV-1 pathogenesis. After infection, WT mice with either IFN-αβγR(-/-) or WT marrow exhibited comparable survival, while IFN-αβγR(-/-) mice with WT marrow had a significant survival advantage over their counterparts with IFN-αβγR(-/-) marrow. Furthermore, using bioluminescent imaging to maximize data acquisition, we showed that the transfer of IFN-competent hematopoietic cells controlled HSV-1 replication and damage in the livers of IFN-αβγR(-/-) mice. Consistent with this, the inability of IFN-αβγR(-/-) immune cells to control liver infection in IFN-αβγR(-/-) mice manifested as profoundly elevated aspartate transaminase (AST) and alanine transaminase (ALT) levels, indicative of severe liver damage. In contrast, IFN-αβγR(-/-) mice receiving WT marrow exhibited only modest elevations of AST and ALT levels. These studies indicate that IFN responsiveness of the immune system is a major determinant of viral tropism and damage during visceral HSV infections. Herpes simplex virus 1 (HSV-1) infection is an incurable viral infection with the most significant morbidity and mortality occurring in neonates and patients with compromised immune systems. Severe pathologies from HSV include the

  6. [Human herpes virus type 6, etiology of an acute encephalitis in childhood: case report].

    Science.gov (United States)

    Afenjar, A; Rodriguez, D; Rozenberg, F; Dorison, N; Guët, A; Mignot, C; Doummar, D; Billette de Villemeur, T; Ponsot, G

    2007-05-01

    Primary infection with human herpesvirus-6 (HHV-6) causes the classical roseola infantum. Otherwise the infection is clinically silent but it may sometimes be responsible for central nervous system involvement. In order to illustrate such a type of lesions, we report on a 16-month-old girl with acute leucoencephalitis. The disease started with pyrexia 40 degrees C, followed by an episode of seizure, erythematous rash on the trunk and then coma. Brain MRI showed wide lesions on white matter. HHV-6 DNA was detected by PCR in the CSF and serum at the acute stage, and tests for HHV-6 antibody showed a significant increase of IgG antibody titre between acute and convalescent sera. One month later complete clinical recovery was observed while the MRI showed a partial disappearance of the lesions. The sero-conversion associated with the detection of the viral DNA in the serum identified a primary HHV-6 infection and the detection of viral nucleic acid in CSF gives arguments for the responsibility of the virus in the pathogenesis. When facing an acute leuco-encephalitis in infants, it is important to perform exhaustive virology investigations to rule out the implication of HHV-6 as well as other commonly incriminated pathogens (EBV, CMV, mycoplasma, enterovirus) to avoid accusing wrongly the vaccines.

  7. Effect of Compound Shenqi Vitamin E Capsules Combined with Famciclovir on Immune Function in Patients with Herpes Zoster%复方参芪维E胶囊联合泛昔洛韦对带状疱疹患者免疫功能的影响

    Institute of Scientific and Technical Information of China (English)

    郝燕生; 杨玉明

    2014-01-01

    目的:探讨复方参芪维 E 胶囊联合泛昔洛韦对带状疱疹患者免疫功能的影响。方法将124例患者随机分为两组,各62例。对照组患者应用泛昔洛韦治疗,同时肌肉注射干扰素α-2b,持续用药7 d;观察组开始用药同对照组,停药后口服复方参芪维 E 胶囊,持续用药10 d。对比分析两组患者临床疗效及症状缓解时间,治疗前后应用流式细胞仪测定两组 T 淋巴细胞亚群。结果观察组总有效率为93.55%,明显高于对照组的77.42%( P <0.05)。观察组止疱、结痂、疼痛缓解、脱痂时间均明显短于对照组( P <0.05)。观察组治疗后CD +3,CD4+,CD4+/ CD +8水平显著高于对照组,而CD +8水平则低于对照组( P <0.05)。观察组后遗神经痛发生率为0(0/62),低于对照组的8.06%(5/62),两组比较有统计学差异( P <0.05)。结论复方参芪维 E 胶囊联合泛昔洛韦治疗带状疱疹,能有效提高疗效,缓解临床症状,且能有效预防后遗神经痛的发生,同时可提高患者的免疫功能。%Objective To investigate the effect of Compound Shenqi Vitamin E Capsules combined with famciclovir on the immune func-tion in the patients with herpes zoster. Methods 124 cases of herpes zoster were randomly divided into the observation group( n = 62) and the control group( n = 62). The control group simultaneously applied famciclovir and intramuscular injection of interferon for continu-ous 7 d;while at the beginning the medication in the observation group was same to the control group,after drug withdrawal oral Compound Shenqi Vitamin E Capsules was given for continuous 10 d. The clinical effects and the symptom remission time were com-pared between the two groups. The levels of CD4+ T lymphocyte subsets before and after treatment in the two groups were detected by the flow cytometry. Results The total effective rate of observation group was 93. 55% ,which was higher than

  8. Clinical study of liquid nitrogen cryotherapy combined with acyclovir and mecobalamin in elderly patients with herpes zoster%液氮冷冻疗法联合阿昔洛韦片及甲钴胺分散片治疗老年人带状疱疹临床观察

    Institute of Scientific and Technical Information of China (English)

    曹鸿玮; 王菲菲; 杨俊亚; 王瑞; 郑晓红

    2014-01-01

    目的 探讨液氮冷冻疗法联合阿昔洛韦片、甲钴胺分散片口服治疗老年人带状疱疹的疗效和安全性. 方法 将520例老年人带状疱疹患者随机数字表法分为试验组和对照组,每组各260例,对照组患者口服阿昔洛韦片和甲钴胺分散片治疗,试验组在对照组用药的基础上加用液态氮冷冻治疗,用棉签蘸取液氮在皮损处轻擦,1次/d,共5次.在治疗的第5、14、30天随访患者,观察两组患者是否有新水疱出现、干燥、结痂情况,记录皮疹止疱时间、结痂时间、结痂脱落时间、疼痛消退时间和后遗神经痛(postherpetic neuralgia,PHN)情况. 结果 试验组有效率为93.9%(244/260),高于对照组84.2%(219例),差异有统计学意义(x2=12.32,P<0.05).试验组患者结痂、水疱干燥、疼痛消退时间分别为(2.6±0.8)d、(8.2±1.7)d、(9.2±2.5)d,均低于对照组(4.8±1.4)d,(11.3±2.2)d,(12.8±3.1)d(均P<0.01).试验组止疱时间(1.9±0.6)d与对照组(1.8±0.8)d比较,差异无统计学意义(t=0.933,P>0.05).试验组患者后遗神经痛发生率6.9%(18/260),与对照组患者后遗神经痛发生率18.1%(47/260),差异有统计学意义(x2=14.787,P<0.01). 结论 液氮冷冻联合阿昔洛韦片、甲钴胺分散片口服疗效优于阿昔洛韦片、甲钴胺分散片口服治疗,试验组具有水疱干燥、结痂时间缩短、疼痛消退快、后遗神经痛发生减少的优点.%Objective To compare the efficacy and safety of liquid nitrogen cryotherapy combined with acyclovir and mecobalamin in the treatment of herpes zoster in elderly patients.Methods 520 elderly patients with herpes zoster were randomly divided into two groups,experimental group and control group (n=260,each).Patients in experimental group were treated with liquid nitrogen cryotherapy,using liquid nitrogen cotton swab to graze the skin lesions 2-3 times per day for successive 5 days,combined with acyclovir and mecobalamin.Patients in control

  9. Animal Models of Varicella Zoster Virus Infection

    Directory of Open Access Journals (Sweden)

    Ilhem Messaoudi

    2013-05-01

    Full Text Available Primary infection with varicella zoster virus (VZV results in varicella (chickenpox followed by the establishment of latency in sensory ganglia. Declining T cell immunity due to aging or immune suppressive treatments can lead to VZV reactivation and the development of herpes zoster (HZ, shingles. HZ is often associated with significant morbidity and occasionally mortality in elderly and immune compromised patients. There are currently two FDA-approved vaccines for the prevention of VZV: Varivax® (for varicella and Zostavax® (for HZ. Both vaccines contain the live-attenuated Oka strain of VZV. Although highly immunogenic, a two-dose regimen is required to achieve a 99% seroconversion rate. Zostavax vaccination reduces the incidence of HZ by 51% within a 3-year period, but a significant reduction in vaccine-induced immunity is observed within the first year after vaccination. Developing more efficacious vaccines and therapeutics requires a better understanding of the host response to VZV. These studies have been hampered by the scarcity of animal models that recapitulate all aspects of VZV infections in humans. In this review, we describe different animal models of VZV infection as well as an alternative animal model that leverages the infection of Old World macaques with the highly related simian varicella virus (SVV and discuss their contributions to our understanding of pathogenesis and immunity during VZV infection.

  10. Severe autoimmune hepatitis triggered by varicella zoster infection

    Institute of Scientific and Technical Information of China (English)

    Waleed K Al-Hamoudi

    2009-01-01

    Autoimmune hepatitis (AIH) is a chronic disease of unknown etiology that is characterized by the presence of circulatory autoantibodies and inflammatory histological changes in the liver. Although the pathogenesis of AIH is not known, it is thought that,in a genetically predisposed individual, environmental factors such as viruses can trigger the autoimmune process. Herpes simplex virus, Epstein-Barr virus,measles virus, and hepatitis viruses are thought to play a role in the etiology of AIH. Proteins belonging to these viruses may be similar to the amino acid chains of different autoantigens in the liver, this causes immune cross reactions and liver tissue damage. We report a case of severe AIH following varicella zoster infection in a 23-year-old man, and speculate that,based on the molecular mimicry hypothesis, the liver damage was caused by an immune cross reaction to the viral proteins. Varicella-zoster-induced AIH has not been reported previously.

  11. Asthma as a risk factor for zoster in adults: A population-based case-control study.

    Science.gov (United States)

    Kwon, Hyo Jin; Bang, Duk Won; Kim, Eun Na; Wi, Chung-Il; Yawn, Barbara P; Wollan, Peter C; Lahr, Brian D; Ryu, Euijung; Juhn, Young J

    2016-05-01

    We recently reported an increased risk of herpes zoster (shingles or zoster) in children with asthma, but little is known about whether the same is true for adults with asthma. We determined whether asthma is associated with an increased risk of zoster in adults. This study was designed as a population-based case-control study. Zoster cases during the study period were identified among adults (aged ≥50 years) who resided in Olmsted County, Minnesota. We compared the frequency of asthma between zoster cases and birthday- and sex-matched control subjects (1:2 matching) without a history of zoster. Asthma status was ascertained based on predetermined criteria. A conditional logistic regression model was used to assess the association of asthma with risk of zoster. A total of 371 zoster cases and their 742 matched control subjects were enrolled. Of the 371 cases, 246 (66%) were female, 348 (94%) were white, and the mean ± SD age was 66.8 ± 10.7 years. Twenty-three percent (n = 87) of zoster cases had a history of asthma compared with 15% (n = 114) of control subjects. Controlling for pertinent covariates and confounders, there was a significant association between a history of asthma and risk of zoster (adjusted odds ratio, 1.70; 95% CI, 1.20-2.42; P = .003). The population attributable risk percentage for asthma was about 10%. Asthma is an unrecognized risk factor for zoster in adults. Consideration should be given to immunizing adults with asthma aged more than 50 years as a target group. Copyright © 2015 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

  12. Topical cidofovir-induced acute kidney injury in two severely immunocompromised patients with refractory multidrug-resistant herpes simplex virus infections.

    Science.gov (United States)

    Saunders, Ila M; Lahoti, Amit; Chemaly, Roy F; Trevino, Cynthia; Westmoreland, Michael; Hosing, Chitra

    2016-04-01

    Cidofovir, a nucleoside analog of deoxycytidine monophosphate, is a water-soluble polar molecule that exhibits antiviral activity against a broad range of DNA viruses. Cidofovir for injection is approved for the treatment of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome. The safety and efficacy of topical cidofovir has been described in a limited number of patients. We present two cases of multidrug-resistant herpes simplex virus infections that responded to topical cidofovir therapy yet resulted in irreversible acute kidney injury.

  13. VARICELLA ZOSTER VIRUS-ITS PATHOGENESIS, LATENCY & CELL-MEDIATED IMMUNITY

    Directory of Open Access Journals (Sweden)

    Anis Ahmed

    2013-07-01

    Full Text Available Varicella zoster virus causes primary infection as chickenpox, at which time latencyis established in the neurons of the dorsal root ganglia or ganglia of the cranial nerves.Reactivation produces herpes zoster infection (HZI, commonly called shingles. Anunderstanding of the mechanisms of latency is crucial in developing effective therapies forVZV infections of the nervous system. This article describes the pathogenesis of VZVwhich includes immune response to the virus, immune evasion by the virus, mechanism ofits latency and cell-mediated immunity.

  14. Herpes Simplex Virus Infection Mimicking Bullous Disease in an Immunocompromised Patient

    Directory of Open Access Journals (Sweden)

    Anne L.Y. Lecluse

    2010-06-01

    Full Text Available Immunodeficient patients are at risk of developing extended or atypical herpes simplex virus infections, which can be easily misdiagnosed. We present the case of a 79-year-old, treatment-induced (oral corticosteroid, immunocompromised female with an extensive atypical herpes simplex virus infection. This patient presented with multiple erosions and vesicles on the trunk with a subacute onset. The clinical differential diagnosis was herpes simplex infection, herpes zoster infection, pemphigus vulgaris or bullous pemphigoid. Due to the atypical clinical presentation and negative Tzanck test, suspicion of viral infection was low. High-dose steroid treatment was initiated. Subsequent histopathology, however, showed a herpes simplex virus infection. After discontinuing steroid treatment and initiating antiviral treatment, the patient recovered within a week. Emphasis must be placed on the importance of clinical awareness of extended and clinically atypical herpes simplex infections in immunocompromised patients. A negative Tzanck test does not rule out the possibility of a herpes infection.

  15. Varicella zoster virus-induced pain and post-herpetic neuralgia in the human host and in rodent animal models.

    Science.gov (United States)

    Kinchington, Paul R; Goins, William F

    2011-12-01

    Pain and post-herpetic neuralgia (PHN) are common and highly distressing complications of herpes zoster that remain a significant public health concern and in need of improved therapies. Zoster results from reactivation of the herpesvirus varicella zoster virus (VZV) from a neuronal latent state established at the primary infection (varicella). PHN occurs in some one fifth to one third of zoster cases with severity, incidence, and duration of pain increasing with rising patient age. While VZV reactivation and the ensuing ganglionic damage trigger the pain response, the mechanisms underlying protracted PHN are not understood, and the lack of an animal model of herpes zoster (reactivation) makes this issue more challenging. A recent preclinical rodent model has developed that opens up the potential to allow the exploration of the underlying mechanisms and treatments for VZV-induced pain. Rats inoculated with live cell-associated human VZV into the hind paw reliably demonstrate thermal hyperalgesia and mechanical allodynia for extended periods and then spontaneously recover. Dorsal root ganglia express a limited VZV gene subset, including the IE62 regulatory protein, and upregulate expression of markers suggesting a neuropathic pain state. The model has been used to investigate treatment modalities and aspects of pain signaling and is under investigation by the authors to delineate VZV genetics involved in the induction of pain. This article compares human zoster-associated pain and PHN to the pain indicators in the rat and poses important questions that, if answered, could be the basis for new treatments.

  16. Serum herpes simplex antibodies

    Science.gov (United States)

    ... 2. HSV-1 most often causes cold sores (oral herpes). HSV-2 causes genital herpes. How the Test ... whether a person has ever been infected with oral or genital herpes . It looks for antibodies to herpes simplex virus ...

  17. Effect of corticosteroid therapy in acute pain edema caused by ...

    African Journals Online (AJOL)

    and skin lesions caused by herpes zoster, and to develop some pertinent therapeutic guidelines. Methods: A total of ... neuralgia continues after skin lesions subside. (usually 4 weeks ..... nursing progress of cancer patients. Med Innov Chin,.

  18. Dose related efficacy of gabapentin in acute herpetic neuralgia among geriatric patients

    Directory of Open Access Journals (Sweden)

    Sanjay Kumar Kanodia

    2012-01-01

    Full Text Available Background: Herpes zoster is an intractable painful condition, more severe in elderly patients. The pain during the first 30 days of onset is known as Acute Herpetic Neuralgia. Multiple treatments using non-steroidal anti-inflammatory drugs (NSAIDs, opioids, and tricyclic anti-depressants are available, but their side effects limit their use in geriatric patients. Gabapentin is also used in chronic neuropathic pain; however, its role in acute herpetic neuralgia is less explored. Aim : This study was aimed to determine dose related efficacy and safety of gabapentin in reducing pain of acute herpetic neuralgia in geriatric patients. Materials and Methods: In this placebo-controlled, four-week trial including 56 subjects, 42 patients received gabapentin in the dosage of 300 mg (n=15, 600 mg (n=14, and 900 mg(n=13 per day in divided doses and 14 patients received placebo within 72 hours of onset of herpes zoster. Results: Subjects receiving gabapentin had a statistically significant reduction (P0.05. Conclusion: The results of this study show that gabapentin is effective in acute herpetic neuralgia in different doses with 600 mg/day being the more appropriate dose in terms of safety and efficacy.

  19. Genital Herpes

    Science.gov (United States)

    ... fetal scalp electrode (tiny wire used to check fetal heart rate). Cesarean birth may be recommended if you have an active herpes sore or prodromal symptoms such as pain or burning when you go into labor. After ...

  20. Genital herpes

    Science.gov (United States)

    ... In: Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious ... JT and Corey L. Herpes simplex virus. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, ...

  1. Refining criteria for diagnosis of cutaneous infections caused by herpes viruses through correlation of morphology with molecular pathology

    Directory of Open Access Journals (Sweden)

    Böer Almut

    2006-01-01

    Full Text Available BACKGROUND: Infections of the skin by herpes viruses do not always present themselves in typical fashion. Early diagnosis, however, is crucial for appropriate treatment. Polymerase chain reaction (PCR allows diagnosis and differential diagnosis of herpes virus infections, but the method is not yet available in large parts of the world, where diagnosis is made based on morphology alone. AIM: To refine criteria for the diagnosis of herpes virus infections of the skin by way of correlation of clinical and histopathologic findings with results of PCR studies. METHODS: We studied 75 clinically diagnosed patients of "zoster," "varicella," and "herpes simplex", to correlate clinical and histopathological findings with results of PCR studies on paraffin embedded biopsy specimens. RESULTS: Clinical suspicion of infection by herpes viruses was confirmed by histopathology in 37% of the cases and by PCR studies in 65% of the cases. Zoster was frequently misdiagnosed as infection with herpes simplex viruses (30%. When diagnostic signs of herpes virus infection were encountered histopathologically, PCR confirmed the diagnosis in 94%. By way of correlation with results of PCR studies, initial lesions of herpes virus infections could be identified to have a distinctive histopathological pattern. Herpetic folliculitis appeared to be a rather common finding in zoster, it occurring in 28% of the cases. CONCLUSION: We conclude that correlation of clinical and histopathological features with results of PCR studies on one and the same paraffin embedded specimen permits identification of characteristic morphologic patterns and helps to refine criteria for diagnosis both clinically and histopathologically.

  2. Varicella zoster vaccines and their implications for development of HSV vaccines

    Energy Technology Data Exchange (ETDEWEB)

    Gershon, Anne A., E-mail: aag1@columbia.edu [Department of Pediatrics, Columbia University College of Physicians and Surgeons, 620W. 168th Street, NY, NY 10032 (United States)

    2013-01-05

    Live attenuated vaccines to prevent varicella and zoster have been available in the US for the past 17 years, with a resultant dramatic decrease in varicella incidence and a predicted future decrease in the incidence of zoster. The pathogenesis and immune responses to varicella zoster virus (VZV) as well as the safety and effectiveness of VZV vaccines are reviewed. The lack of sterilizing immunity provided by VZV vaccines has not prevented them from being safe and effective. Virological and pathological information concerning parallels and differences between VZV and herpes simplex virus (HSV) are highlighted. Although VZV and HSV are distinct pathogens, they appear to have similarities in target organs and immunity that provide an expectation of a high likelihood for the success of vaccination against HSV, and predicted to be similar to that of VZV.

  3. Recurrent facial urticaria following herpes simplex labialis

    Directory of Open Access Journals (Sweden)

    Vijay Zawar

    2012-01-01

    Full Text Available We describe recurrent acute right-sided facial urticaria associated with herpes labialis infection in a middle-aged female patient. Antiviral medications and antihistamines not only successfully cleared the herpes infection and urticaria but also prevented further recurrences.

  4. Anti-NMDA Receptor antibody encephalitis with concomitant detection of Varicella zoster virus.

    Science.gov (United States)

    Solís, Natalia; Salazar, Lucrecia; Hasbun, Rodrigo

    2016-10-01

    The typical presentation of anti-NMDA (N-Methyl-d-Aspartate) receptor encephalitis involves young women with psychiatric, neurologic and autonomic symptoms; it is often associated with mature ovarian teratomas. NMDA receptor encephalitis has been described following Herpes simplex virus (HSV) encephalitis. This case describes a classic presentation of anti-NMDA receptor encephalitis with the concomitant presence of Varicella zoster virus in the cerebrospinal fluid.

  5. Epstein-Barr virus associated acute hepatitis with cross-reacting antibodies to other herpes viruses in immunocompetent patients: report of two cases.

    Science.gov (United States)

    Gupta, Ekta; Bhatia, Vikram; Choudhary, Aashish; Rastogi, Archana; Gupta, Naveen L

    2013-03-01

    Epstein-Barr virus (EBV) is the causative agent of infectious mononucleosis (IM) which is characterized by the triad of fever, sore throat, and lymphadenopathy. Self-limited, mild liver function test abnormalities are seen in IM. Acute hepatitis in primary EBV infection is uncommon. Serum transaminases are elevated but are less than fivefold the normal levels in most cases and rarely exceed 10 times the normal levels in primary EBV infections especially in elderly. Laboratory diagnosis of acute EBV infection is by serological assays confirming the presence of EBV viral capsid antigen (VCA) IgM antibodies. Due to antigenic cross-reactivity with Herpes viruses, serological assays lack specificity; hence specific molecular diagnostic methods are required for confirmation of the etiology. The present report describes two cases of acute hepatitis caused by infection with EBV which had indistinguishable clinical features and biochemical markers from acute hepatitis caused by hepatotropic viruses such as hepatitis viruses A-E. The diagnosis of infection by EBV was confirmed by detection of EBV DNA in blood of both the patients and EBV DNA in the liver tissue of one of the patients.

  6. Analysis of clinical characteristics and prognosis of 72 Herpes Zoster among HIV/AIDS patients in Xinjian g Yang Tongtong, Dong Yujie, Ainiwaer, Li Hong, Zhang Yu, Song Yuxia, Lu Xiaobo%艾滋病合并带状疱疹72例患者临床及预后分析

    Institute of Scientific and Technical Information of China (English)

    杨彤彤; 董玉洁; 艾尼瓦尔; 李弘; 张玉; 宋玉霞; 鲁晓擘

    2016-01-01

    Objective To investigate the clinical features, treatment effect and prognosis of Herpes Zoster( HZ) among patients with acquired immunodeficiency syndrome ( AIDS) .Methods Clinical data of 72 AIDS-HZ patients in our hospital were retrospectively reviewed, then the data including clinical characteristics, laboratory examination, treatment and the prognosis of patients were statistically analyzed. Results Our study showed that the majority of these patients were male ( 65.28%) and Uyghur (79.17%), with a mean age of 37.22 ±8.26 years.39(54.17%) patients have a history of intravenous drug using (IDUs).The rash was common seen in the trunk (68.06%) and limbs (26.39%), two or more than two were seen in 12 patients (16.67%).21(29.17%) were combined by skin infections and 67 patients (93.06%) complained with pain.Forty seven(65.28%) patients had a lower CD4 +T lymphocyte counts (<350 cells/μl).The cure rate was 75%(54/72) and the effective rate was 100%after standard treatment ( including antiretroviral therapy, drugs and analgesia therapy) .Conclusions HIV/AIDS-HZ is common in male Uygur patients in Xinjiang.More than half of the cases are IDUs and have a lower CD4 count ( <350 cells/μl ) .Herpes zoster may occurred as a manifestation of immune reconstitution after HAART.However, most of patients with HIV/AIDS-HZ case had a good prognosis after standard treatment.%目的:分析艾滋病合并带状疱疹患者的临床特征、治疗效果及预后。方法采用回顾性研究的方法,对新疆维吾尔自治区第六人民医院收治的72例艾滋病合并带状疱疹患者的临床表现、实验室检查、治疗及转归进行总结分析。结果患者以男性(65.28%)、维吾尔族(79.17%)为主,平均年龄37.22±8.26岁,有静脉吸毒史者39例(54.17%)。皮疹发生部位以躯干(68.06%)和四肢(26.39%)较常见,16.67%发生在2个及以上部位。21例(29.17%)合并疱疹部位皮肤感染,67

  7. Study on the effect of implementing General practice clinical pathway on patients with Herpes zoster or Facial neuritis%应用全科临床路径治疗带状疱疹、面神经炎的效果分析

    Institute of Scientific and Technical Information of China (English)

    李树然; 吴欣欣

    2015-01-01

    Objective To analyze the effect of implementing General practice clinical pathway on family sickbed patients. Methods 156 cases of home sickbed patients with herpes zoster or facial neuritis were involved in this study.Their medical records and data of 'Home sickbed quality control scale' were collected and analyzed,in which there are methods of General practice clinical pathway,decoction of the Chinese Medicine,ingredients and treatment procedures of the topically used TCMs,and acupuncture treatment procedures were documented.The family sickbed days,prognosis,rate of informed and rate of satisfaction were analyzed before and after General practice clinical pathway treatment. Results In the observation group, the family sickbed days(10.65±1.83)d and rate of referral 10.26% were significantly lower(P < 0.01) than those in the control group(13.65±2.42)d,48.72% respectively. The rate of cure 89.74% ,the rate of informed patient 97.44% and the rate of satisfaction93.59% were significantly higher(P < 0.01) than those in the control group 51.28%、67.95%、51.28%. Conclusion It is worth to implement general practice clinical pathway for patients in home sickbeds with herpes zoster or facial neuritis,It could regulate the behavior of bed setting,improve patient's rate of cur,rate of informed and the rate of satisfaction,prevent medical risk and fully embody the idea of "people-oriented".%目的:分析家庭病床患者实施全科临床路径后的成效。方法收集156例家庭病床中带状疱疹、面神经炎(面瘫)患者的病案资料,统计分析《家庭病床质量控制量表》中带状疱疹、面神经炎的全科临床路径、具体口服药物、外用药物种类及疗程、中医治疗疗程等资料,通过回顾性研究及非同期历史对照,以实施全科临床路径前为对照组,实施全科临床路径后为观察组,比较两组患者的建立家庭病床天数、预后、知情率和满意度等。结果观察组的建

  8. Varicella zoster virus infection of the central nervous system – 10 year experience from a tertiary hospital in South India

    Directory of Open Access Journals (Sweden)

    Ronald Albert Benton Carey

    2017-01-01

    Full Text Available Introduction: Varicella zoster virus is an exclusively human neurotrophic virus. The primary infection with the virus causes varicella. The virus remains latent in nervous tissue and upon secondary activation causes a variety of syndromes involving the central nervous system (CNS including meningoencephalitis and cerebellitis. Materials and Methods: In this study, we looked at the epidemiology, clinical and laboratory features, and outcomes of patients who were admitted with varicella zoster of the CNS from 2005 to 2014. Results: There were 17 patients. Fever was present in 13 patients, seizures in 9 patients and headache and vomiting in 4 patients each. A generalized varicella rash was present in 8 out of 17 patients. A single dermatomal herpes zoster was present in seven patients. Two patients had no rash. Varicella zoster polymerase chain reaction (PCR in cerebrospinal fluid (CSF was done in 5 patients of which 4 were positive and 1 was negative. Nine patients had diabetes with an average glycated hemoglobin of 8.6%. Total number of deaths was five. Conclusions: Patients with diabetes who develop varicella or herpes zoster may be at risk for CNS complications. The diagnosis of varicella encephalitis has to rest on a combination of clinical findings and CSF PCR, as neither the rash nor the PCR is sensitive enough to diagnose all the cases with varicella encephalitis.

  9. Prevalence and clinical consequences of herpes simplex virus type 1 DNA in human cornea tissues

    NARCIS (Netherlands)

    L. Remeijer (Lies); R. Duan (Rui); J.M. van Dun (Jessica); M.A.W. Bettink; A.D.M.E. Osterhaus (Albert); G.M.G.M. Verjans (George)

    2009-01-01

    textabstractBackground. We determined the prevalence and clinical consequences of herpes simplex virus (HSV) type 1 (HSV-1), HSV type 2 (HSV-2), and varicella-zoster virus (VZV) in cornea tissues obtained after penetrating keratoplasty (PKP) was performed. Methods. The excised corneas of 83 patients

  10. Prevalence and clinical consequences of herpes simplex virus type 1 DNA in human cornea tissues

    NARCIS (Netherlands)

    L. Remeijer (Lies); R. Duan (Rui); J.M. van Dun (Jessica); M.A.W. Bettink; A.D.M.E. Osterhaus (Ab); G.M.G.M. Verjans (George)

    2009-01-01

    textabstractBackground. We determined the prevalence and clinical consequences of herpes simplex virus (HSV) type 1 (HSV-1), HSV type 2 (HSV-2), and varicella-zoster virus (VZV) in cornea tissues obtained after penetrating keratoplasty (PKP) was performed. Methods. The excised corneas of 83 patients

  11. Genital Herpes

    Science.gov (United States)

    ... best way to prevent genital herpes is abstinence. Teens who do have sex must properly use a latex condom every time ... Date reviewed: February 2016 previous 1 • ... Boyfriend Has an STD Before We Have Sex? Telling Your Partner You Have an STD Contact ...

  12. Anal herpes

    National Research Council Canada - National Science Library

    Andre Goulart; Jose Pinto; Pedro Leão

    2017-01-01

    ... that irradiated to the buttocks and the physical examination revealed red bumps with ulceration ( figure 1 ). Anal herpes was suspected and the patient was treated with an antiviral (brivudine) and carbamazepine for symptomatic relief. Seven days after treatment the patient had complete resolution of his symptoms and there were no cut...

  13. Genital Herpes (For Parents)

    Science.gov (United States)

    ... Kids to Be Smart About Social Media Genital Herpes KidsHealth > For Parents > Genital Herpes Print A A A What's in this article? Symptoms Contagiousness Treatment Prevention Getting Help Genital herpes is a sexually transmitted disease (STD) that's usually ...

  14. THE DIFFERENCE OF THERMAL SENSATION THRESHOLD IN PATIENTS WITH HERPES ZOSTER AND POST HERPETIC NEURALGIA%带状疱疹与带状疱疹后神经痛患者温度觉阈值变化及其意义

    Institute of Scientific and Technical Information of China (English)

    史学莲; 刘小立; 宛春甫; 吴振华; 张静; 杨书芳; 杨娟丽; 张健; 陈璐

    2011-01-01

    Objective: To analyze the thermal thresholds in patients with herpes zoster (HZ) and post herpetic neuralgia (PHN), and to speculate the mechanism of HZ and PHN. Methods: The TSA-Ⅱ thermal sensory analyzer was used to test the different sensory modalities in patients with HZ and PHN as well as in the control group subjects. Results: The threshold of cold sensation, warm sensation and heat pain sensation in patients with PHN was significantly elevated when compared with corresponding threshold in patients with HZ, especially in cold sensation. No significant correlation between cold sensation threshold and warm sensation threshold was found, while a negative correlation between cold sensation and warm sensation in patients with PHN was observed. Conclusion: The degree of injured Aδ, C primary afferent fibers is aggravated during the process of HZ to PHN, especially the injured Aδ fibers which conducts cold sensation. The tolerances of cold sensation, warm sensation and heat pain sensation in patients with PHN were higher than that in patients with HZ, while the ability to discriminate between thermal sensation and pain sensation was lower than that in patients with HZ.%目的:分析躯干部位带状疱疹、带状疱疹后神经痛患者皮肤温度觉阈值的变化与差异,推测其感觉功能改变及疼痛的病理机制.方法:应用NA-Ⅱ温度觉定量分析仪测定躯干部位带状疱疹、带状疱疹后神经痛患者及对照组相应皮肤的温度觉阈值.结果:带状疱疹后神经痛患者较带状疱疹患者皮肤的冷觉、热觉、热痛觉阈值均升高,其中冷觉阈值升高最为明显.带状疱疹患者冷觉与热觉阈值之间相关性无统计学意义,而带状疱疹后神经痛患者冷觉与热觉阈值之间呈负相关.结论:病变发展过程中,Aδ,C类神经纤维损伤程度有所加重,并以传导冷觉的Aδ神经纤维受损更为严重,表现为带状疱疹后神经痛患者对冷觉、热觉和热痛觉耐

  15. Clinical Observation of Spinal Nerve Dorsal Root Impulse Radio Frequency Combined with Epidural Nerve Block in the Treatment of Post Herpes Zoster Neuralgia%脊神经背根脉冲射频联合硬膜外神经阻滞治疗带状疱疹后神经痛的临床观察

    Institute of Scientific and Technical Information of China (English)

    邓茹; 刘庆

    2016-01-01

    目的:采用新型微创脊神经背根脉冲射频联合硬膜外神经阻滞治疗带状疱疹后神经痛,探讨两种方法结合治疗带状疱疹后神经痛的临床疗效,观测它和生活质量之间关系,从而为PHN治疗提供借